CN101130778A - Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system - Google Patents
Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system Download PDFInfo
- Publication number
- CN101130778A CN101130778A CNA2007100920738A CN200710092073A CN101130778A CN 101130778 A CN101130778 A CN 101130778A CN A2007100920738 A CNA2007100920738 A CN A2007100920738A CN 200710092073 A CN200710092073 A CN 200710092073A CN 101130778 A CN101130778 A CN 101130778A
- Authority
- CN
- China
- Prior art keywords
- sequence
- nucleic acid
- pts
- protein
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 549
- 241000186226 Corynebacterium glutamicum Species 0.000 title claims abstract description 217
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 title description 32
- 108091000080 Phosphotransferase Proteins 0.000 title description 25
- 102000020233 phosphotransferase Human genes 0.000 title description 25
- 235000000346 sugar Nutrition 0.000 title description 10
- 229930029653 phosphoenolpyruvate Natural products 0.000 title description 5
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 341
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 220
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 215
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 215
- 238000000034 method Methods 0.000 claims abstract description 104
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 54
- 238000004519 manufacturing process Methods 0.000 claims abstract description 48
- 239000013604 expression vector Substances 0.000 claims abstract description 44
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 42
- 235000018102 proteins Nutrition 0.000 claims description 334
- 125000003729 nucleotide group Chemical group 0.000 claims description 156
- 239000002773 nucleotide Substances 0.000 claims description 154
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 123
- 150000001413 amino acids Chemical group 0.000 claims description 87
- 241000186216 Corynebacterium Species 0.000 claims description 85
- NLJVXZFCYKWXLH-DXTIXLATSA-N 3-[(3r,6s,9s,12s,15s,17s,20s,22r,25s,28s)-20-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,22,25-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,18,21,24,27-nonaoxo-12-propan-2-yl-1,4,7,10,13,16,19,23,26-nonazabicyclo[26.3.0]hentriacontan Chemical compound C([C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N[C@H](CC=2C=CC=CC=2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)N1)=O)CC(C)C)C(C)C)C1=CC=C(O)C=C1 NLJVXZFCYKWXLH-DXTIXLATSA-N 0.000 claims description 76
- 108010021006 Tyrothricin Proteins 0.000 claims description 76
- 229940024606 amino acid Drugs 0.000 claims description 76
- 235000001014 amino acid Nutrition 0.000 claims description 76
- 229960003281 tyrothricin Drugs 0.000 claims description 76
- 239000000463 material Substances 0.000 claims description 71
- 102000004190 Enzymes Human genes 0.000 claims description 70
- 108090000790 Enzymes Proteins 0.000 claims description 70
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 63
- 230000014509 gene expression Effects 0.000 claims description 61
- 230000000694 effects Effects 0.000 claims description 55
- 244000005700 microbiome Species 0.000 claims description 55
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 48
- 150000001720 carbohydrates Chemical class 0.000 claims description 48
- 229920001184 polypeptide Polymers 0.000 claims description 41
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 37
- 239000012634 fragment Substances 0.000 claims description 34
- 241000186146 Brevibacterium Species 0.000 claims description 33
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 33
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 30
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 29
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 28
- 230000001580 bacterial effect Effects 0.000 claims description 27
- -1 aromatics Chemical class 0.000 claims description 24
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 22
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 22
- 239000011782 vitamin Substances 0.000 claims description 21
- 229940088594 vitamin Drugs 0.000 claims description 20
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 19
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 19
- 229960004799 tryptophan Drugs 0.000 claims description 19
- 229930003231 vitamin Natural products 0.000 claims description 19
- 235000013343 vitamin Nutrition 0.000 claims description 19
- 241000319304 [Brevibacterium] flavum Species 0.000 claims description 17
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 16
- 241000186145 Corynebacterium ammoniagenes Species 0.000 claims description 15
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 15
- 230000000295 complement effect Effects 0.000 claims description 14
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 13
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 13
- 229930182817 methionine Natural products 0.000 claims description 13
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 13
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 12
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 12
- 230000033228 biological regulation Effects 0.000 claims description 12
- 241000186227 Corynebacterium diphtheriae Species 0.000 claims description 11
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 11
- 239000004473 Threonine Substances 0.000 claims description 11
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 10
- 229960002989 glutamic acid Drugs 0.000 claims description 10
- 229960000310 isoleucine Drugs 0.000 claims description 10
- 239000004471 Glycine Substances 0.000 claims description 9
- 235000003704 aspartic acid Nutrition 0.000 claims description 9
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 9
- 150000002632 lipids Chemical class 0.000 claims description 9
- 239000002777 nucleoside Substances 0.000 claims description 9
- 125000003835 nucleoside group Chemical group 0.000 claims description 9
- 239000004475 Arginine Substances 0.000 claims description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 8
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 8
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 claims description 8
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 8
- 229910021529 ammonia Inorganic materials 0.000 claims description 8
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 8
- 239000002585 base Substances 0.000 claims description 8
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 8
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 7
- 239000006035 Tryptophane Substances 0.000 claims description 7
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 7
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 7
- 150000007524 organic acids Chemical class 0.000 claims description 7
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 6
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 6
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 6
- 239000000052 vinegar Substances 0.000 claims description 6
- 235000021419 vinegar Nutrition 0.000 claims description 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 4
- 230000004071 biological effect Effects 0.000 claims description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 4
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 4
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 4
- 229930001119 polyketide Natural products 0.000 claims description 3
- 150000003881 polyketide derivatives Chemical class 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 3
- 241000234435 Lilium Species 0.000 claims description 2
- 239000012188 paraffin wax Substances 0.000 claims description 2
- 108700028369 Alleles Proteins 0.000 claims 2
- 241000186312 Brevibacterium sp. Species 0.000 claims 2
- 238000003745 diagnosis Methods 0.000 claims 2
- 241000362324 Corethrodendron scoparium Species 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 230000000735 allogeneic effect Effects 0.000 claims 1
- 238000001890 transfection Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 52
- 230000000692 anti-sense effect Effects 0.000 abstract description 37
- 238000003259 recombinant expression Methods 0.000 abstract description 12
- 102000037865 fusion proteins Human genes 0.000 abstract description 5
- 108020001507 fusion proteins Proteins 0.000 abstract description 5
- 238000010353 genetic engineering Methods 0.000 abstract description 4
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 186
- 108020004414 DNA Proteins 0.000 description 82
- 125000003275 alpha amino acid group Chemical group 0.000 description 76
- 229940088598 enzyme Drugs 0.000 description 68
- 238000004458 analytical method Methods 0.000 description 58
- 235000014633 carbohydrates Nutrition 0.000 description 47
- 241000894006 Bacteria Species 0.000 description 44
- 230000006870 function Effects 0.000 description 42
- 238000005516 engineering process Methods 0.000 description 40
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 38
- 239000000203 mixture Substances 0.000 description 38
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 37
- 239000008103 glucose Substances 0.000 description 37
- 230000008859 change Effects 0.000 description 33
- 239000000047 product Substances 0.000 description 33
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 32
- 229910052799 carbon Inorganic materials 0.000 description 32
- 238000010367 cloning Methods 0.000 description 32
- 230000001105 regulatory effect Effects 0.000 description 32
- 238000009396 hybridization Methods 0.000 description 30
- 239000002253 acid Substances 0.000 description 26
- 230000004060 metabolic process Effects 0.000 description 26
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 25
- 239000013612 plasmid Substances 0.000 description 24
- 239000002243 precursor Substances 0.000 description 24
- 239000000126 substance Substances 0.000 description 24
- 239000000523 sample Substances 0.000 description 23
- 108020004999 messenger RNA Proteins 0.000 description 22
- 230000019491 signal transduction Effects 0.000 description 22
- 101150001834 PTS gene Proteins 0.000 description 21
- 238000012512 characterization method Methods 0.000 description 21
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 20
- 108091034117 Oligonucleotide Proteins 0.000 description 20
- 230000003570 biosynthesizing effect Effects 0.000 description 18
- 125000000539 amino acid group Chemical group 0.000 description 17
- 230000004927 fusion Effects 0.000 description 17
- 230000026731 phosphorylation Effects 0.000 description 17
- 238000006366 phosphorylation reaction Methods 0.000 description 17
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 16
- 108091026890 Coding region Proteins 0.000 description 16
- 230000037361 pathway Effects 0.000 description 16
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 15
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 14
- 239000013598 vector Substances 0.000 description 14
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 13
- 229930006000 Sucrose Natural products 0.000 description 13
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 13
- 230000000875 corresponding effect Effects 0.000 description 13
- 238000010561 standard procedure Methods 0.000 description 13
- 239000005720 sucrose Substances 0.000 description 13
- 229930091371 Fructose Natural products 0.000 description 12
- 239000005715 Fructose Substances 0.000 description 12
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 12
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 12
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 12
- 238000013459 approach Methods 0.000 description 12
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000013016 damping Methods 0.000 description 12
- 239000012530 fluid Substances 0.000 description 12
- 229960002429 proline Drugs 0.000 description 12
- 238000011160 research Methods 0.000 description 12
- 241000233866 Fungi Species 0.000 description 11
- 238000013461 design Methods 0.000 description 11
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 11
- 230000002068 genetic effect Effects 0.000 description 11
- 230000035772 mutation Effects 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 230000014616 translation Effects 0.000 description 11
- 108700034291 EC 2.7.1.69 Proteins 0.000 description 10
- 230000001851 biosynthetic effect Effects 0.000 description 10
- 238000000855 fermentation Methods 0.000 description 10
- 230000004151 fermentation Effects 0.000 description 10
- 230000000968 intestinal effect Effects 0.000 description 10
- 235000019161 pantothenic acid Nutrition 0.000 description 10
- 239000011713 pantothenic acid Substances 0.000 description 10
- 238000012216 screening Methods 0.000 description 10
- 229960002898 threonine Drugs 0.000 description 10
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 9
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 9
- 239000000306 component Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 230000004952 protein activity Effects 0.000 description 9
- 241000700159 Rattus Species 0.000 description 8
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 8
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 8
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- 229940014662 pantothenate Drugs 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 238000012163 sequencing technique Methods 0.000 description 8
- 108010078791 Carrier Proteins Proteins 0.000 description 7
- 101710088194 Dehydrogenase Proteins 0.000 description 7
- 102000003960 Ligases Human genes 0.000 description 7
- 108090000364 Ligases Proteins 0.000 description 7
- 150000007513 acids Chemical class 0.000 description 7
- 229960003121 arginine Drugs 0.000 description 7
- 230000001413 cellular effect Effects 0.000 description 7
- 230000008034 disappearance Effects 0.000 description 7
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 7
- 230000010354 integration Effects 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 229960004452 methionine Drugs 0.000 description 7
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000032258 transport Effects 0.000 description 7
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 6
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 6
- WQXNXVUDBPYKBA-UHFFFAOYSA-N Ectoine Natural products CC1=NCCC(C(O)=O)N1 WQXNXVUDBPYKBA-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 6
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 6
- 238000005842 biochemical reaction Methods 0.000 description 6
- 239000000969 carrier Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 206010013023 diphtheria Diseases 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 210000003527 eukaryotic cell Anatomy 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 235000019152 folic acid Nutrition 0.000 description 6
- 239000011724 folic acid Substances 0.000 description 6
- 229960002885 histidine Drugs 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 235000001968 nicotinic acid Nutrition 0.000 description 6
- 239000011664 nicotinic acid Substances 0.000 description 6
- 229960005190 phenylalanine Drugs 0.000 description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 229960002477 riboflavin Drugs 0.000 description 6
- 235000019192 riboflavin Nutrition 0.000 description 6
- 239000002151 riboflavin Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 230000002103 transcriptional effect Effects 0.000 description 6
- 238000013519 translation Methods 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 5
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 5
- 108090000994 Catalytic RNA Proteins 0.000 description 5
- 102000053642 Catalytic RNA Human genes 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 5
- 238000000018 DNA microarray Methods 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 108010064711 Homoserine dehydrogenase Proteins 0.000 description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 5
- 108700026244 Open Reading Frames Proteins 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 229930003756 Vitamin B7 Natural products 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 5
- 229960000304 folic acid Drugs 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 238000002744 homologous recombination Methods 0.000 description 5
- 230000006801 homologous recombination Effects 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 229960003136 leucine Drugs 0.000 description 5
- 101150033534 lysA gene Proteins 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 229960003512 nicotinic acid Drugs 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 5
- 238000001243 protein synthesis Methods 0.000 description 5
- 101150079601 recA gene Proteins 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- 108091092562 ribozyme Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 235000011912 vitamin B7 Nutrition 0.000 description 5
- 239000011735 vitamin B7 Substances 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- 241000244202 Caenorhabditis Species 0.000 description 4
- 108090000489 Carboxy-Lyases Proteins 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 4
- 101100465553 Dictyostelium discoideum psmB6 gene Proteins 0.000 description 4
- 241000588722 Escherichia Species 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 4
- 229930195722 L-methionine Natural products 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- 102000003939 Membrane transport proteins Human genes 0.000 description 4
- 108090000301 Membrane transport proteins Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 108091005461 Nucleic proteins Proteins 0.000 description 4
- 102000004316 Oxidoreductases Human genes 0.000 description 4
- 108090000854 Oxidoreductases Proteins 0.000 description 4
- 101100169519 Pyrococcus abyssi (strain GE5 / Orsay) dapAL gene Proteins 0.000 description 4
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 4
- 108020004511 Recombinant DNA Proteins 0.000 description 4
- 241001591005 Siga Species 0.000 description 4
- 241000187747 Streptomyces Species 0.000 description 4
- 108090000340 Transaminases Proteins 0.000 description 4
- 102000003929 Transaminases Human genes 0.000 description 4
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 4
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 4
- 230000008238 biochemical pathway Effects 0.000 description 4
- 239000005515 coenzyme Substances 0.000 description 4
- 238000010835 comparative analysis Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 229940104302 cytosine Drugs 0.000 description 4
- 101150011371 dapA gene Proteins 0.000 description 4
- 101150000582 dapE gene Proteins 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 229940023064 escherichia coli Drugs 0.000 description 4
- 101150111615 ftsZ gene Proteins 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 238000012239 gene modification Methods 0.000 description 4
- 230000005017 genetic modification Effects 0.000 description 4
- 235000013617 genetically modified food Nutrition 0.000 description 4
- 230000004190 glucose uptake Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 108010071598 homoserine kinase Proteins 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 238000002493 microarray Methods 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 101150034514 murC gene Proteins 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000008521 reorganization Effects 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 3
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 3
- OTOIIPJYVQJATP-BYPYZUCNSA-N (R)-pantoic acid Chemical compound OCC(C)(C)[C@@H](O)C(O)=O OTOIIPJYVQJATP-BYPYZUCNSA-N 0.000 description 3
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 3
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 101100096227 Bacteroides fragilis (strain 638R) argF' gene Proteins 0.000 description 3
- 108091033380 Coding strand Proteins 0.000 description 3
- 241000701022 Cytomegalovirus Species 0.000 description 3
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 3
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 3
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 3
- 101100129336 Dictyostelium discoideum malA gene Proteins 0.000 description 3
- 101150099894 GDHA gene Proteins 0.000 description 3
- 101150005343 INHA gene Proteins 0.000 description 3
- 108020003285 Isocitrate lyase Proteins 0.000 description 3
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 3
- 229930182844 L-isoleucine Natural products 0.000 description 3
- 102000004317 Lyases Human genes 0.000 description 3
- 108090000856 Lyases Proteins 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 101100354186 Mycoplasma capricolum subsp. capricolum (strain California kid / ATCC 27343 / NCTC 10154) ptcA gene Proteins 0.000 description 3
- 102000007981 Ornithine carbamoyltransferase Human genes 0.000 description 3
- 101710198224 Ornithine carbamoyltransferase, mitochondrial Proteins 0.000 description 3
- 108700023175 Phosphate acetyltransferases Proteins 0.000 description 3
- 101100408135 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) phnA gene Proteins 0.000 description 3
- 101100190460 Shigella flexneri pic gene Proteins 0.000 description 3
- 102100033451 Thyroid hormone receptor beta Human genes 0.000 description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 3
- 229930003779 Vitamin B12 Natural products 0.000 description 3
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 3
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000000074 antisense oligonucleotide Substances 0.000 description 3
- 238000012230 antisense oligonucleotides Methods 0.000 description 3
- 101150070427 argC gene Proteins 0.000 description 3
- 101150089042 argC2 gene Proteins 0.000 description 3
- 101150056313 argF gene Proteins 0.000 description 3
- 101150040872 aroE gene Proteins 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 102220369445 c.668T>C Human genes 0.000 description 3
- 230000006652 catabolic pathway Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 3
- 239000003184 complementary RNA Substances 0.000 description 3
- 101150073654 dapB gene Proteins 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 150000002016 disaccharides Chemical class 0.000 description 3
- 101150027005 divIB gene Proteins 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 230000004992 fission Effects 0.000 description 3
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 3
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 3
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 3
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 101150002100 ftsK gene Proteins 0.000 description 3
- 101150026421 ftsQ gene Proteins 0.000 description 3
- 108010064177 glutamine synthetase I Proteins 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 101150063051 hom gene Proteins 0.000 description 3
- 101150086151 hrdB gene Proteins 0.000 description 3
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical group O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 101150087199 leuA gene Proteins 0.000 description 3
- 101150035025 lysC gene Proteins 0.000 description 3
- 101150094164 lysY gene Proteins 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
- 238000003499 nucleic acid array Methods 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000002018 overexpression Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 150000002972 pentoses Chemical class 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 210000001236 prokaryotic cell Anatomy 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- 229940107700 pyruvic acid Drugs 0.000 description 3
- 230000006798 recombination Effects 0.000 description 3
- 238000005215 recombination Methods 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 101150102864 rpoD gene Proteins 0.000 description 3
- 238000010008 shearing Methods 0.000 description 3
- 239000013605 shuttle vector Substances 0.000 description 3
- 101150117326 sigA gene Proteins 0.000 description 3
- 101150057107 sigB gene Proteins 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 101150072448 thrB gene Proteins 0.000 description 3
- 101150000850 thrC gene Proteins 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 229940048102 triphosphoric acid Drugs 0.000 description 3
- 101150044170 trpE gene Proteins 0.000 description 3
- 101150108727 trpl gene Proteins 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 235000019163 vitamin B12 Nutrition 0.000 description 3
- 239000011715 vitamin B12 Substances 0.000 description 3
- AUTOLBMXDDTRRT-JGVFFNPUSA-N (4R,5S)-dethiobiotin Chemical compound C[C@@H]1NC(=O)N[C@@H]1CCCCCC(O)=O AUTOLBMXDDTRRT-JGVFFNPUSA-N 0.000 description 2
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 2
- RFLVMTUMFYRZCB-UHFFFAOYSA-N 1-methylguanine Chemical compound O=C1N(C)C(N)=NC2=C1N=CN2 RFLVMTUMFYRZCB-UHFFFAOYSA-N 0.000 description 2
- FZWGECJQACGGTI-UHFFFAOYSA-N 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- 108010038550 3-dehydroquinate dehydratase Proteins 0.000 description 2
- QYOJSKGCWNAKGW-PBXRRBTRSA-N 3-phosphoshikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](OP(O)(O)=O)[C@H]1O QYOJSKGCWNAKGW-PBXRRBTRSA-N 0.000 description 2
- MSTNYGQPCMXVAQ-KIYNQFGBSA-N 5,6,7,8-tetrahydrofolic acid Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-KIYNQFGBSA-N 0.000 description 2
- OIVLITBTBDPEFK-UHFFFAOYSA-N 5,6-dihydrouracil Chemical compound O=C1CCNC(=O)N1 OIVLITBTBDPEFK-UHFFFAOYSA-N 0.000 description 2
- HUNCSWANZMJLPM-UHFFFAOYSA-N 5-methyltryptophan Chemical compound CC1=CC=C2NC=C(CC(N)C(O)=O)C2=C1 HUNCSWANZMJLPM-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 108020005544 Antisense RNA Proteins 0.000 description 2
- 101710149879 Arginine repressor Proteins 0.000 description 2
- 108010014885 Arginine-tRNA ligase Proteins 0.000 description 2
- 108010055400 Aspartate kinase Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 241000606153 Chlamydia trachomatis Species 0.000 description 2
- 101100163308 Clostridium perfringens (strain 13 / Type A) argR1 gene Proteins 0.000 description 2
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 101100381581 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) betP gene Proteins 0.000 description 2
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- 101100098219 Dictyostelium discoideum argS1 gene Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 2
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 2
- 102000009331 Homeodomain Proteins Human genes 0.000 description 2
- 108010048671 Homeodomain Proteins Proteins 0.000 description 2
- 229930010555 Inosine Natural products 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 235000019766 L-Lysine Nutrition 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 241000204051 Mycoplasma genitalium Species 0.000 description 2
- 125000003047 N-acetyl group Chemical group 0.000 description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 108091092724 Noncoding DNA Proteins 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108091007643 Phosphate carriers Proteins 0.000 description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
- 102100036134 Probable arginine-tRNA ligase, mitochondrial Human genes 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 101710150114 Protein rep Proteins 0.000 description 2
- 101100217185 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aruC gene Proteins 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 108010053763 Pyruvate Carboxylase Proteins 0.000 description 2
- 102100039895 Pyruvate carboxylase, mitochondrial Human genes 0.000 description 2
- 108700005075 Regulator Genes Proteins 0.000 description 2
- 101710152114 Replication protein Proteins 0.000 description 2
- 101100381582 Rhizobium meliloti betS gene Proteins 0.000 description 2
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- 241000607720 Serratia Species 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 101100022072 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) lysJ gene Proteins 0.000 description 2
- 108010022394 Threonine synthase Proteins 0.000 description 2
- 102000006843 Threonine synthase Human genes 0.000 description 2
- 108010020764 Transposases Proteins 0.000 description 2
- 102000008579 Transposases Human genes 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 101150008194 argB gene Proteins 0.000 description 2
- 101150050866 argD gene Proteins 0.000 description 2
- 101150118463 argG gene Proteins 0.000 description 2
- 101150029940 argJ gene Proteins 0.000 description 2
- 101150089004 argR gene Proteins 0.000 description 2
- 101150024756 argS gene Proteins 0.000 description 2
- 101150037081 aroA gene Proteins 0.000 description 2
- 101150090235 aroB gene Proteins 0.000 description 2
- 101150102858 aroD gene Proteins 0.000 description 2
- 101150010999 aroP gene Proteins 0.000 description 2
- 101150108612 aroQ gene Proteins 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 2
- 229940000635 beta-alanine Drugs 0.000 description 2
- 229940088623 biologically active substance Drugs 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 102000028406 carbon-sulfur lyase Human genes 0.000 description 2
- 108010076637 carbon-sulfur lyase Proteins 0.000 description 2
- 238000010523 cascade reaction Methods 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 2
- 239000005516 coenzyme A Substances 0.000 description 2
- 229940093530 coenzyme a Drugs 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 108091036078 conserved sequence Proteins 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 101150064416 csp1 gene Proteins 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 101150064923 dapD gene Proteins 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 2
- 238000006209 dephosphorylation reaction Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000004146 energy storage Methods 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 2
- 229940049906 glutamate Drugs 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 229960003786 inosine Drugs 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N itaconic acid Chemical compound OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 2
- 238000011005 laboratory method Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 101150025049 leuB gene Proteins 0.000 description 2
- WQVJUBFKFCDYDQ-BBWFWOEESA-N leubethanol Natural products C1=C(C)C=C2[C@H]([C@H](CCC=C(C)C)C)CC[C@@H](C)C2=C1O WQVJUBFKFCDYDQ-BBWFWOEESA-N 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 101150039489 lysZ gene Proteins 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- 229940049920 malate Drugs 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000007483 microbial process Effects 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- 230000036457 multidrug resistance Effects 0.000 description 2
- 239000003471 mutagenic agent Substances 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 101150021317 odhA gene Proteins 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 238000012261 overproduction Methods 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 108010071189 phosphoenolpyruvate-glucose phosphotransferase Proteins 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 230000004144 purine metabolism Effects 0.000 description 2
- 239000002213 purine nucleotide Substances 0.000 description 2
- 150000003212 purines Chemical class 0.000 description 2
- 101150057603 putP gene Proteins 0.000 description 2
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 2
- 229960001327 pyridoxal phosphate Drugs 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 108700022487 rRNA Genes Proteins 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 102220023257 rs387907546 Human genes 0.000 description 2
- 102220023256 rs387907547 Human genes 0.000 description 2
- 108010038196 saccharide-binding proteins Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012772 sequence design Methods 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 101150111745 sucA gene Proteins 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 2
- 101150014006 thrA gene Proteins 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 108091005703 transmembrane proteins Proteins 0.000 description 2
- 102000035160 transmembrane proteins Human genes 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- 101150100816 trpD gene Proteins 0.000 description 2
- 101150079930 trpGD gene Proteins 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 2
- 229940045145 uridine Drugs 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 230000008016 vaporization Effects 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- TYEIDAYBPNPVII-NFJMKROFSA-N (2r)-2-amino-3-sulfanylbutanoic acid Chemical compound CC(S)[C@H](N)C(O)=O TYEIDAYBPNPVII-NFJMKROFSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- BPQAUXWAEPYEJM-PQSJUMPYSA-N 1-hydroxy-8-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=CC=C1C2=O BPQAUXWAEPYEJM-PQSJUMPYSA-N 0.000 description 1
- WJNGQIYEQLPJMN-IOSLPCCCSA-N 1-methylinosine Chemical compound C1=NC=2C(=O)N(C)C=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O WJNGQIYEQLPJMN-IOSLPCCCSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- NCMVOABPESMRCP-SHYZEUOFSA-N 2'-deoxycytosine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 NCMVOABPESMRCP-SHYZEUOFSA-N 0.000 description 1
- PJODNTCLCCRNCO-UHFFFAOYSA-N 2,2-diaminononanoic acid Chemical compound CCCCCCCC(N)(N)C(O)=O PJODNTCLCCRNCO-UHFFFAOYSA-N 0.000 description 1
- HCYQTNUNMRYQLZ-UHFFFAOYSA-N 2-[(6-methyl-2,4-dioxo-1H-pyrimidin-5-yl)amino]acetic acid Chemical compound C(=O)(O)CNC=1C(NC(NC=1C)=O)=O HCYQTNUNMRYQLZ-UHFFFAOYSA-N 0.000 description 1
- PXTNVJRXRPGATQ-UHFFFAOYSA-N 2-[(6-methyl-4-oxo-2-sulfanylidene-1H-pyrimidin-5-yl)amino]acetic acid Chemical compound C(=O)(O)CNC=1C(NC(NC=1C)=S)=O PXTNVJRXRPGATQ-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- UDOGNMDURIJYQC-UHFFFAOYSA-N 2-amino-6-methyl-1h-pteridin-4-one Chemical compound N1C(N)=NC(=O)C2=NC(C)=CN=C21 UDOGNMDURIJYQC-UHFFFAOYSA-N 0.000 description 1
- XMSMHKMPBNTBOD-UHFFFAOYSA-N 2-dimethylamino-6-hydroxypurine Chemical compound N1C(N(C)C)=NC(=O)C2=C1N=CN2 XMSMHKMPBNTBOD-UHFFFAOYSA-N 0.000 description 1
- 108010082310 2-hydroxyacid dehydrogenase Proteins 0.000 description 1
- SMADWRYCYBUIKH-UHFFFAOYSA-N 2-methyl-7h-purin-6-amine Chemical compound CC1=NC(N)=C2NC=NC2=N1 SMADWRYCYBUIKH-UHFFFAOYSA-N 0.000 description 1
- 108010030844 2-methylcitrate synthase Proteins 0.000 description 1
- 101710157142 2-methylene-furan-3-one reductase Proteins 0.000 description 1
- AQSRRZGQRFFFGS-UHFFFAOYSA-N 2-methylpyridin-3-ol Chemical compound CC1=NC=CC=C1O AQSRRZGQRFFFGS-UHFFFAOYSA-N 0.000 description 1
- 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 1
- WVMWZWGZRAXUBK-SYTVJDICSA-N 3-dehydroquinic acid Chemical compound O[C@@H]1C[C@](O)(C(O)=O)CC(=O)[C@H]1O WVMWZWGZRAXUBK-SYTVJDICSA-N 0.000 description 1
- WVMWZWGZRAXUBK-UHFFFAOYSA-N 3-dehydroquinic acid Natural products OC1CC(O)(C(O)=O)CC(=O)C1O WVMWZWGZRAXUBK-UHFFFAOYSA-N 0.000 description 1
- KPULXFNPTWGJQH-UHFFFAOYSA-N 3-hydroxy-4-oxo-4-propan-2-yloxybutanoic acid Chemical compound CC(C)OC(=O)C(O)CC(O)=O KPULXFNPTWGJQH-UHFFFAOYSA-N 0.000 description 1
- 108010039636 3-isopropylmalate dehydrogenase Proteins 0.000 description 1
- GJAKJCICANKRFD-UHFFFAOYSA-N 4-acetyl-4-amino-1,3-dihydropyrimidin-2-one Chemical compound CC(=O)C1(N)NC(=O)NC=C1 GJAKJCICANKRFD-UHFFFAOYSA-N 0.000 description 1
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
- LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
- ZFTBZKVVGZNMJR-UHFFFAOYSA-N 5-chlorouracil Chemical compound ClC1=CNC(=O)NC1=O ZFTBZKVVGZNMJR-UHFFFAOYSA-N 0.000 description 1
- KSNXJLQDQOIRIP-UHFFFAOYSA-N 5-iodouracil Chemical compound IC1=CNC(=O)NC1=O KSNXJLQDQOIRIP-UHFFFAOYSA-N 0.000 description 1
- KELXHQACBIUYSE-UHFFFAOYSA-N 5-methoxy-1h-pyrimidine-2,4-dione Chemical compound COC1=CNC(=O)NC1=O KELXHQACBIUYSE-UHFFFAOYSA-N 0.000 description 1
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
- SYBMMHDLFFXREU-UHFFFAOYSA-N 6-methyl-2,4-dioxo-1h-pyrimidine-5-carboxylic acid Chemical compound CC=1NC(=O)NC(=O)C=1C(O)=O SYBMMHDLFFXREU-UHFFFAOYSA-N 0.000 description 1
- LZRCZVZMOAAFDC-UHFFFAOYSA-N 6-methyl-5-(methylamino)-1h-pyrimidine-2,4-dione Chemical compound CNC1=C(C)NC(=O)NC1=O LZRCZVZMOAAFDC-UHFFFAOYSA-N 0.000 description 1
- 108010042833 7,8-diaminopelargonic acid aminotransferase Proteins 0.000 description 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
- 239000007991 ACES buffer Substances 0.000 description 1
- 108010058756 ATP phosphoribosyltransferase Proteins 0.000 description 1
- 108010013043 Acetylesterase Proteins 0.000 description 1
- 101800001241 Acetylglutamate kinase Proteins 0.000 description 1
- 108010049445 Acetylornithine transaminase Proteins 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 108010009924 Aconitate hydratase Proteins 0.000 description 1
- ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 1
- 108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
- 102100029457 Adenine phosphoribosyltransferase Human genes 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 102100027211 Albumin Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- 108090000072 Aldehyde-Lyases Proteins 0.000 description 1
- 102000003677 Aldehyde-Lyases Human genes 0.000 description 1
- 101100163490 Alkalihalobacillus halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125) aroA1 gene Proteins 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 1
- 108050005273 Amino acid transporters Proteins 0.000 description 1
- 102000034263 Amino acid transporters Human genes 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 108020001077 Anthranilate Phosphoribosyltransferase Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 102000053640 Argininosuccinate synthases Human genes 0.000 description 1
- 108700024106 Argininosuccinate synthases Proteins 0.000 description 1
- KDZOASGQNOPSCU-WDSKDSINSA-N Argininosuccinic acid Chemical compound OC(=O)[C@@H](N)CCC\N=C(/N)N[C@H](C(O)=O)CC(O)=O KDZOASGQNOPSCU-WDSKDSINSA-N 0.000 description 1
- 241001167018 Aroa Species 0.000 description 1
- 108090000328 Arrestin Proteins 0.000 description 1
- 102000003916 Arrestin Human genes 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 108700016171 Aspartate ammonia-lyases Proteins 0.000 description 1
- 108020004652 Aspartate-Semialdehyde Dehydrogenase Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 1
- 101100216993 Bacillus subtilis (strain 168) aroD gene Proteins 0.000 description 1
- 101100443932 Bacillus subtilis (strain 168) dppE gene Proteins 0.000 description 1
- 101100082080 Bacillus subtilis (strain 168) pabA gene Proteins 0.000 description 1
- 101100242035 Bacillus subtilis (strain 168) pdhA gene Proteins 0.000 description 1
- 101100350224 Bacillus subtilis (strain 168) pdhB gene Proteins 0.000 description 1
- 101100078797 Bacillus subtilis (strain 168) racE gene Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 101100441252 Caenorhabditis elegans csp-2 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 101100339117 Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) hisF1 gene Proteins 0.000 description 1
- 102000004091 Caspase-8 Human genes 0.000 description 1
- 108090000538 Caspase-8 Proteins 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010003662 Chorismate synthase Proteins 0.000 description 1
- 102100034229 Citramalyl-CoA lyase, mitochondrial Human genes 0.000 description 1
- 108010071536 Citrate (Si)-synthase Proteins 0.000 description 1
- 102000006732 Citrate synthase Human genes 0.000 description 1
- 102000008169 Co-Repressor Proteins Human genes 0.000 description 1
- 108010060434 Co-Repressor Proteins Proteins 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000289527 Cordyline terminalis Species 0.000 description 1
- 235000009091 Cordyline terminalis Nutrition 0.000 description 1
- 101100332744 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) ectP gene Proteins 0.000 description 1
- 101100236536 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) glcB gene Proteins 0.000 description 1
- 101100022064 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) lysI gene Proteins 0.000 description 1
- 101100246032 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) ptsM gene Proteins 0.000 description 1
- 101100481367 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) thtR gene Proteins 0.000 description 1
- 101100138542 Cupriavidus necator (strain ATCC 17699 / DSM 428 / KCTC 22496 / NCIMB 10442 / H16 / Stanier 337) phbH gene Proteins 0.000 description 1
- 101100299477 Cupriavidus necator (strain ATCC 17699 / DSM 428 / KCTC 22496 / NCIMB 10442 / H16 / Stanier 337) phbI gene Proteins 0.000 description 1
- 101710095468 Cyclase Proteins 0.000 description 1
- 102100039868 Cytoplasmic aconitate hydratase Human genes 0.000 description 1
- NGHMDNPXVRFFGS-IUYQGCFVSA-N D-erythrose 4-phosphate Chemical compound O=C[C@H](O)[C@H](O)COP(O)(O)=O NGHMDNPXVRFFGS-IUYQGCFVSA-N 0.000 description 1
- 229930195713 D-glutamate Natural products 0.000 description 1
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 description 1
- 229930182818 D-methionine Natural products 0.000 description 1
- FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 230000008265 DNA repair mechanism Effects 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 101710092096 Diaminopimelate decarboxylase Proteins 0.000 description 1
- 101100012958 Dictyostelium discoideum fkbp3 gene Proteins 0.000 description 1
- 101100229207 Dictyostelium discoideum glnA3 gene Proteins 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 description 1
- 102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 description 1
- 102000016607 Diphtheria Toxin Human genes 0.000 description 1
- 108010053187 Diphtheria Toxin Proteins 0.000 description 1
- 108700035100 EC 4.2.1.52 Proteins 0.000 description 1
- 108091006149 Electron carriers Proteins 0.000 description 1
- 101100491986 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) aromA gene Proteins 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108010013369 Enteropeptidase Proteins 0.000 description 1
- 102100029727 Enteropeptidase Human genes 0.000 description 1
- 101100218845 Escherichia coli (strain K12) bioH gene Proteins 0.000 description 1
- 101100138654 Escherichia coli (strain K12) manZ gene Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 108010021555 GTP Pyrophosphokinase Proteins 0.000 description 1
- 108010052375 Glutamate Dehydrogenase (NADP+) Proteins 0.000 description 1
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102100034294 Glutathione synthetase Human genes 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 102100023903 Glycerol kinase Human genes 0.000 description 1
- 108700016170 Glycerol kinases Proteins 0.000 description 1
- 102000002667 Glycine hydroxymethyltransferase Human genes 0.000 description 1
- 108010043428 Glycine hydroxymethyltransferase Proteins 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 241000288105 Grus Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101150057070 HPR gene Proteins 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 101100028493 Haloferax volcanii (strain ATCC 29605 / DSM 3757 / JCM 8879 / NBRC 14742 / NCIMB 2012 / VKM B-1768 / DS2) pan2 gene Proteins 0.000 description 1
- 108090001102 Hammerhead ribozyme Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 241000701109 Human adenovirus 2 Species 0.000 description 1
- 101000805434 Human herpesvirus 8 type P (isolate GK18) viral cyclin homolog Proteins 0.000 description 1
- 108090001042 Hydro-Lyases Proteins 0.000 description 1
- 102000004867 Hydro-Lyases Human genes 0.000 description 1
- 102000006933 Hydroxymethyl and Formyl Transferases Human genes 0.000 description 1
- 108010072462 Hydroxymethyl and Formyl Transferases Proteins 0.000 description 1
- 101100519490 Idiomarina loihiensis (strain ATCC BAA-735 / DSM 15497 / L2-TR) pepQ1 gene Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108010061833 Integrases Proteins 0.000 description 1
- 108010075869 Isocitrate Dehydrogenase Proteins 0.000 description 1
- 102000012011 Isocitrate Dehydrogenase Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 101100123255 Komagataeibacter xylinus aceC gene Proteins 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- GHSJKUNUIHUPDF-BYPYZUCNSA-N L-thialysine Chemical compound NCCSC[C@H](N)C(O)=O GHSJKUNUIHUPDF-BYPYZUCNSA-N 0.000 description 1
- 101100433987 Latilactobacillus sakei subsp. sakei (strain 23K) ackA1 gene Proteins 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 108020004687 Malate Synthase Proteins 0.000 description 1
- 101100129629 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) mrtA gene Proteins 0.000 description 1
- 101100292591 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) mtrA1 gene Proteins 0.000 description 1
- 101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- SGSSKEDGVONRGC-UHFFFAOYSA-N N(2)-methylguanine Chemical compound O=C1NC(NC)=NC2=C1N=CN2 SGSSKEDGVONRGC-UHFFFAOYSA-N 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 1
- RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 102000006746 NADH Dehydrogenase Human genes 0.000 description 1
- 108010086428 NADH Dehydrogenase Proteins 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000008763 Neurofilament Proteins Human genes 0.000 description 1
- 108010088373 Neurofilament Proteins Proteins 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- HDVCHBLHEICPPP-UHFFFAOYSA-N O=P(=O)C1=CC=NC(P(=O)=O)=C1P(=O)=O Chemical class O=P(=O)C1=CC=NC(P(=O)=O)=C1P(=O)=O HDVCHBLHEICPPP-UHFFFAOYSA-N 0.000 description 1
- 101710160107 Outer membrane protein A Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101150093941 PORA gene Proteins 0.000 description 1
- ZNXZGRMVNNHPCA-UHFFFAOYSA-N Pantetheine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS ZNXZGRMVNNHPCA-UHFFFAOYSA-N 0.000 description 1
- 241000364057 Peoria Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 1
- 102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 1
- 108010038555 Phosphoglycerate dehydrogenase Proteins 0.000 description 1
- 108010013381 Porins Proteins 0.000 description 1
- 102000017033 Porins Human genes 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010015724 Prephenate Dehydratase Proteins 0.000 description 1
- 108010078762 Protein Precursors Proteins 0.000 description 1
- 102000014961 Protein Precursors Human genes 0.000 description 1
- 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 1
- 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 101100134871 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceE gene Proteins 0.000 description 1
- 101100406344 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceF gene Proteins 0.000 description 1
- 101100297447 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) phnB gene Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 108010090051 Pyruvate Dehydrogenase Complex Proteins 0.000 description 1
- 102000012751 Pyruvate Dehydrogenase Complex Human genes 0.000 description 1
- 101710189291 Quinone oxidoreductase Proteins 0.000 description 1
- 102100034576 Quinone oxidoreductase Human genes 0.000 description 1
- 102000004879 Racemases and epimerases Human genes 0.000 description 1
- 108090001066 Racemases and epimerases Proteins 0.000 description 1
- 241000232299 Ralstonia Species 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
- 108010082913 S-layer proteins Proteins 0.000 description 1
- 101100434411 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ADH1 gene Proteins 0.000 description 1
- 108010060059 Sarcosine Oxidase Proteins 0.000 description 1
- 102000008118 Sarcosine oxidase Human genes 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 108050008280 Shikimate dehydrogenase Proteins 0.000 description 1
- 108010051611 Signal Recognition Particle Proteins 0.000 description 1
- 102000013598 Signal recognition particle Human genes 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 101800002927 Small subunit Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 108010043943 Starch Phosphorylase Proteins 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 101000870438 Streptococcus gordonii UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase stabilizing protein GtfB Proteins 0.000 description 1
- 101100370749 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) trpC1 gene Proteins 0.000 description 1
- 101100038645 Streptomyces griseus rppA gene Proteins 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 108010056371 Succinyl-diaminopimelate desuccinylase Proteins 0.000 description 1
- 101710117283 Sucrose permease Proteins 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 108091008874 T cell receptors Proteins 0.000 description 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
- 241000718007 Taenionema palladium Species 0.000 description 1
- 241000223892 Tetrahymena Species 0.000 description 1
- 101100157012 Thermoanaerobacterium saccharolyticum (strain DSM 8691 / JW/SL-YS485) xynB gene Proteins 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 108010043652 Transketolase Proteins 0.000 description 1
- 102000014701 Transketolase Human genes 0.000 description 1
- 101100187081 Trichormus variabilis (strain ATCC 29413 / PCC 7937) nifS1 gene Proteins 0.000 description 1
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
- HSCJRCZFDFQWRP-ABVWGUQPSA-N UDP-alpha-D-galactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-ABVWGUQPSA-N 0.000 description 1
- 108010082433 UDP-glucose-hexose-1-phosphate uridylyltransferase Proteins 0.000 description 1
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 1
- ZVNYJIZDIRKMBF-UHFFFAOYSA-N Vesnarinone Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)N1CCN(C=2C=C3CCC(=O)NC3=CC=2)CC1 ZVNYJIZDIRKMBF-UHFFFAOYSA-N 0.000 description 1
- 101000645119 Vibrio campbellii (strain ATCC BAA-1116 / BB120) Nucleotide-binding protein VIBHAR_03667 Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 229930003776 Vitamin B4 Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102100029089 Xylulose kinase Human genes 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- INAPMGSXUVUWAF-GCVPSNMTSA-N [(2r,3s,5r,6r)-2,3,4,5,6-pentahydroxycyclohexyl] dihydrogen phosphate Chemical compound OC1[C@H](O)[C@@H](O)C(OP(O)(O)=O)[C@H](O)[C@@H]1O INAPMGSXUVUWAF-GCVPSNMTSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 1
- BUFLLCUFNHESEH-UHFFFAOYSA-N [5-(2-amino-6-oxo-3h-purin-9-yl)-4-hydroxy-2-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(O)=O)C(OP(O)(=O)OP(O)(O)=O)C1O BUFLLCUFNHESEH-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 101150094017 aceA gene Proteins 0.000 description 1
- 101150036393 aceB gene Proteins 0.000 description 1
- 108020002494 acetyltransferase Proteins 0.000 description 1
- 102000005421 acetyltransferase Human genes 0.000 description 1
- 101150006213 ackA gene Proteins 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 108010064926 acyl-CoA carboxylase Proteins 0.000 description 1
- 101150102866 adc1 gene Proteins 0.000 description 1
- 229960001570 ademetionine Drugs 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 125000005426 adeninyl group Chemical group N1=C(N=C2N=CNC2=C1N)* 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 238000004176 ammonification Methods 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 description 1
- 101150042732 aroC gene Proteins 0.000 description 1
- 101150083869 aroK gene Proteins 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 101150070136 axeA gene Proteins 0.000 description 1
- 230000037358 bacterial metabolism Effects 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- RNBGYGVWRKECFJ-ARQDHWQXSA-J beta-D-fructofuranose 1,6-bisphosphate(4-) Chemical compound O[C@H]1[C@H](O)[C@@](O)(COP([O-])([O-])=O)O[C@@H]1COP([O-])([O-])=O RNBGYGVWRKECFJ-ARQDHWQXSA-J 0.000 description 1
- WQZGKKKJIJFFOK-RWOPYEJCSA-N beta-D-mannose Chemical group OC[C@H]1O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-RWOPYEJCSA-N 0.000 description 1
- 238000007068 beta-elimination reaction Methods 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 101150029327 bioB gene Proteins 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 108700023293 biotin carboxyl carrier Proteins 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 102220369447 c.1352G>A Human genes 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000004700 cellular uptake Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 239000012539 chromatography resin Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 101150036359 clpB gene Proteins 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000002742 combinatorial mutagenesis Methods 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 101150001544 crr gene Proteins 0.000 description 1
- 101150049887 cspB gene Proteins 0.000 description 1
- 101150041068 cspJ gene Proteins 0.000 description 1
- 101150010904 cspLB gene Proteins 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 230000002074 deregulated effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 108010050073 dethiobiotin synthetase Proteins 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 108010056578 diaminopimelate dehydrogenase Proteins 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 101150036185 dnaQ gene Proteins 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 101150026384 dtxR gene Proteins 0.000 description 1
- 239000005712 elicitor Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 108010063460 elongation factor T Proteins 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- AJIPIJNNOJSSQC-NYLIRDPKSA-N estetrol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)[C@@H]4O)O)[C@@H]4[C@@H]3CCC2=C1 AJIPIJNNOJSSQC-NYLIRDPKSA-N 0.000 description 1
- 108010056732 factor EF-P Proteins 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 101150075316 folE gene Proteins 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 101150049376 ftsY gene Proteins 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000003208 gene overexpression Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 101150019449 glnB gene Proteins 0.000 description 1
- 101150013801 glnD gene Proteins 0.000 description 1
- 101150106096 gltA gene Proteins 0.000 description 1
- 101150042350 gltA2 gene Proteins 0.000 description 1
- 101150041871 gltB gene Proteins 0.000 description 1
- 101150039906 gltD gene Proteins 0.000 description 1
- 101150021650 gluA gene Proteins 0.000 description 1
- 101150017583 gluC gene Proteins 0.000 description 1
- 101150074147 gluD gene Proteins 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 108010050322 glutamate acetyltransferase Proteins 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 1
- 101150050908 hisA gene Proteins 0.000 description 1
- 101150054929 hisE gene Proteins 0.000 description 1
- 101150096813 hisF gene Proteins 0.000 description 1
- 101150032598 hisG gene Proteins 0.000 description 1
- 108010034653 homoserine O-acetyltransferase Proteins 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 101150064958 ideR gene Proteins 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 101150009044 impA gene Proteins 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000012499 inoculation medium Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 101150021879 iscS gene Proteins 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940116298 l- malic acid Drugs 0.000 description 1
- 101150109249 lacI gene Proteins 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 101150076679 lysG gene Proteins 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009061 membrane transport Effects 0.000 description 1
- 230000037346 metabolism of cofactors Effects 0.000 description 1
- 230000037345 metabolism of vitamins Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- XBCXJKGHPABGSD-UHFFFAOYSA-N methyluracil Natural products CN1C=CC(=O)NC1=O XBCXJKGHPABGSD-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 101150069500 mtrA gene Proteins 0.000 description 1
- 101150047269 murI gene Proteins 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940031815 mycocide Drugs 0.000 description 1
- 210000004898 n-terminal fragment Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000001320 near-infrared absorption spectroscopy Methods 0.000 description 1
- 210000005044 neurofilament Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 101150082753 nifS gene Proteins 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 238000003558 nucleic acid array method Methods 0.000 description 1
- 230000037360 nucleotide metabolism Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 101150081585 panB gene Proteins 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- ZNXZGRMVNNHPCA-VIFPVBQESA-N pantetheine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS ZNXZGRMVNNHPCA-VIFPVBQESA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000004108 pentose phosphate pathway Effects 0.000 description 1
- 101150017363 pepQ gene Proteins 0.000 description 1
- 102000023856 peptide binding proteins Human genes 0.000 description 1
- 108091008399 peptide binding proteins Proteins 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 108091005706 peripheral membrane proteins Proteins 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 108010085336 phosphoribosyl-AMP cyclohydrolase Proteins 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 230000000865 phosphorylative effect Effects 0.000 description 1
- 230000002186 photoactivation Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- LYCRXMTYUZDUGA-UYRKPTJQSA-N pimeloyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LYCRXMTYUZDUGA-UYRKPTJQSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- FPWMCUPFBRFMLH-HDKIZWTHSA-N prephenic acid Chemical compound O[C@H]1C=C[C@](CC(=O)C(O)=O)(C(O)=O)C=C1 FPWMCUPFBRFMLH-HDKIZWTHSA-N 0.000 description 1
- FPWMCUPFBRFMLH-UHFFFAOYSA-N prephenic acid Natural products OC1C=CC(CC(=O)C(O)=O)(C(O)=O)C=C1 FPWMCUPFBRFMLH-UHFFFAOYSA-N 0.000 description 1
- 101150077403 priA gene Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 201000005484 prostate carcinoma in situ Diseases 0.000 description 1
- 229940076376 protein agonist Drugs 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000007026 protein scission Effects 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- FCHXJFJNDJXENQ-UHFFFAOYSA-N pyridoxal hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(C=O)=C1O FCHXJFJNDJXENQ-UHFFFAOYSA-N 0.000 description 1
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 238000003571 reporter gene assay Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229950001574 riboflavin phosphate Drugs 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 102220023258 rs387907548 Human genes 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 101150004862 secG gene Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- 108020001482 shikimate kinase Proteins 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 101150055071 slaA gene Proteins 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 101150112901 soxA gene Proteins 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 101150027278 thiX gene Proteins 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 150000003579 thiophosphoric acid derivatives Chemical class 0.000 description 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
- 229960002203 tilactase Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- RBNWAMSGVWEHFP-UHFFFAOYSA-N trans-p-Menthane-1,8-diol Chemical compound CC(C)(O)C1CCC(C)(O)CC1 RBNWAMSGVWEHFP-UHFFFAOYSA-N 0.000 description 1
- 238000005891 transamination reaction Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical group OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 101150019416 trpA gene Proteins 0.000 description 1
- 101150081616 trpB gene Proteins 0.000 description 1
- 101150111232 trpB-1 gene Proteins 0.000 description 1
- 101150016309 trpC gene Proteins 0.000 description 1
- 101150034486 trpG gene Proteins 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 230000004143 urea cycle Effects 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000008979 vitamin B4 Nutrition 0.000 description 1
- 239000011579 vitamin B4 Substances 0.000 description 1
- WCNMEQDMUYVWMJ-JPZHCBQBSA-N wybutoxosine Chemical compound C1=NC=2C(=O)N3C(CC([C@H](NC(=O)OC)C(=O)OC)OO)=C(C)N=C3N(C)C=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O WCNMEQDMUYVWMJ-JPZHCBQBSA-N 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 101150110790 xylB gene Proteins 0.000 description 1
- 108091022915 xylulokinase Proteins 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Isolated nucleic acid molecules, designated PTS nucleic acid molecules, which encode novel PTS proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PTS nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated PTS proteins, mutated PTS proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of PTS genes in this organism.
Description
The application is to be the dividing an application of Chinese patent application 00812165.6 " coding phosphoenolpyruvic acid: the proteinic Corynebacterium glutamicum gene of carbohydrate phosphotransferase system " on June 27th, 2000 applying date.
Technical field
The present invention relates to the nucleic acid molecule of the new Corynebacterium glutamicum pts protein of separated coding.The present invention also relates to antisense nucleic acid molecule, contain the recombinant expression vector of PTS nucleic acid molecule, and the host cell that has imported expression vector.The present invention also further relates to isolating pts protein, PTS mutain, fused protein, antigen peptide, and the method that improves the required compound production of being undertaken by this organism based on Corynebacterium glutamicum PTS gene genetic engineering.
Background technology
Specific product in the cell in the naturally occurring metabolic process and by product have purposes in a lot of industries, comprise food, feed, makeup and pharmaceutical industries.These molecules are generically and collectively referred to as " fine chemistry material ", comprise organic acid, protein source and amino acid non-protein source, Nucleotide and nucleosides, lipid and lipid acid, glycol, carbohydrate, aromatics, VITAMIN and cofactor and enzyme.Can produce the bacterium of a large amount of specific desired molecules of justacrine by large scale culturing, these products of the preparation of most convenient.A kind of useful especially organism that is used for this purpose is exactly Corynebacterium glutamicum (Corynebacterium glutamicum), a kind of Gram-positive nonpathogenic bacteria.By bacterial strain screening, the mutant strain of the large quantities of required compounds of many generations has appearred.Yet,, be a consuming time and difficult process for improving the bacterial strain screening that particular molecule production is carried out.
Summary of the invention
The invention provides new bacterial nucleic acid molecule, these molecules serve many purposes.These purposes comprise evaluation can produce the microorganism of fine chemistry material, regulate the somatotype of generation, Corynebacterium glutamicum or relationship bacterium of the fine chemistry material in Corynebacterium glutamicum or the relationship bacterium and evaluation, as the reference point of drawing Corynebacterium glutamicum gene picture group spectrum.The nucleic acid molecule encoding protein that these are new is called phosphoenolpyruvic acid herein: carbohydrate phosphotransferase system (PTS) protein.
Corynebacterium glutamicum is a kind of Gram-positive aerobic bacteria, is used to the various fine chemistry materials of scale operation usually in industry, also is used for degradation of hydrocarbon (for example in Oil spills) and oxidation terpinol.Therefore, PTS nucleic acid molecule of the present invention can be used to identify the microorganism that can be used to produce the fine chemistry material, for example passes through fermentation process.Regulate the expression of PTS nucleic acid molecule of the present invention, perhaps modify the sequence of PTS nucleic acid molecule of the present invention, can be used for regulating the production (for example, improving the generation of one or more fine chemistry materials in excellent bacillus or the tyrothricin) of one or more fine chemistry materials of microorganism.
PTS nucleic acid molecule of the present invention can be used for identifying whether a kind of microorganism is Corynebacterium glutamicum or its relationship bacterial strain, the perhaps existence of Corynebacterium glutamicum or its relationship bacterial strain in the Identifying micro-organisms population mixture.The invention provides the nucleotide sequence of many Corynebacterium glutamicum genes; Under stringent condition, detect the genomic dna that from single microorganism or mixing microorganisms colony culture, extracts with probe, this probe has covered the distinctive one section zone of Corynebacterium glutamicum gene, can determine whether that this microorganism exists.Although the right and wrong of Corynebacterium glutamicum own are pathogenic, it is relevant with the pathogen species in the human body, for example diphtheria corynebacterium (Corynebacterium diphtheriae) (diphtheria is caused a disease former); Survey this microorganism and have great clinical practice.
PTS nucleic acid molecule of the present invention also can perhaps be drawn the reference point of its relationship strain gene picture group spectrum as the reference point of drawing Corynebacterium glutamicum gene picture group spectrum.Similar, these molecules, perhaps its variant or its part can be as the genetic markers of genetic engineering rod bacillus or tyrothricin.
For example, the pts protein of new nucleic acid molecule encoding of the present invention can perhaps participate in signal conduction in the cell in this microorganism similarly being that the such high-energy carbon-containing molecules of glucose is transported into Corynebacterium glutamicum.Consider the practicality of the cloning vector that can in Corynebacterium glutamicum, use, for example at Sinskey et al., United States Patent (USP) numbering No.4,649, disclosed in 119, and consider Genetic Manipulative Technology (Yashihama et al, the J.Bacteriol.162:591-597 (1985) of Corynebacterium glutamicum and relationship tyrothricin bacterial classification (for example brevibacterium); Katsumata et al., J.Bacteriol.159:306-311 (1984); And Santamaria et al., J.Gen.Microbiol.130:2237-2246 (1984)), nucleic acid molecule of the present invention can be used for the genetic engineering of this organism, makes it to become the better or more effective producer of one or more fine chemistry materials.
Can modify PTS molecule of the present invention, thereby make output, production and/or the production efficiency of one or more fine chemistry materials be improved.For example,, can optimize its activity, make and are transported glucose uptake quantity or glucose into the speed of cell is improved by modifying a kind of pts protein that participates in glucose uptake.The degraded of glucose or other carbohydrates can provide energy in the cell, and these energy can be used for promoting the disadvantageous biochemical reaction of energy, and for example those relate to the biosynthetic reaction of fine chemistry material.Degraded also provides some necessary intermediate of fine chemistry material biosynthesizing or precursor molecule, for example amino acid, VITAMIN and cofactor.By modifying PTS molecule of the present invention to increase the quantity of high-energy carbon molecule in the cell, both can increase and finish the energy supply of producing the necessary pathways metabolism of one or more fine chemistry materials, can increase the needed endocellular metabolism material of this production storehouse again.
In addition, PTS molecule of the present invention can participate in signal transduction path in the one or more of cells, and these signal transduction paths can influence the output and/or the throughput rate of one or more fine chemistry materials in the Corynebacterium glutamicum.For example, in case there is the carbohydrate of sufficient amount in the cell, the necessary protein of one or more carbohydrates of input (for example from extracellular medium, HPr, Enzyme I, the perhaps a kind of composition in the Enzyme II complex body) often is translated the back and modifies, thereby they can not be input to sugar in the cell again.The quantity of sugar when movement system is closed may be enough for keeping the cell normal function, and this may limit the excessive production of required chemical substance.Therefore, it is very worthwhile modifying pts protein of the present invention and making it no longer include reaction to this negative adjusting, so, allow interior one or more sugar of cell to reach higher concentration, and extend by reaction, from the organism that contains this pts protein mutant, just can more effectively produce or one or more fine chemistry materials of more large-tonnage acquisition.
The invention provides the nucleic acid molecule of new coded protein, this protein is called phosphoenolpyruvic acid herein: carbohydrate phosphotransferase system (PTS) protein, they the high-energy carbon molecule (for example participate in, glucose, fructose, sucrose) the input Corynebacterium glutamicum, and/or participate in signal transduction path in the one or more of Corynebacterium glutamicum cells.These proteinic examples comprise the protein of the coded by said gene that those are listed in table 1.
Therefore, one aspect of the present invention relates to, the nucleic acid molecule that separates the nucleotide sequence contain one section a kind of pts protein of coding or its biologically-active moiety (for example, cDNA, DNA, and separate to be suitable as and survey or the primer of amplification PTS coding nucleic acid (for example DNA or RNA) or the nucleic acid fragment of hybridization probe perhaps RNA).In particularly preferred embodiments, the nucleotide sequence that it is odd number that isolated nucleic acid molecule comprises one section sequence number that is listed in the sequence table (for example, SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7) or coding region or its complementary sequence of a this nucleotide sequence.In other particularly preferred embodiments, isolating nucleic acid molecule of the present invention comprise with sequence table in sequence number be odd number nucleotide sequence (for example, SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7) or its part about at least 50% homology is arranged, at least about 60% homology is preferably arranged, and preferred have about at least 70%, 80%, or 90% homology, even preferredly have about at least 95%, 96%, 97%, 98%, 99% or higher homology.In other embodiment preferred, the isolated nucleic acid molecule coding is listed in the even number sequence number aminoacid sequence (for example, SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8) in the sequence table.The preferred pts protein of the present invention also preferably has at least a PTS activity described herein.
In another embodiment, encode a kind of protein or its part of isolated nucleic acid molecule, protein wherein or its part comprise one section aminoacid sequence, this sequence and aminoacid sequence of the present invention are (for example, the sequence of even number sequence number in sequence table) sufficient homology is arranged, for example, sufficient homology is arranged and make this protein or its part have the PTS activity with aminoacid sequence of the present invention.Preferably, the protein of nucleic acid molecule encoding or its part, have the ability that participates in high-energy carbon molecule (for example, glucose, fructose, sucrose) input Corynebacterium glutamicum, and/or participate in the ability of signal transduction path in the one or more of Corynebacterium glutamicum cells.In one embodiment, a kind of protein of nucleic acid molecule encoding and aminoacid sequence of the present invention (for example, the complete amino acid sequence of selecting in the even number sequence number sequence from sequence table) have about at least 50% homology, and about at least 60% homology is preferably arranged, preferred have about at least 70%, 80%, 90% homology, most preferred have about at least 95%, 96%, 97%, 98%, 99% or higher homology.In another preferred embodiment, protein is the Corynebacterium glutamicum protein of total length, this protein and full length amino acid sequence of the present invention (by be presented in the corresponding sequence table the odd serial numbers nucleotide sequence (for example, SEQ ID NO:1, SEQ ID NO:3, SEQ IDNO:5, SEQ ID NO:7) the open reading frame coding) abundant homology.
In another preferred embodiment, isolated nucleic acid molecule is from Corynebacterium glutamicum, and a kind of protein of encoding (for example a kind of PTS fusion rotein), this protein comprises one section biological activity zone, this zone and a kind of aminoacid sequence of the present invention are (for example, a sequence in the sequence table even number sequence number sequence) has about at least 50% or higher homology, and this protein (for example can participate in a high-energy carbon molecule, glucose, fructose, sucrose) input Corynebacterium glutamicum, and/or participate in signal transduction path in the one or more of Corynebacterium glutamicum cells, perhaps have one or more and be listed in activity in the table 1, and this protein also includes the heterologous nucleic acid sequence of one section coding heterologous polypeptide or regulation domain.
In another embodiment, isolated nucleic acid molecule has the length of 15 Nucleotide at least, and under stringent condition with contain the making nucleic acid molecular hybridization of nucleotide sequence of the present invention (for example, odd serial numbers sequence in sequence table).Preferably, isolated nucleic acid molecule is consistent with naturally occurring nucleic acid molecule.Be more preferably isolated nucleic acid molecule encode naturally occurring Corynebacterium glutamicum pts protein, perhaps its biologically-active moiety.
Another aspect of the present invention relates to carrier, for example contains the recombinant expression vector of nucleic acid molecule of the present invention and is introduced into the host cell of this carrier.In one embodiment, by cultivating in suitable medium, this host cell is used to produce pts protein.Can from substratum or host cell, separate this pts protein then.
In addition, another aspect of the present invention relates to a kind of microorganism through hereditary change, and the PTS gene has been introduced into wherein or and has been changed.In one embodiment, by introducing nucleic acid molecule of the present invention, changed the genome of this microorganism as genetically modified encoding wild type or mutant PTS sequence.In another embodiment, changed the endogenous PTS gene in this microbial genome, for example, carried out functional destruction by using the PTS gene that has changed to carry out homologous recombination.In another embodiment, PTS gene endogenous or that introduce is changed by one or more point mutation, disappearance or inversion in this microorganism, but still can the encoding function pts protein.In another embodiment, change one or more regulation domain (for example, promotor, repressor or inductor) of microorganism PTS gene, thereby regulate the PTS expression of gene.In preferred embodiments, microorganism belongs to excellent bacillus specie or quarter butt bacterial classification, especially preferably Corynebacterium glutamicum.In preferred embodiments, also use the required compound of microorganisms producing, for example amino acid, especially preferably Methionin.
On the other hand, the invention provides corynebacterium diphtheriae existence or active method among a kind of evaluation experimenter.This method comprises the detection to one or more nucleic acid of the present invention or aminoacid sequence among the experimenter (for example, being listed in the sequence of SEQ ID NO 1 to 34 in the sequence table), thereby can detect existence or the activity of Corynebacterium glutamicum among the experimenter.
In addition, another aspect of the present invention relates to and isolates pts protein or its part, for example its biologically-active moiety.In a preferred embodiment, isolating pts protein or its part (for example can participate in a high-energy carbon molecule, glucose, fructose, sucrose) the input Corynebacterium glutamicum, and also can participate in signal transduction path in the one or more of Corynebacterium glutamicum cells.In another preferred embodiment, isolating its part of pts protein person and a kind of aminoacid sequence of the present invention are (for example, sequence table even number sequence number a: sequence in the sequence) sufficiently high homology is arranged, make this protein or its part (for example can participate in a high-energy carbon molecule, glucose, fructose, sucrose) import the ability of Corynebacterium glutamicum, and/or also participate in the ability of signal transduction path in the one or more of Corynebacterium glutamicum cells.
The present invention also provides the Separation Product of pts protein.In preferred embodiments, pts protein comprises aminoacid sequence of the present invention (for example, sequence table even number sequence number a: sequence in the sequence).In another preferred embodiment, the present invention is relevant with isolating full length protein, and (sequence table even number sequence number: a sequence in the sequence) (is the open reading frame coding of odd number by the sequence number that is presented in the corresponding sequence table) has quite high homology for this protein and complete aminoacid sequence of the present invention.In addition, in another embodiment, protein and complete aminoacid sequence of the present invention are (for example, even number sequence number sequence in the sequence table) about at least 50% homology is arranged, at least about 60% homology is preferably arranged, and preferred have about at least 70%, 80%, or 90% homology, most preferred have about at least 95%, 96%, 97%, 98%, or 99% or higher homology.In another embodiment, an aminoacid sequence that isolating pts protein comprises and an aminoacid sequence of the present invention are (for example, an even number sequence number sequence in the sequence table) has about at least 50% or higher homology, and (for example can participate in a high-energy carbon molecule, glucose, fructose, sucrose) the input Corynebacterium glutamicum, with/and participate in signal transduction path in the one or more of Corynebacterium glutamicum cells, perhaps have one or more activity of listing in the table 1.
In addition, isolating pts protein can contain the aminoacid sequence by nucleic acid sequence encoding, this nucleotide sequence and a nucleic acid array hybridizing that is listed in the even number sequence number in the sequence table, hybridize under stringent condition for example, at least about 50% homology is perhaps arranged with this nucleotide sequence, at least about 60% homology is preferably arranged, preferred have about at least 70%, 80%, or 90% homology, even preferredly have about at least 95%, 96%, 97%, 98%, or 99% or higher homology.The preferred form of pts protein has one or more biological activitys described herein equally, also is preferred.
PTS polypeptide or its biologically-active moiety can effectively be connected on the non-PTS polypeptide and form fused protein.In preferred embodiments, this fused protein has the activity that is different from independent pts protein itself.In other embodiment preferred, this fused protein causes the increase of required Corynebacterium glutamicum fine chemistry material output, production and/or production efficiency.In particularly preferred embodiments, this fusion rotein is integrated into host cell, can regulates the production of required compound in the cell.
On the other hand, the invention provides the method that screening can be regulated the active molecule of pts protein.This molecule by with protein molecule itself or substrate interaction, perhaps combine, perhaps by regulating transcribing or translate and regulating the pts protein activity of PTS nucleic acid molecule of the present invention with the mating partner of pts protein.
Another aspect of the present invention relates to the method for producing the fine chemistry material.This method relates to cultivates the cell that contains a kind of carrier, and this carrier instructs the expression of PTS nucleic acid molecule of the present invention, thereby produces the fine chemistry material.In a preferred embodiment, this method also comprises the step that obtains to contain this carrier cell, in this step, and the carrier transfectional cell that use can instruct the PTS nucleic acid molecule to express.In another preferred embodiment, this method also comprises the step that reclaims the fine chemistry material from substratum.In an especially preferred embodiment, cell is excellent bacillus specie or quarter butt bacterial classification, perhaps is selected from those bacterial strains that are listed in the table 3.
Another aspect of the present invention relates to the method that molecule produces in the microorganism of regulating.This method comprises medicament exposing cell that use to regulate pts protein activity or PTS expression of nucleic acid, makes the activity of related activity when lacking this medicament of cell that change take place.In a preferred embodiment,, regulate cell, make the output of the required fine chemistry material of this microorganism or generation efficient be improved in order to absorb one or more carbohydrates.Regulating the active medicament of pts protein, can be the medicament that stimulates pts protein activity or PTS expression of nucleic acid.Stimulate the example of the medicament of pts protein activity or PTS expression of nucleic acid, comprise small molecules, active pts protein and the nucleic acid of the pts protein of transfered cell of encoding.The example of the medicament that suppresses the pts protein activity or express comprises small molecules and antisense PTS nucleic acid molecule.
Another aspect of the present invention relates to the method for regulating required compound output in the cell, comprises that wild-type or mutant PTS gene transfered cell this gene or be retained on the independent plasmid perhaps is incorporated in the host cell gene group.If be incorporated in the host cell gene group, this integration can be arbitrarily, or takes place by homologous recombination, thereby makes the copy of introducing to replace natural gene, causes in the cell generation of required compound adjusted.In a preferred embodiment, this output obtains increasing.In another preferred embodiment, said fine chemistry material is an amino acid.In an especially preferred embodiment, said amino acid is L-Methionin.
Embodiment
The invention provides PTS nucleic acid and protein molecule, they participate in Corynebacterium glutamicum picked-up high-energy carbon molecule (for example, glucose, fructose, sucrose), and also can participate in the interior signal transduction path of one or more of cells in this microorganism.Molecule of the present invention can be used for regulating the production of fine chemistry material in the microorganism.This adjusting may be the increase owing to the high energy molecular level of required generation in the cell, for example, ATP, it similarly is the molecule of the so unfavorable biochemical reaction of energy of fine chemistry material biosynthesizing that GTP and other are used to promote.The adjusting of fine chemistry material production also may be owing to this fact, and promptly the degraded product of a lot of carbohydrates is used as the intermediate or the precursor of other biological route of synthesis, comprises the biosynthetic pathway of some fine chemistry material.In addition, known pts protein participates in signal transduction path in some cell, and they may have the activity of adjusting to the pathways metabolism of one or more of fine chemistry materials; By utilizing these pts proteins, can activate the biosynthetic pathway of fine chemistry material or suppress its chemical degradation approach.All respects of the present invention further describe as follows.
I. fine chemistry material
" fine chemistry material " this speech is well known in the art, comprises the molecule that uses in various industries that organism produces, for example but not only be confined to pharmacy, agricultural and makeup industry.This compound comprises organic acid, tartrate for example, methylene-succinic acid and diaminopimelic acid, protein source and nonprotein source amino acid, purine bases and pyrimidine bases, nucleosides, and Nucleotide (for example similarly is to be described in Kuninaka, A. (1996) Nucleotides and related compounds, p.561-612, in Biotechnology vol.6, Rehm et al., in eds.VCH:Weinheim and the contained reference thereof), lipid, saturated and unsaturated fatty acids (for example arachidonic acid), glycol (for example, propane diol and butanediol), aromatics (for example, aromatic amine, Vanillin and indigo), VITAMIN and cofactor are (referring to Ullmann ' s Encyclopedia of IndustrialChemistry, vol.A27, " Vitamins ", p.443-613 (1996) VCH:Weinheim and referencestherein; And Ong, A.S., Niki, E.﹠amp; Packer, L. (1995) " Nutrition; Lipids; Health; andDisease " Proceedings of the UNESCO/Confederation of Scientific and TechnologicalAssociations in Malaysia, and the Society for Free Radical Research-Asia, held Sept.1-3,1994 at Penang, Malaysia, AOCS Press, (1995)), enzyme, polyketide (ployketides) (Cane et al., (1998) Science 282:63-68), and all are at Gutcho (1983) Chemicals by Fermentation, Noyes Data Corporation, the chemical substance of describing in ISBN:0818805086 and the reference thereof.The metabolism of some these fine chemistry material and purposes further describe as follows.
A. amino acid whose metabolism and purposes
Amino acid comprises the basic structural unit of all proteins, equally also is that all organism normal cell biological functions are necessary." amino acid " this speech is well known in the art.The amino acid of protein source has 20 kinds, it is proteinic structural unit, be connected by peptide bond each other, but not protein source amino acid (known have hundreds of kind) generally can not appear in the protein (referring to Ulmann ' s Encyclopedia of Industrial Chemistry, vol.A2, p.57-97 VCH:Weinheim (1985)).Though the normally natural unique type that exists in the protein of L-amino acid, amino acid can be D-or L-optical configuration.Each biosynthesizing or degradation pathway in 20 kinds of protein source amino acid, all in prokaryotic cell prokaryocyte or eukaryotic cell, have separately characteristics (for example referring to Stryer, L.Biochemistry, 3
RdEdition, pages 578-590 (1988)).Why like this " essential " amino acid (Histidine, Isoleucine, leucine, Methionin, methionine(Met), phenylalanine, Threonine, tryptophane and Xie Ansuan) name, be that they can be converted into remaining 11 kinds of " nonessential " amino acid (L-Ala, arginine, l-asparagine, aspartic acid, halfcystine, L-glutamic acid, glutamine, glycine, proline(Pro), Serine, tyrosine) by simple biosynthetic pathway because these amino acid bios synthesize complicated normally essential nutritional condition.Though higher organism has more synthetic this amino acid whose abilities really, for normal protein synthesis must replenish indispensable amino acid from diet.
They are except the function in protein synthesis, and these amino acid just himself are interesting chemical substances, and much have various application in them in food, feed, chemistry, makeup, agricultural and pharmaceutical industries.Methionin is a kind of important amino acid for the mankind not only aspect nutrition, and for similarly being that the such monogastric animal of poultry and pig also is important.L-glutamic acid is that (msg powder type MSG), and is widely used in whole food industries, as aspartic acid, glycine, halfcystine to the most frequently used flavor additives useful.Glycine, L-methionine(Met) and tryptophane all are used for pharmaceutical industries.Glutamine, Xie Ansuan, leucine, Isoleucine, Histidine, arginine, proline(Pro), Serine and L-Ala all are applied in pharmaceutical industries and the makeup industry.Threonine, tryptophane and D/L-methionine(Met) are the fodder additives (Leuchtenberger that uses always, W. (1996) Amino aids-technical production and use, p.466-502 in Rehm et al. (eds.) Biocemistry vol.6, chapter 14a, VCH:Weinheim).In addition, these amino acid also are of great use as the precursor of synthesizing amino acid and protein synthesis, N-acetylcystein for example, S-carboxymethyl-L-halfcystine, (S)-5-hydroxyryptophan, and other are at Ulmann ' s Encyclopedia of Industrial Chemistry, vol.A2, p.57-97 VCH:Weinheim, the molecule of describing in 1985.
In the organism that can produce natural amino acid, bacterium for example, these natural amino acid whose biosynthesizing solve very abundant (amino acid whose biosynthesizing of bacterium and adjusting thereof, referring to Umbarger, H.E. (1978) Ann.Rev.Biochem.47:533-606).Aspartic acid is synthetic by the ammonification of α-Tong Wuersuan reduced form, and the latter is the intermediate of tricarboxylic acid cycle.Glutamine, proline(Pro) and arginine are all produced successively by L-glutamic acid.The biosynthesizing of Serine is the process in one three step, starts from 3-phoshoglyceric acid (glucolytic intermediate), after peroxidation, transamination, each step of hydrolytic action, ends at this amino acid.Halfcystine and glycine are all produced by Serine; The former is formed by homocysteine and Serine condensation, and the latter transfers to tetrahydrofolic acid (THFA) to the side chain beta carbon and obtains, and this reaction is catalytic by serine hydroxymethylase.Phenylalanine and tyrosine, synthetic in the biosynthetic pathway in one 9 step by erythrose-4-phosphate and phosphoenolpyruvic acid, they are precursors of glycolytic pathway and pentose-phosphate pathway, these two approach are just different after synthetic prephenic acid.Tryptophane also can be produced by these two kinds initial molecules, but its synthetic be the approach in one 11 step.Tyrosine also can be synthetic by phenylalanine, and its reaction is catalytic by Phenylalanine hydroxylase.L-Ala, Xie Ansuan and leucine all are the biosynthetic products of glycolysis-end product pyruvic acid.Aspartic acid is synthetic by oxaloacetic acid, and the latter is the intermediate of tricarboxylic acid cycle.L-asparagine, methionine(Met), Threonine and Methionin all are transformed by aspartic acid.Isoleucine is formed by Threonine.By 9 approach that go on foot of a complexity, can be from a kind of active sugar, ribose 5-phosphate-1-tetra-sodium produces Histidine.
Exceeding the synthetic required amino acid of cell protein can not store, but (comment is referring to Stryer, and L.Biochemistry 3 for the cell main metabolic pathway provides intermediate after being degraded
RdEd.Ch.21 " Amino Acid Degradation and the Urea Cycle " p.495-516 (1988)).Although it is useful metabolism intermediate that cell can transform unnecessary amino acid, produces amino acid and will consume a lot of energy, precursor molecule and synthetic required enzyme.Therefore it is not astonishing regulating amino acid whose biosynthesizing with feedback inhibition, the existence of special acid can slow down or the generation that stops himself fully (for the comment of amino acid biosynthetic pathway Feedback mechanism, referring to Stryer, L.Biochemistry 3
RdEd.Ch.24 " Biosynthesis of Amino Acid and Heme " p.575-600 (1988)).Therefore, the amino acid quantity that all existed in the cell of the output of any specific amino acids limits.
B. the metabolism of VITAMIN, cofactor and dietetic product and purposes
VITAMIN, cofactor and dietetic product comprise another component, though other biological, for example bacterium can be synthesized these molecules, higher animal lost synthetic they ability and can only absorb.These molecules or itself are biologically active substances, or the precursor of biologically active substance, and this biologically active substance can be the intermediate of electron carrier or various pathways metabolisms.Except its nutritive value, these compounds also have great industrial value as pigment, antioxidant and catalyzer or other processing aids.(for the commentary of these compound structures, activity and industrial application, referring to for example, Ullmann ' s Encyclopedia of Industrial Chemistry, " Vitamins " vol.A27, p.443-613 VCH:Weinheim 1996.) " VITAMIN " this speech is well known in the art, but having comprised that the organism normal function is required again can not self synthetic nutrient substance.VITAMIN can comprise cofactor and dietetic product compound.Term " cofactor " has comprised and has carried out the active required non-protein compound of normal enzyme.These compounds can be inorganic or organic; Cofactor molecule of the present invention is preferably organic." dietetic product " this speech has comprised plant and animal, particularly human body beneficial's dietary supplement.The example of these molecules is VITAMIN, antioxidant and some lipid (for example many saturated fatty acids).
The organism that can produce these molecules, for example biosynthesizing of these molecules in the bacterium, major part identified (Ullman ' s Encyclopedia of Industrial Chemistry, " Vitamins " vol.A27, p.443-613, VCH:Weinheim, 1996; Michal, G. (1999) BiochemicalPathways:An Atlas of Biochemistry and Molecular Biology, John Wiley ﹠amp; Sons; Ong, A.S., Niki, E.﹠amp; Packer, L. (1995) " Nutrition, Lipids, Health; and Disease " Proceedings of the UNESCO/Confederation of Scientific and TechnologicalAssociations in Malaysia, and the Society for Free Radical Research-Asia, held Sept.1-3,1994 at Penang, Malaysia, AOCS Press:Champaign, IL X, 374 S)
VitB1 (VITMAIN B1) is connected generation with thiazole through chemistry by pyrimidine.Riboflavin (Wei ShengsuB2) is synthetic by 5 '-triphosphoric acid guanosine-and 5 '-ribose phosphoric acid.Riboflavin is used for synthetic vitamin B2 phosphate (FMN) and flavin adenine dinucleotide (FAD) successively.The one group of compound (for example, pyridoxol, Pyridoxylamine, 5 '-pyridoxal phosphate, and commercial pyridoxal hydrochloride) that is collectively referred to as " vitamin B6 " all is the derivative of common structure unit 5-hydroxyl-6-picoline.Pantothenate (pantothenic acid, (R)-(+)-N-(2,4-dihydroxyl-3,3-dimethyl-1-oxo butyl)-Beta-alanine) can obtain by chemosynthesis or fermentation.The biosynthetic final step of pantothenate comprises the Beta-alanine of ATP driving and the condensation of pantoic acid.Be responsible for changing into pantoic acid and Beta-alanine enzyme, and the enzyme that is condensed into pantothenate all is known.The metabolic activity form of pantothenate is a coenzyme A, and its biosynthetic process is 5 enzymatic steps.Pantothenate, 5 '-pyridoxal phosphate, halfcystine and ATP are the precursors of coenzyme A.These enzymes are the formation of catalysis pantothenate not only, also catalysis (R)-pantoic acid, (R)-pantolacton, (R)-generation of panthenol (pro-vitamin B5) pantetheine (and derivative).
In microorganism, study very in detail to the biosynthesizing of vitamin H, and related several genes are identified by precursor molecule pimeloyl coenzyme A.A lot of corresponding proteins matter also are found and have participated in the synthetic of iron bunch (Fe-cluster), and are nifS family protein members.Thioctic Acid is used as coenzyme from sad in energy metabolism, can become the part of pyruvate dehydrogenase complex and ketoglurate dehydrogenase mixture.Folate is the derivative of one group of folic acid, successively from L-L-glutamic acid, para-amino benzoic acid and 6-methylpterin.Originate in the folic acid of metabolism intermediate 5 '-triphosphoric acid guanine (GTP), L-L-glutamic acid and para-amino benzoic acid and the biosynthesizing of derivative thereof, detailed research is arranged in certain micro-organisms.
It is the chemical substance of feature that corrinoid (cobalami for example, and particularly vitamin B12) and porphyrin all belong to the tetrapyrrole ring body.The biosynthesizing of vitamin B12 is such complexity, to such an extent as to also thoroughly do not understand its feature, but many enzymes that relate to and substrate are known now.Nicotinic acid (nicotinate) and nicotine are derivatives at the bottom of the pyridine, also are known as " niacin usp ".Niacin usp is the precursor of important coenzyme NAD (Reduced nicotinamide-adenine dinucleotide) and NADP (Triphosphopyridine nucleotide, reduced) and reduction form thereof.
Although some such compound also can be with extensive microorganism culturing production, for example riboflavin, vitamin B6, pantothenic acid and vitamin H, these compounds of scale operation largely also depend on the acellular chemical system.Has only vitamin B12, because its synthetic complicacy can only be used fermentative production.In vitro method needs considerable material and time to drop into, and often costs a lot of money.
C. the metabolism of purine, pyrimidine, nucleosides and Nucleotide and purposes
Purine and pyrimidine metabolic gene and corresponding proteins matter thereof are the important target compounds of tumor disease therapeutic and treatment of viral infections.Term " purine " and " pyrimidine " have comprised the nitrogenous base of forming as nucleic acid, coenzyme and Nucleotide.Term " Nucleotide " comprises the nucleic acid molecule basic structural unit, and (for RNA, this pentose is a ribose to nucleic acid molecule by nitrogenous base, pentose; For DNA, this pentose is a ribodesose) and the phosphoric acid composition.Term " nucleosides " has comprised the molecule as nucleotide precursor, but the phosphoric acid part that lacks Nucleotide and had.By suppressing the biosynthesizing of these molecules, perhaps suppress to be moving that synthetic nucleic acid molecule carries out, may suppress the synthetic of RNA and DNA; Mode by directed tumour cell suppresses this activity, and tumour cell division and the energy that duplicates may be inhibited.In addition, the Nucleotide that has is not used in formation nucleic acid, but as energy storage (for example AMP) or coenzyme (for example FAD and NAD).
Some publication has been described by influencing the metabolism of purine and/or pyrimidine, these chemical substances as the use of these medical science indications (for example, Christopherson, R.I.and Lyons, S.D. (1990) " Potent inhibitors of de novo pyrimidine and purine biosynthesis aschemotherapeutic agents. " Med.Res.Reviews 10:505-548).Relate to the research of purine and pyrimidine metabolic enzyme, concentrate on above the operable new drug development, for example, as immunosuppressor or anti-proliferative agent (Smith, J.L., (1995) " Enzyme in nucleotidesynthesis. " Curr.Opin.Struct.Biol.5:752-757; (1995) Biochem Soc.Transact.23:877-902).Yet, purine and pyrimidine bases, nucleosides and Nucleotide also have other effect: as the biosynthetic intermediate of many fine chemistry materials (for example, VitB1, S-adenosylmethionine, folic acid, perhaps riboflavin), as cellular energy carrier (for example ATP or GTP), and as chemical substance itself, usually as flavour enhancer (for example IMP or GMP) or several medical use (referring to, for example, Kuninaka, A. (1996) Nucleotidesand Related Compounds in Biotechnology vol.6, Rehm et al., eds.VCH:Weinheim,, p.561-612).Equally, relate to the enzyme of purine, pyrimidine, nucleosides or nucleotide metabolism, day by day become the effect target of developing as the chemical substance of protecting farm crop, these chemical substances comprise mycocide, weedicide and sterilant.
In the bacterium metabolism of these compounds have feature (comment referring to, Zalkin for example, H.andDixon, J.E. (1992) " de novo purine nucleotide biosynthesis ", in:Progress in NucleicAcid Research and Molecular Biology, vol.42, Academic Press:, p.259-287; AndMichal, G. (1999) " Nucleotides and Nucleosides ", Chapter 8 in:BiochemicalPathways:An Atlas of Biochemistry and Molecular Biology, Wiley:New York).Purine metabolism is an emphasis research topic always, and it is that the cell normal function is necessary.Purine metabolism impaired in the higher animal can cause serious disease, for example gout.Purine nucleotides is synthetic by 5 '-ribose phosphoric acid, pass through series of steps, through intermediate 5 '-phosphoric acid inosine (IMP), finally produce 5 '-single phosphoric acid guanine (GMP) and 5 '-single Vitamin B4 (AMP), and form the triphosphoric acid form that is used as Nucleotide by them.Also as energy storage, it is degraded to, and various biological process provides energy to these compounds in the cell.The biosynthesizing of pyrimidine is by formed 5 '-phosphoric acid uridine (UMP) by 5 '-ribose phosphoric acid.Next UMP is transformed into 5 '-triphosphoric acid cytosine(Cyt) (CTP).The deoxidation form of all these Nucleotide all produces through a step reduction reaction, by the bisphosphate ribose form of the Nucleotide bisphosphate ribodesose form to Nucleotide.Once phosphorylation, these molecules just can participate in the synthetic of DNA.
D. the metabolism of trehalose and purposes
Trehalose comprises two glucose molecules, and by α, α-1,1 connects.Usually in food industries, be used as sweetener, desiccating food products or frozen product additive, and in the middle of the beverage.And, it also be applied in pharmacy, makeup and biotechnology industry (referring to, Nishimoto et al. for example, (1998) U.S.Patent No.5,759,610; Singer, M.A.and Lindquist, S. (1998) Trends Biotech.16:460-467; Paiva, C.L.A.and Panek, A.D. (1996) Biotech.Ann.Rev.2:293-314; And Shiosaka, M. (1997) J.Japan 172:97-102).Enzyme in a lot of microorganisms can produce trehalose, and with its natural being discharged on every side in the substratum, and the method for knowing on can use technology is therefrom collected.
II. phosphoenolpyruvic acid: carbohydrate phosphotransferase system
Quick growth and the division of cell in substratum depends on cellular uptake and the degree of utilizing the high energy molecule, for example glucose or other carbohydrates to a great extent.Have different transport proteins, they are transported to different carbohydrates in the cell.Have carbohydrate translocator matter, for example transport glucose, fructose, seminose, semi-lactosi, ribose, sorbose, ribulose, lactose, maltose, sucrose, perhaps raffinose also has the translocator matter of starch and cellulose degradation product.Other movement systems are responsible for importing alcohol (for example methyl alcohol or ethanol), alkane, lipid acid, and the organic acid as acetate or lactic acid.In bacterium, by various mechanism, carbohydrate can be transported into cell through cytolemma.Except with the cotransporting of proton, one of carbohydrate capture process of the most normal use is a phosphoenolpyruvic acid: carbohydrate phosphotransferase system (PTS).This system is the transhipment (following phosphorylation) of catalysis carbohydrate and hexitol not only, but also regulates the cellular metabolism that is adapted to carbohydrate validity.This PTS system only is present in the bacterium, and does not appear in archeobacteria and the eukaryotic cell.
Function aspects, PTS system comprise two kinds of cytoplasm proteins, enzyme I and HPr, and the special integration of the carbohydrate of indefinite number and peripheral membrane protein transhipment complex body (every kind all is called as and has carbohydrate special target " enzyme II ", for example " enzyme II down
Glu" expression is in conjunction with the enzyme II complex body of glucose).The known enzyme II special to monose, disaccharides or trisaccharide similarly is to glucose, fructose, seminose, semi-lactosi, ribose, sorbose, ribulose, lactose, maltose, sucrose or raffinose.Enzyme I is transferred to phosphate carrier albumen HPr to phosphate group from phosphoenolpyruvic acid (PEP).HPr is transferred to different enzyme II transhipment complex bodys to phosphate group more then.Though the aminoacid sequence of enzyme I and HPr is very similar in all bacteriums, PTS shifts body can be divided into the incoherent several families of structure.In addition, the number of these genes also has nothing in common with each other in different bacteriums with homology.38 different pts proteins of bacillus coli gene group coding, wherein 33 is to belong to 22 different subunits that shift body.Mycoplasma genitalium (M.genitalium) genome contains each one of enzyme I and HPr gene, and has only two PTS to shift the body genes.T.palladium and chlamydia trachomatis (C.trachomatis) contain enzyme I and HPr similar protein gene, but do not have PTS to shift the body gene.
All PTS shift bodies and comprise 3 functional units, IIA, protein subunit (for example, the IIA among IIB and the IIC, they or complex body
GlcIICB
Glc) or structural region (for example, the IICBA of single polypeptide chain
GlcNAc).IIA and IIB are delivered to the carbohydrate of being transported to phosphate group successively from HPr.IIC contains the carbohydrate binding site, and crosses over inner membrance 6 or 8 times.Carbohydrate shifts and the instantaneous phosphorylation in IIB zone is coupling.Enzyme I, HPr and IIA are in its histidine residues generation phosphorylation, and the IIB subunit is in histidine residues or cysteine residues generation phosphorylation, this depends on related specific transporter.The phosphorylation of input back carbohydrate has such advantage, promptly can stop carbohydrate to spread cytolemma and gets back in the substratum, because charged phosphate group can not pass the hydrophobic core of cytolemma.
Some pts protein also plays a significant role in the signal conduction in cell except active carbohydrate transport function.These subunits are regulated their object by allosteric or phosphorylation.Their adjusting activity changes along with phosphorylation degree (for example, the ratio of non-phosphorylating form and phosphorylation form), and the latter relies on the ratio of phosphorylation along with sugar dependence dephosphorylation and phosphoenolpyruvic acid again and changes.The example of regulating in the cell of this pts protein in the intestinal bacteria comprises, passes through IIA
GlcDephosphorylation suppresses glycerol kinase, and by its phosphorylation form activated adenyl cyclase.And express by the reversible phosphorylation regulatory gene of transcribing anti-terminator in the HPr of some transporter and IIB zone in these microorganisms.In gram positive bacterium, the activity of HPr is regulated by special serine kinase of HPr and Phosphoric acid esterase.For example, the HPr of Serine-46 phosphorylation, its function is the co-repressor that suppresses sub-CcpA as transcribing.At last, find that unphosphorylated enzyme I suppresses the sensor kinase c heA in the bacterium chemotactic device, this kinases provides between the system of bacterium carbohydrate binding transport system and the motion of control bacterium and has contacted directly (Sonenshein, A.L., etal., eds.Bacillus subtilis and other gram-positive bacteria.ASM:Washington, D.C.; Neidhardt, F.C., et al., eds. (1996) Escherichia coli and Salmonella.ASM Press:Washington, D.C.; Lengeler et al., (1999) .Biology of Prokaryotes.Section II, pp.68-87, Thieme Verlag:Stuttgart)
III. element of the present invention and method
The present invention is to be based upon on the basis of finding the recruit to small part, it is called PTS nucleic acid and protein molecule herein, they to the high-energy carbon molecule (for example participate in Corynebacterium glutamicum, glucose, fructose, sucrose) picked-up, and also can participate in these microorganisms signal transduction path in the one or more of cells.In one embodiment, the PTS molecule is exercised the function that the high-energy carbon molecule is changed over to cell, the energy that these molecular degradations provided in cell can be the disadvantageous biochemical reaction energy supply of energy, and their degraded product can be as the intermediate or the precursor of a lot of other pathways metabolisms.In another embodiment, the PTS molecule can participate in signal transduction path, the wherein existence of PTS molecular modification form (for example, phosphorylation PTS molecule) in the one or more of cells, can participate in the signal transduction cascade reaction, this cascade reaction is regulated one or more cell processes.In a preferred embodiment, the activity of PTS molecule of the present invention is for influential with the required fine chemistry material of this microorganisms producing.In an especially preferred embodiment, the activity of PTS molecule of the present invention is conditioned, and makes that output, production and the production efficiency of one or more fine chemistry materials has also obtained adjusting in the Corynebacterium glutamicum.
Term " pts protein " or " PTS polypeptide " have comprised those participations and (for example absorbed one or more high energy compounds to cell interior from the substratum of extracellular, monose, disaccharides or oligosaccharides similarly are fructose, seminose, sucrose, glucose, raffinose, semi-lactosi, ribose, lactose, maltose and sorbose) protein.These pts proteins also can participate in signal transduction path in the one or more of cells, but for example not only are confined to, and those are controlled different carbohydrates and absorb the into approach of cell.The example of pts protein comprises that sequence number is the protein of the PTS genes encoding of odd number in sequence table by being listed in for those.About the comprehensive reference document of PTS system, referring to: Stryer, L. (1998) Biochemistry, Chapter 37: " Membrane Transport ", W.H.Freeman:New York, p.959-961; Darnell, J.et al. (1990) Molecular Cell BiologyScientific American Books:New York, p.552-553, and Michal, G., ed. (1999) Biochemical Pathway:An Atlas of Biochemistry and Molecular Biology, Chapter 15 " Special Bacterial Metabolism ".Term " PTS gene " or " PTS nucleotide sequence " have comprised the nucleotide sequence of coding pts protein, and the latter comprises 5 ' and 3 ' sequence area of coding region and corresponding untranslated.The example of PTS gene comprises that those are listed in the gene in the table 1.Term " production " or " productivity " are well known in the art, have comprised in preset time and given fermentation volume the concentration of tunning (for example, required fine chemistry material) (for example, per hour every liter of kilogram product).Term " production efficiency " has comprised, and reach the specific required time (for example, needing how long just to make cell reach specific fine chemistry material) of production level.Term " income " " product/carbon income " is well known in the art, has comprised the efficient that carbon source is changed into product (for example fine chemistry material).For example, often write every kilogram of carbon source of kilogram product.By improving the income or the production of compound, can increase the quantity that reclaims molecule, perhaps be increased in the quantity of giving the useful recovery molecule of this compound in the culture of determined number in preset time.Term " biosynthesizing " or " biosynthetic pathway " are well known in the art, have comprised in cell, may be multisteps and be the processes of highly regulating and control from middle compound process, synthetic compound, particularly organic compound.Term " degraded " or one " degradation pathway " are well known in the art, have comprised in cell, through being multistep and being the process of highly regulating and control, compound, preferably organic compound is decomposed into degraded product (molecule that generally speaking, be littler or complicacy is littler).Term " metabolism " is well known in the art, has comprised the whole of the biochemical reaction that taken place in the organism.Thereby the metabolism of special compound (for example, similarly being the such amino acid metabolism of glycine) comprises that all biological relevant with this compound in the cell is synthetic, modification and degradation pathway.Term " transhipment " and " input " be well known in the art, comprised the facilitation that one or more compounds pass cytolemma and moved, and these compounds can not pass cytolemma by other mode.
In another embodiment, PTS molecule of the present invention can be regulated in the microorganism, and for example in the Corynebacterium glutamicum, required compound is the generation of fine chemistry material for example.Use the genetic recombination technology can operate one or more PTS molecules of the present invention, thereby regulate its activity.For example, a kind of protein that participates in the glucose input of PTS mediation can be conditioned, and makes its active optimization, and the PTS system that makes the glucose input, and the glucose that can transport greater amt is in cell.Because glucose molecule not only can be as energy to promote the unfavorable biochemical reaction of energy, for example fine chemistry material biosynthesizing, and can be used as the precursor and the intermediate of many biological fine chemistry material biosynthetic pathways (for example, from 3-phoshoglyceric acid synthetic Serine).In each example, perhaps provide by increasing the required energy of production generation, perhaps produce the required compound supply of generation by increasing, can increase the ultimate production or the production efficiency of these required fine chemistry materials.
In addition, a lot of known pts proteins play a crucial role in the signal transduction path in cell, and these approach are regulated and kept cellular metabolism and the carbohydrate picked-up that carbon source is supplied with.For example, in the known cell 1, the increase of 6-hexose diphosphate (compound that produces in the glycolysis-) level can cause the phosphorylation of HPr serine residue, thus stop this protein in any PTS carbohydrate transport process as the phosphate group donor.Make that by mutagenesis HPr its serine residue can not be by phosphorylation, activation HPr that can composition, thereby the carbohydrate in the increase transporte to cells can be guaranteed to be used in the cell the required more energy of one or more required fine chemistry material biosynthesizing then and store and intermediate/precursor molecule.
Isolating nucleotide sequence of the present invention is included in the genome of Corynebacterium glutamicum strain, and this bacterial strain can be obtained by American type culture collection, preserving number ATCC 13032.Isolating Corynebacterium glutamicum PTS DNA nucleotide sequence, and the Corynebacterium glutamicum pts protein aminoacid sequence of prediction are listed with odd serial numbers and even number sequence number respectively in sequence table.
Carried out Computer Analysis, and with the classification of these nucleotide sequences and/or be accredited as the sequence of encoding metabolic pathway proteins matter.
The present invention is also relevant with such protein, and this proteinic aminoacid sequence and aminoacid sequence of the present invention have sufficient homology (for example, the sequence of even number sequence number in the sequence table).Such as used herein, have the protein that the aminoacid sequence of abundant homology is arranged with the aminoacid sequence of picking out, with the aminoacid sequence of picking out, the amino acid complete sequence of for example picking out has about at least 50% homology.The aminoacid sequence that has and pick out has the protein of the aminoacid sequence of very big homology, also can at least approximately 50-60% be arranged with the aminoacid sequence of picking out, at least about 60% homology is preferably arranged, and preferred have about at least 70%, 80%, 90% homology, most preferred have about at least 95%, 96%, 97%, 98%, 99% or higher homology.
Pts protein of the present invention or its biologically-active moiety or its fragment, can participate in transporting similarly is that the such high energy carbon-containing molecules of glucose enters Corynebacterium glutamicum, perhaps participate in signal conduction in the cell in this microorganism, perhaps have one or more activity of listing in the table 1.
Following each several part has been described all respects of the present invention in further detail:
A. isolated nucleic acid molecule
One aspect of the present invention relates to the nucleic acid molecule of separated coding PTS polypeptide or its biologically-active moiety, and enough as the nucleic acid molecule fragment of hybridization probe or primer, these fragments are used to identify or the nucleic acid (for example PTS DNA) of amplification coding PTS.Such as used herein, the meaning of term " nucleic acid molecule " is to comprise dna molecular (for example, cDNA or genomic dna) and RNA molecule (for example mRNA), and by the DNA or the RNA analogue of nucleotide analog deposits yields.This term also comprises and is positioned at genes encoding zone 3 ' and 5 ' terminal non-translated sequence: at least 100 Nucleotide of coding region 5 ' terminal upstream sequence and at least 20 Nucleotide of genes encoding zone 3 ' terminal downstream sequence.Nucleic acid molecule can be strand or double-stranded, but double-stranded DNA preferably." isolating " nucleic acid molecule is meant those and is present in the nucleic acid molecule that other nucleic acid molecule in the nucleic acid natural origin are separated from each other.Preferably, " isolating " nucleic acid does not contain the natural sequence (for example, being positioned at nucleic acid 5 ' and 3 ' terminal sequence) that is positioned at organism genomic dna amplifying nucleic acid both sides, and nucleic acid obtains from this organism.For example, in various embodiments, isolating PTS nucleic acid molecule can contain and be less than about 5kb, 4kb, 3kb, 2kb, 1kb, the nucleotide sequence of 0.5kb or 0.1kb, the natural both sides that are positioned at the cell genomic dna nucleic acid molecule of this sequence, nucleic acid is exactly to obtain from these cells (for example, Corynebacterium glutamicum cell).In addition, " isolating " nucleic acid molecule, for example dna molecular can be substantially devoid of other cellular materials or substratum when producing with recombinant technology, can not contain precursor or other chemical substances when chemosynthesis.
Nucleic acid molecule of the present invention, the nucleotide sequence of odd serial numbers in the sequence table for example, perhaps its part can separate obtaining by standard molecular biological technique with sequence information provided herein.For example, Corynebacterium glutamicum PTS DNA can be from the Corynebacterium glutamicum library, use in the sequence table in the odd serial numbers sequence whole or its part of a sequence as hybridization probe, and the standard hybridization technique (similarly is to be described in Sambrook, J. for example,, Fritsh, E.F., and Maniatis, T.Molecular Cloning:A Laboratory Manual.2
Nd, ed.Cold Spring HarborLaboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY is in 1989) and separation obtains.In addition, (for example comprise a nucleotide sequence of the present invention, the nucleotide sequence of odd serial numbers in the sequence table) whole or a part of nucleic acid molecule, can pass through the polymerase chain reaction, use is based on the oligonucleotide primer of this sequences Design, separate and (for example obtain, (for example comprise a nucleotide sequence of the present invention, the nucleotide sequence of odd serial numbers in the sequence table) whole or a part of nucleic acid molecule, can pass through the polymerase chain reaction, use separates obtaining based on the oligonucleotide primer of this identical sequence design).For example, mRNA can (for example obtain from the normal endothelial cell separation, use the guanidine thiocyanate extracting method among Chirgwin et al. (1979) the Biochemistry 18:5294-5299), DNA can be by reversed transcriptive enzyme (for example, Gibco/BRL, the Moloney MLV reversed transcriptive enzyme that Bethesda, MD provide; Perhaps SeikagakuAmerica, Inc., the AMV reversed transcriptive enzyme that St.Peterburg, FL provide) preparation.Be polymerase chain reaction synthetic oligonucleotide primer, can be based on a nucleotide sequence design of listing in the sequence table.Nucleic acid of the present invention can use cDNA or make template as the genomic dna that another kind is selected, and suitable oligonucleotide primer increases according to Standard PC R amplification technique.The nucleic acid that amplifies like this can be cloned in the suitable carriers, and distinguishes its feature with dna sequence analysis.In addition,, can prepare, for example use automatic dna synthesizer with the standard synthetic technology with the corresponding oligonucleotide of PTS nucleotide sequence.
In a preferred embodiment, isolating nucleic acid molecule of the present invention comprises a nucleotide sequence of listing in the sequence table.Nucleotide sequence of the present invention, as in sequence table, list those, be consistent with Corynebacterium glutamicum PTS DNA of the present invention.These DNA comprise the sequence (i.e. " coding region " is presented at odd serial numbers in every sequence table: in the sequence) of the pts protein of encoding, and 5 ' non-coding sequence and 3 ' non-coding sequence, are also shown in odd serial numbers in every sequence table: in the sequence.Select as another kind, nucleic acid molecule can only comprise the coding region of sequence table amplifying nucleic acid sequence.
For the purpose of this application, be appreciated that every nucleic acid and the aminoacid sequence listed in the sequence table, a RXA who is used to discern is all arranged, RXN, RXS or RXC coding are indicated " RXA ", " RXN ", " RXS ", perhaps there are 5 numerals (that is, RXA01503, RXN01299 in " RXC " back, RXS00315, perhaps RXC00953).Every nucleotide sequence comprises three parts at most: 5 ' upstream region, coding region, downstream area.Trizonal each part is all used identical RXA, RXN, and RXS, perhaps the RXC numbering is determined to obscure with elimination.So narration " sequence of odd number coding in the sequence table " is meant any nucleotide sequence in the sequence table, these sequences also can be with they different RXA, RXN, RXS, perhaps RXC numbering differentiation mutually.The coding region of every this sequence all is translated into amino acid sequence corresponding, and these sequences also are listed in the sequence table, for following corresponding nucleic sequence even number sequence number afterwards closely:.For example, the coding region of RXA02229 is listed in SEQ ID NO:1, and its amino acid sequence coded is listed in SEQ ID NO:2.Sequence of nucleic acid molecules of the present invention, with its amino acids coding molecule, with identical RXA, RXN, RXS, perhaps the expression of RXC numbering makes them connect each other easily.For example, be appointed as RXA01503, RXN01299, the aminoacid sequence of RXS00315 and RXC00953 is respectively RXA01503, RXN01299, the translation in RXS00315 and the nucleotide sequence coded zone of RXC00953 nucleic acid molecule.RXA of the present invention, RXN, the correspondence between RXS and RXC Nucleotide and the aminoacid sequence, and their appointed sequence number column are in table 1.For example, similarly be that the nucleotide sequence RXN01299 that is listed in the table 1 is SEQ ID NO:7, amino acid sequence corresponding is SEQ ID NO:8.
Several gene of the present invention is " gene that F-indicates ".The gene that F-indicates comprises that those are listed in the table 1 and at RXA, RXN, and RXS has the gene of " F " before perhaps RXC indicates.For example, SEQ ID NO:3 is as expression in table 1, be designated as " F RXA00315 ", gene that F-indicates exactly, same also have SEQ ID NO:9,11 and 13 (be marked as " FRXA01229 ", FRXA01883 in the table 1 respectively " and " F RXA01889 ").
In one embodiment, nucleic acid molecule of the present invention does not comprise those Corynebacterium glutamicum molecules that are compiled in the table 2.For the dapD gene, the sequence of this gene is published in Wehrmann, A., et al. (1998) J.Bacteriol.180 (12): 3159-3165.Yet the version that the resulting ratio of the present application person is delivered is long a lot.It is said that the version of delivering has used wrong codon in fact, and therefore only showed the part of true coding region.
In another preferred embodiment, isolating nucleic acid molecule of the present invention, sequence) or the nucleic acid molecule of the complementary molecule of its part comprising those is nucleotide sequence of the present invention (for example, odd serial numbers in the sequence table:.With a nucleotide sequence complementary of the present invention nucleic acid molecule, be meant that a nucleotide sequence listing in this molecule and the sequence table (for example, odd serial numbers: sequence) fully complementary, so it can with a nucleotide sequence hybridization of the present invention, thereby form stable duplex.
Equally in another preferred embodiment, isolating nucleic acid molecule of the present invention comprises such nucleotide sequence, and this sequence and nucleotide sequence of the present invention are (for example, sequence) or its part odd serial numbers in the sequence table:, have about at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59% or 60% homology preferably has about at least 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69% or 70% homology, preferred have about at least 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79% or 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 88%, 89% or 90%, perhaps 91%, 92%, 93%, 94%, and even preferredly have about at least 95%, 96%, 97%, 98%, 99% or higher homology.More than quote scope (for example, 70-90% consistence or 80-95% consistence) intermediary scope and consistence value, be also contained among the present invention.For example, comprised such consistence value scope, these scopes are combinations of the above-cited upper limit and/or lower value.In another kind of embodiment preferred, isolated nucleic acid molecule of the present invention comprises such nucleotide sequence, this sequence can with a nucleotide sequence of the present invention (for example, odd serial numbers in the sequence table: sequence) or its part hybridize, for example, hybridize under stringent condition.
In addition, nucleic acid molecule of the present invention may only comprise the part in odd serial numbers sequence encoding zone in the sequence table, for example, and can be as the fragment of probe or primer, the fragment of the pts protein biologically-active moiety of perhaps encoding.The nucleotide sequence that goes out by Corynebacterium glutamicum PTS gene clone, allow and produce probe and primer, these probes and primer design are the PTS homologues that is used for identifying and/or cloning other cell types or other biological body, and the PTS homologue in other excellent bacillus or the affinity species.Probe/primer typically comprises the oligonucleotide of suitable purifying.Oligonucleotide typically comprises the zone of such one section nucleotide sequence, this zone is under stringent hybridization condition, with nucleotide sequence of the present invention (for example, odd serial numbers sequence in the sequence table) sense strand, the antisense sequences of these sequences, perhaps about at least 12 of its naturally occurring mutant, preferred about 25, preferred about 40,50, perhaps 75 continuous nucleotides hybridization.Based on the primer of nucleotide sequence of the present invention, can be used to clone the PCR reaction of PTS homologue.Based on the probe of PTS nucleotide sequence, can be used to survey transcribing or genome sequence of identical or homologous protein.In a preferred embodiment, probe comprises the other labelling groups that adheres to especially, and for example labelling groups can be the cofactor of radio isotope, fluorescent chemicals, enzyme or enzyme.This probe can be as the part of diagnostic test kits, this test kit is used to identify the cell of false demonstration pts protein, similarly be by measuring the level of PTS coding nucleic acid in the sample cell, for example, detect the level of PTS mRNA, perhaps measure genome PTS gene whether sudden change or disappearance have taken place.
In one embodiment, a kind of protein of nucleic acid molecule encoding of the present invention or its part, the aminoacid sequence of this protein or its part and aminoacid sequence of the present invention are (for example, even number sequence number sequence in the sequence table) sufficient homology is arranged, thereby make this protein or its part have the ability also can participate in signal transduction path in the one or more of cells to high-energy carbon molecule (for example glucose) input Corynebacterium glutamicum.Such as used herein, term " homology fully " is meant the aminoacid sequence of protein or its part, contain minimal number with consensus amino acid sequence of the present invention or of equal value (for example, have to sequence table even number sequence number sequence in the amino-acid residue of the similar side chain of amino-acid residue) amino-acid residue, thereby make this protein or its part, can also can participate in signal transduction path in the one or more of cells in this microorganism similarly being the such high-energy carbon molecule input Corynebacterium glutamicum of glucose.The protein member of this pathways metabolism, as described herein, its function is similarly being the such high-energy carbon molecule input Corynebacterium glutamicum of glucose, also can participate in signal transduction path in the one or more of cells in this microorganism.This active example has also been described here.Thereby, " function of pts protein " has contribution for the repertoire and/or the adjusting of one or more of carbohydrate transporting pathway based on phosphoenolpyruvic acid, and/or the direct or indirect output to one or more fine chemistry materials, production and/or production efficiency have contribution.The active example of pts protein is listed in table 1.
In another embodiment, protein and whole aminoacid sequence of the present invention have at least approximately homology of 50-60%, the approximately homology of 60-70% is preferably arranged at least, and preferred have at least approximately 70-80%, a 80-90%, the homology of 90-95%, most preferred have about at least 96%, 97%, 98%, 99% or higher homology (for example, even number sequence number in the sequence table: sequence).
The proteinic part of PTS nucleic acid molecule encoding of the present invention, the preferably biologically-active moiety of pts protein.Such as used herein, the meaning of term " biologically-active moiety of pts protein " is to comprise the such part of pts protein, structural domain/primitive for example, this part can perhaps participate in signal transduction path in the one or more of cells in this microorganism similarly being the such high-energy carbon molecule input Corynebacterium glutamicum of glucose.Can carry out a kind of enzyme activity assay, to determine whether pts protein or its biologically-active moiety have participated in perhaps having participated in similarly be the such high-energy carbon molecule input Corynebacterium glutamicum of glucose in signal transduction path in the one or more of cells in this microorganism.The person knows this analytical procedure for being familiar with the routine techniques, in the example 8 of example detailed description is arranged.
The extra nucleic acid fragment of coding pts protein biologically-active moiety, can prepare by the following method, (for example separate aminoacid sequence of the present invention, even number sequence number in the sequence table: part sequence), the encoding part of expression pts protein or polypeptide (for example, pass through in-vitro recombination expression), and the activity of estimation pts protein or peptide coding part.
Because the degeneracy of genetic codon, and can encode thus and obtain and the identical pts protein of nucleotide sequence encoding protein matter of the present invention, so further comprising, the present invention is different from nucleotide sequence of the present invention (for example, odd serial numbers in the sequence table: the sequence) nucleic acid molecule of (with its part).In another embodiment, isolating nucleic acid molecule of the present invention has such nucleotide sequence, and this sequence encoding has the protein of the aminoacid sequence of listing in the sequence table (for example, even number sequence number :).Equally in another embodiment, the Corynebacterium glutamicum protein of nucleic acid molecule encoding total length of the present invention, this protein and aminoacid sequence of the present invention are (by odd serial numbers in the sequence table: the open reading frame coding) sufficient homology is arranged.
In one embodiment, technical known sequences before sequence of the present invention and not meaning that comprises, for example those are listed in the just effective Genbank sequence before the present invention in table 2 or the table 4, and person is understandable for being familiar with the routine techniques for this.In one embodiment, the present invention comprises such nucleotide sequence and aminoacid sequence, this sequence and nucleotide sequence of the present invention and aminoacid sequence have the consistence of certain percentage, this per-cent is greater than the per-cent of technical known sequences (the Genbank sequence of for example, listing in table 2 or the table 4 (the perhaps protein of this sequence encoding)) with nucleotide sequence of the present invention and consensus amino acid sequence.For example, the present invention comprise with the nucleotides sequence that is marked as RXA01503 (SEQ ID NO:5) show greater than and/or at least 44% conforming nucleotide sequence, with the nucleotides sequence that is marked as RXA00951 (SEQ ID NO:15) show greater than and/or at least 41% conforming nucleotide sequence, and with the nucleotides sequence that is marked as RXA01300 (SEQ ID NO:21) show greater than and/or at least 38% conforming nucleotide sequence.The person that is familiar with the routine techniques, calculate the per-cent consistence by 3 GPA-that meet the highest that provide for each particular sequence that list in the look-up table 4, and deduct the highest GPA-in 100 percent through associating and calculate the per-cent consistence, can calculate the conforming low side thresholding of any particular sequence per-cent of the present invention.The person also can recognize to be familiar with the routine techniques, and its per-cent consistence is greater than the low side thresholding that so calculates (for example, at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59% or 60%, preferably about at least 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69% or 70%, preferred about at least 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79% or 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 88%, 89% or 90%, perhaps 91%, 92%, 93%, 94%, and even preferred about at least 95%, 96%, 97%, 98%, 99% or higher consistence) nucleic acid and aminoacid sequence, also be included among the present invention.
The person can recognize to be familiar with the routine techniques, except the Corynebacterium glutamicum PTS nucleotide sequence of listing with odd serial numbers in sequence table, the dna polymorphism that causes the pts protein aminoacid sequence to change can exist in certain colony (for example Corynebacterium glutamicum colony).This PTS Gene Polymorphisms can exist in the Different Individual of a colony owing to the variation of natural condition.Such as used herein, term " gene " and " recombination " are meant the nucleic acid molecule of the open reading frame that contains the pts protein of encoding, and preferred pts protein is the Corynebacterium glutamicum pts protein.The variation of this natural condition typically can cause the variation of PTS gene nucleotide series 1-5%.Any and all cause, and do not change the pts protein functionally active owing to the variation of natural condition, the variation of this Nucleotide, and the amino acid whose polymorphism of the PTS that causes all belong within the scope of the invention.
The nucleic acid molecule of corresponding natural variant, non-glutamic acid rod bacillus homologue with Corynebacterium glutamicum PTS DNA of the present invention, can be based on the homology of disclosed herein they and Corynebacterium glutamicum PTS nucleic acid molecule, use Corynebacterium glutamicum DNA or its part as hybridization probe, separation obtains according to the standard hybridization technique under stringent hybridization condition.Therefore, in another embodiment, the length of isolating nucleic acid molecule of the present invention has 15 Nucleotide at least, under stringent condition with contain the ordered list odd serial numbers: the making nucleic acid molecular hybridization of nucleotide sequence.In other embodiments, the length of nucleic acid molecule has 30,50 at least, and 100,250 or more a plurality of Nucleotide.Such as used herein, the meaning of term " hybridize under stringent condition " is to describe the such hybridization and the condition of cleaning, has the nucleotide sequence of at least 60% homology to keep typical hybridization each other under this condition each other.Preferably, this condition be have between the sequence about at least 65%, preferred have about at least 70%, and even preferredly have about at least 75 or higher homology, keep typical hybridization each other.The person is known to this stringent condition for being familiar with the routine techniques, can be at Ausubel et al., and Current Protocols in Molecular Biology, JohnWiley ﹠amp; Sons, N.Y. (1989) finds among the 6.3.1-6.3.6.Preferably a kind of but be not that the stringent hybridization condition of restriction is, in 6X sodium chloride/sodium citrate (SSC), hybridize for about 45 ℃, use 0.2X SSC then, 0.1%SDS is 50-65 ℃ of cleaning once or repeatedly.Preferably, isolating nucleic acid molecule of the present invention with nucleotide sequence hybridization of the present invention, is equivalent to obtain naturally occurring nucleic acid molecule under stringent hybridization condition.Such as used herein, " naturally occurring " nucleic acid molecule is meant RNA or the dna molecular with the nucleotide sequence (for example, coding natural protein) that exists in the nature.In one embodiment, the natural Corynebacterium glutamicum pts protein of nucleic acid encoding.
The person can further recognize to be familiar with the routine techniques, the naturally occurring PTS sequence variants that in colony, exists, can be by sudden change change introducing in the nucleotide sequence of the present invention, thus the change of the aminoacid sequence of the pts protein that causes being encoded, and do not change the function of pts protein.For example, can be in nucleotide sequence of the present invention, carry out causing the Nucleotide of the aminoacid replacement of " nonessential " amino-acid residue to replace." nonessential " amino-acid residue is meant such residue, this residue can be at the wild-type sequence of pts protein (for example, even number sequence number in the sequence table: change sequence), and do not change the activity of pts protein, and " essential " amino-acid residue is that the pts protein activity is necessary.Yet other amino-acid residues (for example, those are nonconservative or be semiconservative amino-acid residue in the PTS active structure domain) may be optional for activity, therefore also can be changed not changing under the active situation of PTS.
Therefore, another aspect of the present invention relates to the nucleic acid molecule of coding such pts protein, and this pts protein contains the variation to the active nonessential amino-acid residue of PTS.These proteinic aminoacid sequences are different from even number sequence number in the sequence table: sequence, but still keep at least a PTS activity described herein.In one embodiment, isolated nucleic acid molecule comprises the nucleotide sequence of one section coded protein, wherein this proteinic aminoacid sequence and aminoacid sequence of the present invention have about at least 50% homology, and can be similarly being that the such high-energy carbon-containing molecules of glucose is transported into Corynebacterium glutamicum, perhaps participate in signal conduction in the cell in this microorganism, perhaps have one or more activity of listing in the table 1.Preferably, odd serial numbers aminoacid sequence in the protein of nucleic acid molecule encoding and the sequence table, at least approximately the homology of 50-60% is arranged, and preferred and this sequence has at least approximately homology of 60-70%, even preferred and this sequence has at least approximately 70-80%, 80-90%, the homology of 90-95%, aminoacid sequence most preferred and of the present invention has about at least 96%, 97%, 98%, perhaps 99% homology.
In order (for example to determine two seed amino acid sequences, a kind of aminoacid sequence of the present invention and its mutant forms) or the percent homology of two kinds of nucleotide sequences, for optimum purpose relatively, sequence (is for example carried out the sequence contrast, in order to carry out optimum sequence contrast, can in the sequence of a kind of protein or nucleic acid, introduce the gap) with other protein or nucleic acid.The Nucleotide of the amino-acid residue of more corresponding amino acid position or nucleic acid position then.When a sequence (for example, an aminoacid sequence of the present invention) position in by with other sequences (for example, when the mutant forms of aminoacid sequence) identical amino-acid residue in corresponding position or Nucleotide occupy, this molecule is homologous (that is, " consistence " of amino acid or nucleic acid " homology " and amino acid or nucleic acid is identical as used herein) in this position.Per-cent homology between the two sequences is the function (that is # * 100 of the # of % consistence=same position/whole positions) that a same position number is divided equally by sequence.
Isolating and protein sequence of the present invention are (for example, even number sequence number in the sequence table: the sequence) nucleic acid molecule of homologous coding pts protein matter, can replace by in nucleotide sequence of the present invention, introducing one or more Nucleotide, insert, disappearance produce, thereby in coded protein, introduce one or more aminoacid replacement, insertion, disappearance.Can use standard technique, for example site-directed mutagenesis and PCR mediated mutagenesis are introduced sudden change in nucleotide sequence of the present invention.Preferably, Bao Shou aminoacid replacement is that non-essential amino acid residue in one or more expection carries out." conservative aminoacid replacement " is meant that the amino-acid residue that amino-acid residue is had a similar side chain replaces.Have the amino-acid residue family of similar side chain, regulation is arranged technically.These families comprise, amino acid with basic side chain (for example, Methionin, arginine, Histidine), amino acid with acid side-chain (for example, aspartic acid, L-glutamic acid), amino acid with no charge polarity side chain (for example, glycine, aspartic acid, glutamine, Serine, Threonine, tyrosine, halfcystine), amino acid with non-polar sidechain (for example, L-Ala, Xie Ansuan, leucine, Isoleucine, proline(Pro), phenylalanine, methionine(Met), tryptophane), amino acid with β-side chain side chain (for example, Threonine, Xie Ansuan, Isoleucine), and amino acid (for example, tyrosine with fragrance group side chain, phenylalanine, tryptophane, Histidine).Therefore, the non-essential amino acid residue in the pts protein of expection is preferably by other aminoacid replacement in the same side chain family.In addition, in another embodiment, can be in PTS encoding sequence total length or part, introducing sudden change at random for example by saturation mutagenesis, has the PTS activity of PTS active mutant according to evaluation described herein, filters out the mutant that obtains.After the mutagenesis of odd serial numbers nucleotide sequence, the protein that is encoded can be recombinant expressed in a sequence table, protein active also can, for example use analysis described herein (referring to the example 8 of example), determined.
Except the nucleic acid molecule of coding pts protein matter described above, another aspect of the present invention is also relevant with isolating antisense nucleic acid molecule." antisense " nucleic acid comprises " justice is arranged " nucleic acid complementary nucleotide sequence with coded protein, for example with the complementation of double chain DNA molecule coding strand, perhaps with the complementation of mRNA sequence.Therefore, antisense nucleic acid can be connected with phosphorothioate odn is arranged by hydrogen bond.Antisense nucleic acid can with the complementation of whole PTS coding strand, also can be only and its part complementation.In one embodiment, antisense nucleic acid molecule is with " coding region " antisense of nucleotide sequence coded chain of coding pts protein.Term " coding region " is meant the nucleotides sequence column region (for example, whole coding regions of SEQ ID NO.5 (RAX01503) comprise 1 to 249 Nucleotide) that comprises the codon of translating into amino-acid residue.In another embodiment, antisense nucleic acid molecule is with the antisense of nucleotide sequence coded chain of coding PTS.Term " non-coding region " is meant that the coding region both sides do not translate into amino acid whose 5 ' and 3 ' sequence (i.e. 5 ' and 3 ' untranslated zone).
Consider the coding strand sequence (for example, the odd serial numbers sequence of listing in the sequence table) of the coding PTS that announces herein, antisense nucleic acid of the present invention can design according to the base pairing rules of Watson and Crick.Antisense nucleic acid molecule can with whole coding region complementations of PTS mRNA, but be more preferably such oligonucleotide, this oligonucleotide is an antisense with the coding region of PTS mRNA or the part of non-coding region only.For example, antisense oligonucleotide can with near the regional complementarity the PTS mRNA translation initiation position.For example, the length of antisense oligonucleotide can be 5,10,15,20,25,30,35,40, and 45 or 50 Nucleotide.Antisense nucleic acid molecule of the present invention, can use technology on known program, make up by chemosynthesis or enzymatic ligation.Can use naturally occurring Nucleotide or various Nucleotide through modifying, chemosynthesis antisense nucleic acid (for example antisense oligonucleotide), those Nucleotide through modifying, be in order to increase the biologically stable of molecule, perhaps in order to increase antisense nucleic acid and to have between the phosphorothioate odn the double-helical physical stability of formation design, the Nucleotide that for example can use thiophosphoric acid derivative and acridine to replace.The example that can be used for producing the modified Nucleotide of antisense nucleic acid comprises, 5 FU 5 fluorouracil, 5-bromouracil, the 5-chlorouracil, 5-iodouracil, xanthoglobulin, xanthine, the 4-acetylcytosine, 5-(carboxyl hydroxymethyl) uridylic, 5-carboxymethylamino methyl-2-thiouracil, 5-carboxymethylamino 6-Methyl Uracil, dihydrouracil, beta-D-galactosyl inosine, N6-isopentyl VITAMIN B4, the 1-methyl guanine, the 1-methylinosine, 2, the 2-dimethylguanine, the 2-methyladenine, the 2-methyl guanine, 3-methylcystein, 5-methylcytosine, the N6-VITAMIN B4, the 7-methyl guanine, 5-methylamino 6-Methyl Uracil, 5-methoxyl group amino methyl uridylic-2-sulfo-uridylic, beta-D-mannose group queosine, 5 '-methoxyl group carboxyl 6-Methyl Uracil, 5-methoxyuracil, 2-methyl sulfo--N6-isopentyl VITAMIN B4, uridylic-5-contains fluoroacetic acid (V), wybutoxosine, pseudouracil, queosine, 2-sulfo-cytosine(Cyt), 5-methyl-2-sulfo-uridylic, 2-sulfo-uridylic, 4-sulfo-uridylic, methyl uracil, uridylic-5-contains the fluoroacetic acid methyl esters, and uridylic-5-contains fluoroacetic acid (v), 5-methyl-2-sulfo-uridylic, 3-(3-amino-3-N-2-carboxyl propyl group) uridylic, (acp3) w, and 2,6-diaminopurine.In addition, antisense nucleic acid can use the expression vector biosynthesizing, and its amplifying nucleic acid (that is, by the RNA that inserts transcribed nucleic acid, is antisense orientation with respect to the purpose nucleic acid that inserts, with the lower section further narration is arranged) in expression vector by the antisense orientation subclone.
Antisense nucleic acid molecule of the present invention, typically be applied to cell or produce in position, thereby they can or combine with the cell mRNA and/or the genomic dna hybridization of coding pts protein, and then the expression of arrestin matter, for example, suppress to transcribe and/or translate.Hybridization can form stable duplex by conventional Nucleotide is complementary, and perhaps, for example, when antisense nucleic acid molecule during in conjunction with the dna double spiral, special interaction takes place for it and double-helical major groove.Antisense molecule can be modified, thereby makes this molecule to combine with acceptor or with the antigen-specific of specific cells surface expression, and for example, antisense nucleic acid molecule combines with polypeptide or antibody, and this antibody combines with cell surface receptor or antigen.Antisense nucleic acid molecule also can use carrier described herein to be delivered to cell.In order to obtain the antisense molecule of enough concentration in the cell, such carrier is preferred, and promptly in this carrier, antisense nucleic acid molecule is placed under the control of protokaryon, virus or eukaryotic promoter.
And in another embodiment, antisense nucleic acid molecule of the present invention is a kind of α-anomer nucleic acid molecule.α-anomer nucleic acid molecule and complementary RNA form special double-stranded crossbred, and two strands of chains move towards parallel to each other in the crossbred, this and common β-unit opposite (Gaultier et al. (1987) Nucleic Acids.Res.15:6625-6641).Antisense nucleic acid molecule also can comprise 2 '-o-methyl ribonucleotides (Inoue et al. (1987) Nucleic Acids.Res.15:6131-3148) or chemical RNA-DNA analogue (Inoue et al. (1987) FEBS Lett.215:327-330).
And in another embodiment, antisense nucleic acid molecule of the present invention is a ribozyme.Ribozyme is a catalytic type RNA molecule, has ribonuclease activity, can cutting single-chain nucleic acid, and mRNA for example, it has and single-chain nucleic acid complementary zone.Therefore, ribozyme (for example, hammerhead ribozyme (being described in Haselhoff and Gerlach (1988) Nature 334:585-591)) can be used for catalyze cleavage PTS mRNA transcript, thereby suppresses the translation of PTS mRNA.For the PTS coding nucleic acid molecule specific ribozyme is arranged, can design based on the PTS dna nucleotide sequence of announcing (being SEQID NO:5 (RAX01503)) herein.For example, can make up the derivative of tetrahymena L-19 IVS RNA, the nucleotide sequence of its avtive spot is a complementary with the nucleotide sequence of the PTS-that is cut coding mRNA.Referring to, for example, Cech et al.U.S.Patent No.4,987,071 and Cech et al.U.S.Patent No.5,116,742.In addition, PTS mRNA can be used for the catalytic type RNA that the screening of RNA library of molecules has special ribozyme activity.Referring to, for example, Bartel, D.and Szostak, J.W. (1993) Science 261:1411-1418.
In addition, as target, form triple-helix structure by handle and PTS nucleotide sequence regulation domain (for example, PTS promotor and/or enhanser) complementary nucleotide sequence, can suppress the PTS expression of gene, this triple-helix structure can stop PTS gene transcribing in the purpose cell.Generally referring to, Helene, C. (1991) Anticancer Drug Des.6 (6): 569-84; Helene, C.et al. (1992) Ann.N.Y.Acad Sci.660:27-36; And Maher, L.J. (1992) Bioassays 14 (12): 807-15.
B. recombinant expression vector and host cell
Another aspect of the present invention relates to carrier, preferably contains coding pts protein (perhaps its part) expression of nucleic acids carrier.Such as used herein, term " carrier " is meant and can connects other nucleic acid, and to its nucleic acid molecule that transports.One type carrier is " plasmid ", and plasmid is meant the circular double-stranded DNA ring, wherein is connected with extra dna fragmentation.The carrier of another kind of type is a virus vector, and wherein extra dna fragmentation can be connected in the viral genome.Some carrier can carry out self-replicating (for example, have the bacteria carrier of bacterium replication orgin, and additive type Mammals carrier) in the host cell that they are introduced into.Other carrier (for example, non-add type Mammals carrier) will be incorporated in the genome of host cell once introducing host cell, thereby together duplicates with host genome.In addition, some carrier can instruct and be attached thereto the expression of gene that connects.These carriers are called " expression vector " herein.In a word, the expression vector of recombinant DNA technology use often is the plasmid form.In this explanation, " plasmid " and " carrier " can exchange use, because plasmid is the carrier format of normal use.Yet the present invention has a mind to comprise other forms of these expression vectors, virus vector (for example, replication defect type retrovirus, adenovirus and adeno associated virus) for example, and they have identical functions.
Recombinant expression vector of the present invention comprises nucleic acid of the present invention, this nucleic acid exists with the form that is fit to expression of nucleic acid in host cell, this just means that recombinant expression vector contains one or more of adjusting sequences, these sequences are based on as the host cell of expressing and select, and they are by feasible being connected on the nucleotide sequence that will express.In recombinant expression vector, the meaning of " feasible connection " is meant, nucleotide sequence interested is connected (for example, in in-vitro transcription/translation system, perhaps in the host cell that carrier is introduced into) with the adjusting sequence in the mode that allows nucleotide sequence to express.The meaning of term " adjusting sequence " is to comprise promotor, enhanser and other expression control elements (for example, polyadenylation signal).This adjusting sequence exists, for example, and Goeddel; GeneExpression Technology:Methods in Enzymology 185, Academic Press, SanDiego, CA has description in (1990).The adjusting sequence comprises that those instruct the sequence of nucleotide sequence constitutive expression in a lot of type host cells, and those instruct the sequence of nucleotide sequence expression in some host cell.The preferred sequence of regulating is, for example, similarly is cos-, tac-, trp-, tet-, trp-tet-, lpp-, lac-, lpp-lac-, lacI
q-, T7-, T5-, T3-, gal-, trc-, ara-, SP6-, arny-, SPO2-, λ-P
R-or λ P
LSuch promotor, these promotors are preferably used in bacterium.Adjusting sequence in addition is, for example, and the promotor of yeast and fungi, ADC1 for example, MF α, AC, P-60, CYC1, GAPDH, TEF, rp28, ADH, the promotor of plant, for example, CaMV/35S, SSU, OCS, lib4, usp, STLS1, B33, no or ubiquitin-or phaseoin-promotor.Also can use artificial promotor.Person can recognize for being familiar with the routine techniques for these, i.e. the design of expression vector depends on these factors: be used for the selection of transformed host cells, the expression level of desired protein etc.Expression vector of the present invention can be introduced host cell, thereby produces coded protein of nucleic acid described herein or polypeptide, comprises fused protein or polypeptide (for example, the mutant form of pts protein, pts protein, fused protein etc.).
Can design recombinant expression vector of the present invention, be used for expressing pts protein at protokaryon or eukaryotic cell.For example, the PTS gene can be expressed in following cell, it similarly is the such bacterial cell of Corynebacterium glutamicum, insect cell (use rhabdovirus expression vector), yeast and other fungal cells are (referring to Romanos, M.A.et al. (1992) " Foreign gene expression in yeast:areview ", Yeast 8:423-488; Van den Hondel, C.A.M.J.J.et al. (1991) " Heterologousgene expression in filamentous fungi " in:More Gene Manipulations in Fungi, J.W.Bennet ﹠amp; LL.Lasure, eds., p.396-428:Academic Press:San Diego; And van denHondel, C.A.M.J.J.﹠amp; Punt, P.J. (1991) " Gene transfer systems and vectordevelopment for filamentous fungi; in:Applied Molecular Genetics of Fungi; Peberdy; J.F.et al.; eds.; p.1-28, Cambridge University Press:Cambridge) algae or metaphyte cell are (referring to Schmidt, R.and Willmitzer, L. (1998) High efficiencyAgrobacterium tumefaciens-mediated transformation of Arabidopsisthaliana leaf and cotyledon explants " Plant Cell Rep.:583-586), perhaps mammalian cell.Appropriate host cell is at Goeddel, Gene Expression Technology:Methods in Enzymology 185, and Academic Press, San Diego, CA has further argumentation in (1990).In addition, recombinant expression vector can for example use the T7 promotor to regulate sequence and T7 polysaccharase in in-vitro transcription and translation.
Protein expression in the prokaryotic cell prokaryocyte often is to be undertaken by the carrier that contains composing type or inducible promoter, and these promotors instruct the expression of fused protein or non-fused protein.Fusion vector adds the amino acid of certain number on coded protein, normally at the N-terminal of recombinant protein.This fusion vector has 3 typical use: 1) increase the expression of recombinant protein; 2) solvability of increase recombinant protein; With 3) as the aglucon of affinity purification, help the fusion rotein purifying.In fusion expression vector, the protein cleavage site often is to be introduced in the junction of merging part and recombinant protein, make after being purified into fused protein, can recombinant protein with merge part and separate.This kind of enzyme, and their cognate recognition sequence comprise Xa factor, zymoplasm and enteropeptidase.
Typical fusion expression vector comprises pGEX (Pharmacia Biotech Inc; Smith, D.B.and Johnson, K.S. (1988) Gene 67:31-40), pMAL (New England Biolabs, Beverly, MA) and pRIT5 (Pharmacia, Piscataway, NJ), they have merged glutathione S-transferring enzyme (GST) with target recombinant protein respectively, maltose E is conjugated protein, perhaps a-protein.In one embodiment, the pts protein encoding sequence is cloned in the pGEX expression vector, produces the carrier of an encoding fusion protein, and this carrier comprises to the C-end from the N-end, GST-zymoplasm cleavage site-X protein matter.Fusion rotein can use glutathione-agarose resin, passes through affinitive layer purification.With the reorganization pts protein that GST separates, can be by obtaining with the zymoplasm splitting fused protein.
The example of suitable intestinal bacteria induction type non-fusion expression carrier comprises, pTrc (Amann etal., (1988) Gene 69:301-315), pLG338, pACYC184, pBR322, pUC18, pUC19, pKC30, pRep4, pSH1, pSH2, pPLc236, pMBL24, pLG200, pUR290, pIN-III 113-B1, λ gt11, pBdC1 and pET 11d (Studier et al., Gene ExpressionTechnology:Methods in Enzymology 185, Academic Press, San Diego, California (1990) 60-89; And Pouwels et al., eds. (1985) Cloning Vectors.Elsevier:New York IBSN 0 444 904018).The target gene of pTrc carrier is expressed, and depends on the transcribing of host RNA polysaccharase of hybridization trp-lac promoter, fusion.The target gene of pET 11d carrier is expressed, and depends on the transcribing of T7gn10-lac promoter, fusion of viral rna polymerase (T7 gn1) mediation of coexpression.This varial polymerases is provided by resident lambda particles phage among host strain BL21 (DE3) or the HMS174 (DE3), and this phage contains the T7 gn1 gene under the control of lacUV 5 promoter transcriptions.For the conversion of other kinds bacterioid, can select suitable carriers.For example, known plasmid pIJ101, it is effectively that pIJ364, pIJ702 and pIJ361 transform streptomycete, and plasmid pUB110, pC194, perhaps pBD214 is fit to transform shaft-like bacterial classification.Help that genetic information is changed over to coryneform several plasmid and comprise pHM1519, pBL1, pSA77 or pAJ667 (Pouwels et al., eds. (1985) Cloning Vectors, Elsevier:NewYork IBSN 0 444 904018).
A kind of scheme that increases expression of recombinant proteins to greatest extent is, in host cell, express such protein, this protein has the ability (Gottesman of the proteolytic cleavage recombinant protein that can not weaken, S., Gene Expression Technology:Methods in Enzymology 185, Academic Press, San Diego, California (1990) 119-128).Another kind of scheme is to change the nucleotide sequence that inserts the expression vector amplifying nucleic acid, make each amino acid whose codon all be that the selected bacterium that is used to express is preferential and use, for example Corynebacterium glutamicum (Wada et al. (1992) Nucleic Acids Res.20:2111-2118).This change of nucleotide sequence of the present invention can be undertaken by the standard DNA synthetic technology.
In another embodiment, the pts protein expression vector is a Yeast expression carrier.The example of the carrier that yeast S.cerivisae is used to express comprises, pYepSec1 (Baldari, et al., (1987) Embo is J.6:229-234), 2 μ, pAG-1, Yep6, Yep13, pEMBK Ye23, pMFa (Kurjan and Herskowitz, (1982) Cell 30:933-943), pJRY88 (Schultz et al., (1987) Gene 54:113-123), and pYES2 (Invitrogen Corporation, San Diego, CA).Be used for structure and be adapted at other fungies, for example in the filamentous fungus, the carrier of the carrier of use and method comprise that those are specified in the following document: van den Hondel, C.A.M.J.J.﹠amp; Punt, P.J. (1991) " Gene transfer systems and vector development forfilamentous fungi; in:Applied Molecular Genetics of Fungi, J.F.Peberdy, etal.; eds.; p.1-28, Cambridge University Press:Cambridge, and Pouwels et al.; eds. (1985) Cloning Vectors, Elsevier:New York IBSN 0 444 904018).
In addition, pts protein of the present invention can use rhabdovirus expression vector in expressed in insect cells.In the insect cell of cultivating (for example Sf9 cell), the baculovirus vector that is used for marking protein comprises, pAC series (Smith et al. (1983) Mol.Cell Biol.3:2156-2165) and pVL series (Lucklow and Summer (1989) Virology 170:31-39).
In another embodiment, pts protein of the present invention can be expressed in one-celled plants cell (for example algae), perhaps expresses in the vegetable cell of higher plant (for example spermatophyte similarly is a crop plants).The example of plant expression vector comprises that those are specified in the following document: Becker, D., Kemper, E., Schell, J.and Masterson, R. (1992) " New plant binaryvectors with selectable markers located proximal to the left border ", Plant Mol.Biol.20:1195-1197; And Bevan, M.W. (1984) " Binary Agrobacterium vectors for planttransformation ", Nucl.Acid.Res.12:8711-8721, comprise pLGV23, pGHlac+, pBIN19, pAK2004 and pDH51 (Pouwels et al., eds. (1985) Cloning Vectors.Elsevier:New York IBSN 0 444 904018).
Also be in another embodiment, nucleic acid of the present invention uses mammalian expression vector to express in mammalian cell.The example of mammalian expression vector comprises pCDM8 (Seed, B. (1987) Nature 329:840) and pMT2PC (Kaufman et al. (1987) EMBO J.6:187-195).The controlled function of expression vector, when being used in the Mammals at that time, often regulating element by virus provides.For example, normally used promotor is from polyoma, adenovirus 2, cytomegalovirus and simian virus 40.Other are for prokaryotic cell prokaryocyte and all suitable expression system of eukaryotic cell, referring to Sambrook, J., Fritsh, E.F., and Maniatis, T.Molecular Cloning:ALaboratory Manual.2nd ed.Cold Spring Harbor Laboratory, Cold SpringHarbor Laboratory Press, Cold Spring Harbor, NY, 1989 16 Zhanghe, 17 chapters.
In another embodiment, the mammalian expression vector of reorganization can instruct the expression (for example, tissue specificity is regulated element and is used to express nucleic acid) of preferred nucleic acid in the particular cell types.It is known technically that tissue specificity is regulated element.The example of suitable tissue-specific promoter including, but not limited to, (liver is special for albumin promoter; Pinkert et al. (1987) Gene Dev.1:268-277), lymph specific promoter (Calame and Eaton (1988) Adv.Immunol.43:235-275), special promoter (Banerji et al. (1983) the Cell 33:729-740 of special promoter of T-cell receptors (Winoto and Baltimore (1989) EMBO is J.8:729-933) and immunoglobulin (Ig); Queen and Baltimore (1983) Cell 33:741-748), the promotor of neuron-specific (neurofilament promotor for example; Byrne and Ruddle (1989) PANS86:5473-5477), the promotor (Edlund et al. (1985) Science 230:912-916) that pancreas is special, and the special promotor of mammary gland (milk whey promotor for example; U.S.Patent No.4,873,316 and European Application Publication No.264,166).Also comprise and grow the promotor of regulating, for example muroid hox promotor (Kessel and Gruss (1990) Science249:374-379) and α-fetoprotein promotor (Campes and Tilghman (1989) Genes Dev.3:537-546).
The present invention provides the recombinant expression vector that contains dna molecular of the present invention in addition, and this dna molecular is cloned in the expression vector with antisense orientation.That is to say that dna molecular can being connected in the following manner of operability be regulated on the sequence, i.e. the mode of the RNA developed by molecule (by transcribing of dna molecular) of permission and PTS mRNA antisense.Can select those in various cell types, to instruct the adjusting sequence of antisense rna molecule continuous expression, for example viral promotors and/or enhanser perhaps can be selected the adjusting sequence that instructs successive, sense-rna tissue-specific or that cell type is special to express, as regulating sequence.Antisense expression vector can exist with the form of recombinant plasmid, phagemid or attenuated virus, and antisense nucleic acid produces under the control of efficient regulation domain therein, and its activity can be determined by the cell type of introducing carrier.About using the inverted defined gene regulatory gene to express, can be referring to Weintraub, H.et al., Antisense RNA as amolecular tool for genetics analysis, Review-Trends in Genetics, Vol.1 (1) 1986.
Another aspect of the present invention relates to the host cell that is introduced into recombinant expression vector of the present invention.Term " host cell " and " recombinant host cell " can be used alternatingly herein.This term is construed as, and not only refers to selected specific cells, and refers to the offspring of these cells or possible offspring.Because sudden change or environmental influence can make some modification occur in the going down to posterity of success, these progeny cells in fact can not be identical with parent cell, but be also contained within the term scope of herein using.
Host cell can be any protokaryon or eukaryotic cell.For example, pts protein can similarly be in the such bacterial cell of Corynebacterium glutamicum, in the insect cell, in the yeast cell or the middle expression of mammalian cell (for example Chinese rat ovary cell (CHO) or COS cell).Other proper host cell, the person knows for being familiar with the routine techniques.Can in table 3, list as the Corynebacterium glutamicum relationship microorganism of nucleic acid of the present invention and protein molecule host cell.
Carrier DNA can transform or rotaring dyeing technology by conventional, introduces protokaryon or eukaryotic cell.Such as used herein, the meaning of term " conversion " and " transfection " is meant various well known in the art, exogenous nucleic acid (for example, linear DNA or RNA are (for example, linear carrier or do not have the independent gene structure of carrier)) or the nucleic acid that exists with carrier format (for example, plasmid, phage, phagemid, phagemid, transposon or other DNA) change the technology of host cell over to, comprise calcium phosphate or calcium chloride co-precipitation, the transfection of DEAE-dextran mediation, lipofection, perhaps fax hole.The appropriate method of conversion or transfection host cell, can be at Sambrook, et al. (Molecular Cloning:A Laboratory Manual.2nd, ed.., ColdSpring Harbor Laboratory, Cold Spring Harbor Laboratory Press, ColdSpring Harbor, NY, 1989), and find on other laboratory manuals.
Known, for stable transfection mammalian cell, the expression vector and the rotaring dyeing technology that rely on to use have only sub-fraction to be incorporated into foreign DNA in himself genome.In order to identify and screen these intasomies, the gene of coding selection markers (for example, to antibiotic resistance) is together introduced host cell with interested gene usually.Preferred selection markers comprises that those can give the mark of drug resistance, for example G418, Totomycin and methotrexate.The nucleic acid of coding selection markers can be introduced into host cell with pts protein on same carrier, perhaps introduce host cell on independent carrier.Through being introduced into the nucleic acid stability cells transfected, can use drug screening to identify (for example, can survive with the cell that the selection markers gene merges, other cells are then died).
In order to create the homologous recombination microorganism, preparation contains to the carrier of small part PTS gene, and this gene has disappearance, adds or replaces, thereby changes for example functional destruction, PTS gene.Preferably this is a Corynebacterium glutamicum PTS gene, but it also can be the homologue from the relationship bacterium, or even from Mammals, yeast or insect.In a preferred embodiment, design vector makes according to homologous recombination, and endogenous PTS gene is by functional destruction (that is code function protein of not being on the permanent staff; Be also referred to as " knocking out " carrier).In addition, can design vector, make that endogenous PTS gene is undergone mutation or changed according to homologous recombination, but encode functional protein matter (for example, change the upstream regulation zone, thereby change endogenous PTS expression of gene) still.In homologous recombination vector, reformed PTS Gene Partial is connected with unnecessary PTS nucleic acid in its 5 ' and 3 ' end profile, makes homologous recombination can occur between the endogenous PTS gene of external source PTS gene that carrier carries and microorganism.The PTS nucleic acid that unnecessary side connects has enough length, can with the generation homologous recombination of native gene success.Typically, contain in the carrier several thousand bases side chain DNA (5 ' and 3 ' end) (referring to, for example, Thomas, K.R., and Capecchi, M.R. (1987) Cell 51:503 for a description of homologous recombinationvectors).Introduce the carrier of microorganism (for example fax hole) and cell, select those the PTS genes wherein introduced and endogenous PTS gene, what known technology can homologous recombination on the use technology.
In another embodiment, can produce the recombinant microorganism that contains the system of being allowed a choice, this system allows to regulate the introducing expression of gene.For example, the PTS gene that comprises is in carrier under the control of lac operon, makes the PTS gene to express when IPTG exists.This regulation system is known technically.
In another embodiment, the endogenous PTS gene in the host cell destroyed (for example, by known genetic method on homologous recombination or the other technologies) makes the expression of its protein not take place.In another embodiment, endogenous in the host cell or the PTS gene of introducing change through one or more point mutation, disappearance or inversion, but encoding function pts protein still.And in another embodiment, one or more regulation domain of microorganism PTS gene (for example, promotor, repressor or elicitor) be changed (for example) by disappearance, shearing, inversion or point mutation, make that the PTS expression of gene is adjusted.The person can recognize to be familiar with the routine techniques, contains the host cell of a more than described PTS gene and protein modification, uses method of the present invention to produce easily, and these cells are also contained among the present invention.
Host cell of the present invention, for example protokaryon of Pei Yanging or eukaryotic host cell can be used for producing (for example expressing) pts protein.Therefore, the present invention further provides, used host cell of the present invention to produce the method for pts protein.In one embodiment, this method is included in cultivation host cell of the present invention in the suitable medium and (has wherein introduced the recombinant expression vector of coding pts protein, perhaps introduced the gene of the pts protein of encoding wild type or change in its genome), up to producing pts protein.In another embodiment, this method further comprises from substratum or host cell and separates pts protein.
C. isolating pts protein
Another aspect of the present invention relates to isolating pts protein and biologically-active moiety thereof." isolating " or " purifying " albumen, perhaps its biologically-active moiety does not have cellular material basically when using recombinant DNA technology to produce, and does not have precursor or other chemical substances when chemosynthesis basically.Term " is substantially free of cellular material " and comprises such pts protein preparation, and wherein protein is isolated from the cellular component of natural or this proteinic cell of reorganization generation.In one embodiment, term " is substantially free of cellular material " and comprises that preparation contains the pts protein of the non-pts protein of about at least 30% (dry weight) (being also referred to as " contaminating protein matter " herein), preferred containing is less than about 20% non-pts protein, even preferred containing be less than about 10% non-pts protein, most preferred containing is less than about 5% non-pts protein.When pts protein or its biologically-active moiety when reorganization produces, preferably be substantially free of substratum, promptly substratum is less than the about 20% of preparation protein volume, preferably is less than 10%, most preferredly is less than about 5%.Term " is substantially free of precursor or other chemical substances " and comprises such pts protein preparation, and wherein protein is isolated from the precursor that participates in protein synthesis or other chemical substances.In one embodiment, term " is substantially free of precursor or other chemical substances " and comprises that preparation contains the pts protein of about at least 30% (dry weight) precursor or non-PTS chemical substance, preferred containing is less than about 20% precursor or non-PTS chemical substance, even preferred containing be less than about 10% precursor or non-PTS chemical substance, most preferred containing is less than about 5% precursor or non-PTS chemical substance.In a preferred embodiment, isolating protein or its biologically-active moiety do not contain the contaminating protein matter from the same organism that obtains pts protein.This protein is typically by recombinant expressed generation, for example the Corynebacterium glutamicum pts protein in the microorganism recombinant expressed as Corynebacterium glutamicum.
Isolating pts protein of the present invention or its biologically-active moiety, can participate in handle similarly is that the such high-energy carbon-containing molecules of glucose is transported into Corynebacterium glutamicum, perhaps participate in signal conduction in the cell in this microorganism, perhaps have one or more and be listed in activity in the table 1.In a preferred embodiment, protein or its part contain such aminoacid sequence, this sequence and aminoacid sequence of the present invention are (for example, sequence table even number sequence number a: sequence in the sequence) sufficient homology is arranged, make this protein or its biologically-active moiety, have the ability to participate in similarly being that the such high-energy carbon-containing molecules of glucose is transported into Corynebacterium glutamicum, perhaps participate in signal conduction in the cell in this microorganism.Proteinic part preferably is meant biologically-active moiety described herein.In another preferred embodiment, pts protein of the present invention has in sequence table with the even number sequence number: the aminoacid sequence of listing.In another preferred embodiment, pts protein has by nucleotide sequence coded aminoacid sequence, this nucleotide sequence and nucleotide sequence of the present invention (for example, sequence table odd serial numbers a: sequence in the sequence) hybridization, for example hybridize under stringent condition.In another preferred embodiment, pts protein has by so nucleotide sequence coded aminoacid sequence, and this nucleotide sequence and a nucleotide sequence of the present invention or its part have about at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59% or 60% homology preferably has about at least 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69% or 70% homology, preferred have about at least 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79% or 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 88%, 89% or 90%, perhaps 91%, 92%, 93%, 94%, and even preferredly have about at least 95%, 96%, 97%, 98%, 99% or higher homology.Scope between above-cited value or consistence value (for example, the consistence of 70-90% or the consistence of 80-95%), that also has a mind to comprises in the present invention.For example, that has a mind to has comprised such consistence value scope, and these scopes are combinations of the above-cited upper limit and/or lower value.The preferred pts protein of the present invention also preferably has at least a PTS activity described herein.For example, the preferred pts protein of a kind of the present invention comprises so nucleotide sequence coded aminoacid sequence, this nucleotide sequence and nucleotide sequence hybridization of the present invention, hybridize under stringent condition for example, and it similarly is that the such high-energy carbon-containing molecules of glucose is transported into Corynebacterium glutamicum that this sequence can participate in handle, perhaps participate in signal conduction in the cell in this microorganism, perhaps have one or more and be listed in activity in the table 1.
In other embodiments, pts protein and aminoacid sequence of the present invention are (for example, sequence table even number sequence number a: sequence in the sequence) sufficient homology is arranged, and has the proteinic functionally active of aminoacid sequence of the present invention, as above I partly describe in detail, its aminoacid sequence is because natural change or sudden change and different.Therefore, in another embodiment, pts protein is such protein, and aminoacid sequence that it has and complete aminoacid sequence of the present invention have about at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59% or 60% homology preferably has about at least 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69% or 70% homology, preferred have about at least 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79% or 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 88%, 89% or 90%, perhaps 91%, 92%, 93%, 94%, and even preferredly have about at least 95%, 96%, 97%, 98%, 99% or higher homology, and have at least a PTS activity described herein.Scope between above-cited value or consistence value (for example, the consistence of 70-90% or the consistence of 80-95%), that also has a mind to comprises in the present invention.For example, that has a mind to has comprised such consistence value scope, and these scopes are combinations of the above-cited upper limit and/or lower value.In another embodiment, the present invention is relevant with such total length Corynebacterium glutamicum protein, and this protein and aminoacid sequence of the present invention have sufficient homology.
The biologically-active moiety of pts protein comprises such polypeptide, this polypeptide contains the aminoacid sequence from the pts protein aminoacid sequence, for example, sequence table even number sequence number: aminoacid sequence or with the aminoacid sequence of pts protein homologous protein, this part contains than total length pts protein or total length pts protein homologous protein amino acid still less, and shows at least a pts protein activity.Typical biologically-active moiety (peptide, for example, amino acid length is for similarly being 5,10,15,20,30,35,36,37,38,39,40,50,100 or more peptide) comprise that one has at least a pts protein active structures territory or primitive.In addition, the other biological active part, wherein proteinic other parts are deleted, can prepare by recombinant technology, and identify its one or more activity described herein.The biologically-active moiety of preferred pts protein contains structural domain/primitive or its part of one or more biologically active of selecting.
Pts protein is preferably by recombinant DNA technology production.For example, the cloned nucleic acid molecule of coded protein (as mentioned above) in expression vector, expression vector is introduced host cell (as mentioned above) and express pts protein in host cell.According to suitable purification scheme, use standard protein purification technique then, from cell, separate pts protein.Except recombinant expressed, can use standard peptide synthetic technology chemosynthesis pts protein, polypeptide or peptide.In addition, natural pts protein can separate from cell (for example endotheliocyte), for example uses anti--PTS antibody, and this antibody can use pts protein of the present invention or its part to produce by standard technique.
The present invention also provides PTS chimeric protein or fusion rotein.As used herein, PTS " chimeric protein " or " fusion rotein " contain operability and are connected to PTS polypeptide on the non-PTS polypeptide." PTS polypeptide " is meant and contains PTS related amino acid polypeptide of sequence, and " non-pts protein " is meant and contains such protein related amino acid polypeptide of sequence, this protein and pts protein do not have basic homology, for example, from the protein different of identical or different organisms with pts protein.In fused protein, the meaning of term " operability connection " is meant that pts protein and non-pts protein are in-frame fusion each other.Non-PTS polypeptide can be fused to the N-end or the C-end of PTS polypeptide.For example, in one embodiment, fused protein is the DST-PTS fusion rotein, and wherein the PTS sequence is fused to the C-end of GST sequence.This fused protein help to recombinate purifying of pts protein.In another embodiment, fused protein is the pts protein that the allos signal sequence is arranged at its N-end.In some host cell (for example mammalian host cell), can increase the expression and/or the secretion of pts protein by using the allos signal sequence.
Preferably, chimeric protein of the present invention or fusion rotein produce by the standard recombinant dna technology.For example, linked together by in-frame according to the encode dna fragmentation of different peptide sequences of routine techniques, for example, use the end of blunt end or staggered end to connect, use Restriction Enzyme to digest so that suitable end to be provided, it is flat as suitable end to use sticky end to mend, and uses alkaline phosphatase treatment avoiding undesirable connection, and uses enzymatic to connect.In another embodiment, can use routine techniques to comprise that automatic dna synthesizer synthesizes fusion gene.In addition, can use the anchor primer to carry out the pcr amplification of gene fragment, the anchor primer can increase by two complementary overhangs between the consecutive gene fragment, consecutive gene can anneal subsequently and again increase and produce chimeric gene sequence (referring to, for example, Current Protocols in MolecularBiology, eds.Ausubel et al.John Wiley ﹠amp; Sons:1992).In addition, the expression vector that merges part (for example gst polypeptide) of much having encoded is that commerce provides.The PTS-coding nucleic acid can be cloned in this expression vector, make to merge that part is in-frame to be connected on the pts protein.
The homologue of pts protein can produce by sudden change, for example sudden change of the point of discontinuity of pts protein or shearing.As used herein, term " homologue " is meant the variant form of pts protein, and they can be used as active agonist of pts protein or antagonist.The agonist of pts protein can have pts protein biological activity identical or part basically.The antagonist of pts protein can suppress one or more activity of the natural existence form of pts protein, for example, and by combining with the downstream or the upstream member competitiveness of the PTS system that comprises pts protein.Therefore, Corynebacterium glutamicum pts protein of the present invention and homologue thereof, the activity that can regulate one or more of carbohydrate transporting pathway, the activity of perhaps regulating signal transduction path in the cell that pts protein plays a role in this microorganism.
In other embodiments, the homologue of pts protein can for example be sheared mutant by the combinatorial library of screening pts protein mutant, identifies pts protein agonist or antagonistic activity.In one embodiment, the diverse libraries of PTS variant produces by the sudden change of associativity on nucleic acid level, and is encoded by diversity gene library.The diverse libraries of PTS variant can pass through, for example, synthetic oligonucleotide mixture enzymatic is connected in the gene order, make the degeneracy of potential PTS sequence gather as single polypeptide, perhaps wherein contain the set of the bigger fused protein (for example for phage display) of PTS arrangement set, can express.There is the whole bag of tricks can be used for, produces potential PTS homologue library from degeneracy oligonucleotide sequence.Can carry out the chemosynthesis of degeneracy gene order with automatic dna synthesizer, synthetic gene is connected in the suitable expression vector then.The use of gene degeneracy set allows blended that the full sequence of the required potential PTS arrangement set of coding is provided.The method of synthetic degeneracy oligonucleotide be technically known (referring to, for example, Narang, S.A. (1983) Tetrahedron 39:3; Itakura et al. (1984) Annu.Rev.Biochem.53:323; Itakura et al. (1984) Science 198:1056; Ike et al. (1983) Nucleic Acid Res.11:477).
In addition, the segmental library of coding pts protein can be used for producing the segmental diversity of PTS colony, and this colony is used to screen and select the homologue of pts protein.In one embodiment, the segmental library of encoding sequence can produce like this, promptly only produce under the condition of an otch at about per molecule, handle the double-stranded PCR fragment of PTS encoding sequence with nuclease, denatured double stranded dna, renaturation DNA to be forming double-stranded DNA, and this double-stranded DNA can comprise from what difference had that the product of otch forms has justice/antisense right, in the duplex that forms again, remove the strand part, and the fragment library that obtains at last is connected in the expression vector by the processing of S1 nuclease.By this method, the N-end that can obtain encoding, C-is terminal and the expression library of different big or small pts protein intermediate segment.
Many technology of the gene product in the combinatorial library that screening is obtained by point mutation or shearing, and the technology that has the characteristic gene product of selecting in the screening cDNA library all are known technically.These technology all are applicable to the rapid screening of the gene library that is obtained by PTS homologue combinatorial mutagenesis.Screen the most widely used technology of large-scale gene pool, can be used in high throughput analysis, comprise genomic library is cloned in the reproducible expression vector, with the vector library conversion carrier library that obtains, and express combination gene under certain condition, the required active detection separation of carrier of detected product gene that helps to encode under this condition.Return assemblage sudden change (REM), a kind of new technology that increases function mutation body frequency in the library can be analyzed one with screening and be used from evaluation PTS homologue (Arkin and Yourvan (1992) PANS 89:7811-7815; Delgrave et al. (1993) Protein Engineering6 (3): 327-331).
In another embodiment, known method on the use technology can be used to analyze diversity PTS library based on the analysis of cell.
D. application of the present invention and method
Nucleic acid molecule described herein, protein, protein homology thing, fused protein, primer, carrier and host cell can be applied in following one or more methods: identify Corynebacterium glutamicum and relationship microorganism; Draw the Genome Atlas of Corynebacterium glutamicum relationship organism; Identify and locate the sequence interested of Corynebacterium glutamicum; Study on Evolution; Determine the essential zone of function of pts protein; Pts protein is active to be regulated; The PTS pathway activities is regulated; Required compound, for example adjusting of the cells produce of fine chemistry material.
PTS nucleic acid molecule of the present invention has various uses.At first, they can be used to identify whether a kind of organism is Corynebacterium glutamicum or its close relative organism.They also can be used for identifying the existence of mixing microorganisms colony Corynebacterium glutamicum or its relationship organism.The invention provides the nucleotide sequence of many Corynebacterium glutamicum genes; Under stringent condition, use the probe of crossing over the Corynebacterium glutamicum specific gene, survey the genomic dna that from single or mixing microorganisms culture, extracts, can determine whether this organism exists.
Although Corynebacterium glutamicum itself is a non-virulent, it is relevant with pathogenic kind, for example corynebacterium diphtheriae.Corynebacterium diphtheriae is the etiology of diphtheria, and diphtheria is a kind of infection rapid, acute, fever that develops, and it relates to local symptom and system's symptom.During this disease, upper respiratory tract generation local patholoic change, and comprise the damage of epithelial cell gangrenosum acne; Bacterium excretes poison, and toxin spreads to the easily infected tip tissue of health from lesion.These tissues comprise heart, muscle, peripheral nerve, suprarenal gland, kidney, liver and spleen, sexually revise owing to protein synthesis is suppressed cause rotten therein, can cause system's symptom of this disease.Many areas keep high incidence to diphtheria in the world, and these areas comprise the independent state of Africa, Asia, Eastern Europe and USSR (Union of Soviet Socialist Republics).From nineteen ninety, lasting popular in latter two regional diphtheria caused at least 5,000 people's death.
In one embodiment, the present invention with identify the experimenter in corynebacterium diphtheriae exist or active method relevant.This method comprises identifies one or more of nucleic acid of the present invention or aminoacid sequence (for example, being listed in odd number or even number sequence number sequence in the sequence table respectively) among the experimenter, thereby detects the existence or the activity of corynebacterium diphtheriae among the experimenter.Corynebacterium glutamicum and corynebacterium diphtheriae are akin bacteriums, and many nucleic acid in the Corynebacterium glutamicum and protein molecule are the homologues of corynebacterium diphtheriae amplifying nucleic acid and protein molecule, therefore also can be used for detecting experimenter's corynebacterium diphtheriae.
Nucleic acid of the present invention and protein molecule also can be as the marks of genome specific region.This is not only useful when drawing Genome Atlas, and can be used for the research of Corynebacterium glutamicum protein function.For example,, can digest the Corynebacterium glutamicum gene group, with fragment and DNA is conjugated protein hatches in order to identify the conjugated protein bonded with it of specific Corynebacterium glutamicum DNA genome area.Can further survey with the fragment of protein bound, preferably use easy certification mark with nucleic acid molecule of the present invention; These nucleic acid molecule combine with genomic fragment, can locate the position of fragment on Corynebacterium glutamicum gene picture group spectrum, and, when using different enzymes to carry out multi-pass operations, help to determine fast protein bonded nucleotide sequence with it.In addition, nucleic acid molecule of the present invention can have sufficient homology with the relationship kind, makes these nucleic acid molecule can be used as the mark that makes up relationship bacterial genomes collection of illustrative plates, for example brevibacterium.
PTS nucleic acid molecule of the present invention can be used for again evolving and protein structure research.The carbohydrate capturing system that molecule of the present invention participates in is used by various bacterium; By comparing the sequence of nucleic acid molecules of sequence of nucleic acid molecules of the present invention and those similar enzymes of in the other biological body, encoding, can estimate the evolution dependency of organism.Similarly, this estimation conserved sequence region and the non-conserved sequence region of relatively allowing, this can help to determine in the protein for the essential zone of enzyme function.Suchly determine that research is valuable for protein engineering, and can indicate those protein to stand to suddenly change and do not lose function.
The operation of PTS nucleic acid molecule of the present invention can cause having the generation with the pts protein of wild-type pts protein difference in functionality.Can improve these proteinic efficient or activity, can make it perhaps to reduce its efficient or activity to appear in the cell than usually more number.
The invention provides screening and can regulate the method for the active molecule of pts protein, these molecules or by with protein itself or substrate interaction, perhaps combine, perhaps by regulating transcribing or translate and regulating the pts protein activity of PTS nucleic acid molecule of the present invention with the mating partner of pts protein.In the method, express the microorganism of one or more pts proteins, contact, and assess of the effect of every kind of test compounds for pts protein activity or expression level with one or more test compounds.
PTS molecule of the present invention can be modified, and makes output, production and/or the production efficiency of one or more chemical substances be improved.For example, its activity is optimized, can increases glucose uptake amount or glucose and be transported the into speed of cell by modifying the pts protein that participates in glucose uptake.The degraded of glucose and other carbohydrates in the cell provides energy to promote the disadvantageous biochemical reaction of energy, and for example those relate to the biosynthetic reaction of fine chemistry material.Degraded also provides the biosynthesizing necessary intermediate of some fine chemistry material or precursor molecule, for example amino acid, VITAMIN and cofactor.By modifying PTS molecule of the present invention to increase the quantity of high-energy carbon molecule in the cell, thereby can both increase the energy of producing the necessary execution pathways metabolism of one or more fine chemistry materials, can increase the needed endocellular metabolism thing of this production storehouse again.Opposite, the degraded product of some carbohydrate contains a kind of compound, this compound only is used for such pathways metabolism, this approach is vied each other with the approach that is used as the required fine chemistry material of generation because of enzyme, cofactor or intermediate, by reducing the input of these carbohydrates, can bear this approach of adjusting.
In addition, PTS molecule of the present invention can participate in signal transduction path in one or more cells, and these approach can influence the output and/or the production efficiency of one or more fine chemistry materials in the Corynebacterium glutamicum.For example, in case there is the carbohydrate of sufficient amount in the cell, the necessary protein of one or more carbohydrates of input (for example from extracellular medium, HPr, Enzyme I, the perhaps a kind of composition in the Enzyme II complex body) often is translated the back and modifies, thereby they can not be input to sugar in the cell again.An example like this appears in the intestinal bacteria, and in the cell 1, the high level of 6-hexose diphosphate causes the phosphorylation of HPr Serine-46, makes this molecule can not participate in the transhipment of any carbohydrate again.Yet, in this endocellular sugar class level that movement system is closed, be enough for the normal function of keeping cell, this may limit the excessive production of required fine chemistry material.Therefore, it is desirable modifying pts protein of the present invention like this, promptly make them no longer effective to this negative adjusting, thereby allow to reach the higher IC of one or more carbohydrates, and, expand, allow from the organism that contains this sudden change pts protein, to obtain more effective production of one or more fine chemistry materials or higher output.
The above-mentioned tabulation that causes the PTS sudden change scheme that required compound output increases, and do not mean that and only be confined to this; The variation of these sudden change schemes knows better for the person skilled in the art.Through these mechanism, nucleic acid of the present invention and protein molecule can be used to produce Corynebacterium glutamicum or its relationship bacterial strain of expressing sudden change PTS nucleic acid and protein molecule, thereby increase output, production and/or the production efficiency of required compound.This required compound can be any natural product of Corynebacterium glutamicum, this comprises the final product and the natural intermediate that has pathways metabolism of biosynthetic pathway, and is not the molecule that natural existence is still produced by Corynebacterium glutamicum strain of the present invention in the Corynebacterium glutamicum metabolism.
The present invention is further by following Examples set, and these examples should not be interpreted as only being confined to this.Content in all reference of being quoted among the application, patent application, patent, the patent application of delivering, table and the sequence list is all integrated with reference hereby.
Table 1: the gene that the present invention includes
Phosphoenolpyruvic acid: carbohydrate phosphotransferase system
Nucleotide SEQ?ID?NO | Amino acid SEQ?ID?NO | Numbering? | Contig? | NT is initial? | NT stops? | Function? |
1 ? 3 ? 5 ? 7 9 11 13 15 ? 17 19 21 23 ? 25 27 29 31 33 | 2 ? 4 ? 6 ? 8 10 12 14 16 ? 18 20 22 24 ? 26 28 30 32 34 | RXS00315 ? F?RXA00315 ? RXA01503 ? RXN01299 F?RXA01299 F?RXA01883 F?RXA01889 RXA00951 ? RXN01244 F?RXA01244 RXA01300 RXN03002 ? RXC00953 RXC03001 RXN01943 F?RXA02191 F?RXA01943 | ? ? GR00053 ? GR00424 ? W0068 GR00375 GR00538 GR00540 GR00261 ? W0068 GR00359 GR00375 W0236 ? W0260 ? W0120 GR00642 GR00557 | ? ? 6537 ? 10392 ? 11954 6 2154 77 564 ? 14141 4837 637 1437 ? 1834 ? 4326 3395 3944 | ? ? 5452 ? 10640 ? 9891 446 2633 631 172 ? 15844 3329 903 1844 ? 1082 ? 6374 4633 3540 | The PTS system, sucrose-specificity IIABC composition (EIIABC-SCR) (sucrose-permease IIABC composition (phosphotransferase II, the ABC composition) (EC 2.7.1.69) PTS system, BETA-glucosides-specificity IIABC composition (EIIABC-BGL) (BETA-glucosides-permease IIABC composition) (phosphotransferase II, the ABC composition) (EC 2.7.1.69) PTS system, BETA-glucosides-specificity IIABC composition (EIIABC-BGL) (BETA-glucosides-permease IIABC composition) (phosphotransferase II, the ABC composition) (EC 2.7.1.69) PTS system, fructose-specificity IIBC composition (EC 2.7.1.69) PTS system, fructose-specificity IIBC composition (EC 2.7.1.69) PTS system, fructose-specificity IIBC composition (EC 2.7.1.69) PTS system, fructose-specificity IIBC composition (EC 2.7.1.69) PTS system, N.F,USP MANNITOL (secret)-specificity IIA composition (EIIA-(C) MTL) (N.F,USP MANNITOL (secret)-permease IIA composition) (phosphotransferase II, the A composition) (EC 2.7.1.69) phosphoenolpyruvic acid-protein phosphatase transferring enzyme (EC 2.7.3.9) phosphoenolpyruvic acid-protein phosphatase transferring enzyme (EC 2.7.3.9) phosphate carrier albumen HPR PTS system, N.F,USP MANNITOL (secret)-specificity IIA composition (EIIA-(C) MTL) (N.F,USP MANNITOL (secret)-permease IIA composition) (phosphotransferase II, the A composition) the transmembrane protein PTS system in the transmembrane protein PTS system in (EC 2.7.1.69) PTS system, glucose-specificity IIABC composition (EC 2.7.1.69) phosphoenolpyruvic acid carbohydrate phosphotransferase crr gene; Phosphotransferase system glucose-specific enzymes III |
Table 2:GENBANK genes identified
GenBank TMSearching number | The gene title | Gene function | Reference |
A09073 | ppg | Phosphoric acid enol pyruvic acid carboxylase | Bachmann,B.et?al.“DNA?fragment?coding?for?phosphoenolpyruvat corboxylase,recombinant?DNA?carrying?said?fragment.strains?carrying?the recombinant?DNA?and?method?for?producing?L-aminino?acids?using?said strains,”Patent:EP?0358940-A?303/21/90 |
A45579, A45581, A45583, A45585 A45587 | Threonine dehydra(ta)se | Moeckel,B.et?al.“Production?of?L-isoleucine?by?means?of?recombinant micro-organisms?with?deregulated?threonine?dehydratase,”Patent:WO 9519442-A?5?07/20/95 | |
AB003132 | murC;ftsQ;ftsZ | Kobayashi,M.et?al.“Cloning,sequencing,and?characterization?of?the?ftsZ gene?from?coryneform?bacteria,”Biochem.Biophys.Res.Commun., 236(2):383-388(1997) | |
AB015023 | murC;ftsQ | Wachi,M.et?al.“A?murC?gene?from?Coryneform?bacteria,”Appl.Microbiol. Biotechnol.,51(2):223-228(1999) | |
AB018530 | dtsR | Kimura,E.et?al.“Molecular?cloning?of?a?novel?gene,dtsR,which?rescues?the detergent?sensitivity?of?a?mutant?derived?from?Brevibacterium lactofermentum,”Biosci.Biotechnol.Biochem.,60(10):1565-1570(1996) | |
AB018531 | dtsR1;dtsR2 | ||
AB020624 | murI | The D-glutamate racemase | |
AB023377 | tkt | Transketolase | |
AB024708 | gltB;gltD | Big and the small subunit of glutamine 2-oxoglutaric acid transaminase | |
AB025424 | acn | Aconitase | |
AB027714 | rep | Replication protein | |
AB027715 | rep;aad | Replication protein; Aminoglycoside adeninyl transferring enzyme | |
AF005242 | argC | N-acetyl aspartic acid-5-semialdehyde desaturase | |
AF005635 | glnA | Glutamine synthetase | |
AF030405 | hisF | Cyclase | |
AF030520 | argG | Argininosuccinate synthetase | |
AF031518 | argF | Ornithine transcarbamylase | |
AF036932 | aroD | The 3-dehydroquinate dehydratase |
GenBank TM | The gene title | Gene function | Reference |
Searching number | |||
AF038548 | pyc | Pyruvate carboxylase | |
AF038651 | dciAE;apt;rel | Two peptide-binding proteins; Adenine phosphoribosyl transferase; The GTP pyrophosphokinase | Wehmeier,L.et?al.“The?role?of?the?Corynebacterium?glutamicum?rel?gene?in (p)ppGpp?metabolism,”Microbiology,144:1853-1862(1998) |
AF041436 | argR | The arginine repressor | |
AF045998 | impA | The inositol monophosphate Starch phosphorylase | |
AF048764 | argH | The argininosuccinic acid lyase | |
AF049897 | argC;argJ;argB; argD;argF;argR; argG;argH | N-acetyl glutamy phosphoric acid reduction enzyme; Ornithine acetyltransferase; The N-acetylglutamat kinases; Acetylornithice transminase; Ornithine transcarbamylase; The arginine repressor; The argininosuccinic acid synthase; The argininosuccinic acid lyase | |
AF050109 | inhA | Alkene acyl-acyl carrier protein reductase enzyme | |
AF050166 | hisG | ATP phosphoribosyltransferase | |
AF051846 | hisA | Phosphoribosyl formimino-5-amino-ribose 1-phosphate-4-imidazoles carboxamide isomerase | |
AF052652 | metA | Homoserine O-Transacetylase | Park,S.et?al.“Isolation?and?analysis?of?metA,a?methionine?biosynthetic?gene encoding?homoserine?acetyltransferase?in?Corynebacterium?glutamicum,”Mol. Cells.,8(3):286-294(1998) |
AF053071 | aroB | The dehydroquinic acid synthetic enzyme | |
AF060558 | hisH | Glutamine acid amides transferring enzyme | |
AF086704 | hisE | Phosphoribosyl-ATP-pyrophosphohydrolase | |
AF114233 | aroA | 5-enol pyruvic acid shikimic acid 3-phosphate synthase | |
AF116184 | panD | L-aspartic acid-alpha-decarboxylase precursor | Dusch,N.et?al.“Expression?of?the?Corynebacterium?glutamicum?panD?gene encoding?L-aspartate-alpha-decarboxylase?leads?to?pantothenate overproduction?in?Escherichia?coli,”Appl.?Environ.Microbiol.,65(4)1530- 1539(1999) |
?GenBank TMSearching number | The gene title | Gene function | Reference |
?AF124518 | aroD;aroE | 3-dehydroquinase; Shikimate dehydrogenase | |
?AF124600 | aroC;aroK;aroB; | Chorismate synthase; Shikimate kinase; The 3-dehydroquinic acid |
pepQ | Synthase; The kytoplasm peptase of inferring | ||
AF145897 | inhA | ||
AF145898 | inhA | ||
AJ001436 | ectP | Ectoine, glycinebetaine, proline(Pro) transhipment | Peter,H.et?al.“Corynebacterium?glutamicum?is?equipped?with?four?secondary carriers?for?compatible?solutes:Identification,sequencing,and?characterization of?the?proline/ectoine?uptake?system,ProP,and?the?ectoine/proline/glycine betaine?carrier,EctP,”J.Bacteriol.,180(22):6005-6012(1998) |
AJ004934 | dapD | Tetrahydrochysene 2, the dipicolimic acid 2 succinyl enzyme is (imperfect i) | Wehrmann,A.et?al.“Different?modes?of?diaminopimelate?synthesis?and?their role?in?cell?wall?integrity:A?study?with?Corynebacterium?glutamicum,”J. Bacteriol.,180(12):3159-3165(1998) |
AJ007732 | ppc;secG;amt;ocd; soxA | Phosphoenolpyruvic acid-carboxylase; High-affinity ammonia absorbs albumen; Ornithine-ring decarboxylase of inferring; Sarcosine oxidase | |
AJ010319 | ftsY,glnB,glnD;srp; amtP | Participate in cell fission; PII albumen; Uridyltransferase (uridine acyl-elimination enzyme); Signal recognition particle; Low-affinity ammonia absorbs albumen | Jakoby,M.et?al.“Nitrogen?regulation?in?Corynebacterium?glutamicum; Isolation?of?genes?involved?in?biochemical?characterization?of?corresponding proteins,”FEMS?Microbiol.,173(2):303-310(1999) |
AJ132968 | cat | E.C. 2.3.1.28 | |
AJ224946 | mqo | L MALIC ACID: quinone oxidoreductase | Molenaar,D.et?al.“Biochemical?and?genetic?characterization?of?the membrane-associated?malate?dehydrogenase(acceptor)from?Corynebacterium glutamicum,”Eur.J.Biochem.,254(2):395-403(1998) |
AJ238250 | ndh | Nadh dehydrogenase | |
AJ238703 | porA | Porin | Lichtinger,T.et?al.“Biochemical?and?biophysical?characterization?of?the?cell wall?porin?of?Corynebacterium?glutamicum:The?channel?is?formed?by?a?low molecular?mass?polypeptide,”Biochemistry,37(43):15024-15032(1998) |
D17429 | Transposable element IS31831 | Vertes,A.A.et?al.“Isolation?and?characterization?of?IS31831,a?transposable element?from?Corynebacterium?glutamicum,”Mol.Microbiol.,11(4):739-746 (1994) |
GenBank TMSearching number | The gene title | Gene function | Reference |
D84102 | odhA | The 2-oxoglutaric acid desaturase | Usuda,Y.et?al.“Molecular?cloning?of?the?Corynebacterium?glutamicum (Brevibacterium?lactofermentum?AJ12036)odhA?gene?encoding?a?novel?type of?2-oxoglutarate?dehydrogenase,”Microbiology,142:3347-3354(1996) |
E01358 | hdh;hk | Homoserine dehydrogenase; Homoserine kinase | Katsumata,R.et?al.“Production?of?L-thereonine?and?L-isoleucine,”Patent:JP 1987232392-A?110/12/87 |
E01359 | Homoserine kinase gene start codon upstream | Katsumata,R.et?al.“Production?of?L-thereonine?and?L-isoleucine,”Patent:JP 1987232392-A?210/12/87 | |
E01375 | Tryptophan operon | ||
E01376 | trpL;trpE | Leading peptide; The o-amino benzoyl acid synthase | Matsui,K.et?al.“Tryptophan?operon,peptide?and?protein?coded?thereby, utilization?of?tryptophan?operon?gene?expression?and?production?of tryptophan,”Patent:JP?1987244382-A?110/24/87 |
E01377 | Tryptophan operon promotor and operator region | Matsui,K.et?al.“Tryptophan?operon,peptide?and?protein?coded?thereby, utilization?of?tryptophan?operon?gene?expression?and?production?of tryptophan,”Patent:JP?1987244382-A?110/24/87 | |
E03937 | Vitamin H-synthase | Hatakeyama,K.et?al.“DNA?fragment?containing?gene?capable?of?coding biotin?synthetase?and?its?utilization,”Patent:JP?1992278088-A?110/02/92 | |
E04040 | The diaminopelargonic acid transaminase | Kohama,K.et?al.“Gene?coding?diaminopelargonic?acid?aminotransferase?and desthiobiotin?synthetase?and?its?utilization,”Patent:JP?1992330284-A?1 11/18/92 | |
E04041 | Dethiobiotin synthetase | Kohama,K.et?al.“Gene?coding?diaminopelargonic?acid?aminotransferase?and desthiobiotin?synthetase?and?its?utilization,”Patent:JP?1992330284-A1 11/18/92 | |
E04307 | The Flavum L-Aspartase | Kurusu,Y.et?al.“Gene?DNA?coding?aspartase?and?utilization?thereof,”Patent: JP?1993030977-A?102/09/93 | |
E04376 | Isocitrate lyase | Katsumata,R.et?al.“Gene?manifestation?controlling?DNA,”Patent:JP 1993056782-A?303/09/93 | |
E04377 | Isocitrate lyase N-terminal fragment | Katsumata,R.et?al.“Gene?manifestation?controlling?DNA,”Patent:JP 1993056782-A?303/09/93 | |
E04484 | Prephenate dehydratase | Sotouchi,N.et?al.“Production?of?L-phenylalanine?by?fermentation,”Patent:JP 1993076352-A?203/30/93 | |
E05108 | E.C. 2.7.2.4. | Fugono,N.et?al.“Gene?DNA?coding?Aspartokinase?and?its?use,”Patent:JP 1993184366-A?107/27/93 | |
E05112 | Dihydro-dipichorinate synthetic enzyme | Hatakeyama,K.et?al.“Gene?DNA?coding?dihydrodipicolinic?acid?synthetase and?its?use,”Patent:JP?1993184371-A?107/27/93 |
GenBank TMSearching number | The gene title | Gene function | Reference |
E05776 | Diaminopimelate dehydrogenase | Kobayashi,M.et?al.“Gene?DNA?coding?Diaminopimelic?acid?dehydrogenase and?its?use,”Patent:JP?1993284970-A?111/02/93 | |
E05779 | Threonine synthase | Kohama,K.et?al.“Gene?DNA?coding?threonine?synthase?and?its?use,”Patent: JP?1993284972-A?111/02/93 |
E06110 | Prephenate dehydratase | Kikuchi,T.et?al.“Production?of?L-phenylalanine?by?fermentation?method,” Patent:JP?1993344881-A?112/27/93 | |
E06111 | The sudden change prephenate dehydratase | Kikuchi,T.et?al.“Production?of?L-phenylalanine?by?fermentation?method,” Patent:JP?1993344881-A?112/27/93 | |
E06146 | Acetohydroxy acid synthetase | Inui,M.et?al.“Gene?capable?of?coding?Acetohydroxy?acid?synthetase?and?its use,”Patent:JP?1993344893-A?112/27/93 | |
E06825 | E.C. 2.7.2.4. | Sugimoto,M.et?al.“Mutant?aspartokinase?gene,”patent:JP?1994062866-A1 03/08/94 | |
E06826 | Sudden change E.C. 2.7.2.4. alpha subunit | Sugimoto,M.et?al.“Mutant?aspartokinase?gene,”patent:JP?1994062866-A1 03/08/94 | |
E06827 | Sudden change E.C. 2.7.2.4. alpha subunit | Sugimnoto,M.et?al.“Mutant?aspartokinase?gene,”patent:JP?1994062866-A1 03/08/94 | |
E07701 | secY | Honno,N.et?al.“Gene?DNA?participating?in?integration?of?membraneous protein?to?membrane,”Patent:JP?1994169780-A?106/21/94 | |
E08177 | E.C. 2.7.2.4. | Sato,Y.et?al.“Genetic?DNA?capable?of?coding?Aspartokinase?released?from feedback?inhibition?and?its?utilization,”Patent:JP?1994261766-A?109/20/94 | |
E08178, E08179, E08180, E08181, E08182 | The E.C. 2.7.2.4. of feedback inhibition-release | Sato,Y.et?al.“Genetic?DNA?capable?of?coding?Aspartokinase?released?from feedback?inhibition?and?its?utilization,”Patent:JP?1994261766-A?109/20/94 | |
E08232 | Acetohydroxy acid isomeroreductase | Inui,M.et?al.“Gene?DNA?coding?acetohydroxy?acid?isomeroreductase,” Patent:JP?1994277067-A?110/04/94 | |
E08234 | secE | Asai,Y.et?al.“Gene?DNA?coding?for?translocation?machinery?of?protein,” Patent:JP?1994277073-A?110/04/94 | |
E08643 | FT transaminase and dethiobiotin synthetase promoter region | Hatakeyama,K.et?al.“DNA?fragment?having?promoter?function?in coryneform?bacterium,”Patent:JP?1995031476-A?102/03/95 | |
E08646 | The vitamin H synthetic enzyme | Hatakeyama,K.et?al.“DNA?fragment?having?promoter?function?in coryneform?bacterium,”Patent:JP?1995031476-A?102/03/95 |
GenBank TMSearching number | The gene title | Gene function | Reference |
E08649 | L-Aspartase | Kohama,K.et?al“DNA?fragment?having?promoter?function?in?coryneform bacterium,”Patent:JP?1995031478-A?102/03/95 | |
E08900 | Dihydro 2, the dipicolimic acid 2 reductase enzyme | Madori,M.et?al.“DNA?fragment?containing?gene?coding?Dihydrodipicolinate acid?reductase?and?utilization?thereof,”Patent:JP?1995075578-A?103/20/95 | |
E08901 | Diaminapimelate decarboxylase | Madori,M.et?al.“DNA?fragment?containing?gene?coding?Diaminopimelic?acid decarboxylase?and?utilization?there?of,”Patent:JP?1995075579-A?103/20/95 | |
E12594 | Serine hydroxymethylase | Hatakeyama,K.et?al.“Production?of?L-trypophan,”Patent:JP?1997028391-A 102/04/97 | |
E12760, E12759, E12758 | Transposase | Moriya,M.et?al.“Amplification?of?gene?using?artificial?transposon,”Patent: JP?1997070291-A?03/18/97 | |
E12764 | Arginyl-tRNA synthetase; Diaminapimelate decarboxylase | Moriya,M.et?al.“Amplification?of?gene?using?artificial?transposon,”Patent: JP?1997070291-A?03/18/97 | |
E12767 | Dihydro 2, the dipicolimic acid 2 synthetic enzyme | Moriya,M.et?al.“Amplification?of?gene?using?artificial?transposon,”Patent: JP?1997070291-A?03/18/97 | |
E12770 | E.C. 2.7.2.4. | Moriya,M.et?al.“Amplification?of?gene?using?artificial?transposon,”Patent: JP?1997070291-A?03/18/97 | |
E12773 | Dihydro 2, the dipicolimic acid 2 reductase enzyme | Moriya,M.et?al.“Amplification?of?gene?using?artificial?transposon,”Patent: JP?1997070291-A?03/18/97 | |
E13655 | Glucose-6-phosphate dehydrogenase (G6PD) | Hatakeyama,K.et?al.“Glucose-6-phosphate?dehydrogenase?and?DNA?capable of?coding?the?same,”Patent:JP?1997224661-A?109/02/97 | |
L01508 | IlvA | Threonine dehydra(ta)se | Moeckel.?B.et?al.“Functional?and?structural?analysis?of?the?threonine dehydratase?of?Corynebacterium?glutamicum,”J.Bacteriol.,174:8065-8072 (1992) |
L07603 | EC?4.2.1.15 | 3-deoxidation-D-pectinose heptanone saccharic acid-7-phosphate synthase | Chen,C.et?al.“The?cloning?and?nucleotide?sequence?of?Corynebacterium glutamicum?3-deoxy-D-arabinoheptulosonate-7-phosphate?synthase?gene,” FEMS?Microbiol.Lett.,107:223-230(1993) |
L09232 | IlvB;ilvN;ilvC | The big subunit of acetohydroxy acid synthase; The acetohydroxy acid synthase small subunit; Acetohydroxy acid isomeroreductase | Keilhauer,C.et?al.“Isoleucine?synthesis?in?Corynebacterium?glutamicum: molecular?analysis?of?the?ilvB-ilvN-ilvC?operon,”J.Bacteriol.,175(17):5595- 5603(1993) |
GenBank TMSearching number | The gene title | Gene function | Reference |
L18874 | PtsM | The phosphoenolpyruvic acid sugar phosphotransferase | Fouet,A?et?al.“Bacillus?subtilis?sucrose-specific?enzyme?II?of?the |
phosphotransferase?system:expression?in?Escherichia?coli?and?homology?to enzymes?II?from?enteric?bacteria,”PNAS?USA,84(24):8773-8777(1987);Lee, J.K.et?al.“Nucleotide?sequence?of?the?gene?encoding?the?Corynebacterium glutamicum?mannose?enzyme?II?and?analyses?of?the?deduced?protein sequence,”FEMS?Microbiol.Lett.,119(1-2):137-145(1994) | |||
L27123 | aceB | Malate synthase | Lee,H-S.et?al.“Molecular?characterization?of?aceB,a?gene?encoding?malate synthase?in?Corynebacterium?glutamicum,”J.Microbiol.Biotechnol., 4(4):256-263(1994) |
L27126 | Pyruvate kinase | Jetten,M.S.et?al.“Structural?and?functional?analysis?of pyruvate?kinase?from Corynebacterium?glutamicum,”Appl.Environ.Microbiol.,60(7):2501-2507 (1994) | |
L28760 | aceA | Isocitrate lyase | |
L35906 | dtxr | The diphtheria toxin repressor | Oguiza,J.A.et?al.“Molecular?cloning,DNA?sequence?analysis,and characterization?of?the?Corynebacterium?diphtheriae?dtxR?from?Brevibacterium lactofermentum,”J.Bacteriol.,177(2):465-467(1995) |
M13774 | Prephenate dehydratase | Follettie,M.T.et?al.“Molecular?cloning?and?nucleotide?sequence?of?the Corynebacterium?glutamicum?pheA?gene,”J.Bacteriol.,167:695-702(1986) | |
M16175 | 5S?rRNA | Park,Y-H?et?al.“Phylogenetic?analysis?of?the?coryneform?bacteria?by?56 rRNA?sequences,”J.Bacteriol.,169:1801-1806(1987) | |
M16663 | trpE | The o-amino benzoyl acid synthase, 5 ' end | Sano,K.et?al.“Structure?and?function?of?the?trp?operon?control?regions?of Brevibacterium?lactofermentum,a?glutamic-acid-producing?bacterium,”Gene, 52:191-200(1987) |
M16664 | trpA | Tryptophan synthetase, 3 ' end | Sano,K.et?al.“Structure?and?function?of?the?trp?operon?control?regions?of Brevibacterium?lactofermentum,a?glutamic-acid-producing?bacterium,”Gene, 52:191-200(1987) |
M25819 | Phosphoenolpyruvate carboxylase | O’Regan,M.et?al.“Cloning?and?nucleotide?sequence?of?the Phosphoenolpyruvate?carboxylase-coding?gene?of?Corynebacterium glutamicum?ATCC13032,”Gene,77(2):237-251(1989) | |
M85106 | 23S rRNA gene insertion sequence | Roller,C.et?al.“Gram-positive?bacteria?with?a?high?DNA?G+C?content?are characterized?by?a?common?insertion?within?their?23S?rRNA?genes,”J.Gen. Microbiol.,138:1167-1175(1992) |
GenBank TMSearching number | The gene title | Gene function | Reference |
M85107, | 23S rRNA gene insertion sequence | Roller,C.et?al.“Gram-positive?bacteria?with?a?high?DNA?G+C?content?are |
M85108 | characterized?by?a?common?insertion?within?their?23S?rRNA?genes,”J.Gen. Microbiol.,138:1167-1175(1992) | ||
M89931 | aecD;bmQ;yhbw | Beta C-S lyase; Branched-chain amino acid absorbs carrier; The albumen yhbw that infers | Rossol,l.et?al.“The?Corynebacterium?glutamicum?aecD?gene?encodes?a?C-S lyase?with?alpha,beta-elimination?activity?that?degrades?aminoethylcysteine,” J.Bacteriol.,174(9):2968-2977(1992);Tauch,A.et?al.“Isoleucine?uptake?in Corynebacterium?glutamicum?ATCC?13032is?directed?by?the?bmQ?gene product,”Arch.Microbiol.,169(4):303-312(1998) |
S59299 | trp | Leading gene (promotor) | Herry,D.M.et?al.“Cloning?of?the?trp?gene?cluster?from?a?tryptophan- hyperproducing?strain?of?Corynebacterium?glutamicum:identification?of?a mutation?in?the?trp?leader?sequence,”Appl.Environ.Microbiol.,59(3):791-799 (1993) |
U11545 | trpD | Anthranilate phosphoribosyl transferase | O’Gara,J.P.and?Dunican,L.K.(1994)Complete?nucleotide?sequence?of?the Corynebacterium?glutamicum?ATCC?21850?tpD?gene.”Thesis,Microbiology Department,University?College?Galway,Ireland. |
U13922 | cglIM;cglIR;clgIIR | The II type 5-cytosine(Cyt) methyltransgerase of inferring; The II type restriction enzyme of inferring; I type or the III type restriction enzyme inferred | Schafer,A.et?al.“Cloning?and?characterization?of?a?DNA?region?encoding?a stress-sensitive?restriction?system?from?Corynebacterium?glutamicum?ATCC 13032and?analysis?of?its?role?in?intergeneric?conjugation?with?Escherichia coli,”J.Bacteriol.,176(23):7309-7319(1994);Schafer,A.et?al.“The Corynebacterium?glutamicum?cglIM?gene?encoding?a?5-cytosine?in?an?McrBC- deficient?Escherichia?coli?strain,”Gene,203(2):95-101(1997) |
U14965 | recA | ||
U31224 | ppx | Ankri,S.et?al.“Mutations?in?the?Corynebacterium?glutamicumproline biosynthetic?pathway:A?natural?bypass?of?the?proA?step,”J.Bacteriol., 178(15):4412-4419(1996) | |
U31225 | proC | L-proline(Pro): NADP+5-oxydo-reductase | Ankri,S.et?al.“Mutations?in?the?Corynebacterium?glutamicumproline biosynthetic?pathway:A?natural?bypass?of?the?proA?step,”J.Bacteriol., 178(15):4412-4419(1996) |
U31230 | obg;proB;unkdh | Gamma glutamy kinases; Be similar to the special 2-hydroxy acid dehydrogenase of D-isomer | Ankri,S.et?al.“Mutations?in?the?Corynebacterium?glutamicumproline biosynthetic?pathway:A?natural?bypass?of?the?proA?step,”J.Bacteriol., 178(15):4412-4419(1996) |
GenBank TMSearching number | The gene title | Gene function | Reference |
U31281 | bioB | The vitamin H synthase | Serebriiskii,I.G.,“Two?new?members?of?the?bio?B?superfamily:Cloning, |
sequencing?and?expression?of?bio?B?genes?ofMethylobacillus?flagellatum?and Corynebacterium?glutamicum,”Gene,175:15-22(1996) | |||
U35023 | ?thtR;accBC | Thiosulfate transsulfurase; The acyl-CoA carboxylase | Jager,W.et?al.“A?Corynebacrerium?glutamicum?gene?encoding?a?two-domain protein?similar?to?biotin?carboxylases?and?biotin-carboxyl-carrier?proteins,” Arch.Microbiol.,166(2);76-82(1996) |
U43535 | cmr | Multi-drug resistance albumen | Jager,W.et?al.“A?Corynebacterium?glutamicum?gene?confering?multidrug resistance?in?the?heterologous?host?Escherichia?coli,”J.Bacteriol., 179(7):2449-2451(1997) |
U43536 | clpB | Heat shock ATP-is conjugated protein | |
U53587 | aphA-3 | 3 ' 5 "-aminoglycoside phosphotransferase | |
U89648 | Participate in the biosynthetic Corynebacterium glutamicum of Histidine and do not identify sequence, partial sequence | ||
X04960 | ?trpA;trpB;trpC;trpD; trpE;trpG;trpL | Tryptophan operon | Matsui,K.et?al.“Complete?nucleotide?and?deduced?amino?acid?sequences?of the?Brevibacterium?lactofermentum?tryptophan?operon,”Nucleic?Acids?Res., 14(24):10113-10114(1986) |
X07563 | lys?A | DAP decarboxylase (meso-diaminapimelate decarboxylase, EC 4.1.1.20) | Yeh,P.et?al.“Nucleic?sequence?of?the?lysA?gene?ofCorynebacterium glutamicum?and?possible?mechanisms?for?modulation?of?its?expression,”Mol. Gen.Genet,212(1):112-119(1988) |
X14234 | EC?4.1.1.31 | Keto acid carboxylase in the phosphoric acid enol | Eikmanns,B.J.et?al.“The?Phosphoenolpyruvate?carboxylase?gene?of Corynebacterium?glutamicum:Molecular?cloning,nueleotide?sequence,and expression,”Mol.Gen.Genet.,218(2):330-339(1989);Lepiniec,L.et?al. “Sorghum?Phosphoenolpyruvate?carboxylase?gene?family:structure,function and?molecular?evolution,”Plant.Mol.Biol.,21(3):487-502(1993) |
X17313 | fda | Fructose-bisphosphate aldolase | Von?der?Osten,C.H?et?al.“Molecular?cloning,nucleotide?sequence?and?fine- structural?analysis?of?the?Corynebacterium?glutamicum?fda?gene:structural comparison?of?C.glutamicum?fructose-1,6-biphosphate?aldolase?to?class?I?and class?II?aldolases,”Mol.Microbiol., |
X53993 | dapA | L-2,3-dihydro 2, dipicolimic acid 2 synthetic enzyme (EC 4.2.1.52) | Bonnassie,S.et?al.“Nucleic?sequence?of?the?dapA?gene?from Corynebacterium?glutamicum,”Nucleic?Acids?Res.,18(21):6421(1990) |
GenBank TMSearching number | The gene title | Gene function | Reference |
X54223 | The AttB-related locus | Cianciotto,N.et?al.“DNA?sequence?homology?between?att?B-related?sites?of |
Corynebacterium?diphtheriae,Corynebacterium?ulcerans,Corynebacterium glutamicum,and?the?attP?site?of?lambdacorynephage,”FEMS.Microbiol, Lett.,66:299-302(1990) | |||
X54740 | argS;lysA | Arginyl-tRNA synthetase; Diaminapimelate decarboxylase | Marcel,T.et?al.“Nucleotide?sequence?and?organization?of?the?upstream?region of?the?Corynebacteriumglutamicum?lysA?gene,”Mol.Microbiol.,4(11):1819- 1830(1990) |
X55994 | trpL;trPE | The leading peptide of inferring; O-amino benzoyl acid synthase composition 1 | Heery,D.M.et?al.“Nucleotide?sequence?of?the?Corynebacterium?glutamicum trpE?gene,”Nucleic?Acids?Res.,18(23):7138(1990) |
X56037 | thrC | Threonine synthase | Han,K.S.et?al.“The?molecular?structure?of?the?Corynebacterium?glutamicum threonine?synthase?gene,”Mol.Microbiol.,4(10):1693-1702(1990) |
X56075 | The attB-related locus | Attachment site | Cianciotto,N.et?al.“DNA?sequence?homology?between?att?B-related?sites?of Corynebacterium?diphtheriae,Corynebacterium?ulcerans,Corynebacterium glutamicum,and?the?attP?site?of?lambdacorynephage,”FEMS.Microbiol. Lett.,66:299-302(1990) |
X57226 | lysC-alpha;lysC-beta; asd | E.C. 2.7.2.4.-alpha subunit; E.C. 2.7.2.4.-beta subunit; Aspartic acid beta semialdehyde desaturase | Kalinowski,J.et?al.“Genetic?and?biochemical?analysis?of?the?Aspartokinase from?Corynebacterium?glutamicum,”Mol.Microbiol.,5(5):1197-1204(1991); Kalinowski,J.et?al.“Aspartokinase?genes?lysC?alpha?and?lysC?beta?overlap and?are?adjacent?to?the?aspertate?beta-semialdehyde?dehydrogenase?gene?asd?in Corynebacterium?glutamicum,”Mol.Gen.Genet.,224(3):317-324(1990) |
X59403 | gap;pgk;tpi | Glyceraldehyde-3-phosphate; Phosphoglyceric kinase; Triose-phosphate isomerase | Eikmanns,B.J.“Identification,sequence?analysis,and?expression?of?a Corynebacterium?glutamicum?gene?cluster?encoding?the?three?glycolytic enzymes?glyceraldehyde-3-phosphate?dehydrogenase,3-phosphoglycerate kinase,and?triosephosphate?isomeras,”J.Bacteriol.,174(19):6076-6086 (1992) |
X59404 | gdh | Glutamate dehydrogenase | Bormann,E.R.et?al.“Molecular?analysis?of?the?Corynebacterium?glutamicum gdh?gene?encoding?glutamate?dehydrogenase,”Mol.Microbiol.,6(3):317-326 (1992) |
X60312 | lysI | L-Methionin permease | Seep-Feldhaus,A.H.et?al.“Molecular?analysis?of?the?Corynebacterium glutamicum?lysl?gene?involved?in?lysine?uptake,”Mol.Microbiol.,5(12):2995- 3005(1991) |
GenBank TMSearching number | The gene title | Gene function | Reference |
X66078 | cop1 | Psl albumen | Joliff,G.et?al.“Cloning?and?nucleotide?sequence?of?the?csp1?gene?encoding |
PS1,one?of?the?two?major?secreted?proteins?of?Corynebacterium?glutamicum: The?deduced?N-terminal?region?of?PS1?is?similar?to?the?Mycobacterium?antigen 85complex,”Mol.Microbiol.,6(16):2349-2362(1992) | |||
X66112 ? ? | glt ? ? | Oxalacetic transacetase | Eikmanns,B.J.et?al.“Cloning?sequence,expression?and?transcriptional analysis?of?the?Corynebacterium?glutamicum?gltA?gene?encoding?citrate synthase,”Microbiol.,140:1817-1828(1994) |
X67737 | dapB | Dihydro 2, the dipicolimic acid 2 reductase enzyme | |
X69103 ? ? | csp2 ? ? | S-layer proteins PS2 | Peyret,J.L.et?al.“Characterization?of?the?cspB?gene?encoding?PS2,an?ordered surface-layer?protein?in?Corynebacterium?glutamicum,”Mol.Microbiol., 9(1):97-109(1993) |
X69104 ? ? | The relevant factor of inserting of IS3 | Bonamy,C.et?al.“Identification?of?IS?1206,a?Corynebacterium?glutamicum IS3-related?insertion?sequence?and?phylogenetic?ahalysis,”Mol.Microbiol., 14(3):571-581(1994) | |
X70959 ? ? | leuA ? ? | Isopropylmalate synthase | Patek,M.et?al.“Leucine?synthesis?in?Corynebacterium?glutamicum:enzyme activities,structure?of?leuA,and?effect?of?leuA?inactivation?on?lysine synthesis,”Appl.Environ.Microbiol.,60(1):133-140(1994) |
X71489 ? ? ? | icd ? ? ? | Isocitric enzyme (NADP+) | Eikmanns,B.J.et?al.“Cloning?sequence?analysis,expression,and?inactivation of?the?Corynebacterium?glutamicum?icd?gene?encoding?isocitrate dehydrogenase?and?biochemical?characterization?of?the?enzyme,”J.Bacteriol., 177(3):774-782(1995) |
X72855 | GDHA | Glutamate dehydrogenase (NADP+) | |
X75083, X70584 ? | mtrA ? ? | The 5-methyl tryptophan resistance | Heery,D.M.et?al.“A?sequence?faom?a?tryptophan-hyperproducing?strain?of Corynebacterium?glutamicum?encoding?resistance?to?5-methyltryptophan,” Biochem.Biophys.Res.Commun.,201(3):1255-1262(1994) |
X75085 ? ? | recA ? ? | Fitzpatrick,R.et?al.“Construction?and?characterization?of?recA?mutant?strains of?Corynebacterium?glutamicum?and?Brevibacterium?lactofermentum,”Appl. Microbiol.Biotechnol.,42(4):575-580(1994) | |
X75504 ? ? | aceA;thiX ? ? | The part isocitrate lyase; | Reinscheid,D.J.et?al.“Characterization?of?the?isocitrate?lyase?gene?from Corynebacterium?glutamicum?and?biochemical?analysis?of?the?enzyme,”J. Bacteriol.,176(12):3474-3483(1994) |
X76875 ? ? | ATP enzyme beta-subunit | Ludwig,W.et?al.“Phylogenetic?relationships?of?bacteria?based?on?comparative sequence?analysis?of?elongation?factor?Tu?and?ATP-synthase?beta-subunit genes,”Antonie?Van?Leeuwenhoeek,64:285-305(1993) | |
GenBank TMSearching number | The gene title | Gene function | Reference |
X77034 | tuf | EF-T u | Ludwig,W.et?al.“Phylogenetic?relationships?of?bacteria?based?on?comparative |
sequence?analysis?of?elongation?factor?Tu?and?ATP-synthase?beta-subunit genes,”Antonie?Van?Leeuwenhoek,64:285-305(1993) | |||
X77384 | recA | Billman-Jacobe,H.“Nucleotide?sequence?of?a?recA?gene?from Corynebacterium?glutamicum,”DNA?Seq.,4(6):403-404(1994) | |
X78491 | aceB | Malate synthase | Reinscheid,D.J.et?al.“Malate?synthase?from?Corynebacterium?glutamicum pta-ack?operon?encoding?phosphotransacetylase:sequence?analysis,” Microbiology,140:3099-3108(1994) |
X80629 | 16S?rDNA | The 16S ribosome-RNA(rRNA) | Rainey,F.A.et?al.“Phylogenetic?analysis?of?the?genera?Rhodococcus?and Norcardia?and?evidence?for?the?evolutionary?origin?of?the?genus?Norcardia from?within?the?radiation?of?Rhodococcus?species,”Microbiol.,141:523-528 (1995) |
X81191 | gluA;gluB;gluC; gluD | The L-glutamic acid absorption system | Kronemeyer,W.et?al.“Structure?of?the?gluABCD?cluster?encoding?the glutamate?uptake?system?of?Corynebacterium?glutamicum,”J.Bacteriol., 177(5):1152-1158(1995) |
X81379 | dapE | Succinyldiaminopimelate desuccinylase | Wehrmann,A.et?al.“Analysis?of?different?DNA?fragments?of Corynebacterium?glutamicum?complementing?dapE?of?Escherichia?coli,” Microbiology,40:3349-56(1994) |
X82061 | 16S?rDNA | The 16S ribosome-RNA(rRNA) | Ruimy,R.et?al.“Phylogeny?of?the?genus?Corynebacterium?deduced?from analyses?of?small-subunit?ribosomal?DNA?sequences,”Int.J.Syst.Bacteriol., 45(4):740-746(1995) |
X82928 | asd;lysC | Aspartate-semialdehyde dehydrogenase; | Serebrijski,I.et?al.“Multicopy?suppression?by?asd?gene?and?osmotic?stress- dependent?complementation?by?heterologous?proA?in?proA?mutants,”J. Bacteriol.,177(24):7255-7260(1995) |
X82929 | proA | Gamma-glutamy phosphoric acid reduction enzyme | Serebrijski,I.et?al.“Multicopy?suppression?by?asd?gene?and?osmotic?stress- dependent?complementation?by?heterologous?proA?in?proA?mutants,”J. Bacteriol.,177(24):7255-7260(1995) |
X84257 | 16S?rDNA | The 16S ribosome-RNA(rRNA) | Pascual,C.et?al.“Phylogenetic?analysis?of?the?genus?Corynebacterium?based on?16S?rRNA?gene?sequences,”Int.J.Syst.Bacteriol.,45(4):724-728(1995) |
X85965 | aroP;dapE | The aromatic amino acid permease; | Wehrmann,A.et?al.“Functional?analysis?of?sequences?adjacent?to?dapE?of Corynebacterium?glutamicumproline?reveals?the?presence?of?aroP,which encodes?the?aromatic?amino?acid?transporter,”J.Bacteriol.,177(20):5991- 5993(1995) |
GenBank TMSearching number | The gene title | Gene function | Reference |
X86157 | argB;argC;argD; argF;argJ | Acetylglutamate kinase; N-acetyl-gamma-glutamy-phosphoric acid reduction enzyme; Acetyl-ornithine transaminase; Ornithine transcarbamylase; Glutamic acid N-Transacetylase | Sakanyan,V.et?al.“Genes?and?enzymes?of?the?acetyl?cycle?of?arginine biosynthesis?in?Corynebacterium?glutamicum:enzyme?evolution?in?the?early steps?of?the?arginine?pathway,”Microbiology,142:99-108(1996) |
X89084 | pta;ackA | Phosphate acetyltransferase; E.C. 2.7.2.1 | Reinscheid,D.J.et?al.“Cloning,sequence?analysis,expression?and?inactivation of?the?Corynebacterium?glutamicum?pta-ack?operon?encoding phosphotransacetylase?and?acetate?kinase,”Microbiology,l45:503-513(1999) |
X89850 | attB | Attachment site | Le?Marrec,C.et?al.“Genetic?characterization?of?site-specific?integration functions?ofphi?AAU2?infecting“Arthrobacter?aureus?C70,”J.Bacteriol., 178(7):1996-2004(1996) |
X90356 | Promoter fragment F1 | Patek,M.et?al.“Promoters?from?Corynebacterium?glutamicum:cloning, molecular?analysis?and?search?for?a?consensus?motif,”Microbiology, 142:1297-1309(1996) | |
X90357 | Promoter fragment F2 | Patek,M.et?al.“Promoters?from?Corynebacterium?glutamicum:cloning, molecular?analysis?and?search?for?a?consensus?motif,”Microbiology, 142:1297-1309(1996) | |
X90358 | Promoter fragment F10 | Patek,M.et?al.“Promoters?from?Corynebacterium?glutamicum:cloning, molecular?analysis?and?search?for?a?consensus?motif,”Microbiology, 142:1297-1309(1996) | |
X90359 | Promoter fragment F13 | Patek,M.et?al.“Promoters?from?Corynebacterium?glutamicum:cloning, molecular?analysis?and?search?for?a?consensus?motif,”Microbiology, 142:1297-1309(1996) | |
X90360 | Promoter fragment F22 | Patek,M.et?al.“Promoters?from?Corynebacterium?glutamicum:cloning, molecular?analysis?and?search?for?a?consensus?motif,”Microbiology, 142:1297-1309(1996) | |
X90361 | Promoter fragment F34 | Patek,M.et?al.“Promoters?from?Corynebacterium?glutamicum:cloning, molecular?analysis?and?search?for?a?consensus?motif,”Microbiology, 142:1297-1309(1996) | |
X90362 | Promoter fragment F37 | Patek,M.et?al.“Promoters?from?Corynebacterium?glutamicum:cloning, molecular?analysis?and?search?for?a?consensus?motif,”Microbiology, 142:1297-1309(1996) |
GenBank TMSearching number | The gene title | Gene function | Reference |
X90363 | Promoter fragment F45 | Patek,M.et?al.“Promoters?from?Corynebacterium?glutamicum:cloning, molecular?analysis?and?search?for?a?consensus?motif,”Microbiology, 142:1297-1309(1996) |
X90364 | Promoter fragment F64 | Patek,M.et?al.“Promoters?from?Corynebacterium?glutamicum:cloning, molccular?analysis?and?search?for?a?consensus?motif,”Microbiology, 142:1297-1309(1996) | |
X90365 | Promoter fragment F75 | Patek,M.et?al.“Promoters?from?Corynebacterium?glutamicum:cloning, molecular?analysis?and?search?for?a?consensus?motif,”Microbiology, 142:1297-1309(1996) | |
X90366 | Promoter fragment PF101 | Patek,M.et?al.“Promoters?from?Corynebacterium?glutamicum:cloning, molecular?analysis?and?search?for?a?consensus?motif,”Microbiology, 142:1297-1309(1996) | |
X90367 | Promoter fragment PF104 | Patek,M.et?al.“Promoters?from?Corynebacterium?glutamicum:cloning, molecular?analysis?and?search?for?a?consensus?motif,”Microbiology, 142:1297-1309(1996) | |
X90368 | Promoter fragment PF109 | Patek,M.et?al.“Promoters?from?Corynebacterium?glutamicum:cloning, molecular?analysis?and?search?for?a?consensus?motif,”Microbiology, 142:1297-1309(1996) | |
X93513 | amt | The ammonia movement system | Siewe,R.M.et?al.“Functional?and?genetic?characterization?of?the(methyl) ammonium?uptake?carrier?of?Corynebacterium?glutamicum,”J.Biol.Chem., 271(10):5398-5403(1996) |
X93514 | betP | The glycinebetaine movement system | Peter,H.et?al.“Isolation,characterization,and?expression?of?the Corynebacterium?glutamicum?betP?gene,encoding?the?transport?system?for?the compatible?solute?glycine?betaine,”J.Bacteriol.,178(17):5229-5234(1996) |
X95649 | orf4 | Patek,M.et?al.“Identification?and?transcriptional?analysis?of?the?dapB-ORF2- dapA-ORF4operon?of?Corynebacterium?glutamicum,encoding?two?enzymes involved?in?L-lysine?synthesis,”Biotechnol.Lett,19:1113-1117(l997) | |
X96471 | lysE;lysG | Methionin output albumen; Albumen is regulated in Methionin output | Vrljic,M.et?al.“A?new?type?of?transporter?with?a?new?type?of?cellular function:L-lysine?export?from?Corynebacterium?glutamicum,”Mol. Microbiol.,22(5):815-826(1996) |
GenBank TMSearching number | The gene title | Gene function | Reference |
X96580 | panB;panC;xylB | 3-methyl-2-oxy butyrate hydroxymethyl transferases; Pantothenic acid-beta-L-Ala ligase enzyme; Xylulokinase | Sahm,H.et?al.“D-pantothenate?synthesis?in?Corynebacterium?glutamicum?and use?of?panBC?and?genes?encoding?L-valine?synthesis?for?D-pantothenate overproduction,”Appl.Environ.Microbiol.,65(5):1973-1979(1999) |
X96962 | Insertion sequence IS1207 and transposase | ||
X99289 | Elongation factor P | Ramos,A.et?al.“Cloning,sequencing?and?expression?of?the?gene?encoding elongation?factor?P?in?the?amino-acid?producer?Brevibacterium?lactofermentum (Corynebacterium?glutamicum?ATCC?13869),”Gene,198:217-222(1997) | |
Y00140 | thrB | Homoserine kinase | Mateos,L.M.et?al.“Nucleotide?sequence?of?the?homoserine?kinase(thrB)gene of?the?Brevibacterium?lactofermentum,”Nucleic?Acids?Res.,15(9):3922(1987) |
Y00151 | ddh | Meso-diaminopimelic acid D-desaturase (EC 1.4.1.16) | Ishino,S.et?al.“Nucleotide?sequence?of?the?meso-diaminopimelate?D- dehydrogenase?gene?from?Corynebacterium?glutamicum,”Nucleic?Acids?Res., 15(9):3917(1987) |
Y00476 | thrA | Homoserine dehydrogenase | Mateos,L.M.et?al.“Nucleotide?sequence?of?the?homoserine?dehydrogenase (thrA)gene?of?the?Brevibacterium?lactofermentum,”Nucleic?Acids?Res., 15(24):10598(1987) |
Y00546 | hom;thrB | Homoserine dehydrogenase; Homoserine kinase | Peoples,O.P.et?al.“Nucleotide?sequence?and?fine?structural?analysis?of?the Corynebacterium?glutamicum?hom-thrB?operon,”Mol.Microbiol.,2(1):63-72 (1988) |
Y08964 | murC;ftsQ/divD;ftsZ | UPD-N-acetylmurami-L-Ala ligase enzyme; Divide initial albumen or cell fission albumen; Cell fission albumen | Honrubia,M.P.et?al.“Identification,characterization,and?chromosomal organization?of?the?ftsZ?gene?from?Brevibacterium?lactofermentum,”Mol. Gen.Genet,259(1):97-104(1998) |
Y09163 | putP | High-affinity proline(Pro) movement system | Peter,H.et?al.“Isolation?of?the?putP?gene?of?Corynebacterium glutamicumproline?and?characterization?of?a?low-affinity?uptake?system?for compatible?solutes,”Arch.Microbiol.,168(2):143-151(1997) |
Y09548 | pyc | Pyruvate carboxylase | Peters-Wendisch,P.G.et?al.“Pyruvate?carboxylase?from?Corynebacterium glutamicum:characterization,expression?and?inactivation?of?the?pyc?gene,” Microbiology,144:915-927(1998) |
Y09578 | leuB | 3-Isopropylmalate dehydrogenase | Patek,M.et?al.“Analysis?of?the?leuB?gene?from?Corynebacterium glutamicum,”Appl.Microbiol.Biotechnol.,50(1):42-47(1998) |
Y12472 | Phage Phi-16 attachment site | Moreau,S.et?al.“Site-specific?integration?of?corynephage?Phi-16:The construction?of?an?integration?vector,”Microbiol.,145:539-548(1999) |
GenBank TMSearching number | The gene title | Gene function | Reference |
Y12537 | proP | Proline(Pro)/ectoine absorption system albumen | Peter,H.et?al.“Corynebacterium?glutamicum?is?equipped?with?four?secondary carriers?for?compatible?solutes:Identification,sequencing,and?characterization of?the?proline/ectoine?uptake?system,ProP,and?the?ectoine/proline/glycine |
betaine?carrier,EctP,”J.Bacteriol.,180(22):6005-6012(1998) | |||
Y13221 | glnA | Glutamine synthetase I | Jakoby,M.et?al.“Isolation?of?Corynebacterium?glutamicum?glnA?gene encoding?glutamine?synthetase?I,”FEMS?Microbiol.Lett.,154(1):81-88(1997) |
Y16642 | lpd | Dihydrolipoamide dehydrogenase | |
Y18059 | Rod bacillus phage 304L attachment site | Moreau,S.et?al.“Analysis?of?the?integration?functions?of?&?phi;304L:An integrase?module?among?corynephages,”Virology,255(1):150-159(1999) | |
Z21501 | argS;lysA | Arginyl-tRNA synthetase; Diaminapimelate decarboxylase (part) | Oguiza,J.A.et?al.“A?gene?encoding?arginyl-tRNA?synthetase?is?located?in?the upstream?region?of?the?lysA?gene?in?Brevibacteriumn?lactofermentum: Regulation?of?argS-lysA?cluster?expression?by?arginine,”J. Bacteriol.,175(22):7356-7362(1993) |
Z21502 | dapA;dapB | Dihydro 2, the dipicolimic acid 2 synthase; Dihydro 2, the dipicolimic acid 2 reductase enzyme | Pisabarro,A.et?al.“A?cluster?of?three?genes(dapA,orf2,and?dapB)of Brevibacterium?lactofermentum?encodes?dihydrodipicoIinate?reductase,and?a third?polypeptide?of?unknown?function,”J.Bacteriol.,175(9):2743-2749 (1993) |
Z29563 | thrC | Threonine synthase | Malumbres,M.et?al.“Analysis?and?expression?of?the?thrC?gene?of?the?encoded threonine?synthase,”Appl.Environ.Microbiol.,60(7)2209-2219(1994) |
Z46753 | 16S?rDNA | The 16S ribosomal RNA gene | |
Z49822 | sigA | The SigA sigma factor | Oguiza,J.A.et?al“Multiple?sigma?factor?genes?in?Brevibacterium lactofermentum:Characterization?of?sigA?and?sigB,”J.Bacteriol.,178(2):550- 553(1996) |
Z49823 | galE;dtxR | UDP-semi-lactosi 4-epimerase catalytic activity; Diphtheria toxin is regulated albumen | Oguiza,J.A.et?al“The?galE?gene?encoding?the?UDP-galactose?4-epimerase?of Brevibacterium?lactofermentum?is?coupled?transcriptionally?to?the?dmdR gene,”Gene,177:103-107(1996) |
Z49824 | orf1;sigB | The SigB sigma factor | Oguiza,J.A.et?al“Multiple?sigma?factor?genes?in?Brevibacterium lactofermentum:Characterization?of?sigA?and?sigB,”J.Bacteriol.,178(2):550- 553(1996) |
Z66534 | Transposase | Correia,A.et?al.“Cloning?and?characterization?of?an?IS-like?element?present?in the?genome?of?Brevibacterium?lactofermentum?ATCC?13869,”Gene, 170(1):91-94(1996) |
1This gene order is open in listed reference.But obviously openly sequence is long for the sequence that the present invention obtains.Inferring disclosed ATG code of sequence mistake, only is a fragment in actual coding district therefore.
Table 3: can be used for implementing excellent bacillus of the present invention and tyrothricin bacterial strain
Generic name | Plant name | ATCC | FERM | NRRL | CECT | NCIMB | ?CBS | NCTC | DSMZ |
Tyrothricin | Brevibacterium ammoniagenes | 21054 | |||||||
Tyrothricin | Brevibacterium ammoniagenes | 19350 | |||||||
Tyrothricin | Brevibacterium ammoniagenes | 19351 | |||||||
Tyrothricin | Brevibacterium ammoniagenes | 19352 | |||||||
Tyrothricin | Brevibacterium ammoniagenes | 19353 | |||||||
Tyrothricin | Brevibacterium ammoniagenes | 19354 | |||||||
Tyrothricin | Brevibacterium ammoniagenes | 19355 | |||||||
Tyrothricin | Brevibacterium ammoniagenes | 19356 | |||||||
Tyrothricin | Brevibacterium ammoniagenes | 21055 | |||||||
Tyrothricin | Brevibacterium ammoniagenes | 21077 | |||||||
Tyrothricin | Brevibacterium ammoniagenes | 21553 | |||||||
Tyrothricin | Brevibacterium ammoniagenes | 21580 | |||||||
Tyrothricin | Brevibacterium ammoniagenes | 39101 | |||||||
Tyrothricin | butanicum | 21196 | |||||||
Tyrothricin | The branch tyrothricin | 21792 | P928 | ||||||
Tyrothricin | Brevibacterium flavum | 21474 | |||||||
Tyrothricin | Brevibacterium flavum | 21129 | |||||||
Tyrothricin | Brevibacterium flavum | 21518 | |||||||
Tyrothricin | Brevibacterium flavum | B11474 | |||||||
Tyrothricin | Brevibacterium flavum | B11472 | |||||||
Tyrothricin | Brevibacterium flavum | 21127 | |||||||
Tyrothricin | Brevibacterium flavum | 21128 | |||||||
Tyrothricin | Brevibacterium flavum | 21427 | |||||||
Tyrothricin | Brevibacterium flavum | 21475 | |||||||
Tyrothricin | Brevibacterium flavum | 21517 | |||||||
Tyrothricin | Brevibacterium flavum | 21528 | |||||||
Tyrothricin | Brevibacterium flavum | 21529 | |||||||
Tyrothricin | Brevibacterium flavum | B11477 | |||||||
Tyrothricin | Brevibacterium flavum | B11478 | |||||||
Tyrothricin | Brevibacterium flavum | 21127 | |||||||
Tyrothricin | Brevibacterium flavum | B11474 | |||||||
Tyrothricin | The Xi Shi tyrothricin | 15527 | |||||||
Tyrothricin | The ketoisocaproic tyrothricin | 21004 | |||||||
Tyrothricin | The ketoisocaproic tyrothricin | 21089 | |||||||
Tyrothricin | ketosoreductum | 21914 | |||||||
Tyrothricin | Brevibacterium | 70 | |||||||
Tyrothricin | Brevibacterium | 74 | |||||||
Tyrothricin | Brevibacterium | 77 | |||||||
Tyrothricin | Brevibacterium | 21798 | |||||||
Tyrothricin | Brevibacterium | 21799 | |||||||
Tyrothricin | Brevibacterium | 21800 | |||||||
Tyrothricin | Brevibacterium | 21801 | |||||||
Tyrothricin | Brevibacterium | B11470 | |||||||
Tyrothricin | Brevibacterium | B11471 | |||||||
Tyrothricin | Brevibacterium | 21086 | |||||||
Tyrothricin | Brevibacterium | 21420 |
Tyrothricin | Brevibacterium | 21086 | |||||||
Tyrothricin | Brevibacterium | 31269 | |||||||
Tyrothricin | Extension brevibacterium | 9174 | |||||||
Tyrothricin | Extension brevibacterium | 19391 | |||||||
Tyrothricin | Extension brevibacterium | 8377 | |||||||
Tyrothricin | Separate the paraffin tyrothricin | ?11160 | |||||||
Tyrothricin | Kind | 717.73 | |||||||
Tyrothricin | Kind | 717.73 | |||||||
Tyrothricin | Kind | 14604 | |||||||
Tyrothricin | Kind | 21860 | |||||||
Tyrothricin | Kind | 21864 | |||||||
Tyrothricin | Kind | 21865 | |||||||
Tyrothricin | Kind | 21866 | |||||||
Tyrothricin | Kind | 19240 | |||||||
The rod bacillus | Corynebacterium acctoacidophlum | 21476 | |||||||
The rod bacillus | Corynebacterium acctoacidophlum | 13870 | |||||||
The rod bacillus | Vinegar paddy rod bacillus | B11473 | |||||||
The rod bacillus | Vinegar paddy rod bacillus | B11475 | |||||||
The rod bacillus | Vinegar paddy rod bacillus | 15806 | |||||||
The rod bacillus | Vinegar paddy rod bacillus | 21491 | |||||||
The rod bacillus | Vinegar paddy rod bacillus | 31270 | |||||||
The rod bacillus | Have a liking for acetyl rod bacillus | B3671 | |||||||
The rod bacillus | Produce ammonia rod bacillus | 6872 | 2399 | ||||||
The rod bacillus | Produce ammonia rod bacillus | 15511 | |||||||
The rod bacillus | fujiokense | 21496 | |||||||
The rod bacillus | Corynebacterium glutamicum | 14067 | |||||||
The rod bacillus | Corynebacterium glutamicum | 39137 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21254 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21255 | |||||||
The rod bacillus | Corynebacterium glutamicum | 31830 | |||||||
The rod bacillus | Corynebacterium glutamicum | 13032 | |||||||
The rod bacillus | Corynebacterium glutamicum | 14305 | |||||||
The rod bacillus | Corynebacterium glutamicum | 15455 | |||||||
The rod bacillus | Corynebacterium glutamicum | 13058 | |||||||
The rod bacillus | Corynebacterium glutamicum | 13059 | |||||||
The rod bacillus | Corynebacterium glutamicum | 13060 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21492 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21513 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21526 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21543 | |||||||
The rod bacillus | Corynebacterium glutamicum | 13287 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21851 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21253 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21514 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21516 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21299 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21300 | |||||||
The rod bacillus | Corynebacterium glutamicum | 39684 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21488 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21649 |
The rod bacillus | Corynebacterium glutamicum | 21650 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19223 | |||||||
The rod bacillus | Corynebacterium glutamicum | 13869 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21157 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21158 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21159 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21355 | |||||||
The rod bacillus | Corynebacterium glutamicum | 31808 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21674 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21562 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21563 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21564 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21565 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21566 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21567 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21568 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21569 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21570 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21571 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21572 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21573 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21579 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19049 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19050 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19051 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19052 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19053 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19054 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19055 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19056 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19057 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19058 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19059 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19060 | |||||||
The rod bacillus | Corynebacterium glutamicum | 19185 | |||||||
The rod bacillus | Corynebacterium glutamicum | 13286 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21515 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21527 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21544 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21492 | |||||||
The rod bacillus | Corynebacterium glutamicum | B8183 | |||||||
The rod bacillus | Corynebacterium glutamicum | B8182 | |||||||
The rod bacillus | Corynebacterium glutamicum | B12416 | |||||||
The rod bacillus | Corynebacterium glutamicum | B12417 | |||||||
The rod bacillus | Corynebacterium glutamicum | B12418 | |||||||
The rod bacillus | Corynebacterium glutamicum | B11476 | |||||||
The rod bacillus | Corynebacterium glutamicum | 21608 | |||||||
The rod bacillus | Lily rod bacillus | P973 | |||||||
The rod bacillus | ?nitrilophilus | 21419 | 11594 | ||||||
The rod bacillus | Kind | P4445 |
The rod bacillus | Kind | ?P4446 | |||||||
The rod bacillus | Kind | 31088 | |||||||
The rod bacillus | Kind | 31089 | |||||||
The rod bacillus | Kind | 31090 | |||||||
The rod bacillus | Kind | 31090 | |||||||
The rod bacillus | Kind | 31090 | |||||||
The rod bacillus | Kind | 15954 | 20145 | ||||||
The rod bacillus | Kind | 21857 | |||||||
The rod bacillus | Kind | 21862 | |||||||
The rod bacillus | Kind | 21863 |
ATCC: American type culture collection, Rockville, MD, USA
FERM: fermentation research institute, Chiba, Japan
NRRL: agricultural research institute preservation center, northern regional research laboratory, Peoria, IL, USA
CECT: Spain typical case's culture collection center, Valencia, Spain
NCIMB: state-run industry and marine microorganism preservation center., Aberdeen, UK
CBS: fungi strain preservation center, Baarn, NL
NCTC: state-run typical culture collection center, London, UK
DSMZ: Germany microbial preservation center, Braunschweig, Germany
Can be referring to Sugawara, H.et al. (1993) World directory of collections of cultures of microorganisms:Bacteria, fungi and yeasts (4
ThEdn), World federation for culture collections world data center onmicroorganisms, Saimata, Japen.
Table 4: sequence comparative result
ID#? ? ? | The Genbank hit results? (NT)? | Length? ? ? | Searching number? ? ? | Genbank hit results title? ? ? | The Genbank hit results The source? | % Homology (GAP) | Warehouse-in day? ? ? |
rxa00315 ? ? ? ? rxa01503 ? ? ? ? ? rxa01299 ? ? ? ? ? rxa00951 ? ? ? ? ? rxa01244 ? ? ? ? ? rxa01300 ? ? rxa00953 ? ? ? ? ? | 1527GB_BA1:AB007125 ? GB_IN1:CELC47D2 GB_HTG2:AC006732 ? 372GB_PR3:AC005019 GB_GSS12:AQ390040 ? GB_GSS5:AQ784231 ? ? 2187GB_EST38:AW047296 ? GB_RO:AB004056 ? GB_RO:AB004056 ? 416GB_BA1:SCJ21 ? GB_VI:MCU68299 GB_VI:U93872 ? ? 1827GB_BA1:AFAPHBHI ? GB_PR3:HSJ836E13 ? GB_EST24:AJ170227 ? 390GB_PR3:HUMDODDA GB_PAT:I40899 GB_PAT:I40900 789GB_BA1:SCJ21 ? GB_BA1:BLTRP ? GB_PAT:E01375 ? | 4078 ? 17381 159453 ? 188362 680 ? 542 ? ? 614 ? 1581 ? 1581 ? 31717 ? 230278 133661 ? ? 4501 ? 78055 ? 409 ? 26764 26764 1317 31717 ? 7725 ? 7726 ? | AB007125 ? U64861 AC006732 ? AC005019 AQ390040 ? AQ784231 ? ? AW047296 ? AB004056 ? AB004056 ? AL109747 ? U68299 U93872 ? ? M69036 ? AL050326 ? Al170227 ? L39874 I40899 I40900 AL109747 ? X04960 ? E01375 ? | Serratia?marcescens?slaA?gene?for?surface?layerprotein.com?plete cds,isolate?8000. Caenorhabditis?elegans?cosmid?C47D2 Caenorhabditis?elegans?clone?Y32G9. ***SEQUENCING?IN PROGRESS ***.9unordered?pieces. Homo?sapiens?BAC?clone?GS250A16from?7p21-p22,complete RPCI11-157C9.TJ?RPCI-11Homo?sapiens?genomic?clone?RPCI- 11-157C9.genomicsurvey?sequence. HS_3087_B1_C10_T7C?Cl--Approved?Human?Genomic?Sperm Library?D?Homo?sapiens?genomuc?clone?Plale=3087Col=19 Row=F,genomic?suryey?sequence. Ul-M-BH1-amh-e-03-0-Ul.s1?NIH_BMAP_M_S2Mus?musculus cDNA?clone?UI-M-BH1-amh-e-03-0-UI3.mRNAsequence Rattus?norvegicus?mRNA?for?BarH-class?homeodomain transcription?factor.complete?cds. Rattus?norvegicus?mRNA?for?BarH-class?homeodomain transcription?factor.complete?cds. Streptomyces?coelicolor?cosmid?J21. ? Mouse?cytomegalovirus?1complete?genomic?sequence. Kaposi′s?sarcoma-associated?herpesvirus?glycoprotein?M.DNA replication?protein.glycoprotein.DNA?replication?protein.FLICE inhibitory?protein?and?v-cyclin?genes.complete?cds.and?tegument Alcaligenes?eutrophus?protein?H(phbH)and?protein?I(phbI) genes.complete?cds. Human?DNA?sequence?from?clone?836E13?on?chromosome?20 Contains?ESTs.STS?and?GSSs.complete?sequence. EST216152?Normalized?rat?lung.Bento?Soares?Rattus?sp.cDNA clone?RLUCF563end.mRNA?sequence. Homo?sapiens?deoxycytidylate?deaminase?gene.complete?cds. Sequence?1from?patent?US?5622851. Sequence?2from?patent?US?5622851. Streptomyces?coelicolor?cosmid?J21. ? Brevibacterium?lactofermentum?tryptophan?operon. ? DNA?sequence?of?tryptophan?operon. ? | Serratia?marcescens ? Caenorhabditis?elegans Caenorhabditis?elegans ? Homo?sapiens Homo?sapiens ? Homo?sapiens ? ? Mus?musculus ? Rattus?norvegicus ? Rattus?norvegicus ? Streptomyces?coelicolor A3(2) Mouse?cytomegalovirus?1 Kaposi′s?sarcoma- associated?herpesvirus ? Ralstonia?eutropha ? Homo?sapiens ? Rattus?sp. ? Homo?sapiens Unknown. Unknown. Streptomyces?coelicolor A3(2) Corynebacterium glutamicum Corynebacterium glutamicum | 40,386 ? 36,207 36,436 ? 39,722 43,137 ? 37,643 ? ? 41,475 ? 41,031 ? 40,717 ? 34,913 ? 40,097 36,029 ? ? 45,624 ? 37,303 ? 39,098 ? 37,644 37,644 37,644 39,398 ? 39,610 ? 46,753 ? | 26-MAR-1998 ? 28-Jul-96 23-Feb-99 ? 27-Aug-98 21-MAY-1999 ? 3-Aug-99 ? ? 18-Sep-99 ? 2-Sep-98 ? 2-Sep-98 ? 5-Aug-99 ? 04-DEC-1996 9-Jul-97 ? ? 26-Apr-93 ? 23-Nov-99 ? 20-Jan-99 ? 11-Aug-95 13-MAY-1997 13-MAY-1997 5-Aug-99 ? 10-Feb-99 ? 29-Sep-97 ? |
Table 4 (continuing)
rxa?01943 | 2172GB_BA1:CORPTSMA ? GB_BA1:BRLPTSG ? GB_BA2:AF045481 ? | 2656 ? 3163 ? 2841 ? | L18874 ? L18875 ? AF045481 ? | Corynebacterium?glutamicum?phosphoenolpyruvate?sugar phosphotransferase(ptsM)mRNA.com?plete?cds. Brevibacterium?lactofermentum?phosphoenolpyruvate?sugar phosphotransferase(ptsG)gene.complete?cds. Corynebacterium?ammoniagenes?glucose?permease(ptsG)gene. complete?cds. | Corynebacterium glutamicum Brevibacterium lactofermentum Corynebacterium ammoniagenes | 100,000 ? 84,963 ? 53,558 ? | 24-Nov-94 ? 01-OCT-1993 ? 29-Jul-98 ? |
Embodiment
Embodiment 1: the preparation of Corynebacterium glutamicum ATCC 13032 full gene group DNA
Corynebacterium glutamicum (ATCC 13032) culture in BHI substratum (Difco), 30 ℃ of thermal agitation overnight incubation.Centrifugal collecting cell is abandoned supernatant, and cell is suspended among the 5ml damping fluid I (all volumes of pointing out of the 5%-of culture original volume all calculate for the 100ml culture volume) again.The composition of damping fluid I: 140.34g/l sucrose, 2.46g/l MgSO
4* 7H
2O, 10ml/l KH
2PO
4Solution (100g/l, KOH is adjusted to PH6.7), 50g/lM12 enriched material (10g/l (NH
4)
2SO
4, 1g/l NaCl, 2g/l MgSO
4* 7H
2O, 0.2g/l CaCl
2, 0.5g/l yeast extract (Difco)), 10ml/l trace element mixture (200mg/l FeSO
4* H
2O, 10mg/l ZnSO
4* 7H
2O, 3mg/l MnCl
2* 4H
2O, 30mg/l H
3BO
3, 20mg/lCoCl
2* 6H
2O, 1mg/l NiCl
2* 6H
2O, 3mg/l Na
2MoO
4* 2H
2O), 500mg/l complexing agent (EDTA or citric acid), 100ml/l vitamine mixture (0.2mg/l vitamin H, 0.2mg/l folic acid, the amino M-nitro benzoic acid of 20mg/l p-, 20mg/l riboflavin, 40mg/lpanthothenate, 140mg/l nicotinic acid, 40mg/l hydrochloric acid Vitamin B6,200mg/l inositol).Add N,O-Diacetylmuramidase in the suspension to final concentration 2.5mg/ml.37 ℃ hatched about 4 hours after, cell walls is degraded, the centrifugal collection of the protoplastis that obtains.Precipitation is washed once with 5ml damping fluid I, and (10mM Tris-HCl, 1ml EDTA pH8) washes once with 5ml TE damping fluid.Precipitation is resuspended with 4ml TE damping fluid, and adds 0.5ml SDS solution (10%) and 0.5ml NaCl solution (5M).Add Proteinase K to final concentration 200 μ g/ml, suspension was hatched about 18 hours at 37 ℃.DNA extracts purifying with phenol, phenol-chloroform-primary isoamyl alcohol, chloroform-primary isoamyl alcohol according to standard program.Then, add 3M sodium acetate and 2 times of volume of ethanol of 1/50 volume, hatched 30 minutes, with the supercentrifuge 12 that uses SS34 rotary head (Sorvall), centrifugal 30 minutes of 000rpm, deposit D NA at-20 ℃.DNA is dissolved in the 1ml TE damping fluid that contains 20 μ g/ml RNaseA, and 4 ℃ of dialysis are at least 3 hours in 1000ml TE damping fluid.During this period of time, exchange buffering liquid 3 times.In the dna solution of every 0.4ml dialysis, add 0.4ml2M LiCl and 0.8ml ethanol.-20 ℃ hatch 30 minutes after, centrifugal (13,000rpm, Biofuge Fresco, Heraeus, Hanau Germany) collects DNA.The DNA precipitation is melted in the TE damping fluid.DNA by this program preparation can be used for all purposes, comprises the structure of southern hybridization and genomic library.
Embodiment 2: the structure of the genomic library of Corynebacterium glutamicum ATCC13032 in intestinal bacteria
Use the DNA of preparation as described in Example 1, according to the method for known and abundant foundation (referring to, Sambrook for example, J.et al. (1989) " Molecular Cloning:ALaboratory Manual " Cold Spring Harbor Laboratory, Cold Spring HarborLaboratory Press, perhaps Ausubel, F.M.et al. (1994) " Current Protocols inMolecular Bilogy ", John Wiley ﹠amp; Sons.), can make up cosmid library and plasmid library.
Can use any plasmid and clay.Plasmid pBR322 (Sutcliffe, J.G. (1979) Proc.Natl.Acad.Sci.USA, 75:3737-3741); PACY177 (Change ﹠amp; Cohen (1978) J.Bacteriol134:1141-1156), pBS series plasmid (pBSSK+, pBSSK-and other plasmids; Stratagene, LaJolla, USA), clay SuperCosl (Stratagene, LaJolla, USA) or Lorist6 (Gibson, T.J., Rosenthal A.and Waterson, R.H. (1987) Gene53:283-286) can be used for special purpose.The special gene library of using in Corynebacterium glutamicum can use plasmid pSL109 (Lee, H-S.and A.J.Sinskey (1994) J.Microbiol.Biotechnol.4:256-263) to make up.
Embodiment 3:DNA order-checking and computer function analysis
According to standard method, use as genomic library described in embodiment 2, can carry out dna sequencing, particularly with the chain termination method of using the ABI377 sequenator (referring to, Fleischman for example, R.D.et al. (1995) " Whole-genome Random Sequencing andAssembly of Haemophilus Influenzae R d., Science, 269:496-512).Use has the sequencing primer of following nucleotide sequence: 5 '-GGAAACAGTATGACCATG-3 ' or 5 '-GTAAAACGACGGCCAGT-3 '.
Embodiment 4: vivo mutations
(for example can pass through intestinal bacteria or other microorganisms, some bacterium of genus bacillus or similarly be the yeast of yeast saccharomyces cerevisiae) the going down to posterity of plasmid (perhaps other carriers) DNA, carry out the vivo mutations of Corynebacterium glutamicum, wherein these microorganisms keep the ability of its genetic information globality to be damaged.Typical mutant strain has sudden change (for example, mutHLS, mutD, mutT etc. in the gene of DNA repair system; Reference is referring to Rupp, W.D. (1996) DNA repair mechanisms, and in:Escherichiacoli and Salmonella, p.2277-2294, ASM:Washington.).These bacterial strains are known for the people who is skilled in technique.The use of these bacterial strains is set forth in, Greener for example, and A.and Callahan is among M. (1994) the Strategies 7:32-34.
Embodiment 5: the DNA that transmits between intestinal bacteria and Corynebacterium glutamicum
Rod bacillus and tyrothricin bacterial classification contain can the spontaneous endogenous plasmid that duplicates (for example similarly being, pHM1519 or pBL1) (comment referring to, for example, Martin, J.F.et al. (1987) Biotechnology, 5:137-146).The shuttle vectors of intestinal bacteria and Corynebacterium glutamicum, can use colibacillary standard vector to be easy to make up (Sambrook, J.et al. (1989) " Molecular Cloning:A Laboratory Manual " Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press or Ausubel, F.M.et al. (1994) " Current Protocols in Molecular Bilogy ", John Wiley ﹠amp; Sons.), promptly add replication fork starting point of Corynebacterium glutamicum and suitable mark therein.This replication origin, what preferably isolating endogenous plasmid obtained from excellent bacillus and tyrothricin bacterial classification.As these these special purposes of bacterial classification transformation marker is kalamycin resistance gene (for example from Tn5 or Tn903 transposon those kalamycin resistance genes) or chloramphenicol resistance gene (Winnacker, E.L. (1987) " From Genes to Clones-Introduction to Gene Technology; VCH, Weinheim).In the document that makes up various wild-type shuttle vectorss, many examples are arranged, these shuttle vectorss can duplicate in intestinal bacteria and Corynebacterium glutamicum, and can be used for various purposes, comprising gene overexpression (reference referring to, for example, Yoshihama, M.et al. (1985) J.Bacteriol.162:591-597, Martin J.F.et al. (1987) Biotechnology, 5:137-146 and Eikmanns, B.J.et a; . (1991) Gene, 102:93-98).
Use the standard method can be in above-mentioned shuttle vectors, and can carry this hybridization and introduce in the Corynebacterium glutamicum strain interested gene clone.The conversion of Corynebacterium glutamicum can be passed through protoplast transformation (Kastsumata, R.et al. (1984) J.Bacteriol.159306-311), fax hole (Liebl, E.et al. (1989) FEMSMicrobiol.Letters, 53:399-303) realize, when using special carrier, also can pass through keying action (for example at Sch fer, A et al. (1990) J.Bacteriol.172:1663-1666) and realize.Also can be by preparing plasmid DNA (known standard method on the use technology) from Corynebacterium glutamicum and it be transformed into the intestinal bacteria, and shuttle vectors is transferred to intestinal bacteria from Corynebacterium glutamicum.This step of converting can use standard method to carry out, but is to use Mcr defective escherichia coli bacterial strain, for example NM522 (Gough; Murray (1983) J.Mol.Biol.166:1-19) be favourable.
Use contains pCG1 (U.S.Patent No.4,617,267) or its segmental plasmid, and can select kalamycin resistance gene (Grindley from TN903, N.D.and Joyce, C.M. (1980) Proc.Natl.Acad Sci.USA 77 (12): 7176-7180), just can be in Corynebacterium glutamicum the overexpression gene.In addition, use plasmid pSL109 (Lee, H.-S.and A.J.Sinskey (1994) J.Microbiol.Biotechnol.4:256-263) also can be in Corynebacterium glutamicum the overexpression gene.
Except using reproducible plasmid, also can realize the overexpression of gene by genome conformity.The genome conformity of Corynebacterium glutamicum or other excellent bacillus or tyrothricin bacterial classification, can realize by the method for knowing, the homologous recombination of genome area for example, the integration (REMI) of restriction endonuclease mediation is (referring to for example, DE Patent 19823834), perhaps by using transposon.Also can be by (for example modifying regulation domain, promotor, repressor and/or enhanser), by using site-directed method (for example homologous recombination) or based on sequence modification, insertion or the disappearance of random occurrence method (for example transposon mutant or REMI), the activity of regulating gene of interest.Nucleotide sequence as transcription terminator also can be inserted into 3 ' of one or more genes encoding zone of the present invention; Such terminator is known technically, and is described in for example Winnacker, among E.L. (1987) the From Genes to Clones-Introduction to Gene Technology.VCH:Weinheim.
Embodiment 6: the estimation that mutein is expressed
By the active observation of mutein in the transformed host cell, depend on this fact, promptly mutein is expressed with similar quantity in the mode similar to wild-type protein.A kind of useful method of determining mutator gene transcriptional level (quantitative index that is used for the mRNA of gene product translation) be carry out Northern hybridization (reference referring to, for example, Ausubel et al. (1988) CurrentProtocols in Molecular Biology, Wiley:New York), wherein the design be used in conjunction with the primer mark of gene of interest detectable mark (normally radioactive or chemiluminescent) is arranged, thereby, when whole RNA of organism culture are extracted out, run gel electrophoresis, transfer on the stable and with this probe and hatch, the combination of bonding probes and quantity have just been indicated the existence and the quantity of this gene mRNA.This information is the evidence that mutator gene is transcribed degree.Can use several method to prepare whole cell RNAs from Corynebacterium glutamicum, this knows technically, for example is described in Bormann, among E.R.et al. (1992) Mol.Microbiol.6:317-326.
In order to estimate proteinic existence and relative populations by this mRNA translation, can use standard technique, for example Wesstern hybridization (referring to, for example, Ausubel et al. (1988) CurrentProtocols in Molecular Biology, Wiley:New York).In the method, extract whole cell proteins, separate by gel electrophoresis, transferring to similarly is to hatch altogether on the such medium of nitrocellulose and with the probe of desired protein specific combination, for example antibody.This probe is marked with the mark of the chemiluminescent or colorimetric that is easy to detect usually.The existence of the mark that observes and quantity have been indicated the existence and the quantity that appear at the required mutein in the cell.
Embodiment 7: growth-medium of the Corynebacterium glutamicum of genetic modification and culture condition
The Corynebacterium glutamicum of genetic modification can be cultivated in synthetic or spontaneous growth substratum.The various growth medium that is used for Corynebacterium glutamicum is known and is to be easy to obtain (Lieb, et al. (1989) Appl.Microbiol.Biotechno., 32:205-210; Von der Ostenet al. (1998) Biotechnology Letters, 11:11-16; Patent DE 4,120,867; Liebl (1992) " The Genus Corynebacterium, in:Procaryotes, Volume II, Balows, A.et al., eds.Springer-Verlag).These substratum contain one or more carbon sources, nitrogenous source, inorganic salt, VITAMIN and trace element.Preferred carbon source is a carbohydrate, for example monose, disaccharides or polysaccharide.For example, glucose, fructose, seminose, semi-lactosi, ribose, sorbose, ribulose, lactose, maltose, sucrose, raffinose, starch or Mierocrystalline cellulose all can be used as good carbon source.Also can provide carbohydrate to substratum, for example molasses or other carbohydrate purified by products by complex compound.The mixture that improves different carbon sources also is favourable.Other available carbon sources have alcohol and organic acid, for example methyl alcohol, ethanol, acetate or lactic acid.The nitrogen compound that nitrogenous source is normally organic or inorganic perhaps contains the material of these compounds.Representational nitrogenous source comprises ammonia or ammonium salt, for example NH
4Cl or (NH
4)
2SO
4, NH
4OH, nitrate, urea, amino acid or complicated nitrogenous source, for example corn steep liquor, soyflour, soybean protein, yeast extract, meat extract or other.
Can be included in the inorganic salt compound in the substratum, comprise calcium, magnesium, sodium, cobalt, molybdenum, potassium, manganese, zinc, copper or the iron of hydrochloride, phosphoric acid salt or vitriol.Sequestrant can be added in the substratum, to keep the solution metal ion.Useful especially sequestrant comprises dihydroxyl phenol, similarly is catechol and Protocatechuic Acid, and perhaps organic acid similarly is a citric acid.Substratum typically also contains somatomedin, for example VITAMIN and growth stimulant, and their example comprises vitamin H, riboflavin, thiamines, folic acid, nicotinic acid, pantothenate and pyridoxol.Somatomedin and salt is often from the medium component of complexity, for example yeast extract, molasses, corn steep liquor and other compositions.The definite composition intensive of substratum compound depends on direct experiment, and for each particular case concrete decision.Pass through at textbook " AppliedMicrobiol.Physiology; A Practical Approach " (eds.P.M.Rhodes about the optimized information of substratum, P.F.Stanbury, IRL Press (1997) pp.53-73, ISBN 0 19 9635773) " in.Also can select growth medium there from commercial supplier, similarly be standard 1 (Merck) or BHI (grain heart infusion, DIFCO) or other.
All nutrient media componentses all will be by heating (1.5bar, 120 ℃, 20 minutes) or sterile filtration sterilization.Component can be sterilized together, perhaps if necessary separately sterilization separately.All nutrient media componentses can just add in the beginning of growth, perhaps can select continuity or adding in batches.
Culture condition is determined respectively each experiment.Temperature should be in 15 ℃ to 45 ℃ scopes.It is constant that temperature can keep, and perhaps changes in experiment.The pH of substratum preferably about 7.0, and can keep by the interpolation of damping fluid in the substratum in 5 to 8.5 scopes.At the representational damping fluid of this purpose is potassium phosphate buffer.Synthetic damping fluid, for example MOPS, HEPES, ACES and other also can replace using or using simultaneously.Also can be by adding NaOH or NH in process of growth
4OH is to keep stable cultivation pH.If using similarly is the so complicated nutrient media components of yeast extract, can reduce the necessity of adding damping fluid, this is because many complex compounds have this fact of very strong surge capability.If use the fermentor cultivation microorganism, also can use ammonia control pH.
Incubation time is usually in several hours to several days scopes.Choosing of this time is in order to allow the product of accumulation maximum in the liquid medium within.The growth experiment of announcing carries out in various containers, and for example microtiter plate, glass test tube, glass shake bottle or the glass of different sizes or the fermentor tank of metal.In order to screen a large amount of clones, microorganism should be cultivated to be had baffle plate or not to have microtiter plate, the glass test tube of baffle plate or shake in the bottle.The preferred 100ml that uses shakes bottle, adds the required substratum of 10% (volume).Shaking bottle should be placed on the shaking table and shake (25 millimeters of amplitudes), velocity range 100-300rpm.Can reduce vaporization losses by keeping moistening air; Perhaps, vaporization losses is carried out the mathematics correction.
If detect the clone of genetic modification, so also should detect not modified contrast clone or contain basic plasmid but without any the contrast clone who inserts.Use is grown in 30 ℃ of cells of hatching on the agar plate, for example CM flat board (10g/l glucose, 2.5g/l NaCl, 2g/l urea, the many peptones of 10g/l, 5g/l yeast extract, 5g/l gravy extract, 22g/l agar, 2M NaOH transfers to pH6.8), inoculation medium is to OD
600Value is 0.5-1.5.The inoculation of substratum can perhaps realize by the pre-culture of the liquid that adds this bacterium by introducing the salt suspensioning liquid from the Corynebacterium glutamicum cell of CM flat board.
Embodiment 8: the analyzed in vitro of mutein function
The activity of enzyme and kinetic parameter to be determined at technical be fine foundation.Any to given determination of activity experiment through the enzyme that changes, must be fit to the sp act of wild-type enzyme, this is fully within technology skilful person's ability.About the comment of the summary of enzyme, and about structure, kinetics, principle, method, application with determine the clear and definite details of many enzymic activity examples, can in for example below with reference to document, find: Dixon, M., and Webb, E.C., (1979) Enzymes.Longmans:London; Fersht, (1985) Enzyme Structure and Mechanism.Freeman:NewYork; Walsh, (1979) Enzymatic Reaction Mechanisms.Freeman:San Francisco; Price, N.C., Stevens, L (1982) Fundamentals of Enzymology.Oxford Univ.Press:Oxford; Boyer, P.D., ed. (1983) The Enzymes, 3
RdEd.Academic Press:New York; Bisswanger, H., (1994) Enzymkinetik, 2
NdEd.VCH:Weinheim (ISBN 3527300325); Bergmeyer, H.U., Bergmeyer, J., Gra β l, M., eds. (1983-1986) Methods of EnzymaticAnalysis, 3
RdEd., vol.I-XII, Verlag Chemie:Weinheim; And Ullmann ' s Encyclopediaof Industrial Chemistry (1987) vol.A9, " Enzymes " .VCH:Weinheim, p.352-363.
Activity of proteins in conjunction with DNA can be measured by several technical known methods, for example DNA band shift analysis (being also referred to as gel retardation assay).These protein are to the effect of other developed by molecule, can be with reporter gene assay determination (for example be described in Kolmar, H.et al (1995) EMBO is in J.14:3895-3904, and the reference of quoting).The reporter gene test macro is known, and the application in protokaryon and eukaryotic cell all sets up, and use similarly is beta-tilactase, green fluorescent protein and the such enzyme of several other protein.
The active mensuration of protein called membrane transporters matter can be according to for example being described in Gennis, R.B. (1989) " Pores, Channels and Transporters ", in Biomembrane, Molecular Structureand Function, Springer:Heidelberg, p.85-137; 199-234; Those technology among the and 270-322 are carried out.
Embodiment 9: the effect Analysis that mutein is produced for required product
The effect that the Corynebacterium glutamicum genetic modification is produced for required compound (for example amino acid), can estimate like this, i.e. microorganism of having modified by (for example described above those) growth under the conditions suitable, and analyzing increases substratum and/or the cellular component that required product (for example, amino acid) is produced.These analytical technologies are known for skilled routine techniques person, comprise spectroscopic analysis, thin-layer chromatography, various dyeing process, enzymatic means and microbial process, and similarly be high performance liquid chromatography (Ullman, Encyclopedia of Industrial Chemistry, vol.A2, p.89-90 andp.443-613, VCH:Weinheim (1985); Fallon, A.et al., (1987) " Applications ofHPLC in Biochemistry " in:Laboratory Techniques in Biochemistry and MolecularBiology, vol.17; Rehm et al. (1993) Biotechnology, vol.3, Chapter III: " Productrecovery and purification ", page 469-714, VCH:Weinheim; Belter, P.A.et al. (1988) Bioseparations:downstream processing for biotechnology, John Wiley and Sons; Kennedy, J.F.and Cabral, J.M.S. (1992) Recovery processes for biologicalmaterials, John Wiley and Sons; Shaeiwitz, J.A.and Henry, J.D. (1988) Biochemicalseparations, in:Ulmann ' s Encyclopedia of Industrial Chemistry, vol.B3, Chapter11, page 1-27, VCH:Weinheim; And Dechow, F.J. (1989) Separation and purificationtechniques in biotechnology, Noyes Publications) such analysis chromatography.
Except mensuration to final tunning, also can analyze other components of the pathways metabolism that is used for required compound production, for example intermediate and by product are with the production efficiency of throughput, output and/or the compound of determining organism.Analytical procedure comprises that nutrient level (for example in the substratum, carbohydrate, hydrocarbon, nitrogenous source, phosphoric acid and other ions) mensuration, the mensuration that biomass is formed and grown, the analysis of the production of the common meta-bolites of biosynthetic pathway, and to producing the mensuration of gas in the fermentation.The standard method of these mensuration outlines at Applied MicrobialPhysiology, A Practical Approach, and P.M.Rhodes and P.F.Stanbury, eds., IRL Press, p.103-163; In and 165-192 (ISBN:0199635773) and the reference quoted thereof.
Embodiment 10: the purifying of required product in the Corynebacterium glutamicum culture
Reclaim required product from the Corynebacterium glutamicum cell or in the supernatant of above-mentioned substratum, can be undertaken by technical known the whole bag of tricks.If required product is not emiocytosis, can use the standard technique lysing cell, for example mechanical force or ultrasonic wave by low-speed centrifugal collecting cell from substratum so.The centrifugal cell debris of removing keeps the supernatant that contains soluble protein and partly is used to be further purified required compound.If product from Corynebacterium glutamicum emiocytosis, is removed cell with low-speed centrifugal so from substratum, keep supernatant and partly be used to be further purified.
The supernatant part that any purification process obtains is carried out chromatography with appropriate resin, and desired molecule is kept by the chromatography resin, and a lot of impurity in the sample are not retained, and perhaps impurity is kept by resin, and sample is not retained.Use identical or different chromatographic resins, can repeat this chromatographic step as required.The person that is familiar with the routine techniques can be very skilled the suitable chromatographic resin of selection, and know these resins for the most effective application of specific molecular to be purified.The product of purifying can be used and filter or ultrafiltration and concentration, and is stored under the temperature of product stability maximum.
Technical known purification process is very many, and aforesaid purification process does not also mean that and only is confined to this.These purification process are described in, Bailey for example, J.E.﹠amp; Ollis, D.F.BiochmicalEngineering Fundamentals is among the McGraw-Hill:New York (1986).
The characteristic of separating compound and purity can technical standard technique be estimated.This comprises high performance liquid chromatography (HPLC), light-splitting method, dyeing process, thin-layer chromatography, NIRS, enzymatic means or microbial process.These analytical procedures have comment in following document: Patek et al. (1994) Appl.Environ.Microbiol.60:133-140; Malakhova et al. (1996) Biotekhnologiya11:27-32; And Schmidt et al. (1998) Bioprocess Engineer.19:67-70.Ulmann ' sEncyclopedia of Industrial Chemistry, (1996) vol.A27, VCH:Weinheim, p.89-90, p.521-540, p.540-547, p.559-566,575-581 and p.581-587; Michal, G. (1999) Biochemical Pathways:An Atlas of Biochemistry and Molecular Biology, JohnWiley and Sons; Fallon, A.et al. (1987) Applications of HPLC in Biochemistry in:Laboratory Techniques in Biochemistry and Molecular Biology, vol.17.
Embodiment 11: analysis of gene sequences of the present invention
The mensuration of percent homology between sequence comparison and the two sequences, it is technical known technology, can use the mathematical operation rule to finish, the algorithm among Karlin and Altschul (1990) the Proc.Natl.Acad.Sci.USA 87:2264-68 for example, this algorithm has modification in Karlin andAltschul (1993) Proc.Natl.Acad.Sci.USA 90:5873-77.This algorithm is incorporated into Altschul, in NBLAST among et al. (1990) J.Mol.Biol.215:403-10 and the XBLAST program (2.0 editions).The search of BLAST Nucleotide can be carried out with the NBLAST program, score=100, and wordlength=12 can obtain and PTS nucleic acid molecule homologous nucleotide sequence of the present invention.The search of BLAST protein can be carried out with the XBLAST program, score=50, and wordlength=3 can obtain and pts protein matter molecule homologous aminoacid sequence of the present invention.For comparison purposes, in order to obtain gapped sequence contrast, can use to be described in Altschul et al., (1997) NucleicAcids Res.25 (17): the GappedBLAST among the 3389-3402.When using BLAST and Gapped blast program, the person that is familiar with the routine techniques knows for the specific sequence to be analyzed parameter of optimizer (for example, XBLAST and NBLAST) how.
Another mathematical operation rule example that is used for the sequence comparison is Meyers and Miller algorithm ((1998) Comput.Appl.Biosci.4:11-17).This algorithm is incorporated in the ALIGN program (2.0 editions), and this program is the part of GCG sequence nucleotide sequence comparison software bag.When using ALIGN program comparing amino acid sequence, can use PAM120 weight residue table, gap length punishment 12, gap punishment 4.Other sequential analysis algorithm also is known technically, comprises ADVANCE and ADAM, is described among Torelli and Robotti (1994) Comput.Appl.Biosci.10:3-5; And FASTA, be described among Pearson and Lipman (1998) P.N.A.S.85:2444-8.
Article two, the per-cent homology between the aminoacid sequence also can use the GAP program in the GCG software package (http://www.gcg.com has to be provided) to realize, use Blosum 62 matrixes or PAM 250 matrixes, gap component 12,10,8,6 or 4, length component 2,3 or 4.Article two, the per-cent homology between the nucleotide sequence can use the GAP program in the GCG software package to realize, uses canonical parameter, for example gap component 50 and length component 3.
Comparative analysis among gene order of the present invention and the Genbank between the sequence, on can use technology known technology carry out (referring to, for example, Bexevanis and Ouellette, eds. (1998) Bioinformatics:A Practical Guide to the Analysis of Genes and Proteins.John Wiley and Sons:New York).Gene order of the present invention compares by the method for three steps and the sequence among the Genbank.In the first step, the nucleotide sequence among the relative Genbank of each bar sequence of the present invention is carried out BLASTN analyze (for example, local sequence comparative analysis), keep 500 the highest couplings and do further to analyze.Then these 500 couplings are made FASTA and search (for example, local and global composite sequence comparative analysis is carried out the sequence contrast to the sequence area that limits therein).Next, to three couplings the highest of every gene order of the present invention and FASTA, use the GAP program (use canonical parameter) in the GCG software package to carry out whole world sequence contrast.In order to obtain correct result, from the sequence length that Genbank selects, the method for knowing on the use technology is adjusted to the length of search sequence.The results are shown in the table 4 of this analysis.The result who obtains although it is so, analyze the result who obtains with the independent GAP (whole world) that every gene of the present invention is carried out with respect to every contrast of Genbank, be consistent, but analyze that significantly reduce required computing time with respect to the GAP (whole world) of big database.Do not obtain the correlated sequence of the present invention of the above sequence of cutoff, in table 4, show, lack the sequence comparative information.The person can furtherly understand to be familiar with the routine techniques, and the GAP sequence contrast percent homology under the title of listing in table 4 " %homology (GPA) " is listed with European digital format, and wherein ', ' represents decimal system point.For example, value " 40, the 345 " representative " 40.345% " in these row.
The structure and the operation of embodiment 12:DNA microarray
Sequence of the present invention can also be used for dna microarray (design of DNA array, methods and applications are technical knows, be described in, for example, Schena, M.te al. (1995) Science 270:467-470; Wodicka, L.et al. (1997) Nature Biotechnology 15:1359-1367; DeSaizieu, A.et al. (1998) Nature Biotechnology 16:45-48; And DeRisi, J.L.et al. (1997) Science 278:680-686) structure and application.
Dna microarray uses solid or flexible upholder, comprises nitrocellulose, nylon, glass, silicon or other materials.Nucleic acid molecule can be connected the surface in an orderly way.After the appropriate flags, other nucleic acid or nucleic acid mixture can with the fixed making nucleic acid molecular hybridization, mark can be used to monitor and measure the independent strength of signal of determining the area hybridization molecule.Present method allows the relative or absolute quantity of the whole or selected nucleic acid in quantitatively suitable simultaneously nucleic acid samples or the mixture.Therefore, dna microarray allow multiple (as many as 6800 or more) similar expression of nucleic acid analysis (referring to for example, Schena, M. (1996) BioEssays 18 (5): 427-431).
Sequence of the present invention can be used to design oligonucleotide primer, can increase by the nucleic acid amplification reaction as the polymerase chain reaction definite zone of one or more of Corynebacterium glutamicum genes of these primers.The selection of 5 ' or 3 ' oligonucleotide primer or suitable linker and design, and the covalently bound surface to above-mentioned supporting dielectric of PCR product that allows to obtain (also be described in, for example, Schena, M.et al. (1995) Science 270:467-470).
Nucleic acid microarray also can pass through as at Wodicka, the original position oligonucleotide of describing among L.et al. (1997) the NatureBiotechnology 15:1359-1367 is synthetic to be made up.By the photograph plate method, exactly determined zone in the matrix can be exposed in the light.Blocking group is a photo-labile, thereby is activated and adds through subject nucleotide, but is covered up and any modification is not carried out in zone that can not see light.Ensuing protection and photoactivation circulation allow determining the synthetic of the different oligonucleotides in position.The zonule that the present invention determines can be synthesized by the solid phase oligonucleotide on microarray.
Appear at the nucleic acid molecule of the present invention in sample or the mixture of ribonucleotides, can with microarray hybridization.Can be according to these nucleic acid molecule of standard method mark.Briefly, nucleic acid molecule (for example, mRNA molecule or dna molecular) can be labeled by combining with isotropic substance or fluorescently-labeled Nucleotide, for example, and in reverse transcription or DNA are synthetic.The hybridization of labeling nucleic acid and microarray have description (for example at Schena, M.et al. (1995) supra; Wodicka, L.et al. (1997), supra; And DeSaizieu A.et al. (1998) is among the supra).The detection of hybrid molecule and quantitatively will be fit to specific bonding mark.Radio-labeling can be detected, and for example, at Schena, describes among M.et al. (1995) supra, and fluorescent mark also can be surveyed, and for example uses the method for Shalon etal. (1996) Gemone Research 6:639-645.
As mentioned above, the application of sequence of the present invention in dna microarray allows different Corynebacterium glutamicum strains or the comparative analysis of other excellent bacillus.For example,, can promote the research that changes based in the bacterial strain of transcribing the figure of branch individually by the nucleic acid array method, and promote to specific and/or required similarly be the evaluation of the such bacterial strain character important function of gene of pathogenic, throughput and pressure tolerance.Equally, use the nucleic acid array technology, also can compare the figure of branch of genetic expression of the present invention in the fermentation reaction process.
Embodiment 13: the analysis of cell protein group dynamics (proteomics)
Gene of the present invention, composition and method can be used to study the interaction and the kinetics of protein colony, are called " proteomics ".Protein of interest matter colony comprises, but be not limited to, the all protein colony of Corynebacterium glutamicum (for example, with the protein colony of other biological body by comparison), under particular surroundings or metabolism condition (for example, fermentation medium and high temperature or low temperature or high pH or low pH) activated those protein, perhaps at particular growth or activated those protein of etap.
Can be with the various technical Analysis protein colonies of knowing, example gel electrophoresis.Cell protein can or extract by for example cracking and obtain, and also can use various electrophoretic techniques separated from one another.SDS-PAGE (SDS-PAGE) isolated protein is to a great extent based on their molecular wt.Isoelectrofocusing polyacrylamide gel electrophoresis (IEF-PAGE) by etc. some point (this has not only reflected aminoacid sequence, and has shown proteinic posttranslational modification) isolated protein.The protein analysis method that another kind is more preferably is that the continuous combination of IEF-PAGE and SDS-PAGE is called the 2-D-gel electrophoresis (at for example Hermann et al. (1998) Electrophoresis 19:3217-3221; Fountoulakis et al. (1998) Electrophoresis 19:1193-1202; Langen et al. (1997) Electrophoresis 18:1184-1192; Among Antelmann et al. (1997) Electrophoresis18:1451-1463 description is arranged).
Can manifest by standard technique with the isolating protein of these methods, for example by dyeing or mark.Suitable dyeing is known technically, comprises that Xylene Brilliant Cyanine G, silver dye or fluorescence dye, for example Sypro Ruby (Molecular Probes).(for example, include radiolabeled amino acid or other protein precursors in the Corynebacterium glutamicum substratum
35The S-methionine(Met),
35The S-halfcystine,
14The C-labeled amino acid,
15N-amino acid,
15NO
3Perhaps
15NH
4 +Perhaps
13The C-labeled amino acid), can so that these cells before its protein separation with regard to labelled protein.Similarly, also can use fluorescent mark.Can extract, isolate and separate these labelled proteins according to aforementioned techniques.
With the protein that these technology manifest, can do further to analyze by measuring used dyestuff or mark.The quantity of specified protein can be used for example optical means, carry out quantitatively determining, and can with compare in other the proteinic quantity on the same clotting glue or on other gels.Can pass through for example optics comparison, spectrum analysis, gel images analysis and scanning, perhaps, the protein on the gel be compared by using photographic film or indicating meter.These technology are known technically.
In order to determine the characteristic of specified protein, can use direct sequence to measure or other standard techniques.For example, can use N-and/or C-end amino acid order-checking (for example Edman degraded), and mass spectroscopy (particularly MALDI or ESI technology (referring to for example, Langen et al. (1997) Electrophoresis 18:1184-1192)).Protein sequence provided herein can be as the Corynebacterium glutamicum identification of proteins of being undertaken by these technology.
The information that obtains by these technology, can be used for the various patterns that (for example, the different organisms in other conditions, fermentation time point, culture medium condition or coenocorrelation) different sample rooms are modified under comparison protein existence, activity, the different biotic conditions.The data that these tests obtain, can be independent, what perhaps combine with other technologies is used for various application, the behavior of for example comparing (for example metabolism situation) various organisms under the particular case, increase the throughput of the bacterial strain of producing the fine chemistry material, perhaps increase the efficient of fine chemistry material production.
Be equal to statement
The person can recognize to be familiar with the routine techniques, perhaps can determine only to use normal experiment, and particular of the present invention described herein has a lot of Equivalents.Following claim intention comprises these Equivalents.
Sequence table
<110〉BASF AG (BASF Aktiengesellschaft)
<120〉coding phosphoenolpyruvic acid: the proteic Corynebacterium glutamicum gene of carbohydrate phosphotransferase system
<130>BGI-122CPPC
<140>PCT/IB00/00973
<141>2000-06-27
<150>US?60/142,691
<151>1999-07-01
<150>US?60/150,310
<151>1999-08-23
<150>DE?19942095.5
<151>1999-09-03
<150>DE?19942097.1
<151>1999-09-03
<160>36
<210>1
<211>1527
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(1504)
<223>RXS00315
<400>1
ctcatggcat?ctgcgccgtt?cgcgttcttg?ccagtgttgg?ttggtttcac?cgcaaccaag?60
cgtttcggcg?gcaatgagtt?cctgggcgcc?gcgtattggt?atg?gcg?atg?gtg?ttc 115
Met?Ala?Met?Val?Phe
1 5
ccg?agc?ttg?gtg?aac?ggc?tac?gac?gtg?gcc?gcc?acc?atg?gct?gcg?ggc 163
Pro?Ser?Leu?Val?Asn?Gly?Tyr?Asp?Val?Ala?Ala?Thr?Met?Ala?Ala?Gly
10 15 20
gaa?atg?cca?atg?tgg?tcc?ctg?ttt?ggt?tta?gat?gtt?gcc?caa?gcc?ggt 211
Glu?Met?Pro?Met?Trp?Ser?Leu?Phe?Gly?Leu?Asp?Val?Ala?Gln?Ala?Gly
25 30 35
tac?cag?ggc?acc?gtg?ctt?cct?gtg?ctg?gtg?gtt?tct?tgg?att?ctg?gca 259
Tyr?Gln?Gly?Thr?Val?Leu?Pro?Val?Leu?Val?Val?Ser?Trp?Ile?Leu?Ala
40 45 50
acg?atc?gag?aag?ttc?ctg?cac?aag?cga?ctc?aag?ggc?act?gca?gac?ttc 307
Thr?Ile?Glu?Lys?Phe?Leu?His?Lys?Arg?Leu?Lys?Gly?Thr?Ala?Asp?Phe
55 60 65
ctg?atc?act?cca?gtg?ctg?acg?ttg?ctg?ctc?acc?gga?ttc?ctt?aca?ttc 355
Leu?Ile?Thr?Pro?Val?Leu?Thr?Leu?Leu?Leu?Thr?Gly?Phe?Leu?Thr?Phe
70 75 80 85
atc?gcc?att?ggc?cca?gca?atg?cgc?tgg?gtg?ggc?gat?gtg?ctg?gca?cac 403
Ile?Ala?Ile?Gly?Pro?Ala?Met?Arg?Trp?Val?Gly?Asp?Val?Leu?Ala?His
90 95 100
ggt?cta?cag?gga?ctt?tat?gat?ttc?ggt?ggt?cca?gtc?ggc?ggt?ctg?ctc 451
Gly?Leu?Gln?Gly?Leu?Tyr?Asp?Phe?Gly?Gly?Pro?Val?Gly?Gly?Leu?Leu
105 110 115
ttc?ggt?ctg?gtc?tac?tca?cca?atc?gtc?atc?act?ggt?ctg?cac?cag?tcc 499
Phe?Gly?Leu?Val?Tyr?Ser?Pro?Ile?Val?Ile?Thr?Gly?Leu?His?Gln?Ser
120 125 130
ttc?ccg?cca?att?gag?ctg?gag?ctg?ttt?aac?cag?ggt?gga?tcc?ttc?atc 547
Phe?Pro?Pro?Ile?Glu?Leu?Glu?Leu?Phe?Asn?Gln?Gly?Gly?Ser?Phe?Ile
135 140 145
ttc?gca?acg?gca?tct?atg?gct?aat?atc?gcc?cag?ggt?gcg?gca?tgt?ttg 595
Phe?Ala?Thr?Ala?Ser?Met?Ala?Asn?Ile?Ala?Gln?Gly?Ala?Ala?Cys?Leu
150 155 160 165
gca?gtg?ttc?ttc?ctg?gcg?aag?agt?gaa?aag?ctc?aag?ggc?ctt?gca?ggt 643
Ala?Val?Phe?Phe?Leu?Ala?Lys?Ser?Glu?Lys?Leu?Lys?Gly?Leu?Ala?Gly
170 175 180
gct?tca?ggt?gtc?tcc?gct?gtt?ctt?ggt?att?acg?gag?cct?gcg?atc?ttc 691
Ala?Ser?Gly?Val?Ser?Ala?Val?Leu?Gly?Ile?Thr?Glu?Pro?Ala?Ile?Phe
185 190 195
ggt?gtg?aac?ctt?cgc?ctg?cgc?tgg?ccg?ttc?ttc?atc?ggt?atc?ggt?acc 739
Gly?Val?Asn?Leu?Arg?Leu?Arg?Trp?Pro?Phe?Phe?Ile?Gly?Ile?Gly?Thr
200 205 210
gca?gct?atc?ggt?ggc?get?ttg?att?gca?ctc?ttt?aat?atc?aag?gca?gtt 787
Ala?Ala?Ile?Gly?Gly?Ala?Leu?Ile?Ala?Leu?Phe?Asn?Ile?Lys?Ala?Val
215 220 225
gcg?ttg?ggc?gct?gca?ggt?ttc?ttg?ggt?gtt?gtt?tct?att?gat?gct?cca 835
Ala?Leu?Gly?Ala?Ala?Gly?Phe?Leu?Gly?Val?Val?Ser?Ile?Asp?Ala?Pro
230 235 240 245
gat?atg?gtc?atg?ttc?ttg?gtg?tgt?gca?gtt?gtt?acc?ttc?ttc?atc?gca 883
Asp?Met?Val?Met?Phe?Leu?Val?Cys?Ala?Val?Val?Thr?Phe?Phe?Ile?Ala
250 255 260
ttc?ggc?gca?gcg?att?gct?tat?ggc?ctt?tac?ttg?gtt?cgc?cgc?aac?ggc 931
Phe?Gly?Ala?Ala?Ile?Ala?Tyr?Gly?Leu?Tyr?Leu?Val?Arg?Arg?Asn?Gly
265 270 275
agc?att?gat?cca?gat?gca?acc?gct?gct?cca?gtg?cct?gca?gga?acg?acc 979
Ser?Ile?Asp?Pro?Asp?Ala?Thr?Ala?Ala?Pro?Val?Pro?Ala?Gly?Thr?Thr
280 285 290
aaa?gcc?gaa?gca?gaa?gca?ccc?gca?gaa?ttt?tca?aac?gat?tcc?acc?atc 1027
Lys?Ala?Glu?Ala?Glu?Ala?Pro?Ala?Glu?Phe?Ser?Asn?Asp?Ser?Thr?Ile
295 300 305
atc?cag?gca?cct?ttg?acc?ggt?gaa?gct?att?gca?ctg?agc?agc?gtc?agc 1075
Ile?Gln?Ala?Pro?Leu?Thr?Gly?Glu?Ala?Ile?Ala?Leu?Ser?Ser?Val?Ser
310 315 320 325
gat?gcc?atg?ttt?gcc?agc?gga?aag?ctt?ggc?tcg?ggc?gtt?gcc?atc?gtc 1123
Asp?Ala?Met?Phe?Ala?Ser?Gly?Lys?Leu?Gly?Ser?Gly?Val?Ala?Ile?Val
330 335 340
cca?acc?aag?ggg?cag?tta?gtt?tct?ccg?gtg?agt?gga?aag?att?gtg?gtg 1171
Pro?Thr?Lys?Gly?Gln?Leu?Val?Ser?Pro?Val?Ser?Gly?Lys?Ile?Val?Val
345 350 355
gca?ttc?cca?tct?ggc?cat?gct?ttc?gca?gtt?cgc?acc?aag?gct?gag?gat 1219
Ala?Phe?Pro?Ser?Gly?His?Ala?Phe?Ala?Val?Arg?Thr?Lys?Ala?Glu?Asp
360 365 370
ggt?tcc?aat?gtg?gat?atc?ttg?atg?cac?att?ggt?ttc?gac?aca?gta?aac 1267
Gly?Ser?Asn?Val?Asp?Ile?Leu?Met?His?Ile?Gly?Phe?Asp?Thr?Val?Asn
375 380 385
ctc?aac?ggc?acg?cac?ttt?aac?ccg?ctg?aag?aag?cag?ggc?gat?gaa?gtc 1315
Leu?Asn?Gly?Thr?His?Phe?Asn?Pro?Leu?Lys?Lys?Gln?Gly?Asp?Glu?Val
390 395 400 405
aaa?gca?ggg?gag?ctg?ctg?tgt?gaa?ttc?gat?att?gat?gcc?att?aag?gct 1363
Lys?Ala?Gly?Glu?Leu?Leu?Cys?Glu?Phe?Asp?Ile?Asp?Ala?Ile?Lys?Ala
410 415 420
gca?ggt?tat?gag?gta?acc?acg?ccg?att?gtt?gtt?tcg?aat?tac?aag?aaa 1411
Ala?Gly?Tyr?Glu?Val?Thr?Thr?Pro?Ile?Val?Val?Ser?Asn?Tyr?Lys?Lys
425 430 435
acc?gga?cct?gta?aac?act?tac?ggt?ttg?ggc?gaa?att?gaa?gcg?gga?gcc 1459
Thr?Gly?Pro?Val?Asn?Thr?Tyr?Gly?Leu?Gly?Glu?Ile?Glu?Ala?Gly?Ala
440 445 450
aac?ctg?ctc?aac?gtc?gca?aag?aaa?gaa?gcg?gtg?cca?gca?aca?cca 1504
Asn?Leu?Leu?Asn?Val?Ala?Lys?Lys?Glu?Ala?Val?Pro?Ala?Thr?Pro
455 460 465
taagttgaaa?ccttgagtgt?tcg 1527
<210>2
<211>468
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>2
Met?Ala?Met?Val?Phe?Pro?Ser?Leu?Val?Asn?Gly?Tyr?Asp?Val?Ala?Ala
1 5 10 15
Thr?Met?Ala?Ala?Gly?Glu?Met?Pro?Met?Trp?Ser?Leu?Phe?Gly?Leu?Asp
20 25 30
Val?Ala?Gln?Ala?Gly?Tyr?Gln?Gly?Thr?Val?Leu?Pro?Val?Leu?Val?Val
35 40 45
Ser?Trp?Ile?Leu?Ala?Thr?Ile?Glu?Lys?Phe?Leu?His?Lys?Arg?Leu?Lys
50 55 60
Gly?Thr?Ala?Asp?Phe?Leu?Ile?Thr?Pro?Val?Leu?Thr?Leu?Leu?Leu?Thr
65 70 75 80
Gly?Phe?Leu?Thr?Phe?Ile?Ala?Ile?Gly?Pro?Ala?Met?Arg?Trp?Val?Gly
85 90 95
Asp?Val?Leu?Ala?His?Gly?Leu?Gln?Gly?Leu?Tyr?Asp?Phe?Gly?Gly?Pro
100 105 110
Val?Gly?Gly?Leu?Leu?Phe?Gly?Leu?Val?Tyr?Ser?Pro?Ile?Val?Ile?Thr
115 120 125
Gly?Leu?His?Gln?Ser?Phe?Pro?Pro?Ile?Glu?Leu?Glu?Leu?Phe?Asn?Gln
130 135 140
Gly?Gly?Ser?Phe?Ile?Phe?Ala?Thr?Ala?Ser?Met?Ala?Asn?Ile?Ala?Gln
145 150 155 160
Gly?Ala?Ala?Cys?Leu?Ala?Val?Phe?Phe?Leu?Ala?Lys?Ser?Glu?Lys?Leu
165 170 175
Lys?Gly?Leu?Ala?Gly?Ala?Ser?Gly?Val?Ser?Ala?Val?Leu?Gly?Ile?Thr
180 185 190
Glu?Pro?Ala?Ile?Phe?Gly?Val?Asn?Leu?Arg?Leu?Arg?Trp?Pro?Phe?Phe
195 200 205
Ile?Gly?Ile?Gly?Thr?Ala?Ala?Ile?Gly?Gly?Ala?Leu?Ile?Ala?Leu?Phe
210 215 220
Asn?Ile?Lys?Ala?Val?Ala?Leu?Gly?Ala?Ala?Gly?Phe?Leu?Gly?Val?Val
225 230 235 240
Ser?Ile?Asp?Ala?Pro?Asp?Met?Val?Met?Phe?Leu?Val?Cys?Ala?Val?Val
245 250 255
Thr?Phe?Phe?Ile?Ala?Phe?Gly?Ala?Ala?Ile?Ala?Tyr?Gly?Leu?Tyr?Leu
260 265 270
Val?Arg?Arg?Asn?Gly?Ser?Ile?Asp?Pro?Asp?Ala?Thr?Ala?Ala?Pro?Val
275 280 285
Pro?Ala?Gly?Thr?Thr?Lys?Ala?Glu?Ala?Glu?Ala?Pro?Ala?Glu?Phe?Ser
290 295 300
Asn?Asp?Ser?Thr?Ile?Ile?Gln?Ala?Pro?Leu?Thr?Gly?Glu?Ala?Ile?Ala
305 310 315 320
Leu?Ser?Ser?Val?Ser?Asp?Ala?Met?Phe?Ala?Ser?Gly?Lys?Leu?Gly?Ser
325 330 335
Gly?Val?Ala?Ile?Val?Pro?Thr?Lys?Gly?Gln?Leu?Val?Ser?Pro?Val?Ser
340 345 350
Gly?Lys?Ile?Val?Val?Ala?Phe?Pro?Ser?Gly?His?Ala?Phe?Ala?Val?Arg
355 360 365
Thr?Lys?Ala?Glu?Asp?Gly?Ser?Asn?Val?Asp?Ile?Leu?Met?His?Ile?Gly
370 375 380
Phe?Asp?Thr?Val?Asn?Leu?Asn?Gly?Thr?His?Phe?Asn?Pro?Leu?Lys?Lys
385 390 395 400
Gln?Gly?Asp?Glu?Val?Lys?Ala?Gly?Glu?Leu?Leu?Cys?Glu?Phe?Asp?Ile
405 410 415
Asp?Ala?Ile?Lys?Ala?Ala?Gly?Tyr?Glu?Val?Thr?Thr?Pro?Ile?Val?Val
420 425 430
Ser?Asn?Tyr?Lys?Lys?Thr?Gly?Pro?Val?Asn?Thr?Tyr?Gly?Leu?Gly?Glu
435 440 445
Ile?Glu?Ala?Gly?Ala?Asn?Leu?Leu?Asn?Val?Ala?Lys?Lys?Glu?Ala?Val
450 455 460
Pro?Ala?Thr?Pro
465
<210>3
<211>1109
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(1)..(1086)
<223>FRXA00315
<400>3
tat?gat?ttc?ggc?ggt?cca?gtc?ggc?ggt?ctg?ctc?ttc?ggt?ctg?gtc?tac 48
Tyr?Asp?Phe?Gly?Gly?Pro?Val?Gly?Gly?Leu?Leu?Phe?Gly?Leu?Val?Tyr
1 5 10 15
tca?cca?atc?gtc?atc?act?ggt?ctg?cac?cag?tcc?ttc?ccg?cca?att?gag 96
Ser?Pro?Ile?Val?Ile?Thr?Gly?Leu?His?Gln?Ser?Phe?Pro?Pro?Ile?Glu
20 25 30
ctg?gag?ctg?ttt?aac?cag?ggt?gga?tcc?ttc?atc?ttc?gca?acg?gca?tct 144
Leu?Glu?Leu?Phe?Asn?Gln?Gly?Gly?Ser?Phe?Ile?Phe?Ala?Thr?Ala?Ser
35 40 45
atg?gct?aat?atc?gcc?cag?ggt?gcg?gca?tgt?ttg?gca?gtg?ttc?ttc?ctg 192
Met?Ala?Asn?Ile?Ala?Gln?Gly?Ala?Ala?Cys?Leu?Ala?Val?Phe?Phe?Leu
50 55 60
gcg?aag?agt?gaa?aag?ctc?aag?ggc?ctt?gca?ggt?gct?tca?ggt?gtc?tcc 240
Ala?Lys?Ser?Glu?Lys?Leu?Lys?Gly?Leu?Ala?Gly?Ala?Ser?Gly?Val?Ser
65 70 75 80
gct?gtt?ctt?ggt?att?acg?gag?cct?gcg?atc?ttc?ggt?gtg?aac?ctt?cgc 288
Ala?Val?Leu?Gly?Ile?Thr?Glu?Pro?Ala?Ile?Phe?Gly?Val?Asn?Leu?Arg
85 90 95
ctg?cgc?tgg?ccg?ttc?ttc?atc?ggt?atc?ggt?acc?gca?get?atc?ggt?ggc 336
Leu?Arg?Trp?Pro?Phe?Phe?Ile?Gly?Ile?Gly?Thr?Ala?Ala?Ile?Gly?Gly
100 105 110
gct?ttg?att?gca?ctc?ttt?aat?atc?aag?gca?gtt?gcg?ttg?ggc?gct?gca 384
Ala?Leu?Ile?Ala?Leu?Phe?Asn?Ile?Lys?Ala?Val?Ala?Leu?Gly?Ala?Ala
115 120 125
ggt?ttc?ttg?ggt?gtt?gtt?tct?att?gat?gct?cca?gat?atg?gtc?atg?ttc 432
Gly?Phe?Leu?Gly?Val?Val?Ser?Ile?Asp?Ala?Pro?Asp?Met?Val?Met?Phe
130 135 140
ttg?gtg?tgt?gca?gtt?gtt?acc?ttc?ttc?atc?gca?ttc?ggc?gca?gcg?att 480
Leu?Val?Cys?Ala?Val?Val?Thr?Phe?Phe?Ile?Ala?Phe?Gly?Ala?Ala?Ile
145 150 155 160
gct?tat?ggc?ctt?tac?ttg?gtt?cgc?cgc?aac?ggc?agc?att?gat?cca?gat 528
Ala?Tyr?Gly?Leu?Tyr?Leu?Val?Arg?Arg?Asn?Gly?Ser?Ile?Asp?Pro?Asp
165 170 175
gca?acc?gct?gct?cca?gtg?cct?gca?gga?acg?acc?aaa?gcc?gaa?gca?gaa 576
Ala?Thr?Ala?Ala?Pro?Val?Pro?Ala?Gly?Thr?Thr?Lys?Ala?Glu?Ala?Glu
180 185 190
gca?ccc?gca?gaa?ttt?tca?aac?gat?tcc?acc?atc?atc?cag?gca?cct?ttg 624
Ala?Pro?Ala?Glu?Phe?Ser?Asn?Asp?Ser?Thr?Ile?Ile?Gln?Ala?Pro?Leu
195 200 205
acc?ggt?gaa?gct?att?gca?ctg?agc?agc?gtc?agc?gat?gcc?atg?ttt?gcc 672
Thr?Gly?Glu?Ala?Ile?Ala?Leu?Ser?Ser?Val?Ser?Asp?Ala?Met?Phe?Ala
210 215 220
agc?gga?aag?ctt?ggc?tcg?ggc?gtt?gcc?atc?gtc?cca?acc?aag?ggg?cag 720
Ser?Gly?Lys?Leu?Gly?Ser?Gly?Val?Ala?Ile?Val?Pro?Thr?Lys?Gly?Gln
225 230 235 240
tta?gtt?tct?ccg?gtg?agt?gga?aag?att?gtg?gtg?gca?ttc?cca?tct?ggc 768
Leu?Val?Ser?Pro?Val?Ser?Gly?Lys?Ile?Val?Val?Ala?Phe?Pro?Ser?Gly
245 250 255
cat?gct?ttc?gca?gtt?cgc?acc?aag?gct?gag?gat?ggt?tcc?aat?gtg?gat 816
His?Ala?Phe?Ala?Val?Arg?Thr?Lys?Ala?Glu?Asp?Gly?Ser?Asn?Val?Asp
260 265 270
atc?ttg?atg?cac?att?ggt?ttc?gac?aca?gta?aac?ctc?aac?ggc?acg?cac 864
Ile?Leu?Met?His?Ile?Gly?Phe?Asp?Thr?Val?Asn?Leu?Asn?Gly?Thr?His
275 280 285
ttt?aae?ccg?ctg?aag?aag?cag?ggc?gat?gaa?gtc?aaa?gca?ggg?gag?ctg 912
Phe?Asn?Pro?Leu?Lys?Lys?Gln?Gly?Asp?Glu?Val?Lys?Ala?Gly?Glu?Leu
290 295 300
ctg?tgt?gaa?ttc?gat?att?gat?gcc?att?aag?gct?gca?ggt?tat?gag?gta 960
Leu?Cys?Glu?Phe?Asp?Ile?Asp?Ala?Ile?Lys?Ala?Ala?Gly?Tyr?Glu?Val
305 310 315 320
acc?acg?ccg?att?gtt?gtt?tcg?aat?tac?aag?aaa?acc?gga?cct?gta?aac 1008
Thr?Thr?Pro?Ile?Val?Val?Ser?Asn?Tyr?Lys?Lys?Thr?Gly?Pro?Val?Asn
325 330 335
act?tac?ggt?ttg?ggc?gaa?att?gaa?gcg?gga?gcc?aac?ctg?crc?aac?gtc 1056
Thr?Tyr?Gly?Leu?Gly?Glu?Ile?Glu?Ala?Gly?Ala?Asn?Leu?Leu?Asn?Val
340 345 350
gca?aag?aaa?gaa?gcg?gtg?cca?gca?aca?cca?taagttgaaa?ccttgagtgt 1106
Ala?Lys?Lys?Glu?Ala?Val?Pro?Ala?Thr?Pro
355 360
tcg 1109
<210>4
<211>362
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>4
Tyr?Asp?Phe?Gly?Gly?Pro?Val?Gly?Gly?Leu?Leu?Phe?Gly?Leu?Val?Tyr
1 5 10 15
Ser?Pro?Ile?Val?Ile?Thr?Gly?Leu?His?Gln?Ser?Phe?Pro?Pro?Ile?Glu
20 25 30
Leu?Glu?Leu?Phe?Asn?Gln?Gly?Gly?Ser?Phe?Ile?Phe?Ala?Thr?Ala?Ser
35 40 45
Met?Ala?Asn?Ile?Ala?Gln?Gly?Ala?Ala?Cys?Leu?Ala?Val?Phe?Phe?Leu
50 55 60
Ala?Lys?Ser?Glu?Lys?Leu?Lys?Gly?Leu?Ala?Gly?Ala?Ser?Gly?Val?Ser
65 70 75 80
Ala?Val?Leu?Gly?Ile?Thr?Glu?Pro?Ala?Ile?Phe?Gly?Val?Asn?Leu?Arg
85 90 95
Leu?Arg?Trp?Pro?Phe?Phe?Ile?Gly?Ile?Gly?Thr?Ala?Ala?Ile?Gly?Gly
100 105 110
Ala?Leu?Ile?Ala?Leu?Phe?Asn?Ile?Lys?Ala?Val?Ala?Leu?Gly?Ala?Ala
115 120 125
Gly?Phe?Leu?Gly?Val?Val?Ser?Ile?Asp?Ala?Pro?Asp?Met?Val?Met?Phe
130 135 140
Leu?Val?Cys?Ala?Val?Val?Thr?Phe?Phe?Ile?Ala?Phe?Gly?Ala?Ala?Ile
145 150 155 160
Ala?Tyr?Gly?Leu?Tyr?Leu?Val?Arg?Arg?Asn?Gly?Ser?Ile?Asp?Pro?Asp
165 170 175
Ala?Thr?Ala?Ala?Pro?Val?Pro?Ala?Gly?Thr?Thr?Lys?Ala?Glu?Ala?Glu
180 185 190
Ala?Pro?Ala?Glu?Phe?Ser?Asn?Asp?Ser?Thr?Ile?Ile?Gln?Ala?Pro?Leu
195 200 205
Thr?Gly?Glu?Ala?Ile?Ala?Leu?Ser?Ser?Val?Ser?Asp?Ala?Met?Phe?Ala
210 215 220
Ser?Gly?Lys?Leu?Gly?Ser?Gly?Val?Ala?Ile?Val?Pro?Thr?Lys?Gly?Gln
225 230 235 240
Leu?Val?Ser?Pro?Val?Ser?Gly?Lys?Ile?Val?Val?Ala?Phe?Pro?Ser?Gly
245 250 255
His?Ala?Phe?Ala?Val?Arg?Thr?Lys?Ala?Glu?Asp?Gly?Ser?Asn?Val?Asp
260 265 270
Ile?Leu?Met?His?Ile?Gly?Phe?Asp?Thr?Val?Asn?Leu?Asn?Gly?Thr?His
275 280 285
Phe?Asn?Pro?Leu?Lys?Lys?Gln?Gly?Asp?Glu?Val?Lys?Ala?Gly?Glu?Leu
290 295 300
Leu?Cys?Glu?Phe?Asp?Ile?Asp?Ala?Ile?Lys?Ala?Ala?Gly?Tyr?Glu?Val
305 310 315 320
Thr?Thr?Pro?Ile?Val?Val?Ser?Asn?Tyr?Lys?Lys?Thr?Gly?Pro?Val?Asn
325 330 335
Thr?Tyr?Gly?Leu?Gly?Glu?Ile?Glu?Ala?Gly?Ala?Asn?Leu?Leu?Asn?Val
340 345 350
Ala?Lys?Lys?Glu?Ala?Val?Pro?Ala?Thr?Pro
355 360
<210>5
<211>372
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(349)
<223>RXA01503
<400>5
gtatcctcaa?aggccttcta?gctgttgcag?ctgcagcgca?ctcggtggat?acgacatcca?60
cgacctatca?aattctttat?gctgcaggcg?atgccttttc?atg?ttc?ttg?gca?gtc 115
Met?Phe?Leu?Ala?Val
1 5
att?ttg?gcg?att?act?gcg?gct?cgt?aaa?ttc?ggt?gcc?aat?gtc?ttt?aca 163
Ile?Leu?Ala?Ile?Thr?Ala?Ala?Arg?Lys?Phe?Gly?Ala?Asn?Val?Phe?Thr
10 15 20
tca?gtc?gca?ctc?gct?ggt?gca?ttg?ctg?cac?aca?cag?ctt?cag?gca?gta 211
Ser?Val?Ala?Leu?Ala?Gly?Ala?Leu?Leu?His?Thr?Gln?Leu?Gln?Ala?Val
25 30 35
acc?gtg?ttg?gtt?gac?ggt?gaa?ctc?cag?tcg?atg?act?ctg?gtg?gct?ttc 259
Thr?Val?Leu?Val?Asp?Gly?Glu?Leu?Gln?Ser?Met?Thr?Leu?Val?Ala?Phe
40 45 50
caa?aag?gct?ggt?aat?gac?gtc?acc?ttc?ctg?ggc?att?cca?gtg?gtg?ctg 307
Gln?Lys?Ala?Gly?Asn?Asp?Val?Thr?Phe?Leu?Gly?Ile?Pro?Val?Val?Leu
55 60 65
cag?ttg?gcg?ttg?cat?gta?gcg?agt?ttg?atg?aag?ttg?tcg?cga 349
Gln?Leu?Ala?Leu?His?Val?Ala?Ser?Leu?Met?Lys?Leu?Ser?Arg
70 75 80
taagaggagg?ggcgtgtcgg?tct 372
<210>6
<211>83
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>6
Met?Phe?Leu?Ala?Val?Ile?Leu?Ala?Ile?Thr?Ala?Ala?Arg?Lys?Phe?Gly
1 5 10 15
Ala?Asn?Val?Phe?Thr?Ser?Val?Ala?Leu?Ala?Gly?Ala?Leu?Leu?His?Thr
20 25 30
Gln?Leu?Gln?Ala?Val?Thr?Val?Leu?Val?Asp?Gly?Glu?Leu?Gln?Ser?Met
35 40 45
Thr?Leu?Val?Ala?Phe?Gln?Lys?Ala?Gly?Asn?Asp?Val?Thr?Phe?Leu?Gly
50 55 60
Ile?Pro?Val?Val?Leu?Gln?Leu?Ala?Leu?His?Val?Ala?Ser?Leu?Met?Lys
65 70 75 80
Leu?Ser?Arg
<210>7
<211>2187
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(2164)
<223>RXN01299
<400>7
cgactgcggc?gtctcttcct?ggcactacca?ttcctcgtcc?tgaccaactc?gccacagctg 60
gtgcaacggt?cacccaagtc?aaaggattga?aagaatcagc?atg?aat?agc?gta?aat 115
Met?Asn?Ser?Val?Asn
1 5
aat?tcc?tcg?ctt?gtc?cgg?ctg?gat?gtc?gat?ttc?ggc?gac?tcc?acc?acg 163
Asn?Ser?Ser?Leu?Val?Arg?Leu?Asp?Val?Asp?Phe?Gly?Asp?Ser?Thr?Thr
10 15 20
gat?gtc?atc?aac?aac?ctt?gcc?act?gtt?att?ttc?gac?gct?ggc?cga?gct 211
Asp?Val?Ile?Asn?Asn?Leu?Ala?Thr?Val?Ile?Phe?Asp?Ala?Gly?Arg?Ala
25 30 35
tcc?tcc?gcc?gac?gcc?ctt?gcc?aaa?gac?gcg?ctg?gat?cgt?gaa?gca?aag 259
Ser?Ser?Ala?Asp?Ala?Leu?Ala?Lys?Asp?Ala?Leu?Asp?Arg?Glu?Ala?Lys
40 45 50
tcc?ggc?acc?ggc?gtt?cct?ggt?caa?gtt?gct?atc?ccc?cac?tgc?cgt?tcc 307
Ser?Gly?Thr?Gly?Val?Pro?Gly?Gln?Val?Ala?Ile?Pro?His?Cys?Arg?Ser
55 60 65
gaa?gcc?gta?tct?gtc?cct?acc?ttg?ggc?ttt?gct?cgc?ctg?agc?aag?ggt 355
Glu?Ala?Val?Ser?Val?Pro?Thr?Leu?Gly?Phe?Ala?Arg?Leu?Ser?Lys?Gly
70 75 80 85
gtg?gac?ttc?agc?gga?cct?gat?ggc?gat?gcc?aac?ttg?gtg?ttc?ctc?att 403
Val?Asp?Phe?Ser?Gly?Pro?Asp?Gly?Asp?Ala?Asn?Leu?Val?Phe?Leu?Ile
90 95 100
gca?gca?cct?gct?ggc?ggc?ggc?aaa?gag?cac?ctg?aag?atc?ctg?tcc?aag 451
Ala?Ala?Pro?Ala?Gly?Gly?Gly?Lys?Glu?His?Leu?Lys?Ile?Leu?Ser?Lys
105 110 115
ctt?gct?cgc?tcc?ttg?gtg?aag?aag?gat?ttc?atc?aag?gct?ctg?cag?gaa 499
Leu?Ala?Arg?Ser?Leu?Val?Lys?Lys?Asp?Phe?Ile?Lys?Ala?Leu?Gln?Glu
120 125 130
gcc?acc?acc?gag?cag?gaa?atc?gtc?gac?gtt?gtc?gat?gcc?gtg?ctc?aac 547
Ala?Thr?Thr?Glu?Gln?Glu?Ile?Val?Asp?Val?Val?Asp?Ala?Val?Leu?Asn
135 140 145
cca?gca?cca?aaa?acc?acc?gag?cca?gct?gca?gct?ccg?gct?gcg?gcg?gcg 595
Pro?Ala?Pro?Lys?Thr?Thr?Glu?Pro?Ala?Ala?Ala?Pro?Ala?Ala?Ala?Ala
150 155 160 165
gtt?gct?gag?agt?ggg?gcg?gcg?tcg?aca?agc?gtt?act?cgt?atc?gtg?gca 643
Val?Ala?Glu?Ser?Gly?Ala?Ala?Ser?Thr?Ser?Val?Thr?Arg?Ile?Val?Ala
170 175 180
atc?acc?gca?tgc?cca?acc?ggt?atc?gca?cac?acc?tac?atg?gct?gcg?gat 691
Ile?Thr?Ala?Cys?Pro?Thr?Gly?Ile?Ala?His?Thr?Tyr?Met?Ala?Ala?Asp
185 190 195
tcc?ctg?acg?caa?aac?gcg?gaa?ggc?cgc?gat?gat?gtg?gaa?ctc?gtt?gtg 739
Ser?Leu?Thr?Gln?Asn?Ala?Glu?Gly?Arg?Asp?Asp?Val?Glu?Leu?Val?Val
200 205 210
gag?act?cag?ggc?tct?tcc?gct?gtc?acc?cca?gtc?gat?ccg?aag?atc?atc 787
Glu?Thr?Gln?Gly?Ser?Ser?Ala?Val?Thr?Pro?Val?Asp?Pro?Lys?Ile?Ile
215 220 225
gaa?gct?gcc?gac?gcc?gtc?atc?ttc?gcc?acc?gac?gtg?gga?gtt?aaa?gac 835
Glu?Ala?Ala?Asp?Ala?Val?Ile?Phe?Ala?Thr?Asp?Val?Gly?Val?Lys?Asp
230 235 240 245
cgc?gag?cgt?ttc?gct?ggc?aag?cca?gtc?att?gaa?tcc?ggc?gtc?aag?cgc 883
Arg?Glu?Arg?Phe?Ala?Gly?Lys?Pro?Val?Ile?Glu?Ser?Gly?Val?Lys?Arg
250 255 260
gcg?atc?aat?gag?cca?gcc?aag?atg?atc?gac?gag?gcc?atc?gca?gcc?tcc 931
Ala?Ile?Asn?Glu?Pro?Ala?Lys?Met?Ile?Asp?Glu?Ala?Ile?Ala?Ala?Ser
265 270 275
aag?aac?cca?aac?gcc?cgc?aag?gtt?tcc?ggt?tcc?ggt?gtc?gcg?gca?tct 979
Lys?Asn?Pro?Asn?Ala?Arg?Lys?Val?Ser?Gly?Ser?Gly?Val?Ala?Ala?Ser
280 285 290
gct?gaa?acc?acc?ggc?gag?aag?ctc?ggc?tgg?ggc?aag?cgc?atc?cag?cag 1027
Ala?Glu?Thr?Thr?Gly?Glu?Lys?Leu?Gly?Trp?Gly?Lys?Arg?Ile?Gln?Gln
295 300 305
gca?gtc?atg?acc?ggc?gtg?tcc?tac?atg?gtt?cca?ttc?gta?gct?gcc?ggc 1075
Ala?Val?Met?Thr?Gly?Val?Ser?Tyr?Met?Val?Pro?Phe?Val?Ala?Ala?Gly
310 315 320 325
ggc?ctc?ctg?ttg?gct?ctc?ggc?ttc?gca?ttc?ggt?gga?tac?gac?atg?gcg 1123
Gly?Leu?Leu?Leu?Ala?Leu?Gly?Phe?Ala?Phe?Gly?Gly?Tyr?Asp?Met?Ala
330 335 340
aac?ggc?tgg?caa?gca?atc?gcc?acc?cag?ttc?tct?ctg?acc?aac?ctg?cca 1171
Asn?Gly?Trp?Gln?Ala?Ile?Ala?Thr?Gln?Phe?Ser?Leu?Thr?Asn?Leu?Pro
345 350 355
ggc?aac?acc?gtc?gat?gtt?gac?ggc?gtg?gcc?atg?acc?ttc?gag?cgt?tca 1219
Gly?Asn?Thr?Val?Asp?Val?Asp?Gly?Val?Ala?Met?Thr?Phe?Glu?Arg?Ser
360 365 370
ggc?ttc?ctg?ttg?tac?ttc?ggc?gca?gtc?ctg?ttc?gcc?acc?ggc?caa?gca 1267
Gly?Phe?Leu?Leu?Tyr?Phe?Gly?Ala?Val?Leu?Phe?Ala?Thr?Gly?Gln?Ala
375 380 385
gcc?atg?ggc?ttc?atc?gtg?gca?gcc?ctg?tct?ggc?tac?acc?gca?tac?gca 1315
Ala?Met?Gly?Phe?Ile?Val?Ala?Ala?Leu?Ser?Gly?Tyr?Thr?Ala?Tyr?Ala
390 395 400 405
ctt?gct?gga?cgc?cca?ggc?atc?gcg?ccg?ggc?ttc?gtc?ggt?ggc?gcc?atc 1363
Leu?Ala?Gly?Arg?Pro?Gly?Ile?Ala?Pro?Gly?Phe?Val?Gly?Gly?Ala?Ile
410 415 420
tcc?gtc?acc?atc?ggc?gct?ggc?ttc?att?ggt?ggt?ctg?gtt?acc?ggt?atc 1411
Ser?Val?Thr?Ile?Gly?Ala?Gly?Phe?Ile?Gly?Gly?Leu?Val?Thr?Gly?Ile
425 430 435
ttg?gct?ggt?ctc?att?gcc?ctg?tgg?att?ggc?tcc?tgg?aag?gtg?cca?cgc 1459
Leu?Ala?Gly?Leu?Ile?Ala?Leu?Trp?Ile?Gly?Ser?Trp?Lys?Val?Pro?Arg
440 445 450
gtg?gtg?cag?tca?ctg?atg?cct?gtg?gtc?atc?atc?ccg?cta?ctt?acc?tca 1507
Val?Val?Gln?Ser?Leu?Met?Pro?Val?Val?Ile?Ile?Pro?Leu?Leu?Thr?Ser
455 460 465
gtg?gtt?gtt?ggt?ctc?gtc?atg?tac?ctc?ctg?ctg?ggt?cgc?cca?ctc?gca 1555
Val?Val?Val?Gly?Leu?Val?Met?Tyr?Leu?Leu?Leu?Gly?Arg?Pro?Leu?Ala
470 475 480 485
tcc?atc?atg?act?ggt?ttg?cag?gac?tgg?cta?tcg?tca?atg?tcc?gga?agc 1603
Ser?Ile?Met?Thr?Gly?Leu?Gln?Asp?Trp?Leu?Ser?Ser?Met?Ser?Gly?Ser
490 495 500
tcc?gcc?atc?ttg?ctg?ggt?atc?atc?ttg?ggc?ctc?atg?atg?tgt?ttc?gac 1651
Ser?Ala?Ile?Leu?Leu?Gly?Ile?Ile?Leu?Gly?Leu?Met?Met?Cys?Phe?Asp
505 510 515
ctc?ggc?gga?cca?gta?aac?aag?gca?gcc?tac?ctc?ttt?ggt?acc?gca?ggc 1699
Leu?Gly?Gly?Pro?Val?Asn?Lys?Ala?Ala?Tyr?Leu?Phe?Gly?Thr?Ala?Gly
520 525 530
ctg?tct?acc?ggc?gac?caa?gct?tcc?atg?gaa?atc?atg?gcc?gcg?atc?atg 1747
Leu?Ser?Thr?Gly?Asp?Gln?Ala?Ser?Met?Glu?Ile?Met?Ala?Ala?Ile?Met
535 540 545
gca?gct?ggc?atg?gtc?cca?cca?atc?gcg?ttg?tcc?att?gct?acc?ctg?ctg 1795
Ala?Ala?Gly?Met?Val?Pro?Pro?Ile?Ala?Leu?Ser?Ile?Ala?Thr?Leu?Leu
550 555 560 565
cgc?aag?aag?ctg?ttc?acc?cca?gca?gag?caa?gaa?aac?ggc?aag?tct?tcc 1843
Arg?Lys?Lys?Leu?Phe?Thr?Pro?Ala?Glu?Gln?Glu?Asn?Gly?Lys?Ser?Ser
570 575 580
tgg?ctg?ctt?ggc?ctg?gca?ttc?gtc?tcc?gaa?ggt?gcc?atc?cca?ttc?gcc 1891
Trp?Leu?Leu?Gly?Leu?Ala?Phe?Val?Ser?Glu?Gly?Ala?Ile?Pro?Phe?Ala
585 590 595
gca?gct?gac?cca?ttc?cgt?gtg?atc?cca?gca?atg?atg?gct?ggc?ggt?gca 1939
Ala?Ala?Asp?Pro?Phe?Arg?Val?Ile?Pro?Ala?Met?Met?Ala?Gly?Gly?Ala
600 605 610
acc?act?ggt?gca?atc?tcc?atg?gca?ctg?ggc?gtc?ggc?tct?cgg?gct?cca 1987
Thr?Thr?Gly?Ala?Ile?Ser?Met?Ala?Leu?Gly?Val?Gly?Ser?Arg?Ala?Pro
615 620 625
cac?ggc?ggt?atc?ttc?gtg?gtc?tgg?gca?atc?gaa?cca?tgg?tgg?ggc?tgg 2035
His?Gly?Gly?Ile?Phe?Val?Val?Trp?Ala?Ile?Glu?Pro?Trp?Trp?Gly?Trp
630 635 640 645
ctc?atc?gca?ctt?gca?gca?ggc?acc?atc?gtg?tcc?acc?atc?gtt?gtc?atc 2083
Leu?Ile?Ala?Leu?Ala?Ala?Gly?Thr?Ile?Val?Ser?Thr?Ile?Val?Val?Ile
650 655 660
gca?ctg?aag?cag?ttc?tgg?cca?aac?aag?gcc?gtc?gct?gca?gaa?gtc?gcg 2131
Ala?Leu?Lys?Gln?Phe?Trp?Pro?Asn?Lys?Ala?Val?Ala?Ala?Glu?Val?Ala
665 670 675
aag?caa?gaa?gca?caa?caa?gca?gct?gta?aac?gca?taatcggacc?ttgacccgat?2184
Lys?Gln?Glu?Ala?Gln?Gln?Ala?Ala?Val?Asn?Ala
680 685
gtc 2187
<210>8
<211>688
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>8
Met?Asn?Ser?Val?Asn?Asn?Ser?Ser?Leu?Val?Arg?Leu?Asp?Val?Asp?Phe
1 5 10 15
Gly?Asp?Ser?Thr?Thr?Asp?Val?Ile?Asn?Asn?Leu?Ala?Thr?Val?Ile?Phe
20 25 30
Asp?Ala?Gly?Arg?Ala?Ser?Ser?Ala?Asp?Ala?Leu?Ala?Lys?Asp?Ala?Leu
35 40 45
Asp?Arg?Glu?Ala?Lys?Ser?Gly?Thr?Gly?Val?Pro?Gly?Gln?Val?Ala?Ile
50 55 60
Pro?His?Cys?Arg?Ser?Glu?Ala?Val?Ser?Val?Pro?Thr?Leu?Gly?Phe?Ala
65 70 75 80
Arg?Leu?Ser?Lys?Gly?Val?Asp?Phe?Ser?Gly?Pro?Asp?Gly?Asp?Ala?Asn
85 90 95
Leu?Val?Phe?Leu?Ile?Ala?Ala?Pro?Ala?Gly?Gly?Gly?Lys?Glu?His?Leu
100 105 110
Lys?Ile?Leu?Ser?Lys?Leu?Ala?Arg?Ser?Leu?Val?Lys?Lys?Asp?Phe?Ile
115 120 125
Lys?Ala?Leu?Gln?Glu?Ala?Thr?Thr?Glu?Gln?Glu?Ile?Val?Asp?Val?Val
130 135 140
Asp?Ala?Val?Leu?Asn?Pro?Ala?Pro?Lys?Thr?Thr?Glu?Pro?Ala?Ala?Ala
145 150 155 160
Pro?Ala?Ala?Ala?Ala?Val?Ala?Glu?Ser?Gly?Ala?Ala?Ser?Thr?Ser?Val
165 170 175
Thr?Arg?Ile?Val?Ala?Ile?Thr?Ala?Cys?Pro?Thr?Gly?Ile?Ala?His?Thr
180 185 190
Tyr?Met?Ala?Ala?Asp?Ser?Leu?Thr?Gln?Asn?Ala?Glu?Gly?Arg?Asp?Asp
195 200 205
Val?Glu?Leu?Val?Val?Glu?Thr?Gln?Gly?Ser?Ser?Ala?Val?Thr?Pro?Val
210 215 220
Asp?Pro?Lys?Ile?Ile?Glu?Ala?Ala?Asp?Ala?Val?Ile?Phe?Ala?Thr?Asp
225 230 235 240
Val?Gly?Val?Lys?Asp?Arg?Glu?Arg?Phe?Ala?Gly?Lys?Pro?Val?Ile?Glu
245 250 255
Ser?Gly?Val?Lys?Arg?Ala?Ile?Asn?Glu?Pro?Ala?Lys?Met?Ile?Asp?Glu
260 265 270
Ala?Ile?Ala?Ala?Ser?Lys?Asn?Pro?Asn?Ala?Arg?Lys?Val?Ser?Gly?Ser
275 280 285
Gly?Val?Ala?Ala?Ser?Ala?Glu?Thr?Thr?Gly?Glu?Lys?Leu?Gly?Trp?Gly
290 295 300
Lys?Arg?Ile?Gln?Gln?Ala?Val?Met?Thr?Gly?Val?Ser?Tyr?Met?Val?Pro
305 310 315 320
Phe?Val?Ala?Ala?Gly?Gly?Leu?Leu?Leu?Ala?Leu?Gly?Phe?Ala?Phe?Gly
325 330 335
Gly?Tyr?Asp?Met?Ala?Asn?Gly?Trp?Gln?Ala?Ile?Ala?Thr?Gln?Phe?Ser
340 345 350
Leu?Thr?Asn?Leu?Pro?Gly?Asn?Thr?Val?Asp?Val?Asp?Gly?Val?Ala?Met
355 360 365
Thr?Phe?Glu?Arg?Ser?Gly?Phe?Leu?Leu?TyrPhe?Gly?Ala?Val?Leu?Phe
370 375 380
Ala?Thr?Gly?Gln?Ala?Ala?Met?Gly?Phe?Ile?Val?Ala?Ala?Leu?Ser?Gly
385 390 395 400
Tyr?Thr?Ala?Tyr?Ala?Leu?Ala?Gly?Arg?Pro?Gly?Ile?Ala?Pro?Gly?Phe
405 410 415
Val?Gly?Gly?Ala?Ile?Ser?Val?Thr?Ile?Gly?Ala?Gly?Phe?Ile?Gly?Gly
420 425 430
Leu?Val?Thr?Gly?Ile?Leu?Ala?Gly?Leu?Ile?Ala?Leu?Trp?Ile?Gly?Ser
435 440 445
Trp?Lys?Val?Pro?Arg?Val?Val?Gln?Ser?Leu?Met?Pro?Val?Val?Ile?Ile
450 455 460
Pro?Leu?Leu?Thr?Ser?Val?Val?Val?Gly?Leu?Val?Met?Tyr?Leu?Leu?Leu
465 470 475 480
Gly?Arg?Pro?Leu?Ala?Ser?Ile?Met?Thr?Gly?Leu?Gln?Asp?Trp?Leu?Ser
485 490 495
Ser?Met?Ser?Gly?Ser?Ser?Ala?Ile?Leu?Leu?Gly?Ile?Ile?Leu?Gly?Leu
500 505 510
Met?Met?Cys?Phe?Asp?Leu?Gly?Gly?Pro?Val?Asn?Lys?Ala?Ala?Tyr?Leu
515 520 525
Phe?Gly?Thr?Ala?Gly?Leu?Ser?Thr?Gly?Asp?Gln?Ala?Ser?Met?Glu?Ile
530 535 540
Met?Ala?Ala?Ile?Met?Ala?Ala?Gly?Met?Val?Pro?Pro?Ile?Ala?Leu?Ser
545 550 555 560
Ile?Ala?Thr?Leu?Leu?Arg?Lys?Lys?Leu?Phe?Thr?Pro?Ala?Glu?Gln?Glu
565 570 575
Asn?Gly?Lys?Ser?Ser?Trp?Leu?Leu?Gly?Leu?Ala?Phe?Val?Ser?Glu?Gly
580 585 590
Ala?Ile?Pro?Phe?Ala?Ala?Ala?Asp?Pro?Phe?Arg?Val?Ile?Pro?Ala?Met
595 600 605
Met?Ala?Gly?Gly?Ala?Thr?Thr?Gly?Ala?Ile?Ser?Met?Ala?Leu?Gly?Val
610 615 620
Gly?Ser?Arg?Ala?Pro?His?Gly?Gly?Ile?Phe?Val?Val?Trp?Ala?Ile?Glu
625 630 635 640
Pro?Trp?Trp?Gly?Trp?Leu?Ile?Ala?Leu?Ala?Ala?Gly?Thr?Ile?Val?Ser
645 650 655
Thr?Ile?Val?Val?Ile?Ala?Leu?Lys?Gln?Phe?Trp?Pro?Asn?Lys?Ala?Val
660 665 670
Ala?Ala?Glu?Val?Ala?Lys?Gln?Glu?Ala?Gln?Gln?Ala?Ala?Val?Asn?Ala
675 680 685
<210>9
<211>464
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(1)..(441)
<223>FRXA01299
<400>9
atg?gaa?atc?atg?gcc?gcg?atc?atg?gca?gct?ggc?atg?gtc?cca?cca?atc 48
Met?Glu?Ile?Met?Ala?Ala?Ile?Met?Ala?Ala?Gly?Met?Val?Pro?Pro?Ile
1 5 10 15
gcg?ttg?tcc?att?gct?acc?ctg?ctg?cgc?aag?aag?ctg?ttc?acc?cca?gca 96
Ala?Leu?Ser?Ile?Ala?Thr?Leu?Leu?Arg?Lys?Lys?Leu?Phe?Thr?Pro?Ala
20 25 30
gag?caa?gaa?aac?ggc?aag?tct?tcc?tgg?ctg?ctt?ggc?ctg?gca?ttc?gtc 144
Glu?Gln?Glu?Asn?Gly?Lys?Ser?Ser?Trp?Leu?Leu?Gly?Leu?Ala?Phe?Val
35 40 45
tcc?gaa?ggt?gcc?atc?cca?ttc?gcc?gca?gct?gac?cca?ttc?cgt?gtg?atc 192
Ser?Glu?Gly?Ala?Ile?Pro?Phe?Ala?Ala?Ala?Asp?Pro?Phe?Arg?Val?Ile
50 55 60
cca?gca?atg?atg?gct?ggc?ggt?gca?acc?act?ggt?gca?atc?tcc?atg?gca 240
Pro?Ala?Met?Met?Ala?Gly?Gly?Ala?Thr?Thr?Gly?Ala?Ile?Ser?Met?Ala
65 70 75 80
ctg?ggc?gtc?ggc?tct?cgg?gct?cca?cac?ggc?ggt?atc?ttc?gtg?gtc?tgg 288
Leu?Gly?Val?Gly?Ser?Arg?Ala?Pro?His?Gly?Gly?Ile?Phe?Val?Val?Trp
85 90 95
gca?atc?gaa?cca?tgg?tgg?ggc?tgg?ctc?atc?gca?ctt?gca?gca?ggc?acc 336
Ala?Ile?Glu?Pro?Trp?Trp?Gly?Trp?Leu?Ile?Ala?Leu?Ala?Ala?Gly?Thr
100 105 110
atc?gtg?tcc?acc?atc?gtt?gtc?atc?gca?ctg?aag?cag?ttc?tgg?cca?aac 384
Ile?Val?Ser?Thr?Ile?Val?Val?Ile?Ala?Leu?Lys?Gln?Phe?Trp?Pro?Asn
115 120 125
aag?gcc?gtc?gct?gca?gaa?gtc?gcg?aag?caa?gaa?gca?caa?caa?gca?gct 432
Lys?Ala?Val?Ala?Ala?Glu?Val?Ala?Lys?Gln?Glu?Ala?Gln?Gln?Ala?Ala
130 135 140
gta?aac?gca?taatcggacc?ttgacccgat?gtc 464
Val?Asn?Ala
145
<210>10
<211>147
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>10
Met?Glu?Ile?Met?Ala?Ala?Ile?Met?Ala?Ala?Gly?Met?Val?Pro?Pro?Ile
1 5 10 15
Ala?Leu?Ser?Ile?Ala?Thr?Leu?Leu?Arg?Lys?Lys?Leu?Phe?Thr?Pro?Ala
20 25 30
Glu?Gln?Glu?Asn?Gly?Lys?Ser?Ser?Trp?Leu?Leu?Gly?Leu?Ala?Phe?Val
35 40 45
Ser?Glu?Gly?Ala?Ile?Pro?Phe?Ala?Ala?Ala?Asp?Pro?Phe?Arg?Val?Ile
50 55 60
Pro?Ala?Met?Met?Ala?Gly?Gly?Ala?Thr?Thr?Gly?Ala?Ile?Ser?Met?Ala
65 70 75 80
Leu?Gly?Val?Gly?Ser?Arg?Ala?Pro?His?Gly?Gly?Ile?Phe?Val?Val?Trp
85 90 95
Ala?Ile?Glu?Pro?Trp?Trp?Gly?Trp?Leu?Ile?Ala?Leu?Ala?Ala?Gly?Thr
100 105 110
Ile?Val?Ser?Thr?Ile?Val?Val?Ile?Ala?Leu?Lys?Gln?Phe?Trp?Pro?Asn
115 120 125
Lys?Ala?Val?Ala?Ala?Glu?Val?Ala?Lys?Gln?Glu?Ala?Gln?Gln?Ala?Ala
130 135 140
Val?Asn?Ala
145
<210>11
<211>580
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(580)
<223>FRXA01883
<400>11
cgactgcggc?gtctcttcct?ggcactacca?ttcctcgtcc?tgaccaactc?gccacagctg?60
gtgcaacggt?cacccaagtc?aaaggattga?aagaatcagc?atg?aat?agc?gta?aat 115
Met?Asn?Ser?Val?Asn
1 5
aat?tcc?tcg?ctt?gtc?cgg?ctg?gat?gtc?gat?ttc?ggc?gac?tcc?acc?acg 163
Asn?Ser?Ser?Leu?Val?Arg?Leu?Asp?Val?Asp?Phe?Gly?Asp?Ser?Thr?Thr
10 15 20
gat?gtc?atc?aac?aac?ctt?gcc?act?gtt?att?ttc?gac?gct?ggc?cga?gct 211
Asp?Val?Ile?Asn?Asn?Leu?Ala?Thr?Val?Ile?Phe?Asp?Ala?Gly?Arg?Ala
25 30 35
tcc?tcc?gcc?gac?gcc?ctt?gcc?aaa?gac?gcg?ctg?gat?cgt?gaa?gca?aag 259
Ser?Ser?Ala?Asp?Ala?Leu?Ala?Lys?Asp?Ala?Leu?Asp?Arg?Glu?Ala?Lys
40 45 50
tcc?ggc?acc?ggc?gtt?cct?ggt?caa?gtt?gct?atc?ccc?cac?tgc?cgt?tcc 307
Ser?Gly?Thr?Gly?Val?Pro?Gly?Gln?Val?Ala?Ile?Pro?His?Cys?Arg?Ser
55 60 65
gaa?gcc?gta?tct?gtc?cct?acc?ttg?ggc?ttt?gct?cgc?ctg?agc?aag?ggt 355
Glu?Ala?Val?Ser?Val?Pro?Thr?Leu?Gly?Phe?Ala?Arg?Leu?Ser?Lys?Gly
70 75 80 85
gtg?gac?ttc?agc?gga?cct?gat?ggc?gat?gcc?aac?ttg?gtg?ttc?ctc?att 403
Val?Asp?Phe?Ser?Gly?Pro?Asp?Gly?Asp?Ala?Asn?Leu?Val?Phe?Leu?Ile
90 95 100
gca?gca?cct?gct?ggc?ggc?ggc?aaa?gag?cac?ctg?aag?atc?ctg?tcc?aag 451
Ala?Ala?Pro?Ala?Gly?Gly?Gly?Lys?Glu?His?Leu?Lys?Ile?Leu?Ser?Lys
105 110 115
ctt?gct?cgc?tcc?ttg?gtg?aag?aag?gat?ttc?atc?aag?gct?ctg?cag?gaa 499
Leu?Ala?Arg?Ser?Leu?Val?Lys?Lys?Asp?Phe?Ile?Lys?Ala?Leu?Gln?Glu
120 125 130
gcc?acc?acc?gag?cag?gaa?atc?gtc?gac?gtt?gtc?gat?gcc?gtg?ctc?aac 547
Ala?Thr?Thr?Glu?Gln?Glu?Ile?Val?Asp?Val?Val?Asp?Ala?Val?Leu?Asn
135 140 145
cca?gca?cca?aaa?aac?cac?cga?gcc?agc?tgc?agc 580
Pro?Ala?Pro?Lys?Asn?His?Arg?Ala?Ser?Cys?Ser
150 155 160
<210>12
<211>160
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>12
Met?Asn?Ser?Val?Asn?Asn?Ser?Ser?Leu?Val?Arg?Leu?Asp?Val?Asp?Phe
1 5 10 15
Gly?Asp?Ser?Thr?Thr?Asp?Val?Ile?Asn?Asn?Leu?Ala?Thr?Val?Ile?Phe
20 25 30
Asp?Ala?Gly?Arg?Ala?Ser?Ser?Ala?Asp?Ala?Leu?Ala?Lys?Asp?Ala?Leu
35 40 45
Asp?Arg?Glu?Ala?Lys?Ser?Gly?Thr?Gly?Val?Pro?Gly?Gln?Val?Ala?Ile
50 55 60
Pro?His?Cys?Arg?Ser?Glu?Ala?Val?Ser?Val?Pro?Thr?Leu?Gly?Phe?Ala
65 70 75 80
Arg?Leu?Ser?Lys?Gly?Val?Asp?Phe?Ser?Gly?Pro?Asp?Gly?Asp?Ala?Asn
85 90 95
Leu?Val?Phe?Leu?Ile?Ala?Ala?Pro?Ala?Gly?Gly?Gly?Lys?Glu?His?Leu
100 105 110
Lys?Ile?Leu?Ser?Lys?Leu?Ala?Arg?Ser?Leu?Val?Lys?Lys?Asp?Phe?Ile
115 120 125
Lys?Ala?Leu?Gln?Glu?Ala?Thr?Thr?Glu?Gln?Glu?Ile?Val?Asp?Val?Val
130 135 140
Asp?Ala?Val?Leu?Asn?Pro?Ala?Pro?Lys?Asn?His?Arg?Ala?Ser?Cys?Ser
145 150 155 160
<210>13
<211>631
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(77)..(631)
<223>FRXA01889
<400>13
accgagccag?ctgcagctcc?ggctgcggcg?gccggttgtt?aagagtgggg?cggcgtcgac?60
aagcgttact?cgtatc?gtg?gca?atc?acc?gca?tgc?cca?acc?ggt?atc?gca?cac?112
Val?Ala?Ile?Thr?Ala?Cys?Pro?Thr?Gly?Ile?Ala?His
1 5 10
acc?tac?atg?gct?gcg?gat?tcc?ctg?acg?caa?aac?gcg?gaa?ggc?cgc?gat 160
Thr?Tyr?Met?Ala?Ala?Asp?Ser?Leu?Thr?Gln?Asn?Ala?Glu?Gly?Arg?Asp
15 20 25
gat?gtg?gaa?ctc?gtt?gtg?gag?act?cag?ggc?tct?tcc?gct?gtc?acc?cca 208
Asp?Val?Glu?Leu?Val?Val?Glu?Thr?Gln?Gly?Ser?Ser?Ala?Val?Thr?Pro
30 35 40
gtc?gat?ccg?aag?atc?atc?gaa?gct?gcc?gac?gcc?gtc?atc?ttc?gcc?acc 256
Val?Asp?Pro?Lys?Ile?Ile?Glu?Ala?Ala?Asp?Ala?Val?Ile?Phe?Ala?Thr
45 50 55 60
gac?gtg?gga?gtt?aaa?gac?cgc?gag?cgt?ttc?gct?ggc?aag?cca?gtc?att 304
Asp?Val?Gly?Val?Lys?Asp?Arg?Glu?Arg?Phe?Ala?Gly?Lys?Pro?Val?Ile
65 70 75
gaa?tcc?ggc?gtc?aag?cgc?gcg?atc?aat?gag?cca?gcc?aag?atg?atc?gac?352
Glu?Ser?Gly?Val?Lys?Arg?Ala?Ile?Asn?Glu?Pro?Ala?Lys?Met?Ile?Asp
80 85 90
gag?gcc?atc?gca?gcc?tcc?aag?aac?cca?aac?gcc?cgc?aag?gtt?tcc?ggt?400
Glu?Ala?Ile?Ala?Ala?Ser?Lys?Asn?Pro?Asn?Ala?Arg?Lys?Val?Ser?Gly
95 100 105
tcc?ggt?gtc?gcg?gca?tct?gct?gaa?acc?acc?ggc?gag?aag?ctc?ggc?tgg?448
Ser?Gly?Val?Ala?Ala?Ser?Ala?Glu?Thr?Thr?Gly?Glu?Lys?Leu?Gly?Trp
110 115 120
ggc?aag?cgc?atc?cag?cag?gca?gtc?atg?acc?ggc?gtg?tcc?tac?atg?gtt?496
Gly?Lys?Arg?Ile?Gln?Gln?Ala?Val?Met?Thr?Gly?Val?Ser?Tyr?Met?Val
125 130 135 140
cca?ttc?gta?gct?gcc?ggc?ggc?ctc?ctg?ttg?gct?ctc?ggc?ttc?gca?ttc?544
Pro?Phe?Val?Ala?Ala?Gly?Gly?Leu?Leu?Leu?Ala?Leu?Gly?Phe?Ala?Phe
145 150 155
ggt?gga?tac?gac?atg?gcg?aac?ggc?tgg?caa?gca?atc?gcc?acc?cag?ttc?592
Gly?Gly?Tyr?Asp?Met?Ala?Asn?Gly?Trp?Gln?Ala?Ile?Ala?Thr?Gln?Phe
160 165 170
tct?ctg?acc?aac?ctg?cca?ggc?aac?acc?gtc?gat?gtt?gac 631
Ser?Leu?Thr?Asn?Leu?Pro?Gly?Asn?Thr?Val?Asp?Val?Asp
175 180 185
<210>14
<211>185
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>14
Val?Ala?Ile?Thr?Ala?Cys?Pro?Thr?Gly?Ile?Ala?His?Thr?Tyr?Met?Ala
1 5 10 15
Ala?Asp?Ser?Leu?Thr?Gln?Asn?Ala?Glu?Gly?Arg?Asp?Asp?Val?Glu?Leu
20 25 30
Val?Val?Glu?Thr?Gln?Gly?Ser?Ser?Ala?Val?Thr?Pro?Val?Asp?Pro?Lys
35 40 45
Ile?Ile?Glu?Ala?Ala?Asp?Ala?Val?Ile?Phe?Ala?Thr?Asp?Val?Gly?Val
50 55 60
Lys?Asp?Arg?Glu?Arg?Phe?Ala?Gly?Lys?Pro?Val?Ile?Glu?Ser?Gly?Val
65 70 75 80
Lys?Arg?Ala?Ile?Asn?Glu?Pro?Ala?Lys?Met?Ile?Asp?Glu?Ala?Ile?Ala
85 90 95
Ala?Ser?Lys?Asn?Pro?Asn?Ala?Arg?Lys?Val?Ser?Gly?Ser?Gly?Val?Ala
100 105 110
Ala?Ser?Ala?Glu?Thr?Thr?Gly?Glu?Lys?Leu?Gly?Trp?Gly?Lys?Arg?Ile
115 120 125
Gln?Gln?Ala?Val?Met?Thr?Gly?Val?Ser?Tyr?Met?Val?Pro?Phe?Val?Ala
130 135 140
Ala?Gly?Gly?Leu?Leu?Leu?Ala?Leu?Gly?Phe?Ala?Phe?Gly?Gly?Tyr?Asp
145 150 155 160
Met?Ala?Asn?Gly?Trp?Gln?Ala?Ile?Ala?Thr?Gln?Phe?Ser?Leu?Thr?Asn
165 170 175
Leu?Pro?Gly?Asn?Thr?Val?Asp?Val?Asp
180 185
<210>15
<211>416
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(1)..(393)
<223>RXA00951
<400>15
atc?caa?gca?atc?tta?gag?aag?gca?gca?gcg?ccg?gcg?aag?cag?aag?gct 48
Ile?Gln?Ala?Ile?Leu?Glu?Lys?Ala?Ala?Ala?Pro?Ala?Lys?Gln?Lys?Ala
1 5 10 15
cct?gct?gtg?gct?cct?gct?gta?aca?ccc?act?gac?gct?cct?gca?gcc?tca 96
Pro?Ala?Val?Ala?Pro?Ala?Val?Thr?Pro?Thr?Asp?Ala?Pro?Ala?Ala?Ser
20 25 30
gtc?caa?tcc?aaa?acc?cac?gac?aag?atc?ctc?acc?gtc?tgt?ggc?aac?ggc 144
Val?Gln?Ser?Lys?Thr?His?Asp?Lys?Ile?Leu?Thr?Val?Cys?Gly?Asn?Gly
35 40 45
ttg?ggt?acc?tcc?ctc?ttc?ctc?aaa?aac?acc?ctt?gag?caa?gtt?ttc?gac 192
Leu?Gly?Thr?Ser?Leu?Phe?Leu?Lys?Asn?Thr?Leu?Glu?Gln?Val?Phe?Asp
50 55 60
acc?tgg?ggt?tgg?ggt?cca?tac?atg?acg?gtg?gag?gca?acc?gac?act?atc 240
Thr?Trp?Gly?Trp?Gly?Pro?Tyr?Met?Thr?Val?Glu?Ala?Thr?Asp?Thr?Ile
65 70 75 80
tcc?gcc?aag?ggc?aaa?gcc?aag?gaa?gct?gat?ctc?atc?atg?acc?tct?ggt 288
Ser?Ala?Lys?Gly?Lys?Ala?Lys?Glu?Ala?Asp?Leu?Ile?Met?Thr?Ser?Gly
85 90 95
gaa?atc?gcc?cgc?acg?ttg?ggt?gat?gtt?gga?atc?ccg?gtt?cac?gtg?atc 336
Glu?Ile?Ala?Arg?Thr?Leu?Gly?Asp?Val?Gly?Ile?Pro?Val?His?Val?Ile
100 105 110
aat?gac?ttc?acg?agc?acc?gat?gaa?atc?gat?gct?gcg?ctt?cgt?gaa?cgc 384
Asn?Asp?Phe?Thr?Ser?Thr?Asp?Glu?Ile?Asp?Ala?Ala?Leu?Arg?Glu?Arg
115 120 125
tac?gac?atc?taactacttt?aaaaggacga?aaa 416
Tyr?Asp?Ile
130
<210>16
<211>131
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>16
Ile?Gln?Ala?Ile?Leu?Glu?Lys?Ala?Ala?Ala?Pro?Ala?Lys?Gln?Lys?Ala
1 5 10 15
Pro?Ala?Val?Ala?Pro?Ala?Val?Thr?Pro?Thr?Asp?Ala?Pro?Ala?Ala?Ser
20 25 30
Val?Gln?Ser?Lys?Thr?His?Asp?Lys?Ile?Leu?Thr?Val?Cys?Gly?Asn?Gly
35 40 45
Leu?Gly?Thr?Ser?Leu?Phe?Leu?Lys?Asn?Thr?Leu?Glu?Gln?Val?Phe?Asp
50 55 60
Thr?Trp?Gly?Trp?Gly?Pro?Tyr?Met?Thr?Val?Glu?Ala?Thr?Asp?Thr?Ile
65 70 75 80
Ser?Ala?Lys?Gly?Lys?Ala?Lys?Glu?Ala?Asp?Leu?Ile?Met?Thr?Ser?Gly
85 90 95
Glu?Ile?Ala?Arg?Thr?Leu?Gly?Asp?Val?Gly?Ile?Pro?Val?His?Val?Ile
100 105 110
Asn?Asp?Phe?Thr?Ser?Thr?Asp?Glu?Ile?Asp?Ala?Ala?Leu?Arg?Glu?Arg
115 120 125
Tyr?Asp?Ile
130
<210>17
<211>1827
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(1804)
<223>RXN01244
<400>17
gatatgtgtt?tgtttgtcaa?tatccaaatg?tttgaatagt?tgcacaactg?ttggttttgt?60
ggtgatcttg?aggaaattaa?ctcaatgatt?gtgaggatgg?gtg?gct?act?gtg?gct 115
Val?Ala?Thr?Val?Ala
1 5
gat?gtg?aat?caa?gac?act?gta?ctg?aag?ggc?acc?ggc?gtt?gtc?ggt?gga 163
Asp?Val?Ash?Gln?Asp?Thr?Val?Leu?Lys?Gly?Thr?Gly?Val?Val?Gly?Gly
10 15 20
gtc?cgt?tat?gca?agc?gcg?gtg?tgg?att?acc?cca?cgc?ccc?gaa?cta?ccc 211
Val?Arg?Tyr?Ala?Ser?Ala?Val?Trp?Ile?Thr?Pro?Arg?Pro?Glu?Leu?Pro
25 30 35
caa?gca?ggc?gaa?gtc?gtc?gcc?gaa?gaa?aac?cgt?gaa?gca?gag?cag?gag 259
Gln?Ala?Gly?Glu?Val?Val?Ala?Glu?Glu?Asn?Arg?Glu?Ala?Glu?Gln?Glu
40 45 50
cgt?ttc?gac?gcc?gct?gca?gcc?aca?gtc?tct?tct?cgt?ttg?ctt?gag?cgc 307
Arg?Phe?Asp?Ala?Ala?Ala?Ala?Thr?Val?Ser?Ser?Arg?Leu?Leu?Glu?Arg
55 60 65
tcc?gaa?gct?gct?gaa?gga?cca?gca?gct?gag?gtg?ctt?aaa?gct?act?gct 355
Ser?Glu?Ala?Ala?Glu?Gly?Pro?Ala?Ala?Glu?Val?Leu?Lys?Ala?Thr?Ala
70 75 80 85
ggc?atg?gtc?aat?gac?cgt?ggc?tgg?cgt?aag?gct?gtc?atc?aag?ggt?gtc 403
Gly?Met?Val?Asn?Asp?Arg?Gly?Trp?Arg?Lys?Ala?Val?Ile?Lys?Gly?Val
90 95 100
aag?ggt?ggt?cac?cct?gcg?gaa?tac?gcc?gtg?gtt?gca?gca?aca?acc?aag 451
Lys?Gly?Gly?His?Pro?Ala?Glu?Tyr?Ala?Val?Val?Ala?Ala?Thr?Thr?Lys
105 110 115
ttc?atc?tcc?atg?ttc?gaa?gcc?gca?ggc?ggc?ctg?atc?gcg?gag?cgc?acc 499
Phe?Ile?Ser?Met?Phe?Glu?Ala?Ala?Gly?Gly?Leu?Ile?Ala?Glu?Arg?Thr
120 125 130
aca?gac?ttg?cgc?gac?atc?cgc?gac?cgc?gtc?atc?gca?gaa?ctt?cgt?ggc 547
Thr?Asp?Leu?Arg?Asp?Ile?Arg?Asp?Arg?Val?Ile?Ala?Glu?Leu?Arg?Gly
135 140 145
gat?gaa?gag?cca?ggt?ctg?cca?gct?gtt?tcc?gga?cag?gtc?att?ctc?ttt 595
Asp?Glu?Glu?Pro?Gly?Leu?Pro?Ala?Val?Ser?Gly?Gln?Val?Ile?Leu?Phe
150 155 160 165
gca?gat?gac?ctc?tcc?cca?gca?gac?acc?gcg?gca?cta?gac?aca?gat?ctc 643
Ala?Asp?Asp?Leu?Ser?Pro?Ala?Asp?Thr?Ala?Ala?Leu?Asp?Thr?Asp?Leu
170 175 180
ttt?gtg?gga?ctt?gtc?act?gag?ctg?ggt?ggc?cca?acg?agc?cac?acc?gcg 691
Phe?Val?Gly?Leu?Val?Thr?Glu?Leu?Gly?Gly?Pro?Thr?Ser?His?Thr?Ala
185 190 195
atc?atc?gca?cgc?cag?ctc?aac?gtg?cct?tgc?atc?gtc?gca?tcc?ggc?gcc 739
Ile?Ile?Ala?Arg?Gln?Leu?Asn?Val?Pro?Cys?Ile?Val?Ala?Ser?Gly?Ala
200 205 2l0
ggc?atc?aag?gac?atc?aag?tcc?ggc?gaa?aag?gtg?ctt?atc?gac?ggc?agc 787
Gly?Ile?Lys?Asp?Ile?Lys?Ser?Gly?Glu?Lys?Val?Leu?Ile?Asp?Gly?Ser
215 220 225
ctc?ggc?acc?att?gac?cgc?aac?gcg?gac?gaa?gct?gaa?gca?acc?aag?ctc 835
Leu?Gly?Thr?Ile?Asp?Arg?Asn?Ala?Asp?Glu?Ala?Glu?Ala?Thr?Lys?Leu
230 235 240 245
gtc?tcc?gag?tcc?ctc?gag?cgc?gct?gct?cgc?atc?gcc?gag?tgg?aag?ggt 883
Val?Ser?Glu?Ser?Leu?Glu?Arg?Ala?Ala?Arg?Ile?Ala?Glu?Trp?Lys?Gly
250 255 260
cct?gca?caa?acc?aag?gac?ggc?tac?cgc?gtt?cag?ctg?ttg?gcc?aac?gtc 931
Pro?Ala?Gln?Thr?Lys?Asp?Gly?Tyr?Arg?Val?Gln?Leu?Leu?Ala?Asn?Val
265 270 275
caa?gac?ggc?aac?tct?gca?cag?cag?gct?gca?cag?acc?gaa?gca?gaa?ggc 979
Gln?Asp?Gly?Asn?Ser?Ala?Gln?Gln?Ala?Ala?Gln?Thr?Glu?Ala?Glu?Gly
280 285 290
atc?ggc?ctg?ttc?cgc?acc?gaa?ctg?tgc?ttc?ctt?tcc?gcc?acc?gaa?gag 1027
Ile?Gly?Leu?Phe?Arg?Thr?Glu?Leu?Cys?Phe?Leu?Ser?Ala?Thr?Glu?Glu
295 300 305
cca?agc?gtt?gat?gag?cag?gct?gcg?gtc?tac?tca?aag?gtg?ctt?gaa?gca 1075
Pro?Ser?Val?Asp?Glu?Gln?Ala?Ala?Val?Tyr?Ser?Lys?Val?Leu?Glu?Ala
310 315 320 325
ttc?cca?gag?tcc?aag?gtc?gtt?gtc?cgc?tcc?ctc?gac?gca?ggt?tct?gac 1123
Phe?Pro?Glu?Ser?Lys?Val?Val?Val?Arg?Ser?Leu?Asp?Ala?Gly?Ser?Asp
330 335 340
aag?cca?gtt?cca?ttc?gca?tcg?atg?gct?gat?gag?atg?aac?cca?gca?ctg 1171
Lys?Pro?Val?Pro?Phe?Ala?Ser?Met?Ala?Asp?Glu?Met?Asn?Pro?Ala?Leu
345 350 355
ggt?gtt?cgt?ggc?ctg?cgt?atc?gca?cgt?gga?cag?gtt?gat?ctg?ctg?act 1219
Gly?Val?Arg?Gly?Leu?Arg?Ile?Ala?Arg?Gly?Gln?Val?Asp?Leu?Leu?Thr
360 365 370
cgc?cag?ctc?gac?gca?att?gcg?aag?gcc?agc?gaa?gaa?ctc?ggc?cgt?ggc 1267
Arg?Gln?Leu?Asp?Ala?Ile?Ala?Lys?Ala?Ser?Glu?Glu?Leu?Gly?Arg?Gly
375 380 385
gac?gac?gcc?cca?acc?tgg?gtt?atg?gct?cca?atg?gtg?gct?acc?gct?tat 1315
Asp?Asp?Ala?Pro?Thr?Trp?Val?Met?Ala?Pro?Met?Val?Ala?Thr?Ala?Tyr
390 395 400 405
gaa?gca?aag?tgg?ttt?gct?gac?atg?tgc?cgt?gag?cgt?ggc?cta?atc?gcc 1363
Glu?Ala?Lys?Trp?Phe?Ala?Asp?Met?Cys?Arg?Glu?Arg?Gly?Leu?Ile?Ala
410 415 420
ggc?gcc?atg?atc?gaa?gtt?cca?gca?gca?tcc?ctg?atg?gca?gac?aag?atc 1411
Gly?Ala?Met?Ile?Glu?Val?Pro?Ala?Ala?Ser?Leu?Met?Ala?Asp?Lys?Ile
425 430 435
atg?cct?cac?ctg?gac?ttt?gtt?tcc?atc?ggt?acc?aac?gac?ctg?acc?cag 1459
Met?Pro?His?Leu?Asp?Phe?Val?Ser?Ile?Gly?Thr?Asn?Asp?Leu?Thr?Gln
440 445 450
tac?acc?atg?gca?gcg?gac?cgc?atg?tct?cct?gag?ctt?gcc?tac?ctg?acc 1507
Tyr?Thr?Met?Ala?Ala?Asp?Arg?Met?Ser?Pro?Glu?Leu?Ala?Tyr?Leu?Thr
455 460 465
gat?cct?tgg?cag?cca?gca?gtc?ctg?cgc?ctg?atc?aag?cac?acc?tgt?gac 1555
Asp?Pro?Trp?Gln?Pro?Ala?Val?Leu?Arg?Leu?Ile?Lys?His?Thr?Cys?Asp
470 475 480 485
gaa?ggt?gct?cgc?ttt?aac?acc?ccg?gtc?ggt?gtt?tgt?ggt?gaa?gca?gca 1603
Glu?Gly?Ala?Arg?Phe?Asn?Thr?Pro?Val?Gly?Val?Cys?Gly?Glu?Ala?Ala
490 495 500
gca?gac?cca?ctg?ttg?gca?act?gtc?ctc?acc?ggt?ctt?ggc?gtg?aac?tcc 1651
Ala?Asp?Pro?Leu?Leu?Ala?Thr?Val?Leu?Thr?Gly?Leu?Gly?Val?Asn?Ser
505 510 515
ctg?tcc?gca?gca?tcc?act?gct?ctc?gca?gca?gtc?ggt?gca?aag?ctg?tca 1699
Leu?Ser?Ala?Ala?Ser?Thr?Ala?Leu?Ala?Ala?Val?Gly?Ala?Lys?Leu?Ser
520 525 530
gag?gtc?acc?ctg?gaa?acc?tgt?aag?aag?gca?gca?gaa?gca?gca?ctt?gac 1747
Glu?Val?Thr?Leu?Glu?Thr?Cys?Lys?Lys?Ala?Ala?Glu?Ala?Ala?Leu?Asp
535 540 545
gct?gaa?ggt?gca?act?gaa?gca?cgc?gat?gct?gta?cgc?gca?gtg?atc?gac 1795
Ala?Glu?Gly?Ala?Thr?Glu?Ala?Arg?Asp?Ala?Val?Arg?Ala?Val?Ile?Asp
550 555 560 565
gca?gca?gtc?taaaccactg?ttgagctaaa?aag 1827
Ala?Ala?Val
<210>18
<211>568
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>18
Val?Ala?Thr?Val?Ala?Asp?Val?Asn?Gln?Asp?Thr?Val?Leu?Lys?Gly?Thr
1 5 10 15
Gly?Val?Val?Gly?Gly?Val?Arg?Tyr?Ala?Ser?Ala?Val?Trp?Ile?Thr?Pro
20 25 30
Arg?Pro?Glu?Leu?Pro?Gln?Ala?Gly?Glu?Val?Val?Ala?Glu?Glu?Asn?Arg
35 40 45
Glu?Ala?Glu?Gln?Glu?Arg?Phe?Asp?Ala?Ala?Ala?Ala?Thr?Val?Ser?Ser
50 55 60
Arg?Leu?Leu?Glu?Arg?Ser?Glu?Ala?Ala?Glu?Gly?Pro?Ala?Ala?Glu?Val
65 70 75 80
Leu?Lys?Ala?Thr?Ala?Gly?Met?Val?Asn?Asp?Arg?Gly?Trp?Arg?Lys?Ala
85 90 95
Val?Ile?Lys?Gly?Val?Lys?Gly?Gly?His?Pro?Ala?Glu?Tyr?Ala?Val?Val
100 105 110
Ala?Ala?Thr?Thr?Lys?Phe?Ile?Ser?Met?Phe?Glu?Ala?Ala?Gly?Gly?Leu
115 120 125
Ile?Ala?Glu?Arg?Thr?Thr?Asp?Leu?Arg?Asp?Ile?Arg?Asp?Arg?Val?Ile
130 135 140
Ala?Glu?Leu?Arg?Gly?Asp?Glu?Glu?Pro?Gly?Leu?Pro?Ala?Val?Ser?Gly
145 150 155 160
Gln?Val?Ile?Leu?Phe?Ala?Asp?Asp?Leu?Ser?Pro?Ala?Asp?Thr?Ala?Ala
165 170 175
Leu?Asp?Thr?Asp?Leu?Phe?Val?Gly?Leu?Val?Thr?Glu?Leu?Gly?Gly?Pro
180 185 190
Thr?Ser?His?Thr?Ala?Ile?Ile?Ala?Arg?Gln?Leu?Asn?Val?Pro?Cys?Ile
195 200 205
Val?Ala?Ser?Gly?Ala?Gly?Ile?Lys?Asp?Ile?Lys?Ser?Gly?Glu?Lys?Val
210 215 220
Leu?Ile?Asp?Gly?Ser?Leu?Gly?Thr?Ile?Asp?Arg?Asn?Ala?Asp?Glu?Ala
225 230 235 240
Glu?Ala?Thr?Lys?Leu?Val?Ser?Glu?Ser?Leu?Glu?Arg?Ala?Ala?Arg?Ile
245 250 255
Ala?Glu?Trp?Lys?Gly?Pro?Ala?Gln?Thr?Lys?Asp?Gly?Tyr?Arg?Val?Gln
260 265 270
Leu?Leu?Ala?Asn?Val?Gln?Asp?Gly?Asn?Ser?Ala?Gln?Gln?Ala?Ala?Gln
275 280 285
Thr?Glu?Ala?Glu?Gly?Ile?Gly?Leu?Phe?Arg?Thr?Glu?Leu?Cys?Phe?Leu
290 295 300
Ser?Ala?Thr?Glu?Glu?Pro?Ser?Val?Asp?Glu?Gln?Ala?Ala?Val?Tyr?Ser
305 310 315 320
Lys?Val?Leu?Glu?Ala?Phe?Pro?Glu?Ser?Lys?Val?Val?Val?Arg?Ser?Leu
325 330 335
Asp?Ala?Gly?Ser?Asp?Lys?Pro?Val?Pro?Phe?Ala?Ser?Met?Ala?Asp?Glu
340 345 350
Met?Asn?Pro?Ala?Leu?Gly?Val?Arg?Gly?Leu?Arg?Ile?Ala?Arg?Gly?Gln
355 360 365
Val?Asp?Leu?Leu?Thr?Arg?Gln?Leu?Asp?Ala?Ile?Ala?Lys?Ala?Ser?Glu
370 375 380
Glu?Leu?Gly?Arg?Gly?Asp?Asp?Ala?Pro?Thr?Trp?Val?Met?Ala?Pro?Met
385 390 395 400
Val?Ala?Thr?Ala?Tyr?Glu?Ala?Lys?Trp?Phe?Ala?Asp?Met?Cys?Arg?Glu
405 410 415
Arg?Gly?Leu?Ile?Ala?Gly?Ala?Met?Ile?Glu?Val?Pro?Ala?Ala?Ser?Leu
420 425 430
Met?Ala?Asp?Lys?Ile?Met?Pro?His?Leu?Asp?Phe?Val?Ser?Ile?Gly?Thr
435 440 445
Asn?Asp?Leu?Thr?Gln?Tyr?Thr?Met?Ala?Ala?Asp?Arg?Met?Ser?Pro?Glu
450 455 460
Leu?Ala?Tyr?Leu?Thr?Asp?Pro?Trp?Gln?Pro?Ala?Val?Leu?Arg?Leu?Ile
465 470 475 480
Lys?His?Thr?Cys?Asp?Glu?Gly?Ala?Arg?Phe?Asn?Thr?Pro?Val?Gly?Val
485 490 495
Cys?Gly?Glu?Ala?Ala?Ala?Asp?Pro?Leu?Leu?Ala?Thr?Val?Leu?Thr?Gly
500 505 510
Leu?Gly?Val?Asn?Ser?Leu?Ser?Ala?Ala?Ser?Thr?Ala?Leu?Ala?Ala?Val
515 520 525
Gly?Ala?Lys?Leu?Ser?Glu?Val?Thr?Leu?Glu?Thr?Cys?Lys?Lys?Ala?Ala
530 535 540
Glu?Ala?Ala?Leu?Asp?Ala?Glu?Gly?Ala?Thr?Glu?Ala?Arg?Asp?Ala?Val
545 550 555 560
Arg?Ala?Val?Ile?Asp?Ala?Ala?Val
565
<210>19
<211>1629
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(98)..(1606)
<223>FRXA01244
<400>19
agatgtcgat?ttctcgagga?agaagttaac?gccgaagaaa?accgtgaatc?agagcaggag 60
cgcttcgacg?ccgctgcagc?cacagtctct?tcttcgt?ttg?ctt?gag?cgc?tcc?gaa 115
Leu?Leu?Glu?Arg?Ser?Glu
1 5
gct?gct?gaa?gga?cca?gca?gct?gag?gtg?ctt?aaa?gct?act?gct?ggc?atg 163
Ala?Ala?Glu?Gly?Pro?Ala?Ala?Glu?Val?Leu?Lys?Ala?Thr?Ala?Gly?Met
10 15 20
gtc?aat?gac?cgt?ggc?tgg?cgt?aag?gct?gtc?atc?aag?ggt?gtc?aag?ggt 211
Val?Asn?Asp?Arg?Gly?Trp?Arg?Lys?Ala?Val?Ile?Lys?Gly?Val?Lys?Gly
25 30 35
ggt?cac?cct?gcg?gaa?tac?gcc?gtg?gtt?gca?gca?aca?acc?aag?ttc?atc 259
Gly?His?Pro?Ala?Glu?Tyr?Ala?Val?Val?Ala?Ala?Thr?Thr?Lys?Phe?Ile
40 45 50
tcc?atg?ttc?gaa?gcc?gca?ggc?ggc?ctg?atc?gcg?gag?cgc?acc?aca?gac 307
Ser?Met?Phe?Glu?Ala?Ala?Gly?Gly?Leu?Ile?Ala?Glu?Arg?Thr?Thr?Asp
55 60 65 70
ttg?cgc?gac?atc?cgc?gac?cgc?gtc?atc?gca?gaa?ctt?cgt?ggc?gat?gaa 355
Leu?Arg?Asp?Ile?Arg?Asp?Arg?Val?Ile?Ala?Glu?Leu?Arg?Gly?Asp?Glu
75 80 85
gag?cca?ggt?ctg?cca?gct?gtt?tcc?gga?cag?gtc?att?ctc?ttt?gca?gat 403
Glu?Pro?Gly?Leu?Pro?Ala?Val?Ser?Gly?Gln?Val?Ile?Leu?Phe?Ala?Asp
90 95 100
gac?ctc?tcc?cca?gca?gac?acc?gcg?gca?cta?gac?aca?gat?ctc?ttt?gtg 451
Asp?Leu?Ser?Pro?Ala?Asp?Thr?Ala?Ala?Leu?Asp?Thr?Asp?Leu?Phe?Val
105 110 115
gga?ctt?gtc?act?gag?ctg?ggt?ggc?cca?acg?agc?cac?acc?gcg?atc?atc 499
Gly?Leu?Val?Thr?Glu?Leu?Gly?Gly?Pro?Thr?Ser?His?Thr?Ala?Ile?Ile
120 125 130
gca?cgc?cag?ctc?aac?gtg?cct?tgc?atc?gtc?gca?tcc?ggc?gcc?ggc?atc 547
Ala?Arg?Gln?Leu?Asn?Val?Pro?Cys?Ile?Val?Ala?Ser?Gly?Ala?Gly?Ile
135 140 145 150
aag?gac?atc?aag?tcc?ggc?gaa?aag?gtg?ctt?atc?gac?ggc?agc?ctc?ggc 595
Lys?Asp?Ile?Lys?Ser?Gly?Glu?Lys?Val?Leu?Ile?Asp?Gly?Ser?Leu?Gly
155 160 165
acc?att?gac?cgc?aac?gcg?gac?gaa?gct?gaa?gca?acc?aag?ctc?gtc?tcc 643
Thr?Ile?Asp?Arg?Asn?Ala?Asp?Glu?Ala?Glu?Ala?Thr?Lys?Leu?Val?Ser
170 175 180
gag?tcc?ctc?gag?cgc?gct?gct?cgc?atc?gcc?gag?tgg?aag?ggt?cct?gca 691
Glu?Ser?Leu?Glu?Arg?Ala?Ala?Arg?Ile?Ala?Glu?Trp?Lys?Gly?Pro?Ala
185 190 195
caa?acc?aag?gac?ggc?tac?cgc?gtt?cag?ctg?ttg?gcc?aac?gtc?caa?gac 739
Gln?Thr?Lys?Asp?Gly?Tyr?Arg?Val?Gln?Leu?Leu?Ala?Asn?Val?Gln?Asp
200 205 210
ggc?aac?tct?gca?cag?cag?gct?gca?cag?acc?gaa?gca?gaa?ggc?atc?ggc 787
Gly?Asn?Ser?Ala?Gln?Gln?Ala?Ala?Gln?Thr?Glu?Ala?Glu?Gly?Ile?Gly
215 220 225 230
ctg?ttc?cgc?acc?gaa?ctg?tgc?ttc?ctt?tcc?gcc?acc?gaa?gag?cca?agc 835
Leu?Phe?Arg?Thr?Glu?Leu?Cys?Phe?Leu?Ser?Ala?Thr?Glu?Glu?Pro?Ser
235 240 245
gtt?gat?gag?cag?gct?gcg?gtc?tac?tca?aag?gtg?ctt?gaa?gca?ttc?cca 883
Val?Asp?Glu?Gln?Ala?Ala?Val?Tyr?Ser?Lys?Val?Leu?Glu?Ala?Phe?Pro
250 255 260
gag?tcc?aag?gtc?gtt?gtc?cgc?tcc?ctc?gac?gca?ggt?tct?gac?aag?cca 931
Glu?Ser?Lys?Val?Val?Val?Arg?Ser?Leu?Asp?Ala?Gly?Ser?Asp?Lys?Pro
265 270 275
gtt?cca?ttc?gca?tcg?atg?gct?gat?gag?atg?aac?cca?gca?ctg?ggt?gtt 979
Val?Pro?Phe?Ala?Ser?Met?Ala?Asp?Glu?Met?Asn?Pro?Ala?Leu?Gly?Val
280 285 290
cgt?ggc?ctg?cgt?atc?gca?cgt?gga?cag?gtt?gat?ctg?ctg?act?cgc?cag 1027
Arg?Gly?Leu?Arg?Ile?Ala?Arg?Gly?Gln?Val?Asp?Leu?Leu?Thr?Arg?Gln
295 300 305 310
ctc?gac?gca?att?gcg?aag?gcc?agc?gaa?gaa?ctc?ggc?cgt?ggc?gac?gac 1075
Leu?Asp?Ala?Ile?Ala?Lys?Ala?Ser?Glu?Glu?Leu?Gly?Arg?Gly?Asp?Asp
315 320 325
gcc?cca?acc?tgg?gtt?atg?gct?cca?atg?gtg?gct?acc?gct?tat?gaa?gca 1123
Ala?Pro?Thr?Trp?Val?Met?Ala?Pro?Met?Val?Ala?Thr?Ala?Tyr?Glu?Ala
330 335 340
aag?tgg?ttt?gct?gac?atg?tgc?cgt?gag?cgt?ggc?cta?atc?gcc?ggc?gcc 1171
Lys?Trp?Phe?Ala?Asp?Met?Cys?Arg?Glu?Arg?Gly?Leu?Ile?Ala?Gly?Ala
345 350 355
atg?atc?gaa?gtt?cca?gca?gca?tcc?ctg?atg?gca?gac?aag?atc?atg?cct 1219
Met?Ile?Glu?Val?Pro?Ala?Ala?Ser?Leu?Met?Ala?Asp?Lys?Ile?Met?Pro
360 365 370
GaG?ctg?gac?ttt?gtt?tcc?atc?ggt?acc?aac?gac?ctg?acc?cag?tac?acc 1267
His?Leu?Asp?Phe?Val?Ser?Ile?Gly?Thr?Asn?Asp?Leu?Thr?Gln?Tyr?Thr
375 380 385 390
atg?gca?gcg?gac?cgc?atg?tct?cct?gag?ctt?gcc?tac?ctg?acc?gat?cct 1315
Met?Ala?Ala?Asp?Arg?Met?Ser?Pro?Glu?Leu?Ala?Tyr?Leu?Thr?Asp?Pro
395 400 405
tgg?cag?cca?gca?gtc?ctg?cgc?ctg?atc?aag?cac?acc?tgt?gac?gaa?ggt 1363
Trp?Gln?Pro?Ala?Val?Leu?Arg?Leu?Ile?Lys?His?Thr?Cys?Asp?Glu?Gly
410 415 420
gct?cgc?ttt?aac?acc?ccg?gtc?ggt?gtt?tgt?ggt?gaa?gca?gca?gca?gac 1411
Ala?Arg?Phe?Asn?Thr?Pro?Val?Gly?Val?Cys?Gly?Glu?Ala?Ala?Ala?Asp
425 430 435
cca?ctg?ttg?gca?act?gtc?ctc?acc?ggt?ctt?ggc?gtg?aac?tcc?ctg?tcc 1459
Pro?Leu?Leu?Ala?Thr?Val?Leu?Thr?Gly?Leu?Gly?Val?Asn?Ser?Leu?Ser
440 445 450
gca?gca?tcc?act?gct?ctc?gca?gca?gtc?ggt?gca?aag?ctg?tca?gag?gtc 1507
Ala?Ala?Ser?Thr?Ala?Leu?Ala?Ala?Val?Gly?Ala?Lys?Leu?Ser?Glu?Val
455 460 465 470
acc?ctg?gaa?acc?tgt?aag?aag?gca?gca?gaa?gca?gca?ctt?gac?gct?gaa 1555
Thr?Leu?Glu?Thr?Cys?Lys?Lys?Ala?Ala?Glu?Ala?Ala?Leu?Asp?Ala?Glu
475 480 485
ggt?gca?act?gaa?gca?cgc?gat?gct?gta?cgc?gca?gtg?atc?gac?gca?gca 1603
Gly?Ala?Thr?Glu?Ala?Arg?Asp?Ala?Val?Arg?Ala?Val?Ile?Asp?Ala?Ala
490 495 500
gtc?taaaccactg?ttgagctaaa?aag 1629
Val
<210>20
<211>503
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>20
Leu?Leu?Glu?Arg?Ser?Glu?Ala?Ala?Glu?Gly?Pro?Ala?Ala?Glu?Val?Leu
1 5 10 15
Lys?Ala?Thr?Ala?Gly?Met?Val?Asn?Asp?Arg?Gly?Trp?Arg?Lys?Ala?Val
20 25 30
Ile?Lys?Gly?Val?Lys?Gly?Gly?His?Pro?Ala?Glu?Tyr?Ala?Val?Val?Ala
35 40 45
Ala?Thr?Thr?Lys?Phe?Ile?Ser?Met?Phe?Glu?Ala?Ala?Gly?Gly?Leu?Ile
50 55 60
Ala?Glu?Arg?Thr?Thr?Asp?Leu?Arg?Asp?Ile?Arg?Asp?Arg?Val?Ile?Ala
65 70 75 80
Glu?Leu?Arg?Gly?Asp?Glu?Glu?Pro?Gly?Leu?Pro?Ala?Val?Ser?Gly?Gln
85 90 95
Val?Ile?Leu?Phe?Ala?Asp?Asp?Leu?Ser?Pro?Ala?Asp?Thr?Ala?Ala?Leu
100 105 110
Asp?Thr?Asp?Leu?Phe?Val?Gly?Leu?Val?Thr?Glu?Leu?Gly?Gly?Pro?Thr
115 120 125
Ser?His?Thr?Ala?Ile?Ile?Ala?Arg?Gln?Leu?Asn?Val?Pro?Cys?Ile?Val
130 135 140
Ala?Ser?Gly?Ala?Gly?Ile?Lys?Asp?Ile?Lys?Ser?Gly?Glu?Lys?Val?Leu
145 150 155 160
Ile?Asp?Gly?Ser?Leu?Gly?Thr?Ile?Asp?Arg?Asn?Ala?Asp?Glu?Ala?Glu
165 170 175
Ala?Thr?Lys?Leu?Val?Ser?Glu?Ser?Leu?Glu?Arg?Ala?Ala?Arg?Ile?Ala
180 185 190
Glu?Trp?Lys?Gly?Pro?Ala?Gln?Thr?Lys?Asp?Gly?Tyr?Arg?Val?Gln?Leu
195 200 205
Leu?Ala?Asn?Val?Gln?Asp?Gly?Asn?Ser?Ala?Gln?Gln?Ala?Ala?Gln?Thr
210 215 220
Glu?Ala?Glu?Gly?Ile?Gly?Leu?Phe?Arg?Thr?Glu?Leu?Cys?Phe?Leu?Ser
225 230 235 240
Ala?Thr?Glu?Glu?Pro?Ser?Val?Asp?Glu?Gln?Ala?Ala?Val?Tyr?Ser?Lys
245 250 255
Val?Leu?Glu?Ala?Phe?Pro?Glu?Ser?Lys?Val?Val?Val?Arg?Ser?Leu?Asp
260 265 270
Ala?Gly?Ser?Asp?Lys?Pro?Val?Pro?Phe?Ala?Ser?Met?Ala?Asp?Glu?Met
275 280 285
Asn?Pro?Ala?Leu?Gly?Val?Arg?Gly?Leu?Arg?Ile?Ala?Arg?Gly?Gln?Val
290 295 300
Asp?Leu?Leu?Thr?Arg?Gln?Leu?Asp?Ala?Ile?Ala?Lys?Ala?Ser?Glu?Glu
305 310 315 320
Leu?Gly?Arg?Gly?Asp?Asp?Ala?Pro?Thr?Trp?Val?Met?Ala?Pro?Met?Val
325 330 335
Ala?Thr?Ala?Tyr?Glu?Ala?Lys?Trp?Phe?Ala?Asp?Met?Cys?Arg?Glu?Arg
340 345 350
Gly?Leu?Ile?Ala?Gly?Ala?Met?Ile?Glu?Val?Pro?Ala?Ala?Ser?Leu?Met
355 360 365
Ala?Asp?Lys?Ile?Met?Pro?His?Leu?Asp?Phe?Val?Ser?Ile?Gly?Thr?Asn
370 375 380
Asp?Leu?Thr?Gln?Tyr?Thr?Met?Ala?Ala?Asp?Arg?Met?Ser?Pro?Glu?Leu
385 390 395 400
Ala?Tyr?Leu?Thr?Asp?Pro?Trp?Gln?Pro?Ala?Val?Leu?Arg?Leu?Ile?Lys
405 410 415
His?Thr?Cys?Asp?Glu?Gly?Ala?Arg?Phe?Asn?Thr?Pro?Val?Gly?Val?Cys
420 425 430
Gly?Glu?Ala?Ala?Ala?Asp?Pro?Leu?Leu?Ala?Thr?Val?Leu?Thr?Gly?Leu
435 440 445
Gly?Val?Asn?Ser?Leu?Ser?Ala?Ala?Ser?Thr?Ala?Leu?Ala?Ala?Val?Gly
450 455 460
Ala?Lys?Leu?Ser?Glu?Val?Thr?Leu?Glu?Thr?Cys?Lys?Lys?Ala?Ala?Glu
465 470 475 480
Ala?Ala?Leu?Asp?Ala?Glu?Gly?Ala?Thr?Glu?Ala?Arg?Asp?Ala?Val?Arg
485 490 495
Ala?Val?Ile?Asp?Ala?Ala?Val
500
<210>21
<211>390
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(367)
<223>RXA01300
<400>21
gatcgacatt?aaatcccctc?ccttgggggg?tttaactaac?aaatcgctgc?gccctaatcc?60
gttcggatta?acggcgtagc?aacacgaaag?gacactttcc?atg?gct?tcc?aag?act 115
Met?Ala?Set?Lys?Thr
1 5
gta?acc?gtc?ggt?tcc?tcc?gtt?ggc?ctg?cac?gca?cgt?cca?gca?tcc?atc 163
Val?Thr?Val?Gly?Ser?Ser?Val?Gly?Leu?His?Ala?Arg?Pro?Ala?Ser?Ile
10 15 20
arc?gct?gaa?gcg?gct?gct?gag?tac?gac?gac?gaa?atc?ttg?ctg?acc?ctg 211
Ile?Ala?Glu?Ala?Ala?Ala?Glu?Tyr?Asp?Asp?Glu?Ile?Leu?Leu?Thr?Leu
25 30 35
gtt?ggc?tcc?gat?gat?gac?gaa?gag?acc?gac?gcg?tcc?tct?tcc?ctc?atg 259
Val?Gly?Ser?Asp?Asp?Asp?Glu?Glu?Thr?Asp?Ala?Ser?Ser?Ser?Leu?Met
40 45 50
atc?atg?gcg?ctg?ggc?gca?gag?cac?ggc?aac?gaa?gtt?acc?gtc?acc?tcc 307
Ile?Met?Ala?Leu?Gly?Ala?Glu?His?Gly?Asn?Glu?Val?Thr?Val?Thr?Ser
55 60 65
gac?aac?gct?gaa?gct?gtt?gag?aag?atc?gct?gcg?ctt?atc?gca?cag?gac 355
Asp?Asn?Ala?Glu?Ala?Val?Glu?Lys?Ile?Ala?Ala?Leu?Ile?Ala?Gln?Asp
70 75 80 85
ctt?gac?gct?gag?taaacaacgc?tctgcttgtt?aaa 390
Leu?Asp?Ala?Glu
<210>22
<211>89
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>22
Met?Ala?Ser?Lys?Thr?Val?Thr?Val?Gly?Ser?Ser?Val?Gly?Leu?His?Ala
1 5 10 15
Arg?Pro?Ala?Ser?Ile?Ile?Ala?Glu?Ala?Ala?Ala?Glu?Tyr?Asp?Asp?Glu
20 25 30
Ile?Leu?Leu?Thr?Leu?Val?Gly?Ser?Asp?Asp?Asp?Glu?Glu?Thr?Asp?Ala
35 40 45
Ser?Ser?Ser?Leu?Met?Ile?Met?Ala?Leu?Gly?Ala?Glu?His?Gly?Asn?Glu
50 55 60
Val?Thr?Val?Thr?Ser?Asp?Asn?Ala?Glu?Ala?Val?Glu?Lys?Ile?Ala?Ala
65 70 75 80
Leu?Ile?Ala?Gln?Asp?Leu?Asp?Ala?Glu
85
<210>23
<211>508
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(508)
<223>RXN03002
<400>23
ggaacttcga?ggtgtcttcg?tggggcgtac?ggagatctag?caagtgtggc?tttatgtttg?60
accctatccg?aatcaacatg?cagtgaatta?acatctactt?atg?ttt?gta?ctc?aaa 115
Met?Phe?Val?Leu?Lys
1 5
gat?ctg?cta?aag?gca?gaa?cgc?ata?gaa?ctc?gac?cgc?acg?gtc?acc?gat 163
Asp?Leu?Leu?Lys?Ala?Glu?Arg?Ile?Glu?Leu?Asp?Arg?Thr?Val?Thr?Asp
10 15 20
tgg?cgt?gaa?ggc?atc?cgc?gcc?gca?ggt?gta?ctc?cta?gaa?aag?aca?aac 211
Trp?Arg?Glu?Gly?Ile?Arg?Ala?Ala?Gly?Val?Leu?Leu?Glu?Lys?Thr?Asn
25 30 35
agc?att?gat?tcc?gcc?tac?acc?gat?gcc?atg?atc?gcc?agc?gtg?gaa?gaa 259
Ser?Ile?Asp?Ser?Ala?Tyr?Thr?Asp?Ala?Met?Ile?Ala?Ser?Val?Glu?Glu
40 45 50
aaa?ggc?ccc?tac?att?gtg?gtc?gct?cca?ggt?ttc?gct?ttc?gcg?cac?gcc 307
Lys?Gly?Pro?Tyr?Ile?Val?Val?Ala?Pro?Gly?Phe?Ala?Phe?Ala?His?Ala
55 60 65
cgc?ccc?agc?aga?gca?gtc?cgc?gag?acc?gct?atg?tcg?tgg?gtg?cgc?ctg 355
Arg?Pro?Ser?Arg?Ala?Val?Arg?Glu?Thr?Ala?Met?Ser?Trp?Val?Arg?Leu
70 75 80 85
gcc?tcc?cct?gtt?tcc?ttc?ggt?cac?agt?aag?aat?gat?ccc?ctc?aat?ctc?403
Ala?Ser?Pro?Val?Ser?Phe?Gly?His?Ser?Lys?Asn?Asp?Pro?Leu?Asn?Leu
90 95 100
atc?gtt?gct?ctc?gct?gcc?aaa?gat?gcc?acc?gca?cat?acc?caa?gcg?atg?451
Ile?Val?Ala?Leu?Ala?Ala?Lys?Asp?Ala?Thr?Ala?His?Thr?Gln?Ala?Met
105 110 115
gcg?gca?ttg?gct?aaa?gct?tta?gga?aaa?tac?cga?aag?gat?ctc?gac?gag?499
Ala?Ala?Leu?Ala?Lys?Ala?Leu?Gly?Lys?Tyr?Arg?Lys?Asp?Leu?Asp?Glu
120 125 130
gca?caa?agt 508
Ala?Gln?Ser
135
<210>24
<211>136
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>24
Met?Phe?Val?Leu?Lys?Asp?Leu?Leu?Lys?Ala?Glu?Arg?Ile?Glu?Leu?Asp
1 5 10 15
Arg?Thr?Val?Thr?Asp?Trp?Arg?Glu?Gly?Ile?Arg?Ala?Ala?Gly?Val?Leu
20 25 30
Leu?Glu?Lys?Thr?Asn?Ser?Ile?Asp?Ser?Ala?Tyr?Thr?Asp?Ala?Met?Ile
35 40 45
Ala?Ser?Val?Glu?Glu?Lys?Gly?Pro?Tyr?Ile?Val?Val?Ala?Pro?Gly?Phe
50 55 60
Ala?Phe?Ala?His?Ala?Arg?Pro?Ser?Arg?Ala?Val?Arg?Glu?Thr?Ala?Met
65 70 75 80
Ser?Trp?Val?Arg?Leu?Ala?Ser?Pro?Val?Ser?Phe?Gly?His?Ser?Lys?Asn
85 90 95
Asp?Pro?Leu?Asn?Leu?Ile?Val?Ala?Leu?Ala?Ala?Lys?Asp?Ala?Thr?Ala
100 105 110
His?Thr?Gln?Ala?Met?Ala?Ala?Leu?Ala?Lys?Ala?Leu?Gly?Lys?Tyr?Arg
115 120 125
Lys?Asp?Leu?Asp?Glu?Ala?Gln?Ser
130 135
<210>25
<211>789
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(14)..(766)
<223>RXC00953
<400>25
cttgcattcc?cca?atg?gcg?cca?cca?acg?gta?ggc?aac?tac?atc?atg?cag?tcc 52
Met?Ala?Pro?Pro?Thr?Val?Gly?Asn?Tyr?Ile?Met?Gln?Ser
1 5 10
ttc?act?caa?ggt?ctg?cag?ttc?ggc?gtt?gca?gtt?gcc?gtg?att?ctc?ttt 100
Phe?Thr?Gln?Gly?Leu?Gln?Phe?Gly?Val?Ala?Val?Ala?Val?Ile?Leu?Phe
15 20 25
ggt?gtc?cgc?acc?att?ctt?ggt?gaa?ctg?gtc?ccc?gca?ttc?caa?ggt?att 148
Gly?Val?Arg?Thr?Ile?Leu?Gly?Glu?Leu?Val?Pro?Ala?Phe?Gln?Gly?Ile
30 35 40 45
gct?gcg?aag?gtt?gtt?ccc?gga?gct?atc?ccc?gca?ttg?gat?gca?ccg?atc 196
Ala?Ala?Lys?Val?Val?Pro?Gly?Ala?Ile?Pro?Ala?Leu?Asp?Ala?Pro?Ile
50 55 60
gtg?ttc?ccc?tac?gcg?cag?aac?gcc?gtt?ctc?att?ggt?ttc?ttg?tct?tcc 244
Val?Phe?Pro?Tyr?Ala?Gln?Asn?Ala?Val?Leu?Ile?Gly?Phe?Leu?Ser?Ser
65 70 75
ttc?gtc?ggt?ggc?ttg?gtt?ggc?ctg?act?gtt?ctt?gca?tcg?tgg?ctg?aac 292
Phe?Val?Gly?Gly?Leu?Val?Gly?Leu?Thr?Val?Leu?Ala?Ser?Trp?Leu?Asn
80 85 90
cca?gct?ttt?ggt?gtc?gcg?ttg?att?ctg?cct?ggt?ttg?gtc?ccc?cac?ttc 340
Pro?Ala?Phe?Gly?Val?Ala?Leu?Ile?Leu?Pro?Gly?Leu?Val?Pro?His?Phe
95 100 105
ttc?act?ggt?ggc?gcg?gcg?ggc?gtt?tac?ggt?aat?gcc?acg?ggt?ggt?cgt 388
Phe?Thr?Gly?Gly?Ala?Ala?Gly?Val?Tyr?Gly?Asn?Ala?Thr?Gly?Gly?Arg
110 115 120 125
cga?gga?gca?gta?ttt?ggc?gcc?ttt?gcc?aac?ggt?ctt?ctg?att?acc?ttc 436
Arg?Gly?Ala?Val?Phe?Gly?Ala?Phe?Ala?Asn?Gly?Leu?Leu?Ile?Thr?Phe
130 135 140
ctc?cct?gct?ttc?ctg?ctt?ggt?gtg?ctt?ggt?tcc?ttc?ggg?tca?gag?aac 484
Leu?Pro?Ala?Phe?Leu?Leu?Gly?Val?Leu?Gly?Ser?Phe?Gly?Ser?Glu?Asn
145 150 155
acc?act?ttc?ggt?gat?gcg?gac?ttt?ggt?tgg?ttc?gga?atc?gtt?gtt?ggt 532
Thr?Thr?Phe?Gly?Asp?Ala?Asp?Phe?Gly?Trp?Phe?Gly?Ile?Val?Val?Gly
160 165 170
tct?gca?gcc?aag?gtg?gaa?ggt?gct?ggc?ggg?ctc?atc?ttg?ttg?ctc?atc 580
Ser?Ala?Ala?Lys?Val?Glu?Gly?Ala?Gly?Gly?Leu?Ile?Leu?Leu?Leu?Ile
175 180 185
atc?gca?gcg?gtt?ctt?ctg?ggt?ggc?gcg?atg?gtc?ttc?cag?aag?cgc?gtc 628
Ile?Ala?Ala?Val?Leu?Leu?Gly?Gly?Ala?Met?Val?Phe?Gln?Lys?Arg?Val
190 195 200 205
gtg?aat?ggg?cac?tgg?gat?cca?gct?ccc?aac?cgt?gag?cgc?gtg?gag?aag 676
Val?Asn?Gly?His?Trp?Asp?Pro?Ala?Pro?Asn?Arg?Glu?Arg?Val?Glu?Lys
210 215 220
gcg?gaa?gct?gat?gcc?act?cca?acg?gct?ggg?gct?cgg?acc?tac?cct?aag 724
Ala?Glu?Ala?Asp?Ala?Thr?Pro?Thr?Ala?Gly?Ala?Arg?Thr?Tyr?Pro?Lys
225 230 235
att?gct?cct?ccg?gcg?ggc?gct?cct?acc?cca?ccg?gct?cga?agc 766
Ile?Ala?Pro?Pro?Ala?Gly?Ala?Pro?Thr?Pro?Pro?Ala?Arg?Ser
240 245 250
taagatctcc?aaaaccctga?gat 789
<210>26
<211>251
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>26
Met?Ala?Pro?Pro?Thr?Val?Gly?Asn?Tyr?Ile?Met?Gln?Ser?Phe?Thr?Gln
1 5 10 15
Gly?Leu?Gln?Phe?Gly?Val?Ala?Val?Ala?Val?Ile?Leu?Phe?Gly?Val?Arg
20 25 30
Thr?Ile?Leu?Gly?Glu?Leu?Val?Pro?Ala?Phe?Gln?Gly?Ile?Ala?Ala?Lys
35 40 45
Val?Val?Pro?Gly?Ala?Ile?Pro?Ala?Leu?Asp?Ala?Pro?Ile?Val?Phe?Pro
50 55 60
Tyr?Ala?Gln?Asn?Ala?Val?Leu?Ile?Gly?Phe?Leu?Ser?Ser?Phe?Val?Gly
65 70 75 80
Gly?Leu?Val?Gly?Leu?Thr?Val?Leu?Ala?Ser?Trp?Leu?Asn?Pro?Ala?Phe
85 90 95
Gly?Val?Ala?Leu?Ile?Leu?Pro?Gly?Leu?Val?Pro?His?Phe?Phe?Thr?Gly
100 105 110
Gly?Ala?Ala?Gly?Val?Tyr?Gly?Asn?Ala?Thr?Gly?Gly?Arg?Arg?Gly?Ala
115 120 125
Val?Phe?Gly?Ala?Phe?Ala?Asn?Gly?Leu?Leu?Ile?Thr?Phe?Leu?Pro?Ala
130 135 140
Phe?Leu?Leu?Gly?Val?Leu?Gly?Ser?Phe?Gly?Ser?Glu?Asn?Thr?Thr?Phe
145 150 155 160
Gly?Asp?Ala?Asp?Phe?Gly?Trp?Phe?Gly?Ile?Val?Val?Gly?Ser?Ala?Ala
165 170 175
Lys?Val?Glu?Gly?Ala?Gly?Gly?Leu?Ile?Leu?Leu?Leu?Ile?Ile?Ala?Ala
180 185 190
Val?Leu?Leu?Gly?Gly?Ala?Met?Val?Phe?Gln?Lys?Arg?Val?Val?Asn?Gly
195 200 205
His?Trp?Asp?Pro?Ala?Pro?Asn?Arg?Glu?Arg?Val?Glu?Lys?Ala?Glu?Ala
210 215 220
Asp?Ala?Thr?Pro?Thr?Ala?Gly?Ala?Arg?Thr?Tyr?Pro?Lys?Ile?Ala?Pro
225 230 235 240
Pro?Ala?Gly?Ala?Pro?Thr?Pro?Pro?Ala?Arg?Ser
245 250
<210>27
<211>553
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(553)
<223>RXC03001
<400>27
cccggttcac?gtgatcaatg?acttcacgag?caccgatgaa?atcgatgctg?cgcttcgtga?60
acgctacgac?atctaactac?tttaaaagga?cgaaaatatt?atg?gac?tgg?tta?acc 115
Met?Asp?Trp?Leu?Thr
1 5
att?cct?ctt?ttc?ctc?gtt?aat?gaa?atc?ctt?gcg?gtt?ccg?gct?ttc?ctc 163
Ile?Pro?Leu?Phe?Leu?Val?Asn?Glu?Ile?Leu?Ala?Val?Pro?Ala?Phe?Leu
10 15 20
atc?ggt?atc?atc?acc?gcc?gtg?gga?ttg?ggt?gcc?atg?ggg?cgt?tcc?gtc 211
Ile?Gly?Ile?Ile?Thr?Ala?Val?Gly?Leu?Gly?Ala?Met?Gly?Arg?Ser?Val
25 30 35
ggt?cag?gtt?atc?ggt?gga?gca?atc?aaa?gca?acg?ttg?ggc?ttt?ttg?ctc 259
Gly?Gln?Val?Ile?Gly?Gly?Ala?Ile?Lys?Ala?Thr?Leu?Gly?Phe?Leu?Leu
40 45 50
att?ggt?gcg?ggt?gcc?acg?ttg?gtc?act?gcc?tcc?ctg?gag?cca?ctg?ggt 307
Ile?Gly?Ala?Gly?Ala?Thr?Leu?Val?Thr?Ala?Ser?Leu?Glu?Pro?Leu?Gly
55 60 65
gcg?atg?atc?atg?ggt?gcc?aca?ggc?atg?cgt?ggt?gtt?gtc?cca?acg?aat 355
Ala?Met?Ile?Met?Gly?Ala?Thr?Gly?Met?Arg?Gly?Val?Val?Pro?Thr?Asn
70 75 80 85
gaa?gcc?atc?gcc?gga?atc?gca?cag?gct?gaa?tac?ggc?gcg?cag?gtg?gcg 403
Glu?Ala?Ile?Ala?Gly?Ile?Ala?Gln?Ala?Glu?Tyr?Gly?Ala?Gln?Val?Ala
90 95 100
tgg?ctg?atg?att?ctg?ggc?ttc?gcc?atc?tct?ttg?gtg?ttg?gct?cgt?ttc?451
Trp?Leu?Met?Ile?Leu?Gly?Phe?Ala?Ile?Ser?Leu?Val?Leu?Ala?Arg?Phe
105 110 115
acc?aac?ctg?cgt?tat?gtc?ttg?ctc?aac?gga?cac?cac?gtg?ctg?ttg?atg?499
Thr?Asn?Leu?Arg?Tyr?Val?Leu?Leu?Asn?Gly?His?His?Val?Leu?Leu?Met
120 125 130
tgc?acc?atg?ctc?acc?atg?gtc?ttg?gcc?acc?gga?aga?gtt?gat?gcg?tgg?547
Cys?Thr?Met?Leu?Thr?Met?Val?Leu?Ala?Thr?Gly?Arg?Val?Asp?Ala?Trp
135 140 145
atc?ttc 553
Ile?Phe
150
<210>28
<211>151
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>28
Met?Asp?Trp?Leu?Thr?Ile?Pro?Leu?Phe?Leu?Val?Asn?Glu?Ile?Leu?Ala
1 5 10 15
Val?Pro?Ala?Phe?Leu?Ile?Gly?Ile?Ile?Thr?Ala?Val?Gly?Leu?Gly?Ala
20 25 30
Met?Gly?Arg?Ser?Val?Gly?Gln?Val?Ile?Gly?Gly?Ala?Ile?Lys?Ala?Thr
35 40 45
Leu?Gly?Phe?Leu?Leu?Ile?Gly?Ala?Gly?Ala?Thr?Leu?Val?Thr?Ala?Ser
50 55 60
Leu?Glu?Pro?Leu?Gly?Ala?Met?Ile?Met?Gly?Ala?Thr?Gly?Met?Arg?Gly
65 70 75 80
Val?Val?Pro?Thr?Asn?Glu?Ala?Ile?Ala?Gly?Ile?Ala?Gln?Ala?Glu?Tyr
85 90 95
Gly?Ala?Gln?Val?Ala?Trp?Leu?Met?Ile?Leu?Gly?Phe?Ala?Ile?Ser?Leu
100 105 110
Val?Leu?Ala?Arg?Phe?Thr?Asn?Leu?Arg?Tyr?Val?Leu?Leu?Asn?Gly?His
115 120 125
His?Val?Leu?Leu?Met?Cys?Thr?Met?Leu?Thr?Met?Val?Leu?Ala?Thr?Gly
130 135 140
Arg?Val?Asp?Ala?Trp?Ile?Phe
145 150
<210>29
<211>2172
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(2149)
<223>RXN01943
<400>29
ccgattcttt?ttcggcccaa?ttcgtaacgg?cgatcctctt?aagtggacaa?gaaagtctct?60
tgcccgcggg?agacagaccc?tacgtttaga?aaggtttgac?atg?gcg?tcc?aaa?ctg 115
Met?Ala?Ser?Lys?Leu
1 5
acg?acg?aca?tcg?caa?cat?att?ctg?gaa?aac?ctt?ggt?gga?cca?gac?aat 163
Thr?Thr?Thr?Set?Gln?His?Ile?Leu?Glu?Asn?Leu?Gly?Gly?Pro?Asp?Asn
10 15 20
att?act?tcg?atg?act?cac?tgt?gcg?act?cgc?ctt?cgc?ttc?caa?gtg?aag 211
Ile?Thr?Ser?Met?Thr?His?Cys?Ala?Thr?Arg?Leu?Arg?Phe?Gln?Val?Lys
25 30 35
gat?caa?tcc?att?gtt?gat?caa?caa?gaa?att?gac?tcc?gac?cca?tca?gtt 259
Asp?Gln?Ser?Ile?Val?Asp?Gln?Gln?Glu?Ile?Asp?Ser?Asp?Pro?Ser?Val
40 45 50
ctt?ggc?gta?gta?ccc?caa?gga?tcc?acc?ggt?atg?cag?gtg?gtg?atg?ggt 307
Leu?Gly?Val?Val?Pro?Gln?Gly?Ser?Thr?Gly?Met?Gln?Val?Val?Met?Gly
55 60 65
gga?tct?gtt?gca?aac?tat?tac?caa?gaa?atc?ctc?aaa?ctt?gat?gga?atg 355
Gly?Ser?Val?Ala?Asn?Tyr?Tyr?Gln?Glu?Ile?Leu?Lys?Leu?Asp?Gly?Met
70 75 80 85
aag?cac?ttc?gcc?gac?ggt?gaa?gct?aca?gag?agt?tca?tcc?aag?aag?gaa?403
Lys?His?Phe?Ala?Asp?Gly?Glu?Ala?Thr?Glu?Ser?Ser?Ser?Lys?Lys?Glu
90 95 100
tac?ggc?gga?gtc?cgt?ggc?aag?tac?tcg?tgg?att?gac?tac?gcc?ttc?gag 451
Tyr?Gly?Gly?Val?Arg?Gly?Lys?Tyr?Ser?Trp?Ile?Asp?Tyr?Ala?Phe?Glu
105 110 115
ttc?ttg?tct?gat?act?ttc?cga?cca?atc?ctg?tgg?gcc?ctg?ctt?ggt?gcc 499
Phe?Leu?Ser?Asp?Thr?Phe?Arg?Pro?Ile?Leu?Trp?Ala?Leu?Leu?Gly?Ala
120 125 130
tca?ctg?att?att?acc?ttg?ttg?gtt?ctt?gcg?gat?act?ttc?ggt?ttg?caa 547
Ser?Leu?Ile?Ile?Thr?Leu?Leu?Val?Leu?Ala?Asp?Thr?Phe?Gly?Leu?Gln
135 140 145
gac?ttc?cgc?gct?cca?atg?gat?gag?cag?cct?gat?act?tat?gta?ttc?ctg 595
Asp?Phe?Arg?Ala?Pro?Met?Asp?Glu?Gln?Pro?Asp?Thr?Tyr?Val?Phe?Leu
150 155 160 165
cac?tcc?atg?tgg?cgc?tcg?gtc?ttc?tac?ttc?ctg?cca?att?atg?gtt?ggt 643
His?Ser?Met?Trp?Arg?Ser?Val?Phe?Tyr?Phe?Leu?Pro?Ile?Met?Val?Gly
170 175 180
gcc?acc?gca?gct?cga?aag?ctc?ggc?gca?aac?gag?tgg?att?ggt?gca?gct 691
Ala?Thr?Ala?Ala?Arg?Lys?Leu?Gly?Ala?Asn?Glu?Trp?Ile?Gly?Ala?Ala
185 190 195
att?cca?gcc?gca?ctt?ctt?act?cca?gaa?ttc?ttg?gca?ctg?ggt?tct?gcc 739
Ile?Pro?Ala?Ala?Leu?Leu?Thr?Pro?Glu?Phe?Leu?Ala?Leu?Gly?Ser?Ala
200 205 210
ggc?gat?acc?gtc?aca?gtc?ttt?ggc?ctg?cca?atg?gtt?ctg?aat?gac?tac 787
Gly?Asp?Thr?Val?Thr?Val?Phe?Gly?Leu?Pro?Met?Val?Leu?Asn?Asp?Tyr
215 220 225
tcc?gga?cag?gta?ttc?cca?ccg?ctg?att?gca?gca?att?ggt?ctg?tac?tgg 835
Ser?Gly?Gln?Val?Phe?Pro?Pro?Leu?Ile?Ala?Ala?Ile?Gly?Leu?Tyr?Trp
230 235 240 245
gtg?gaa?aag?gga?ctg?aag?aag?atc?atc?cct?gaa?gca?gtc?caa?atg?gtg 883
Val?Glu?Lys?Gly?Leu?Lys?Lys?Ile?Ile?Pro?Glu?Ala?Val?Gln?Met?Val
250 255 260
ttc?gtc?cca?ttc?ttc?tcc?ctg?ctg?att?atg?atc?cca?gcg?acc?gca?ttc 931
Phe?Val?Pro?Phe?Phe?Ser?Leu?Leu?Ile?Met?Ile?Pro?Ala?Thr?Ala?Phe
265 270 275
ctg?ctt?gga?cct?ttc?ggc?atc?ggt?gtt?ggt?aac?gga?att?tcc?aac?ctg 979
Leu?Leu?Gly?Pro?Phe?Gly?Ile?Gly?Val?Gly?Asn?Gly?Ile?Ser?Asn?Leu
280 285 290
ctt?gaa?gcg?att?aac?aac?ttc?agc?cca?ttt?att?ctt?tcc?atc?gtt?atc 1027
Leu?Glu?Ala?Ile?Asn?Asn?Phe?Ser?Pro?Phe?Ile?Leu?Ser?Ile?Val?Ile
295 300 305
cca?ttg?ctc?tac?cca?ttc?ttg?gtt?cca?ctt?gga?ttg?cac?tgg?cca?cta 1075
Pro?Leu?Leu?Tyr?Pro?Phe?Leu?Val?Pro?Leu?Gly?Leu?His?Trp?Pro?Leu
310 315 320 325
aac?gcc?atc?atg?atc?cag?aac?atc?aac?acc?ctg?ggt?tac?gac?ttc?att 1123
Asn?Ala?Ile?Met?Ile?Gln?Asn?Ile?Asn?Thr?Leu?Gly?Tyr?Asp?Phe?Ile
330 335 340
cag?gga?cca?atg?ggt?gcc?tgg?aac?ttc?gcc?tgc?ttc?ggc?ctg?gtc?acc 1171
Gln?Gly?Pro?Met?Gly?Ala?Trp?Asn?Phe?Ala?Cys?Phe?Gly?Leu?Val?Thr
345 350 355
ggc?gtg?ttc?ttg?ctc?tcc?att?aag?gaa?cga?aac?aag?gcc?atg?cgt?cag 1219
Gly?Val?Phe?Leu?Leu?Ser?Ile?Lys?Glu?Arg?Asn?Lys?Ala?Met?Arg?Gln
360 365 370
gtt?tcc?ctg?ggt?ggc?atg?ttg?gct?ggt?ttg?ctc?ggc?ggc?att?tcc?gag 1267
Val?Ser?Leu?Gly?Gly?Met?Leu?Ala?Gly?Leu?Leu?Gly?Gly?Ile?Ser?Glu
375 380 385
cct?tcc?ctc?tac?ggt?gtt?ctg?ctc?cga?ttc?aag?aag?acc?tac?ttc?cgc 1315
Pro?Ser?Leu?Tyr?Gly?Val?Leu?Leu?Arg?Phe?Lys?Lys?Thr?Tyr?Phe?Arg
390 395 400 405
ctc?ctg?ccg?ggt?tgt?ttg?gca?ggc?ggt?atc?gtg?atg?ggc?atc?ttc?gac 1363
Leu?Leu?Pro?Gly?Cys?Leu?Ala?Gly?Gly?Ile?Val?Met?Gly?Ile?Phe?Asp
410 415 420
atc?aag?gcg?tac?gct?ttc?gtg?ttc?acc?tcc?ttg?ctt?acc?atc?cca?gca 1411
Ile?Lys?Ala?Tyr?Ala?Phe?Val?Phe?Thr?Ser?Leu?Leu?Thr?Ile?Pro?Ala
425 430 435
atg?gac?cca?tgg?ttg?ggc?tac?acc?att?ggt?atc?gca?gtt?gca?ttc?ttc 1459
Met?Asp?Pro?Trp?Leu?Gly?Tyr?Thr?Ile?Gly?Ile?Ala?Val?Ala?Phe?Phe
440 445 450
gtt?tcc?atg?ttc?ctt?gtt?ctc?gca?ctg?gac?tac?cgt?tcc?aac?gaa?gag 1507
Val?Ser?Met?Phe?Leu?Val?Leu?Ala?Leu?Asp?Tyr?Arg?Ser?Asn?Glu?Glu
455 460 465
cgc?gat?gag?gca?cgt?gca?aag?gtt?gct?gct?gac?aag?cag?gca?gaa?gaa 1555
Arg?Asp?Glu?Ala?Arg?Ala?Lys?Val?Ala?Ala?Asp?Lys?Gln?Ala?Glu?Glu
470 475 480 485
gat?ctg?aag?gca?gaa?gct?aat?gca?act?cct?gca?gct?cca?gta?gct?gct 1603
Asp?Leu?Lys?Ala?Glu?Ala?Asn?Ala?Thr?Pro?Ala?Ala?Pro?Val?Ala?Ala
490 495 500
gca?ggt?gcg?gga?gcc?ggt?gca?ggt?gca?gga?gcc?gct?gct?ggc?gct?gca 1651
Ala?Gly?Ala?Gly?Ala?Gly?Ala?Gly?Ala?Gly?Ala?Ala?Ala?Gly?Ala?Ala
505 510 515
acc?gcc?gtg?gca?gct?aag?ccg?aag?ctg?gcc?gct?ggg?gaa?gta?gtg?gac 1699
Thr?Ala?Val?Ala?Ala?Lys?Pro?Lys?Leu?Ala?Ala?Gly?Glu?Val?Val?Asp
520 525 530
att?gtt?tcc?cca?ctc?gaa?ggc?aag?gca?att?cca?ctt?tct?gaa?gta?cct 1747
Ile?Val?Ser?Pro?Leu?Glu?Gly?Lys?Ala?Ile?Pro?Leu?Ser?Glu?Val?Pro
535 540 545
gac?cca?atc?ttt?gca?gca?ggc?aag?ctt?gga?cca?ggc?att?gca?atc?caa 1795
Asp?Pro?Ile?Phe?Ala?Ala?Gly?Lys?Leu?Gly?Pro?Gly?Ile?Ala?Ile?Gln
550 555 560 565
cca?act?gga?aac?acc?gtt?gtt?gct?cca?gca?gac?gct?act?gtc?atc?ctt 1843
Pro?Thr?Gly?Asn?Thr?Val?Val?Ala?Pro?Ala?Asp?Ala?Thr?Val?Ile?Leu
570 575 580
gtc?cag?aaa?tct?gga?cac?gca?gtg?gca?ttg?cgc?tta?gat?agc?gga?gtt 1891
Val?Gln?Lys?Ser?Gly?His?Ala?Val?Ala?Leu?Arg?Leu?Asp?Ser?Gly?Val
585 590 595
gaa?atc?ctt?gtc?cac?gtt?gga?ttg?gac?acc?gtg?caa?ttg?ggc?ggc?gaa 1939
Glu?Ile?Leu?Val?His?Val?Gly?Leu?Asp?Thr?Val?Gln?Leu?Gly?Gly?Glu
600 605 610
ggc?ttc?acc?gtt?cac?gtt?gag?cgc?agg?cag?caa?gtc?aag?gcg?ggg?gat 1987
Gly?Phe?Thr?Val?His?Val?Glu?Arg?Arg?Gln?Gln?Val?Lys?Ala?Gly?Asp
615 620 625
cca?ctg?atc?act?ttt?gac?gct?gac?ttc?att?cga?tcc?aag?gat?cta?cct 2035
Pro?Leu?Ile?Thr?Phe?Asp?Ala?Asp?Phe?Ile?Arg?Ser?Lys?Asp?Leu?Pro
630 635 640 645
ttg?atc?acc?cca?gtt?gtg?gtg?tct?aac?gcc?gcg?aaa?ttc?ggt?gaa?att 2083
Leu?Ile?Thr?Pro?Val?Val?Val?Ser?Asn?Ala?Ala?Lys?Phe?Gly?Glu?Ile
650 655 660
gaa?ggt?att?cct?gca?gat?cag?gca?aat?tct?tcc?acg?act?gtg?atc?aag 2131
Glu?Gly?Ile?Pro?Ala?Asp?Gln?Ala?Asn?Ser?Ser?Thr?Thr?Val?Ile?Lys
665 670 675
gtc?aac?ggc?aag?aac?gag?taacctggga?tccatgttgc?gca 2172
Val?Asn?Gly?Lys?Asn?Glu
680
<210>30
<211>683
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>30
Met?Ala?Ser?Lys?Leu?Thr?Thr?Thr?Ser?Gln?His?Ile?Leu?Glu?Asn?Leu
1 5 10 15
Gly?Gly?Pro?Asp?Asn?Ile?Thr?Ser?Met?Thr?His?Cys?Ala?Thr?Arg?Leu
20 25 30
Arg?Phe?Gln?Val?Lys?Asp?Gln?Ser?Ile?Val?Asp?Gln?Gln?Glu?Ile?Asp
35 40 45
Ser?Asp?Pro?Ser?Val?Leu?Gly?Val?Val?Pro?Gln?Gly?Ser?Thr?Gly?Met
50 55 60
Gln?Val?Val?Met?Gly?Gly?Ser?Val?Ala?Asn?Tyr?Tyr?Gln?Glu?Ile?Leu
65 70 75 80
Lys?Leu?Asp?Gly?Met?Lys?His?Phe?Ala?Asp?Gly?Glu?Ala?Thr?Glu?Ser
85 90 95
Ser?Ser?Lys?Lys?Glu?Tyr?Gly?Gly?Val?Arg?Gly?Lys?Tyr?Ser?Trp?Ile
100 105 110
Asp?Tyr?Ala?Phe?Glu?Phe?Leu?Ser?Asp?Thr?Phe?Arg?Pro?Ile?Leu?Trp
115 120 125
Ala?Leu?Leu?Gly?Ala?Ser?Leu?Ile?Ile?Thr?Leu?Leu?Val?Leu?Ala?Asp
130 135 140
Thr?Phe?Gly?Leu?Gln?Asp?Phe?Arg?Ala?Pro?Met?Asp?Glu?Gln?Pro?Asp
145 150 155 160
Thr?Tyr?Val?Phe?Leu?His?Ser?Met?Trp?Arg?Ser?Val?Phe?Tyr?Phe?Leu
165 170 175
Pro?Ile?Met?Val?Gly?Ala?Thr?Ala?Ala?Arg?Lys?Leu?Gly?Ala?Asn?Glu
180 185 190
Trp?Ile?Gly?Ala?Ala?Ile?Pro?Ala?Ala?Leu?Leu?Thr?Pro?Glu?Phe?Leu
195 200 205
Ala?Leu?Gly?Ser?Ala?Gly?Asp?Thr?Val?Thr?Val?Phe?Gly?Leu?Pro?Met
210 215 220
Val?Leu?Asn?Asp?Tyr?Ser?Gly?Gln?Val?Phe?Pro?Pro?Leu?Ile?Ala?Ala
225 230 235 240
Ile?Gly?Leu?Tyr?Trp?Val?Glu?Lys?Gly?Leu?Lys?Lys?Ile?Ile?Pro?Glu
245 250 255
Ala?Val?Gln?Met?Val?Phe?Val?Pro?Phe?Phe?Ser?Leu?Leu?Ile?Met?Ile
260 265 270
Pro?Ala?Thr?Ala?Phe?Leu?Leu?Gly?Pro?Phe?Gly?Ile?Gly?Val?Gly?Asn
275 280 285
Gly?Ile?Ser?Asn?Leu?Leu?Glu?Ala?Ile?Asn?Asn?Phe?Ser?Pro?Phe?Ile
290 295 300
Leu?Ser?Ile?Val?Ile?Pro?Leu?Leu?Tyr?Pro?Phe?Leu?Val?Pro?Leu?Gly
305 310 315 320
Leu?His?Trp?Pro?Leu?Asn?Ala?Ile?Met?Ile?Gln?Asn?Ile?Asn?Thr?Leu
325 330 335
Gly?Tyr?Asp?Phe?Ile?Gln?Gly?Pro?Met?Gly?Ala?Trp?Asn?Phe?Ala?Cys
340 345 350
Phe?Gly?Leu?Val?Thr?Gly?Val?Phe?Leu?Leu?Ser?Ile?Lys?Glu?Arg?Asn
355 360 365
Lys?Ala?Met?Arg?Gln?Val?Ser?Leu?Gly?Gly?Met?Leu?Ala?Gly?Leu?Leu
370 375 380
Gly?Gly?Ile?Ser?Glu?Pro?Ser?Leu?Tyr?Gly?Val?Leu?Leu?Arg?Phe?Lys
385 390 395 400
Lys?Thr?Tyr?Phe?Arg?Leu?Leu?Pro?Gly?Cys?Leu?Ala?Gly?Gly?Ile?Val
405 410 415
Met?Gly?Ile?Phe?Asp?Ile?Lys?Ala?Tyr?Ala?Phe?Val?Phe?Thr?Ser?Leu
420 425 430
Leu?Thr?Ile?Pro?Ala?Met?Asp?Pro?Trp?Leu?Gly?Tyr?Thr?Ile?Gly?Ile
435 440 445
Ala?Val?Ala?Phe?Phe?Val?Ser?Met?Phe?Leu?Val?Leu?Ala?Leu?Asp?Tyr
450 455 460
Arg?Ser?Asn?Glu?Glu?Arg?Asp?Glu?Ala?Arg?Ala?Lys?Val?Ala?Ala?Asp
465 470 475 480
Lys?Gln?Ala?Glu?Glu?Asp?Leu?Lys?Ala?Glu?Ala?Asn?Ala?Thr?Pro?Ala
485 490 495
Ala?Pro?Val?Ala?Ala?Ala?Gly?Ala?Gly?Ala?Gly?Ala?Gly?Ala?Gly?Ala
500 505 510
Ala?Ala?Gly?Ala?Ala?Thr?Ala?Val?Ala?Ala?Lys?Pro?Lys?Leu?Ala?Ala
515 520 525
Gly?Glu?Val?Val?Asp?Ile?Val?Ser?Pro?Leu?Glu?Gly?Lys?Ala?Ile?Pro
530 535 540
Leu?Ser?Glu?Val?Pro?Asp?Pro?Ile?Phe?Ala?Ala?Gly?Lys?Leu?Gly?Pro
545 550 555 560
Gly?Ile?Ala?Ile?Gln?Pro?Thr?Gly?Asn?Thr?Val?Val?Ala?Pro?Ala?Asp
565 570 575
Ala?Thr?Val?Ile?Leu?Val?Gln?Lys?Ser?Gly?His?Ala?Val?Ala?Leu?Arg
580 585 590
Leu?Asp?Ser?Gly?Val?Glu?Ile?Leu?Val?His?Val?Gly?Leu?Asp?Thr?Val
595 600 605
Gln?Leu?Gly?Gly?Glu?Gly?Phe?Thr?Val?His?Val?Glu?Arg?Arg?Gln?Gln
610 615 620
Val?Lys?Ala?Gly?Asp?Pro?Leu?Ile?Thr?Phe?Asp?Ala?Asp?Phe?Ile?Arg
625 630 635 640
Ser?Lys?Asp?Leu?Pro?Leu?Ile?Thr?Pro?Val?Val?Val?Ser?Asn?Ala?Ala
645 650 655
Lys?Phe?Gly?Glu?Ile?Glu?Gly?Ile?Pro?Ala?Asp?Gln?Ala?Asn?Ser?Ser
660 665 670
Thr?Thr?Val?Ile?Lys?Val?Asn?Gly?Lys?Asn?Glu
675 680
<210>31
<211>1339
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(1339)
<223>FRXA02191
<400>31
ccgattcttt?ttcggcccaa?ttcgtaacgg?cgatcctctt?aagtggacaa?gaaagtctct?60
tgcccgcggg?agacagaccc?tacgtttaga?aaggtttgac?atg?gcg?tcc?aaa?ctg 115
Met?Ala?Ser?Lys?Leu
1 5
acg?acg?aca?tcg?caa?cat?att?ctg?gaa?aac?ctt?ggt?gga?cca?gac?aat 163
Thr?Thr?Thr?Ser?Gln?His?Ile?Leu?Glu?Asn?Leu?Gly?Gly?Pro?Asp?Asn
10 15 20
att?act?tcg?atg?act?cac?tgt?gcg?act?cgc?ctt?cgc?ttc?caa?gtg?aag 211
Ile?Thr?Ser?Met?Thr?His?Cys?Ala?Thr?Arg?Leu?Arg?Phe?Gln?Val?Lys
25 30 35
gat?caa?tcc?att?gtt?gat?caa?caa?gaa?att?gac?tcc?gac?cca?tca?gtt 259
Asp?Gln?Ser?Ile?Val?Asp?Gln?Gln?Glu?Ile?Asp?Ser?Asp?Pro?Ser?Val
40 45 50
ctt?ggc?gta?gta?ccc?caa?gga?tcc?acc?ggt?atg?cag?gtg?gtg?atg?ggt 307
Leu?Gly?Val?Val?Pro?Gln?Gly?Ser?Thr?Gly?Met?Gln?Val?Val?Met?Gly
55 60 65
gga?tct?gtt?gca?aac?tat?tac?caa?gaa?atc?ctc?aaa?ctt?gat?gga?atg 355
Gly?Ser?Val?Ala?Asn?Tyr?Tyr?Gln?Glu?Ile?Leu?Lys?Leu?Asp?Gly?Met
70 75 80 85
aag?cac?ttc?gcc?gac?ggt?gaa?gct?aca?gag?agt?tca?tcc?aag?aag?gaa 403
Lys?His?Phe?Ala?Asp?Gly?Glu?Ala?Thr?Glu?Ser?Ser?Ser?Lys?Lys?Glu
90 95 100
tac?ggc?gga?gtc?cgt?ggc?aag?tac?tcg?tgg?att?gac?tac?gcc?ttc?gag 451
Tyr?Gly?Gly?Val?Arg?Gly?Lys?Tyr?Ser?Trp?Ile?Asp?Tyr?Ala?Phe?Glu
105 110 115
ttc?ttg?tct?gat?act?ttc?cga?cca?atc?ctg?tgg?gcc?ctg?ctt?ggt?gcc 499
Phe?Leu?Ser?Asp?Thr?Phe?Arg?Pro?Ile?Leu?Trp?Ala?Leu?Leu?Gly?Ala
120 125 130
tca?ctg?att?att?acc?ttg?ttg?gtt?ctt?gcg?gat?act?ttc?ggt?ttg?caa 547
Ser?Leu?Ile?Ile?Thr?Leu?Leu?Val?Leu?Ala?Asp?Thr?Phe?Gly?Leu?Gln
135 140 145
gac?ttc?cgc?gct?cca?atg?gat?gag?cag?cct?gat?act?tat?gta?ttc?ctg 595
Asp?Phe?Arg?Ala?Pro?Met?Asp?Glu?Gln?Pro?Asp?Thr?Tyr?Val?Phe?Leu
150 155 160 165
cac?tcc?atg?tgg?cgc?tcg?gtc?ttc?tac?ttc?ctg?cca?att?atg?gtt?ggt 643
His?Ser?Met?Trp?Arg?Ser?Val?Phe?Tyr?Phe?Leu?Pro?Ile?Met?Val?Gly
170 175 180
gcc?acc?gca?gct?cga?aag?ctc?ggc?gca?aac?gag?tgg?att?ggt?gca?gct 691
Ala?Thr?Ala?Ala?Arg?Lys?Leu?Gly?Ala?Asn?Glu?Trp?Ile?Gly?Ala?Ala
185 190 195
att?cca?gcc?gca?ctt?ctt?act?cca?gaa?ttc?ttg?gca?ctg?ggt?tct?gcc 739
Ile?Pro?Ala?Ala?Leu?Leu?Thr?Pro?Glu?Phe?Leu?Ala?Leu?Gly?Ser?Ala
200 205 210
ggc?gat?acc?gtc?aca?gtc?ttt?ggc?ctg?cca?atg?gtt?ctg?aat?gac?tac 787
Gly?Asp?Thr?Val?Thr?Val?Phe?Gly?Leu?Pro?Met?Val?Leu?Asn?Asp?Tyr
215 220 225
tcc?gga?cag?gta?ttc?cca?ccg?ctg?att?gca?gca?att?ggt?ctg?tac?tgg 835
Ser?Gly?Gln?Val?Phe?Pro?Pro?Leu?Ile?Ala?Ala?Ile?Gly?Leu?Tyr?Trp
230 235 240 245
gtg?gaa?aag?gga?ctg?aag?aag?atc?atc?cct?gaa?gca?gtc?caa?atg?gtg 883
Val?Glu?Lys?Gly?Leu?Lys?Lys?Ile?Ile?Pro?Glu?Ala?Val?Gln?Met?Val
250 255 260
ttc?gtc?cca?ttc?ttc?tcc?ctg?ctg?att?atg?atc?cca?gcg?acc?gca?ttc 931
Phe?Val?Pro?Phe?Phe?Ser?Leu?Leu?Ile?Met?Ile?Pro?Ala?Thr?Ala?Phe
265 270 275
ctg?ctt?gga?cct?ttc?ggc?atc?ggt?gtt?ggt?aac?gga?att?tcc?aac?ctg 979
Leu?Leu?Gly?Pro?Phe?Gly?Ile?Gly?Val?Gly?Asn?Gly?Ile?Ser?Asn?Leu
280 285 290
ctt?gaa?gcg?att?aac?aac?ttc?agc?cca?ttt?att?ctt?tcc?atc?gtt?atc 1027
Leu?Glu?Ala?Ile?Asn?Asn?Phe?Ser?Pro?Phe?Ile?Leu?Ser?Ile?Val?Ile
295 300 305
cca?ttg?ctc?tac?cca?ttc?ttg?gtt?cca?ctt?gga?ttg?cac?tgg?cca?cta 1075
Pro?Leu?Leu?Tyr?Pro?Phe?Leu?Val?Pro?Leu?Gly?Leu?His?Trp?Pro?Leu
310 315 320 325
aac?gcc?atc?atg?atc?cag?aac?atc?aac?acc?ctg?ggt?tac?gac?ttc?att 1123
Asn?Ala?Ile?Met?Ile?Gln?Asn?Ile?Asn?Thr?Leu?Gly?Tyr?Asp?Phe?Ile
330 335 340
cag?gga?cca?atg?ggt?gcc?tgg?aac?ttc?gcc?tgc?ttc?ggc?ctg?gtc?acc 1171
Gln?Gly?Pro?Met?Gly?Ala?Trp?Asn?Phe?Ala?Cys?Phe?Gly?Leu?Val?Thr
345 350 355
ggc?gtg?ttc?ttg?ctc?tcc?att?aag?gaa?cga?aac?aag?gcc?atg?cgt?cag 1219
Gly?Val?Phe?Leu?Leu?Ser?Ile?Lys?Glu?Arg?Asn?Lys?Ala?Met?Arg?Gln
360 365 370
gtt?tcc?ctg?ggt?ggc?atg?ttg?gct?ggt?ttg?ctc?ggc?ggc?att?tcc?gag 1267
Val?Ser?Leu?Gly?Gly?Met?Leu?Ala?Gly?Leu?Leu?Gly?Gly?Ile?Ser?Glu
375 380 385
cct?tcc?ctc?tac?ggt?gtt?ctg?ctc?cga?ttc?aag?aag?acc?tac?ttc?cgc 1315
Pro?Ser?Leu?Tyr?Gly?Val?Leu?Leu?Arg?Phe?Lys?Lys?Thr?Tyr?Phe?Arg
390 395 400 405
ctc?ctg?ccg?ggt?tgt?ttg?gca?gca 1339
Leu?Leu?Pro?Gly?Cys?Leu?Ala?Ala
410
<210>32
<211>413
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>32
Met?Ala?Ser?Lys?Leu?Thr?Thr?Thr?Ser?Gln?His?Ile?Leu?Glu?Asn?Leu
1 5 10 15
Gly?Gly?Pro?Asp?Asn?Ile?Thr?Ser?Met?Thr?His?Cys?Ala?Thr?Arg?Leu
20 25 30
Arg?Phe?Gln?Val?Lys?Asp?Gln?Ser?Ile?Val?Asp?Gln?Gln?Glu?Ile?Asp
35 40 45
Ser?Asp?Pro?Ser?Val?Leu?Gly?Val?Val?Pro?Gln?Gly?Ser?Thr?Gly?Met
50 55 60
Gln?Val?Val?Met?Gly?Gly?Ser?Val?Ala?Asn?Tyr?Tyr?Gln?Glu?Ile?Leu
65 70 75 80
Lys?Leu?Asp?Gly?Met?Lys?His?Phe?Ala?Asp?Gly?Glu?Ala?Thr?Glu?Ser
85 90 95
Ser?Ser?Lys?Lys?Glu?Tyr?Gly?Gly?Val?Arg?Gly?Lys?Tyr?Ser?Trp?Ile
100 105 110
Asp?Tyr?Ala?Phe?Glu?Phe?Leu?Ser?Asp?Thr?Phe?Arg?Pro?Ile?Leu?Trp
115 120 125
Ala?Leu?Leu?Gly?Ala?Ser?Leu?Ile?Ile?Thr?Leu?Leu?Val?Leu?Ala?Asp
130 135 140
Thr?Phe?Gly?Leu?Gln?Asp?Phe?Arg?Ala?Pro?Met?Asp?Glu?Gln?Pro?Asp
145 150 155 160
Thr?Tyr?Val?Phe?Leu?His?Ser?Met?Trp?Arg?Ser?Val?Phe?Tyr?Phe?Leu
165 170 175
Pro?Ile?Met?Val?Gly?Ala?Thr?Ala?Ala?Arg?Lys?Leu?Gly?Ala?Asn?Glu
180 185 190
Trp?Ile?Gly?Ala?Ala?Ile?Pro?Ala?Ala?Leu?Leu?Thr?Pro?Glu?Phe?Leu
195 200 205
Ala?Leu?Gly?Ser?Ala?Gly?Asp?Thr?Val?Thr?Val?Phe?Gly?Leu?Pro?Met
210 215 220
Val?Leu?Asn?Asp?Tyr?Ser?Gly?Gln?Val?Phe?Pro?Pro?Leu?Ile?Ala?Ala
225 230 235 240
Ile?Gly?Leu?Tyr?Trp?Val?Glu?Lys?Gly?Leu?Lys?Lys?Ile?Ile?Pro?Glu
245 250 255
Ala?Val?Gln?Met?Val?Phe?Val?Pro?Phe?Phe?Ser?Leu?Leu?Ile?Met?Ile
260 265 270
Pro?Ala?Thr?Ala?Phe?Leu?Leu?Gly?Pro?Phe?Gly?Ile?Gly?Val?Gly?Asn
275 280 285
Gly?Ile?Ser?Asn?Leu?Leu?Glu?Ala?Ile?Asn?Asn?Phe?Ser?Pro?Phe?Ile
290 295 300
Leu?Ser Ile?Val?Ile?Pro?Leu?Leu?Tyr?Pro?Phe?Leu?Val?Pro?Leu?Gly
305 310 315 320
Leu?His?Trp?Pro?Leu?Asn?Ala?Ile?Met?Ile?Gln?Asn?Ile?Asn?Thr?Leu
325 330 335
Gly?Tyr?Asp?Phe?Ile?Gln?Gly?Pro?Met?Gly?Ala?Trp?Asn?Phe?Ala?Cys
340 345 350
Phe?Gly?Leu?Val?Thr?Gly?Val?Phe?Leu?Leu?Ser?Ile?Lys?Glu?Arg?Asn
355 360 355
Lys?Ala?Met?Arg?Gln?Val?Ser?Leu?Gly?Gly?Met?Leu?Ala?Gly?Leu?Leu
370 375 380
Gly?Gly?Ile?Ser?Glu?Pro?Ser?Leu?Tyr?Gly?Val?Leu?Leu?Arg?Phe?Lys
385 390 395 400
Lys?Thr?Tyr?Phe?Arg?Leu?Leu?Pro?Gly?Cys?Leu?Ala?Ala
405 410
<210>33
<211>428
<212>DNA
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(1)..(405)
<223>FRXA01943
<400>33
cct?gac?cca?atc?ttt?gca?gca?ggc?aag?ctt?gga?cca?ggc?att?gca?atc 48
Pro?Asp?Pro?Ile?Phe?Ala?Ala?Gly?Lys?Leu?Gly?Pro?Gly?Ile?Ala?Ile
1 5 10 15
caa?cca?act?gga?aac?acc?gtt?gtt?gct?cca?gca?gac?gct?act?gtc?atc 96
Gln?Pro?Thr?Gly?Asn?Thr?Val?Val?Ala?Pro?Ala?Asp?Ala?Thr?Val?Ile
20 25 30
ctt?gtc?cag?aaa?tct?gga?cac?gca?gtg?gca?ttg?cgc?tta?gat?age?gga 144
Leu?Val?Gln?Lys?Ser?Gly?His?Ala?Val?Ala?Leu?Arg?Leu?Asp?Ser?Gly
35 40 45
gtt?gaa?atc?ctt?gtc?cac?gtt?gga?ttg?gac?acc?gtg?caa?ttg?ggc?ggc 192
Val?Glu?Ile?Leu?Val?His?Val?Gly?Leu?Asp?Thr?Val?Gln?Leu?Gly?Gly
50 55 60
gaa?ggc?ttc?acc?gtt?cac?gtt?gag?cgc?agg?cag?caa?gtc?aag?gcg?ggg 240
Glu?Gly?Phe?Thr?Val?His?ValGlu?Arg?Arg?Gln?Gln?Val?Lys?Ala?Gly
65 70 75 80
gat?cca?ctg?atc?act?ttt?gac?gct?gac?ttc?att?cga?tcc?aag?gat?eta 288
Asp?Pro?Leu?Ile?Thr?Phe?Asp?Ala?Asp?Phe?Ile?Arg?Ser?Lys?Asp?Leu
85 90 95
cct?ttg?atc?acc?cca?gtt?gtg?gtg?tct?aac?gcc?gcg?aaa?ttc?ggt?gaa 336
Pro?Leu?Ile?Thr?Pro?Val?Val?Val?Ser?Asn?Ala?Ala?Lys?Phe?Gly?Glu
100 105 110
att?gaa?ggt?att?cct?gca?gat?cag?gca?aat?tct?tcc?acg?act?gtg?atc 384
Ile?Glu?Gly?Ile?Pro?Ala?Asp?Gln?Ala?Asn?Ser?Ser?Thr?Thr?Val?IIe
115 120 125
aag?gtc?aac?ggc?aag?aac?gag?taacctggga?tccatgttgc?gca 428
Lys?Val?Asn?Gly?Lys?Asn?Glu
130 135
<210>34
<211>135
<212>PRT
<213〉Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>34
Pro?Asp?Pro?Ile?Phe?Ala?Ala?Gly?Lys?Leu?Gly?Pro?Gly?Ile?Ala?Ile
1 5 10 15
Gln?Pro?Thr?Gly?Asn?Thr?Val?Val?Ala?Pro?Ala?Asp?Ala?Thr?Val?Ile
20 25 30
Leu?Val?Gln?Lys?Ser?Gly?His?Ala?Val?Ala?Leu?Arg?Leu?Asp?Ser?Gly
35 40 45
Val?Glu?Ile?Leu?Val?His?Val?Gly?Leu?Asp?Thr?Val?Gln?Leu?Gly?Gly
50 55 60
Glu?Gly?Phe?Thr?Val?His?Val?Glu?Arg?Arg?Gln?Gln?Val?Lys?Ala?Gly
65 70 75 80
Asp?Pro?Leu?Ile?Thr?Phe?Asp?Ala?Asp?Phe?Ile?Arg?Ser?Lys?Asp?Leu
85 90 95
Pro?Leu?Ile?Thr?Pro?Val?Val?Val?Set?Asn?Ala?Ala?Lys?Phe?Gly?Glu
100 105 110
Ile?Glu?Gly?Ile?Pro?Ala?Asp?Gln?Ala?Asn?Ser?Ser?Thr?Thr?Val?Ile
115 120 125
Lys?Val?Asn?Gly?Lys?Asn?Glu
130 135
<210>35
<211>18
<212>DNA
<213〉artificial sequence
<220>
<223〉artificial sequence note: primer
<400>35
ggaaacagta?tgaccatg 18
<210>36
<211>17
<212>DNA
<213〉artificial sequence
<220>
<223〉artificial sequence note: primer
<400>36
gtaaaacgac?ggccagt 17
Claims (35)
1. the isolated nucleic acid molecule that comprises the nucleotide sequence of SEQ ID NO:17, or its complementary sequence.
2. coding comprises the isolated nucleic acid molecule of polypeptide of the aminoacid sequence of SEQ ID NO:18, or its complementary sequence.
3. coding comprises the natural isolated nucleic acid molecule that has allele variant of polypeptide of the aminoacid sequence of SEQ ID NO:18, or its complementary sequence.
4. isolated nucleic acid molecule comprises the nucleotide sequence of showing at least 50% identity with the complete nucleotides sequence of SEQ ID NO:17, or its complementary sequence.
5. isolated nucleic acid molecule, it comprises the fragment of at least 15 continuous nucleotides of the nucleotide sequence of SEQ ID NO:17, or its complementary sequence.
6. isolated nucleic acid molecule, its coding comprises the polypeptide that the aminoacid sequence of at least 50% identity is arranged with the complete amino acid sequence of SEQ ID NO:18, or its complementary sequence.
7. isolated nucleic acid molecule comprises each nucleic acid molecule and the nucleotide sequence of coding heterologous polypeptide among the claim 1-6.
8. the carrier that comprises each nucleic acid molecule among the claim 1-7.
9. the carrier of claim 8, this carrier is an expression vector.
10. the host cell of the expression vector transfection of claim 9.
11. the host cell of claim 10, wherein this cell is a microorganism.
12. the host cell of claim 11, wherein this cell belongs to Corynebacterium or brevibacterium sp.
13. the host cell of claim 10, the wherein expression of said nucleic acid molecule causes the adjusting of this cell fine chemistry material production.
14. the host cell of claim 14, wherein said fine chemistry material is selected from following material: organic acid, protein source amino acid, nonprotein source amino acid, purine bases and pyrimidine bases, nucleosides, Nucleotide, lipid, saturated and unsaturated fatty acids, glycol, carbohydrate, aromatics, VITAMIN, cofactor, polyketide and enzyme.
15. produce the method for polypeptide, be included in the host cell of cultivating claim 10 in the suitable medium, thereby produce polypeptide.
16. isolated polypeptide comprises the aminoacid sequence of SEQ ID NO:18.
17. isolated polypeptide comprises the natural allele variant that exists of the polypeptide of the aminoacid sequence that contains SEQ ID NO:18.
18. isolated polypeptide, by a kind of nucleic acid molecule encoding, this nucleic acid molecule comprises the nucleotide sequence of showing at least 50% identity with the complete nucleotides sequence of SEQ ID NO:17.
19. isolated polypeptide comprises the aminoacid sequence that at least 50% identity is arranged with the complete amino acid sequence of SEQ ID NO:18.
20. isolated polypeptide comprises the fragment of the polypeptide of the aminoacid sequence that contains SEQ ID NO:18, wherein said polypeptide fragment keeps containing the biologic activity of polypeptide of the aminoacid sequence of SEQ ID NO:18.
21. isolated polypeptide.Comprise aminoacid sequence by the nucleic acid molecule encoding of the nucleotide sequence that comprises SEQ ID NO:17.
22. each isolated polypeptide among the claim 16-21 further comprises the allogeneic amino acid sequence.
23. produce the method for fine chemistry material, comprise the cell of cultivating claim 10, thereby produce the fine chemistry material.
24. the method for claim 23, wherein said method comprise the step that reclaims the fine chemistry material from said culture in addition.
25. the method for claim 23, wherein said cell belongs to Corynebacterium or brevibacterium sp.
26. the method for claim 23, wherein said cell is selected from down group: Corynebacterium glutamicum, man of great strength's rod bacillus, lily hedysarum scoparium bacillus, Corynebacterium acctoacidophlum, vinegar paddy rod bacillus, have a liking for acetyl rod bacillus, produce ammonia rod bacillus, Corynebacterium fujiokense, Corynebacteriumnitrilophilus, Brevibacterium ammoniagenes, Brevibacterium butanicum, the difference tyrothricin, brevibacterium flavum, the Xi Shi tyrothricin, the ketoisocaproic tyrothricin, Brevibacteriumketosoreductum, brevibacterium, extension brevibacterium, separate the listed bacterial strain of paraffin tyrothricin and table 3.
27. the method for claim 23, the wherein expression of the nucleic acid molecule of said carrier causes the adjusting of this cell fine chemistry material production.
28. the method for claim 23, wherein said fine chemistry material is selected from following material: organic acid, protein source amino acid, nonprotein source amino acid, purine bases and pyrimidine bases, nucleosides, Nucleotide, lipid, saturated and unsaturated fatty acids, glycol, carbohydrate, aromatics, VITAMIN, cofactor, polyketide and enzyme.
29. the method for claim 23, wherein said fine chemistry material is an amino acid.
30. the method for claim 29, wherein said amino acid is selected from following amino acid: Methionin, L-glutamic acid, glutamine, L-Ala, aspartic acid, glycine, Serine, Threonine, methionine(Met), halfcystine, Xie Ansuan, leucine, Isoleucine, arginine, proline(Pro), Histidine, tyrosine, phenylalanine, tryptophane.
31. produce the method for fine chemistry material, comprise and cultivate such cell that the genomic dna of this cell has been inserted among the claim 1-6 each nucleic acid molecule and has changed.
32. the existence or the active method of corynebacterium diphtheriae among the diagnosis experimenter, comprise the existence of the peptide molecule of at least a nucleic acid molecule that detects claim 1-6 among the experimenter or claim 16-21, thus the existence or the activity of corynebacterium diphtheriae among the diagnosis experimenter.
33. contain the host cell of the nucleic acid molecule of SEQ ID NO:17, wherein said nucleic acid molecule is destroyed.
34. contain the host cell of the nucleic acid molecule of SEQ ID NO:17, nucleic acid molecule wherein contains one or more to be modified the nucleic acid of listing sequence at SEQ ID NO:17.
35. contain the host cell of the nucleic acid molecule of SEQ ID NO:17, wherein this nucleic acid molecule regulation domain is modified with respect to this molecule wild-type regulation domain.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14269199P | 1999-07-01 | 1999-07-01 | |
US60/142691 | 1999-07-01 | ||
US60/150310 | 1999-08-23 | ||
DE19942097.1 | 1999-09-03 | ||
DE19942095.5 | 1999-09-03 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN00812165A Division CN1371420A (en) | 1999-07-01 | 2000-06-27 | Orynebacterium glutamicum genes encoding phosphoenolpyruvate sugar phosphotransferase system proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101130778A true CN101130778A (en) | 2008-02-27 |
Family
ID=34078497
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007100920723A Pending CN101054592A (en) | 1999-07-01 | 2000-06-27 | Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system |
CNA2007100920742A Pending CN101054593A (en) | 1999-07-01 | 2000-06-27 | Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system |
CNA2007100920738A Pending CN101130778A (en) | 1999-07-01 | 2000-06-27 | Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007100920723A Pending CN101054592A (en) | 1999-07-01 | 2000-06-27 | Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system |
CNA2007100920742A Pending CN101054593A (en) | 1999-07-01 | 2000-06-27 | Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system |
Country Status (2)
Country | Link |
---|---|
CN (3) | CN101054592A (en) |
ZA (1) | ZA200200816B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109517771A (en) * | 2017-09-18 | 2019-03-26 | 赢创德固赛有限公司 | The method of fermentation producing L-amino-acid |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113015807A (en) * | 2018-08-31 | 2021-06-22 | 新加坡科技研究局 | Method for producing terpenoid |
CN109652490B (en) * | 2019-02-25 | 2019-09-03 | 内蒙古拜克生物有限公司 | A kind of fermentation of L-Leu and isolation and purification method |
CN113249286B (en) * | 2021-05-25 | 2023-12-08 | 洛阳华荣生物技术有限公司 | Method for constructing L-sarcosine producing strain |
CN115746110A (en) * | 2021-09-02 | 2023-03-07 | 中国科学院天津工业生物技术研究所 | Mutant of transcriptional regulatory factor LysG and application thereof |
-
2000
- 2000-06-27 CN CNA2007100920723A patent/CN101054592A/en active Pending
- 2000-06-27 CN CNA2007100920742A patent/CN101054593A/en active Pending
- 2000-06-27 CN CNA2007100920738A patent/CN101130778A/en active Pending
-
2002
- 2002-01-30 ZA ZA200200816A patent/ZA200200816B/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109517771A (en) * | 2017-09-18 | 2019-03-26 | 赢创德固赛有限公司 | The method of fermentation producing L-amino-acid |
Also Published As
Publication number | Publication date |
---|---|
CN101054593A (en) | 2007-10-17 |
ZA200200816B (en) | 2004-10-27 |
CN101054592A (en) | 2007-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU783703B2 (en) | Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins | |
US20070015252A1 (en) | Corynebacterium glutamicum genes encoding regulatory proteins | |
EP2292763A1 (en) | Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production | |
US7410766B2 (en) | Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins | |
CN1962870A (en) | Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport | |
AU2001223903B2 (en) | Corynebacterium glutamicum genes encoding metabolic pathway proteins | |
MXPA01012845A (en) | Corynebacterium glutamicum. | |
US20070077576A1 (en) | Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins | |
EP2302058A1 (en) | Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation | |
AU783697B2 (en) | Orynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins | |
US20060269975A1 (en) | Corynebacterium glutamicum genes encoding proteins involved in DNA replication, protein synthesis, and pathogenesis | |
US20070111232A1 (en) | Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation | |
CN101130778A (en) | Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system | |
CA2585907A1 (en) | Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation | |
AU2007202317A1 (en) | Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins | |
AU783707B2 (en) | Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport | |
CA2590403A1 (en) | Corynebacterium glutamicum genes encoding phosphoenolpyruvate:sugar phospho-transferase system proteins | |
EP1702980A1 (en) | Corynebacterium glutamicum gene encoding Hpr of phosphoenolpyruvate:sugar phosphotransferase system | |
AU2006200801A1 (en) | Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins | |
AU2006200800A1 (en) | Corynebacterium Glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins | |
EP1683859A2 (en) | Putative gene coding for Catechol 1,2-Dioxygenase from Corynebacterium glutamicum | |
AU2007202394A1 (en) | Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins | |
AU2006200795A1 (en) | Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport | |
AU2006252111A1 (en) | Corynebacterium glutamicum genes encoding metabolic pathway proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080227 |